
<html lang="en"     class="pb-page"  data-request-id="533023c3-23eb-45dd-a1c4-81a92c9696c6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01317"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives" /></meta><meta name="dc.Creator" content="Chunlin  Zhuang" /></meta><meta name="dc.Creator" content="Fener  Chen" /></meta><meta name="dc.Description" content="Necroptosis, an important form of programmed cell death (PCD), is a highly regulated caspase-independent type of cell death that plays a critical role in the pathophysiology of various inflammatory..." /></meta><meta name="Description" content="Necroptosis, an important form of programmed cell death (PCD), is a highly regulated caspase-independent type of cell death that plays a critical role in the pathophysiology of various inflammatory..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 17, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01317" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01317" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01317" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01317" /></link>
        
    
    

<title>Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01317" /></meta><meta property="og:title" content="Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0021.jpeg" /></meta><meta property="og:description" content="Necroptosis, an important form of programmed cell death (PCD), is a highly regulated caspase-independent type of cell death that plays a critical role in the pathophysiology of various inflammatory, infectious, and degenerative diseases. Currently, receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) have been widely recognized as critical therapeutic targets of the necroptotic machinery. Targeting RIPK1, RIPK3, and/or MLKL is a promising strategy for necroptosis-related diseases. Following the identification of the first RIPK1 inhibitor Nec-1 in 2005, the antinecroptosis field is attracting increasing research interest from multiple disciplines, including the biological and medicinal chemistry communities. Herein, we will review the functions of necroptosis in human diseases, as well as the related targets and representative small-molecule inhibitors, mainly focusing on research articles published during the past 10 years. Outlooks and perspectives on the associated challenges are also discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01317"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01317">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01317&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01317&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01317&amp;href=/doi/10.1021/acs.jmedchem.9b01317" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1490-1510</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01152" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01478" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chunlin Zhuang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunlin Zhuang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China</div><div class="loa-info-affiliations-info">Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>C.Z.: e-mail, <a href="/cdn-cgi/l/email-protection#3d475e51535c49555c537d0c0b0e135e5250"><span class="__cf_email__" data-cfemail="7f051c13111e0b171e113f4e494c511c1012">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunlin++Zhuang">Chunlin Zhuang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Fener Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fener Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China</div><div class="loa-info-affiliations-info">Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>F.C.: e-mail, <a href="/cdn-cgi/l/email-protection#2a584c49424f446a4c5f4e4b44044f4e5f044944"><span class="__cf_email__" data-cfemail="522034313a373c12342736333c7c3736277c313c">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fener++Chen">Fener Chen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6734-3388" title="Orcid link">http://orcid.org/0000-0002-6734-3388</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01317&amp;href=/doi/10.1021%2Facs.jmedchem.9b01317" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1490–1510</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 17, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 August 2019</li><li><span class="item_label"><b>Published</b> online</span>17 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01317" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01317</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1490%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChunlin%2BZhuang%252C%2BFener%2BChen%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D4%26contentID%3Dacs.jmedchem.9b01317%26title%3DSmall-Molecule%2BInhibitors%2Bof%2BNecroptosis%253A%2BCurrent%2BStatus%2Band%2BPerspectives%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1510%26publicationDate%3DFebruary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01317"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3228</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01317" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chunlin&quot;,&quot;last_name&quot;:&quot;Zhuang&quot;},{&quot;first_name&quot;:&quot;Fener&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1490-1510&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01317&quot;},&quot;abstract&quot;:&quot;Necroptosis, an important form of programmed cell death (PCD), is a highly regulated caspase-independent type of cell death that plays a critical role in the pathophysiology of various inflammatory, infectious, and degenerative diseases. Currently, receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) have been widely recognized as critical therapeutic targets of the necroptotic machinery. Targeting RIPK1, RIPK3, and/or MLKL is a promising strategy for necroptosis-related diseases. Following the identification of the first RIPK1 inhibitor Nec-1 in 2005, the antinecroptosis field is attracting increasing research interest from multiple disciplines, including the biological and medicinal chemistry communities. Herein, we will review the functions of necroptosis in human diseases, as well as the related targets and representative small-molecule inhibitors, mainly focusing on research articles published during the past 10 years. Outlooks and perspectives on the &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01317&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01317" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01317&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01317" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01317&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01317" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01317&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01317&amp;href=/doi/10.1021/acs.jmedchem.9b01317" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01317" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01317" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01317%26sid%3Dliteratum%253Aachs%26pmid%3D31622096%26genre%3Darticle%26aulast%3DZhuang%26date%3D2020%26atitle%3DSmall-Molecule%2BInhibitors%2Bof%2BNecroptosis%253A%2BCurrent%2BStatus%2Band%2BPerspectives%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D4%26spage%3D1490%26epage%3D1510%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/jmcmar.2020.63.issue-4/20200227/jmcmar.2020.63.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Necroptosis, an important form of programmed cell death (PCD), is a highly regulated caspase-independent type of cell death that plays a critical role in the pathophysiology of various inflammatory, infectious, and degenerative diseases. Currently, receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) have been widely recognized as critical therapeutic targets of the necroptotic machinery. Targeting RIPK1, RIPK3, and/or MLKL is a promising strategy for necroptosis-related diseases. Following the identification of the first RIPK1 inhibitor Nec-1 in 2005, the antinecroptosis field is attracting increasing research interest from multiple disciplines, including the biological and medicinal chemistry communities. Herein, we will review the functions of necroptosis in human diseases, as well as the related targets and representative small-molecule inhibitors, mainly focusing on research articles published during the past 10 years. Outlooks and perspectives on the associated challenges are also discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">This Perspective was published ASAP on October 31, 2019. Structure <b>48</b> in Figure 12 and the second-to-last sentence in section 2.1.4. have been updated. The corrected version was reposted on November 20, 2019.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Necroptosis Is an Important Form of Programmed Cell Death</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis had long been recognized as the only form of programmed cell death (PCD).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An intact plasma membrane with blebbing is considered to be a morphological hallmark of apoptotic cell death.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Apoptosis is a caspase-dependent noninflammatory form of cell death.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> In contrast to apoptosis, necrosis was considered a form of accidental cell death (ACD) triggered by physical stresses that functioned in a distinct manner for a long time.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> In 1988, Laster et al. reported that tumor necrosis factor (TNF) caused not only apoptosis but also a “balloon-like” plasma membrane boiling form of necrosis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Vercammen et al. found that caspase inhibition favored TNF-induced necrosis in murine L929 cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These researchers both provided important evidence of nonaccidental programmed necrosis. In the past 30 years, increasing numbers of studies have led to the disclosure that a subset of necrosis, namely, necroptosis, as first described by Yuan et al.,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> is an important form of PCD. Morphologically, this process is similar to necrosis, showing swelling, ruptured plasma membrane, moderate chromatin condensation, loss of intracellular content, and finally cell lysis.<a onclick="showRef(event, 'ref5 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref9">(5,9)</a> For morphological images of apoptosis and necroptosis, a well-reviewed paper by Han et al. should be referenced.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Necroptosis is now defined as a death-receptor-mediated caspase-independent cell death that triggers inflammation.<a onclick="showRef(event, 'ref3 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11 ref12">(3,10−12)</a> The stimulus can be TNF superfamily members, CD95 (FAS), Toll-like receptors 3/4 (TLR3/4), and interferons (IFNs). The TNFα-induced necroptotic mechanism is the best-characterized process to date (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> The homotrimerization of TNF receptor 1 (TNFR1) triggered by TNFα results in the formation of a membrane-signaling complex, namely, complex I, which consists of TNFR1-associated death domain protein (TRADD), TNF receptor 2 (TRAF2), cellular inhibitor of apoptosis proteins 1/2 (cIAP1/2), and receptor-interacting protein kinase 1 (RIPK1).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Complex I could lead to the activation of prosurvival NF-κB pathway. Under these circumstances, RIPK1 is ubiquitylated by E3 ligases and cIAP1/2, subsequently leading to the activation of NF-κB and cell survival.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> If the ubiquitination of RIPK1 is prevented by inhibition of cIAP1/2 using second mitochondria-derived activator of caspase (SMAC) or SMAC mimetic chemicals, complex I is released and forms cytoplasmic complex II by recruiting Fas-associated death domain protein (FADD), which mediates the activation of caspase 8.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Then, apoptosis is in turn triggered by the activation of downstream caspases, such as caspase 3.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> The necrosome containing RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL) is formed in the absence of caspase 8, and the death signals are switched from apoptotic to necrotic. The inhibition of caspase 8 is commonly achieved by z-Val-Ala-Asp-(OMe)-fluoromethyl ketone (z-VAD-FMK).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Then, the recruited MLKL in necrosomes is phosphorylated by RIPK3, leading to its oligomerization and plasma membrane localization, which is essential for the rupture of the plasma membrane.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> However, the exact mechanism of plasma membrane rupture has not been fully elucidated and needs further investigation.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> The activation of calcium or sodium cation channels and the ion flow to enhance cellular osmotic pressure<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> or direct breakdown of the plasma membrane by pore structures of MLKL<a onclick="showRef(event, 'ref26 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref28">(26,28)</a> were both reported. Finally, damage-associated molecular patterns (DAMPs) in the cytosol are released through the ruptured plasma membrane, leading to inflammation and organ injury.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular mechanism of TNFα-triggered apoptosis and necroptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive studies have demonstrated that RIPK1, RIPK3, and MLKL are potential therapeutic targets of necroptosis.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33−36)</a> In 2000, a pioneering work by Tschopp et al. reported that RIPK1 was required for necrotic death induced by TNF or TNF-related apoptosis-inducing ligand (TRAIL).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In 2005, Yuan et al. reported the first definition of “necroptosis” and the identification of necrostatins as necroptosis inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which were later shown to target RIPK1, identifying the role of RIPK1 as a key mediator of necroptosis.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The discovery of RIPK3 as an essential regulator of TNF-induced necrosis is a key step in disclosing the necroptosis pathway.<a onclick="showRef(event, 'ref33 ref34 ref38'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref38">(33,34,38)</a> Wang et al. reported that RIPK3 knockout mice were resistant to necrosis and devoid of inflammation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A similar study reported that RIPK3 knockout made the mice severely impaired with virus-induced tissue necrosis, inflammation, and control of viral replication.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Wang et al. reported a chemical probe that blocked necrosis downstream of RIPK3 activation, which was identified to target MLKL (see <a class="ref internalNav" href="#sec2_3" aria-label="section 2.3">section 2.3</a>), a key mediator of necrosis signaling downstream of RIPK3.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This result was confirmed by Liu et al. through screening a kinase/phosphatase shRNA library in human colon adenocarcinoma HT-29 cells.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p last">Strong evidence has suggested that necroptosis has a crucial role in the pathogenesis of various diseases,<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a> such as ischemia–reperfusion injury,<a onclick="showRef(event, 'ref8 ref42'); return false;" href="javascript:void(0);" class="ref ref8 ref42">(8,42)</a> neurodegenerative diseases (e.g., amyotrophic lateral sclerosis, ALS; Alzheimer’s disease, AD),<a onclick="showRef(event, 'ref40 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref40 ref43 ref44 ref45 ref46">(40,43−46)</a> inflammatory diseases (e.g., colitis, pancreatitis, skin inflammation),<a onclick="showRef(event, 'ref31 ref32 ref39 ref47'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref39 ref47">(31,32,39,47)</a> infectious diseases (e.g., viral infection, bacterial infection),<a onclick="showRef(event, 'ref14 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref14 ref48 ref49">(14,48,49)</a> hepatic and kidney damages,<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> and tumor metastasis.<a onclick="showRef(event, 'ref12 ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref12 ref52 ref53 ref54 ref55">(12,52−55)</a> Therefore, the discovery of necroptosis inhibitors will be important for necroptosis-associated diseases and will undoubtedly have broad clinical relevance.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Discovery of Necroptosis Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of the human physiological process of necroptosis, a general cell-based necroptosis model has been widely used for drug screening.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Necrosomes are generated by TNFα or other cytokines, triggering cell death, while SMAC mimetics (commonly SM-164, BV6, or birinapant) inhibit cIAPs<a onclick="showRef(event, 'ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59 ref60 ref61">(57−61)</a> and z-VAD-FMK blocks the activation of caspase 8. This is known as the TSZ (TNFα-SMAC-z-VAD-FMK)-induced human necroptotic cell model.<a onclick="showRef(event, 'ref32 ref34 ref62'); return false;" href="javascript:void(0);" class="ref ref32 ref34 ref62">(32,34,62)</a> This cell model has been used for the discovery of novel necroptosis inhibitors in the following four directions: (1) the discovery of novel active compounds by modern medicinal strategies; (2) drug repurposing of approved drugs; (3) screening of commercial compound libraries and structural optimizations; (4) analysis of natural products. To date, many active compounds have been identified by targeting the key components of necroptosis, RIPK1, RIPK3, and/or MLKL.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  RIPK1 Inhibitors</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.1.1.  Tryptophan Series</h4><div class="NLM_p">The discovery of compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), named necrostatin-1 (abbreviated as Nec-1), was a significant milestone in necroptosis research. In 2005, Yuan et al. first reported that <b>1</b> bearing a methyl-thiohydantoin-tryptophan (MTH-Trp) scaffold exhibited an EC<sub>50</sub> of 490 nM against necroptosis by screening a chemical library of ∼15 000 compounds (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Medicinal chemistry analysis later determined the structure–activity relationship (SAR) of Nec-1.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Compound <b>2</b>, without the methyl group on the thiohydantoin, lost the antinecroptosis activity, and nonbranched alkyl groups were suitable at this position. Introducing a chloride to the 7-position of the indole (compound <b>3</b>) improved the activity to an EC<sub>50</sub> of 180 nM. As sulfur limited the metabolic stability of Nec-1 (<i>t</i><sub>1/2</sub> < 5 min in a mouse microsomal assay),<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> replacement of the sulfur on the thiohydantoin by oxygen for compound <b>4</b>, namely, Nec-1s, maintained the antinecroptotic activity (EC<sub>50</sub> = 210 nM). Removal of a carbonyl group to give either a cyclic urea or a carbamate resulted in complete loss of activity. The <i>R</i>-enantiomer (EC<sub>50</sub> = 50 nM) was found to be approximately 4-fold more active than the <i>S</i>-enantiomer (EC<sub>50</sub> = 230 nM), indicating the importance of the chiral center. The metabolic stability of <b>4</b> showed a robust improvement with a <i>t</i><sub>1/2</sub> of approximately 60 min in the liver microsomal assay and an in vivo pharmacokinetics (PK) study.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Compound <b>4</b> also delayed mouse ischemic brain injury by blocking necroptosis in a dose-dependent manner, providing a novel mechanism for these human pathologies.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure optimization workflow of Nec-1 series compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2008, Yuan et al. provided definitive evidence for RIPK1 as the target of <b>1</b> and its improved analogue <b>4</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The binding mode of Nec with RIPK1 was predicted by homology modeling using B-Raf as the template, which had a very similar conformation to the RIPK1 activation segment. Researchers predicted that the Nec series of inhibitors may target the inactive DLG (Asp-Leu-Gly)-out state of RIPK1. Shi et al. subsequently reported the crystal structures of RIPK1 with Nec-1s and determined the inhibitory constant of <b>4</b> (IC<sub>50</sub> = 0.32 μM).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> On the basis of the X-ray complex (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), RIPK1 exhibited a canonical kinase fold with a C-lobe, an N-lobe, and an activation loop (highlighted in green). The αC-helix in RIPK1 was rotated by approximately 40° compared with that of the catalytic subunit of protein kinase A (PKA; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CPK">2CPK</a>), and the vacated space was partially occupied by the activation loop and inhibitor <b>4</b>, locking RIPK1 in an inactive conformation.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> Compound <b>4</b> was bound between the lobes near the activation loop and did not interact with the kinase hinge loop, occupying an allosteric lipophilic pocket at the back of the ATP binding site in a type III binding mode. Three specific hydrogen-bonding interactions were observed to anchor the orientation of <b>4</b> in the greasy pocket of RIPK1. The interaction between the indole nitrogen atom and the hydroxyl oxygen of S161 on the activation loop was critical to the activity and was confirmed by mutation of S161 to A161 or E161, which led to a 4- or 10-fold decrease in the inhibition. The carbonyl oxygen of V76 and the amide nitrogen of D156 with the five-membered ring of <b>4</b> formed two hydrogen bonds. In addition, the indole moiety of <b>4</b> interacted with M67, L70, V75, L129, V134, and H136 by van der Waals contacts, and the five-membered hydantoin hydrophobically interacted with V76, L78, L90, M92, L157, L159, and F162 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The structural analysis provided an explanation for the SAR and offered insights into potential structure-based drug design (SBDD).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of RIPK1 and <b>4</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITH">4ITH</a>): (A) perpendicular view; (B) close-up view. The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The specificity of the therapeutic target is always a critical issue for kinase-targeting small molecules. From a chemical point of view, the MTH-Trp scaffold of compound <b>1</b> has potential inhibitory effects on the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) (IC<sub>50</sub> ≈ 100 μM).<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> The IDO enzymatic assay showed that both compounds <b>1</b> and <b>2</b> inhibited human IDO with EC<sub>50</sub> values of ∼110 nM, while <b>4</b> did not inhibit the enzyme at 2000 nM.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In addition, compound <b>4</b> displayed >1000-fold selectivity toward RIPK1 in a screen of 485 human kinases.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>2</b>, the inactive analogue of <b>1</b> and <b>4</b>, still inhibited TNF-induced necroptosis in mouse cells and an in vivo mouse model.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> This observation, to some extent, may reflect species specificity of <b>2</b>. Vandenabeele et al. proposed that <b>2</b> might be converted to a Nec-1-like inhibitory compound by methylation of the thiohydantoin moiety in some cells or even in vivo.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> However, why compound <b>2</b> displays this activity is still not clear. Therefore, compound <b>2</b> cannot be used alone as a tool compound to exclude nonspecific off-target effects.</div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">2.1.2.  Benzoxazepinone Series</h4><div class="NLM_p">In recent years, DNA-encoded library (DEL) screening has been used as a modern robust tool for hit generation in the pharmaceutical industry.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> GlaxoSmithKline (GSK) utilized their prioritized DEL library to identify novel RIPK1 inhibitor chemotypes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> Benzo[<i>b</i>][1,4]xazepin-4-one (<b>5</b>) was found to be potent in both a fluorescence polarization (FP) binding assay and an ADP-Glo functional biochemical assay. The chiral amine of benzoxazepinone was determined to have an effect on the activity. The <i>S</i> enantiomer blocked human monocytic U937 necrotic cell death with an IC<sub>50</sub> of 200 nM, while the <i>R</i> enantiomer was completely inactive at 10 μM. The results indicated that this molecule was an excellent starting point for optimization due to the good enzymatic and cellular activities and acceptable oral PK profiles (AUC = 2.2 μg·h/mL, <i>C</i><sub>max</sub> = 810 ng/mL, <i>t</i><sub>1/2</sub> = 2.9 h at a dose of 2 mg/kg). Then, methylation at the NH of benzoxazepinone yielded compound <b>6</b> (also known as GSK’481), which showed a 3- or 10-fold increase in the biochemical activity against RIPK1 and excellent translation in the U937 cellular assay with an IC<sub>50</sub> of 10 nM. For the target specificity, <b>6</b> had a >7500-fold selectivity window at a concentration of 10 μM against 318 kinases of the Reaction Biology Corporation and 456 kinases of DiscoveRx KINOMEscan. However, <b>6</b> exhibited low oral exposure (AUC<sub>0–∞</sub> = 0.38 μg·h/mL at 2 mg/kg), high clearance (69 mL min<sup>–1</sup> kg<sup>–1</sup>), and high volume of distribution (8.5 L/kg) in rats and was thus probably not suitable for in vivo analysis.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Then, the in vivo efficacy was determined for the potent analogue benzodiazepinone <b>7</b> (IC<sub>50,ADP-Glo,RIPK1</sub> = 0.79 nM), which showed 82% protection at 50 mg/kg against TNF-induced mouse lethal shock and a rat oral bioavailability of 75%.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure optimization workflow of benzoxazepine RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Before determination of the binding mode of compound <b>6</b> with RIPK1 by cocrystallization, two photolabeling probes were generated by introducing a photolabile trifluoromethyldiazirine moiety at the benzyl ring (<b>8</b>, IC<sub>50,FP,RIPK1</sub> = 35 nM) and the 7-position of the benzazepinone heterocycle (<b>9</b>, IC<sub>50,FP,RIPK1</sub> = 210 nM). MS/MS sequencing revealed that these molecules labeled the activation-loop residue S161 and the glycine-rich-loop residue F28, respectively, with photoactivation, indicating the potential binding profile as a nonhinge binding kinase inhibitor. This finding was further confirmed by the X-ray structure of the RIPK1 kinase domain with <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The molecule was deeply buried in the pocket between the C-lobe and N-lobe, and no interactions with the hinge residues were observed, confirming the type III binding mode of compound <b>6</b>. The benzyl group of <b>6</b> occupied the same allosteric lipophilic pocket at the back of the ATP binding site as inhibitor <b>4</b> surrounded by the D156, S161, and F162 residues. A key hydrogen-bonding interaction was formed by the amide carbonyl with the backbone amide NH of D156. The SAR study indicated that the benzoxazepinone group had a narrow window for optimizations.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> (1) Replacement of the <i>N</i>-methyl substituent with an ethyl or cyclopropyl group led to a dramatic loss in potency, as it was located at a small pocket on the face of the β-sheet defined by L90 and I43 residues. (2) The <i>S</i> chiral center was important for binding as it orientates the molecule in the activation loop. Increasing the molecule size using a methyl at the chiral center was not tolerated. (3) Methylation of the exocyclic NH or removal of the benzoxazepinone carbonyl led to complete loss of activity. (4) Expanding or contracting the lactam to an eight-membered ring or a quinolinone resulted in a loss of potency. (5) The benzoxazepinone moiety occupied a tight pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), indicating a negative effect in altering the oxazepinone conformation. The benzo was an essential group because removal or saturation of the benzo resulted in inactive analogues. Substitutions at the aryl ring were tolerated. (6) The benzyl group was located in an allosteric hydrophobic pocket at the back of the ATP binding site, showing a quite narrow site for optimization. Only fluorine was tolerant at the phenyl ring; removal of the phenyl group and replacement of phenyl with <i>n</i>-butyl, isopropyl, or cyclohexyl groups had negative effects on the activity. (7) The isoxazole heterocycle had a significant effect on potency.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal complexes of RIPK1 with (A) <b>6</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HX6">5HX6</a>), (B) <b>10</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TX5">5TX5</a>), (C) <b>11</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RLN">6RLN</a>), (D) <b>12</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C3E">6C3E</a>), (E) <b>14</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C4D">6C4D</a>), and (F) <b>15</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NW2">6NW2</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>10</b> (also known as GSK2982772) with 1,2,4-triazoles possessed an optimal combination of in vitro potency (IC<sub>50,ADP-Glo,RIPK1</sub> = 1.0 nM), low lipophilicity (log <i>D</i> = 3.8), good solubility (∼450 μM at pH 7.4), and rat oral exposure (AUC<sub>0–∞</sub> = 2.3 μg·h/mL at 2 mg/kg). Similar to compound <b>6</b>, compound <b>10</b> bound deeply in the pocket in close proximity to the activation loop in the type III binding mode (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), giving an explanation of the improved RIPK1 binding activity. The amide carbonyl attached to the triazole formed a direct hydrogen-bonding interaction with the backbone amide NH of D156. A water-mediated hydrogen bond was observed between the carbonyl oxygen of M67 and the triazole nitrogen. With this nonhinge binding mode, compound <b>10</b> at a concentration of 10 μM showed a >10 000-fold target specificity based on the RIPK1 ADP-Glo potency of 1 nM against 318 kinases of the Reaction Biology Corporation and 456 kinases of DiscoveRx KINOMEscan. In a mouse TNF-induced shock model, 93% protection at 50 mg/kg and a good PK profile were observed across both rats and monkeys. Currently, this compound has been advanced to phase II trials in patients with chronic immunoinflammatory disorders, such as active ulcerative colitis (NCT02903966), psoriasis (NCT02776033), or moderate to severe rheumatoid arthritis (NCT02858492).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">GSK then developed compound <b>11</b> (named GSK3145095), which selectively targeted RIPK1 inhibitors (>1500-fold selectivity window), for the treatment of pancreatic cancer.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Given the metabolic demethylation of the <i>N</i>-methyl lactam, the methyl was removed, leading to a possible long hydrogen-bonding interaction with L90 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). The 9-fluorine of the benzazepinone occupied a small pocket between M92 and I43. This compound blocked necrotic death in both mouse fibrosarcoma L929 cells (IC<sub>50</sub> = 1.3 μM) and human U937 cells (IC<sub>50</sub> = 10 nM). A tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures was promoted by the inhibitor treatment, highlighting its potential as a novel cancer therapy. This molecule proceeded to be evaluated alone and in combination with other anticancer agents in phase I clinical evaluations for pancreatic adenocarcinoma and other advanced solid tumors (NCT03681951).</div><div class="NLM_p">Takeda Pharmaceutical developed a series of brain-penetrating RIPK1 inhibitors on the basis of a benzoxazepinone scaffold and the initially identified RIPK1 inhibitor <b>12</b> (<i>K</i><sub>i</sub> = 63 nM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The X-ray structure revealed that <b>12</b> occupied an allosteric lipophilic pocket at the back of the ATP binding site, did not bind with the hinge region, and interacted with D156 by a hydrogen bond, indicating a very similar binding location to the five-membered heteroaromatic ring of <b>10</b> and <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Compound <b>13</b> was then obtained by hybridization of these two compounds at the central core structure. The P-gp-mediated efflux (ER = 1.9) was improved compared with that of <b>10</b> (ER = 3.1), likely due to the decreased topological polar surface area (TPSA) and the number of hydrogen-bonding donors (HBDs). Further optimizations focused on improving the metabolic stability and blocking the HBD by the SBDD strategy. Compound <b>14</b> possessed highly potent activity in vitro (hRIPK1, <i>K</i><sub>i</sub> = 0.91 nM). This compound bound to RIPK1 in a type III kinase inhibitor mode (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E), leading to a high target specificity against 406 kinases. The new core structure maintained the hydrogen-bonding interaction with D156, and the chloride presumably interacted with M67 by a halogen bond, resulting in the improvement of the binding affinity. In addition, this molecule suppressed necroptotic cell death in both mouse and human cells, possessed good brain-penetrating effects (ER = 0.6) and brain exposure (<i>C</i><sub>b,u</sub> = 0.0230 μg/g), showed metabolic stability in human (<1 μL min<sup>–1</sup> mg<sup>–1</sup>) and mouse (<1 μL min<sup>–1</sup> mg<sup>–1</sup>) liver microsomes and was also effective in an experimental autoimmune encephalomyelitis (EAE) mouse model.</div><div class="NLM_p">Genentech recently reported a series of benzoxazepinone analogues with bicyclic heterocycles replacing an aromatic back pocket group.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Among them, compound <b>15</b> showed promising RIPK1 inhibitory activity (<i>K</i><sub>i</sub><sup>app</sup> = 16 nM) and antinecroptotic activity (EC<sub>50,HT-29cell</sub> = 130 nM). The X-ray complex revealed that <b>15</b> bound to RIPK1 in a similar type III kinase inhibitor mode and that the methyl occupied a similar space as the phenyl ring of <b>6</b>, suggesting a space for optimization to better fill the pocket. Compound <b>16</b> with pentafluoroethyl azaindazole exhibited a <i>K</i><sub>i</sub><sup>app</sup> of 6 nM against RIPK1 and excellent monokinase selectivity with no observed inhibition of >30% at 10 μM against the 219 human kinase panel of Thermo Fisher. The antinecroptotic activity was improved to an EC<sub>50</sub> of 54 nM, and the metabolic stability in human (11 mL min<sup>–1</sup> kg<sup>–1</sup>) and rat (14 mL min<sup>–1</sup> kg<sup>–1</sup>) liver microsomes was acceptable. This molecule exhibited low clearance (7.1 mL min<sup>–1</sup> kg<sup>–1</sup>), a moderate volume of distribution (2.8 L/kg), and an oral bioavailability of 63% in rats, encouraging further evaluations. Compound <b>17</b> (also known as GNE684) is another bicyclic benzoxazepinone analogue released by Genentech (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> This compound bound to RIPK1 in a similar ATP back pocket and formed two hydrogen-bonding interactions with D156. Furthermore, the molecule was a potent cross-species RIPK1 inhibitor (<i>K</i><sub>i</sub><sup>app</sup>, human = 21 nM, mouse = 189 nM, rat = 691 nM) and inhibited TNF-induced necroptosis in human HT-29 (EC<sub>50</sub> = 6.6 nM), mouse L929 (EC<sub>50</sub> = 81 nM), and rat H9c2 (EC<sub>50</sub> = 154 nM) cells. The compound showed 100% protection at 5 mg/kg against a TNF-induced systemic inflammatory response syndrome (SIRS) mouse model. In addition, it effectively reduced collagen antibody-induced arthritis and prevented skin inflammation caused by mutation of <i>Sharpin</i> or colitis caused by deletion of Nemo from intestinal epithelial cells. However, this molecule did not block tumor growth or death in Kras mutant pancreatic tumor models and did not reduce lung metastases in a B16 melanoma model.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of <b>17</b> and the cocrystal complex with RIPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NYH">6NYH</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.1.3.  Dihydropyrazole Series</h4><div class="NLM_p">In 2015, GSK reported a novel chemotype of dihydropyrazoles by hybridization of two high-throughput screen (HTS) hits <b>18</b> and <b>19</b>, which possessed submicromolar activity in both a RIPK1 FP binding assay and a U937 necroptosis assay (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77,78)</a> The racemic hybrid <b>20</b> significantly improved the activity in the nanomolar range. The activity was stereochemical-dependent. The <i>S</i> enantiomer <b>21</b> (named GSK’963) was the active form, while compound <b>22</b> (named GSK’962), the <i>R</i> enantiomer of <b>20</b>, was completely inactive at 10 μM. Compound <b>21</b> (2 mg/kg, ip) completely inhibited temperature-related loss in response to TNF+zVAD. However, high systematic clearance and low oral exposure in rats (2 mg/kg) were below the limit of detection. For the RIPK1 specificity, <b>21</b> showed no additional activity at 10 μM against the 339 kinases of the Reaction Biology Corporation, suggesting a type III binding mode.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structure optimization workflow of dihydropyrazole RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An initial crystal structure was determined for pyrrolidine analogue <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Analyses confirmed that <b>23</b> occupied the allosteric pocket in the back of the ATP binding site but did not interact with the kinase hinge region, and the pivaloyl carbonyl formed a hydrogen bond with D156. On the basis of the structural information and limitations of the lead compound <b>21</b>, an SAR study was performed focused on the dihydropyrazole, phenyl, and <i>tert</i>-butyl fragments.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> (1) Methyl introduction, reduction, or expansion of the dihydropyrazole ring or thiazoline or azetidine replacement showed decreased or complete loss of the RIPK1 inhibitory potency. (2) On the phenyl ring, small lipophilic groups such as methyl and fluoro were acceptable to maintain potency, but no improvements in clearance were observed (<i>t</i><sub>1/2</sub> < 10 min), while bulkier substitutions reduced the activity. Polar heterocycles and nonpolar cycle replacements of the phenyl ring decreased the potency. (3) On the basis of the binding mode of <b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A), the <i>tert</i>-butyl group pointed to the opening pocket between the N- and C-lobes, suggesting a space for optimization. Compound <b>24</b> with a <i>S</i>-<i>N</i>-acetylpiperidine group was both potent and stable in rat and human liver microsomes (<i>t</i><sub>1/2</sub> > 165 min) and showed 22, 43, and 96% protection orally at doses of 1.4, 14, and 140 mg/kg in the TNF/zVAD.fmk-injected mouse model. Further PK and efficacy optimizations identified <b>25</b> (also named GSK’547) and <b>26</b> with nitrogen-containing heterocycles, occupying the solvent-exposed space at the entrance to the active site pocket (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B), with good PK profiles in multiple species and satisfactory efficacy in mouse models of both multiple sclerosis and human retinitis pigmentosa. In addition, <b>25</b> was applied to determine the efficacy of the RIPK1 inhibitor against pancreatic ductal adenocarcinoma cancer (PDAC).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> When mice were treated with <b>25</b> and simultaneously challenged with Pdx1<sup>Cre</sup>, Kras<sup>G12D</sup>, Trp53<sup>R172H</sup> (KPC) mouse PDAC tumor cells, which highly expressed RIPK1, the tumor burden and liver metastases were reduced, and mouse survival was extended.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cocrystal complexes of RIPK1 with (A) <b>23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OCQ">6OCQ</a>) and (B) <b>26</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6R5F">6R5F</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.1.4.  Other RIPK1 Inhibitors Discovered by HTS or Repurposing</h4><div class="NLM_p">In 2017, Wang et al. performed a phenotypic screening of a 200 000-compound library in the TSZ-induced HT-29 necroptotic assay.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Compound <b>27</b> with a benzylamide scaffold was shown to block cell necroptotic death with an EC<sub>50</sub> of 4100 nM (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). A methylated analogue of <b>27</b> significantly improved the activity by 10-fold, and 2,3,5-trifluoro substitution on the phenyl ring (<b>28</b>) further improved the potency to 12 nM. However, the liver microsomal stability of <b>28</b> in humans (<i>t</i><sub>1/2</sub> = 2.25 min) and mice (<i>t</i><sub>1/2</sub> = 0.75 min) was extremely poor. Changing the methyl to a polar hydroxyl group obtained compound <b>29</b> (also named RIPA-56) with an EC<sub>50</sub> of 28 nM in HT-29 cells. This change significantly improved the liver microsomal stability to 128 min in humans and 35.5 min in mice. The binding target of <b>29</b> was confirmed to be RIPK1 (IC<sub>50</sub> = 13 nM). The compound was inactive against RIPK3 at 10 μM, and no inhibition against the Reaction Biology kinase panel at 2 μM was observed, identifying <b>29</b> as a type III kinase inhibitor. This compound showed 100% protection at 3 or 6 mg/kg ip in the SIRS mouse model and possessed good oral PK (<i>t</i><sub>1/2</sub> = 3.1 h, <i>F</i> = 22%). A follow-up study by the same group found that the male reproductive organs of wild-type mice blocked the signs of aging for approximately 5 months if the animals were fed food containing <b>29</b> prior to the onset of reproductive system aging (13 months), providing evidence for the relationship of necroptosis and male reproductive system aging.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure optimization workflow of benzylamide RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Repurposing clinically approved drugs or commercial active compound libraries is a widely used strategy in early-stage drug discovery for molecules with strong drug-like properties but lacking target selectivity.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Compounds <b>30</b>–<b>32</b>, as type II RIPK1 inhibitors, were identified by screening the GSK kinase inhibitor library (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> These molecules have three common structural features:<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> (1) a heterocycle to form hydrogen bonds with the kinase hinge (the fragments highlighted in blue); (2) an aryl moiety to occupy the allosteric hydrophobic pocket (e.g., the 2-F-4-CF<sub>3</sub>-phenyl group, <i>tert</i>-butylisoxazole); (3) an aryl urea or amide moiety as the linker of the above two parts. The 1-aminoisoquinoline compound <b>30</b> had IC<sub>50</sub> values of 16 nM (FP) and 10 nM (ADP-Glo) against RIPK1. In a TNF-zVAD.fmk-induced U937 cell model, this compound prevented necrotic cell death with an IC<sub>50</sub> of 630 nM. The crystal complex (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) confirmed the type II binding mode with a DLG-out inactive form of RIPK1, which was different from the inactive conformation observed for RIPK1 with compound <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) or other type III inihibitors.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The 1-aminoisoquinoline was a hinge binder forming hydrogen bonds with M95. The isoxazole heterocycle inserted deeply into the allosteric pocket, and hydrogen bonding interactions occurred between the urea and D156 and E63 to fix the conformation in the DLG motif. Compounds <b>31</b> and <b>32</b> with changes in the heterocyclic hinge binders both showed good RIPK1 and antinecroptosis activity. However, their kinase selectivity profile showed inhibition of several other kinases at 1 μM against a 300 kinase panel of the Reaction Biology Corporation.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of <b>30</b>–<b>36</b> and the cocrystal complex of <b>30</b> with RIPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NEU">4NEU</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2018, Yang et al. reported a similar series of RIPK1 inhibitors bearing the pyrrolopyrimidine amine scaffold by screening an in-house 20 000-compound library in a TSZ-induced HT-29 cell necroptosis model (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Compound <b>33</b> had promising antinecroptotic activity with an IC<sub>50</sub> of 1450 nM and RIPK1 inhibition with an IC<sub>50</sub> of 77 nM. Structural optimizations on the phenylamine, terminal phenyl, and heterocycle regions led to the most active compound, <b>34</b>, which inhibited RIPK1 with a binding affinity (<i>K</i><sub>D</sub>) of 4.4 nM and an enzymatic IC<sub>50</sub> value of 11 nM. This compound efficiently protected HT-29 cells from necroptosis with an IC<sub>50</sub> of 2 nM and potently protected U937, L929, and J774A.1 cells from necroptosis. Within the RIP kinase family, this compound had >1500-fold selectivity toward RIPK1 over RIPK2, RIPK3, and RIPK4. However, the target selectivity was not outstanding such that some other kinases were inhibited by <b>34</b> at 10 μM, which was the limitation of the type II kinase inhibitors. In addition, the compound could effectively inhibit tumor metastasis in a B16 melanoma cell intravenously injected lung metastasis mouse model with favorable PK properties.</div><div class="NLM_p">In 2019, from a library of ∼240 compounds, He et al. found compound <b>35</b> (PK6) as a novel necroptosis inhibitor with EC<sub>50</sub> values of 1200 nM against human HT-29 cells and 760 nM against murine L929 cells (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Structural optimizations led to <b>36</b> (PK68) containing structural features of sp<sup>3</sup> cyclohexane ring and an oxygen between the new ring and amide. The antinecroptotic activity was improved to 23 nM against human HT-29 cells and 13 nM against murine L929 cells. The in vitro kinase assays showed that <b>35</b> and <b>36</b> both effectively inhibited RIPK1 (IC<sub>50</sub> = 200 nM, 90 nM) but did not affect RIPK3 even up to 1000 nM. <b>36</b> strongly protected against TNFα-induced SIRS in vivo at the dose of 1 mg/kg, similar to the effect of <b>35</b> at 30 mg/kg. In addition, pretreatment of <b>36</b> significantly repressed metastasis of melanoma and lung carcinoma cells in mouse models. The PK profile was favorable with an oral bioavailability of 61%.</div><div class="NLM_p">In 2015, Superti-Furga et al. reported that a screening of 268 FDA-approved drugs in FADD-deficient Jurkat cells identified two BCR-Abl inhibitors, <b>37</b> (ponatinib) and <b>38</b> (pazopanib) to effectively block TNFα-induced necroptosis (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The antinecroptosis targets of <b>37</b> were further revealed by a chemical proteomic approach and validated to be RIPK1, RIPK3, and transforming growth factor-β-activated kinase 1 (TAK1) by multiple assays, while <b>38</b> preferentially targeted RIPK1. A similar result was reported earlier by Degterev et al., and they further improved the selectivity of <b>37</b> by hybridization with Nec-1.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The hinge binding heterocycle part was maintained, and allosteric RIPK1 binding of Nec-1 was introduced by different linkers, of which compound <b>39</b> (also named PN10) showed RIPK1 inhibition with an IC<sub>50</sub> of 90 nM and no inhibition toward RIPK3 and Abl at 10 μM.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of <b>37</b>–<b>43</b> identified by repurposing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Two PKR-like ER kinase (PERK) inhibitors, <b>40</b> (GSK’414) and <b>41</b> (GSK’157), were demonstrated to effectively inhibit TNF-mediated RIPK1-dependent death but did not affect PERK activity in cells.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Their antinecroptotic target was proposed to be RIPK1, and they were much more potent than compounds <b>4</b> and <b>21</b> in both in vitro cell death assays and in vivo TNF-induced SIRS mouse models. This study highlighted the risk of these “selective” PERK inhibitors, and more analogues are needed to obtain specificity for RIPK1 and PERK.</div><div class="NLM_p">In addition to the above type II or III RIPK1 inhibitors, compound <b>42</b> (tozasertib, VX-680), a type I Aurora kinase (AurK) inhibitor, was reported to have a good affinity against RIPK1 (IC<sub>50</sub> = 208 nM).<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> Structural optimizations led to compound <b>43</b>, maintaining RIPK1 inhibitory activity (IC<sub>50</sub> = 295 nM) and decreasing AurK activity 3- to 5-fold, with lower cytotoxicity and better anti-SIRS activity than those of <b>42</b>. The antinecroptosis binding target was confirmed by Meng et al. to be RIPK1. Pretreatment of <b>43</b> attenuated cisplatin-induced renal injury and necroptosis in an acute kidney injury mouse model.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Another pan-AurK inhibitor, CCT137690, was reported to induce necrosis-like death in PDAC cell lines through RIPK1, RIPK3, and MLKL.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Therefore, further investigations are required to determine the exact binding mode of AurK inhibitors with RIPK1, target specificity, and how it affects necroptosis.</div><div class="NLM_p">To expand the diversity and address the drug-like properties of the Nec-1 series, Yuan et al. reported other necrostatin compounds (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), such as <b>44</b> (Nec-3),<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a><b>45</b> (Nec-4),<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> and <b>46</b> (Nec-5),<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> with potent antinecroptotic activity targeting RIPK1.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The cocrystal complexes of RIPK1 with a Nec-3 analogue (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITI">4ITI</a>), <b>45</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITJ">4ITJ</a>), revealed a type III binding mode.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> However, follow-up studies on these novel necrostatins are lacking. Compound <b>47</b> was identified as a novel necroptosis inhibitor that prevented retinal degeneration by targeting RIPK1 and did not affect RIPK3.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Compound <b>48</b> from a noncommercial kinase-focused chemical library was identified to inhibit TNF-induced FADD-deficient Jurkat cell death.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> RIPK1 was shown to be among the top kinases targeted in a panel of 456 kinases, but other kinases, such as JAK2, PDGFRβ, KIT, and AURKC, were targeted as well, indicating a potential type II binding property. The compound could inhibit RIPK1-dependent necroptosis and apoptosis and protect mice from concanavalin A-induced hepatitis.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structures of <b>44</b>–<b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.1.5.  Fluorescent Probes for the RIPK1 Assay</h4><div class="NLM_p">Two fluorescence-based assays, FP and time-resolved fluorescence resonance energy transfer (TR-FRET), have been developed to determine RIPK1 binding affinity. GSK developed a fluorescently labeled ATP-competitive ligand for the FP assay to compete with a small molecule.<a onclick="showRef(event, 'ref71 ref72 ref77'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref77">(71,72,77)</a> Degterev et al. synthesized two fluorescein-labeled probes based on Nec-1 (compound <b>49</b>) and Nec-3 (compound <b>50</b>) for an HTS FP assay (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> In this assay, the tested DMSO was tolerated up to 5%, and <i>Z</i>′ scores for <b>49</b> and <b>50</b> were 0.62 and 0.57, respectively. Takeda Pharmaceutical developed the BODIPY probe <b>51</b> based on compound <b>32</b> for TR-FRET, which was useful to not only measure the binding affinity for RIPK1 but also determine the kinetic profiles of the target compounds.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of <b>49</b>–<b>51</b> as fluorescent probes. The fluorescent groups are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.2.  RIPK3 Inhibitors</h3><div class="NLM_p">On the basis of the mechanism of necroptosis, RIPK3 plays a central role in downstream necroptotic signal events and can signal necroptosis independent of RIPK1.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Thus, RIPK3 inhibitors have potential therapeutic relevance in multiple pathological conditions.</div><div class="NLM_p">In 2013, Kaiser et al. first identified three RIPK3 inhibitors from the GSK DEL compound library or other conventional small-molecule libraries by FP-binding and ADP-Glo kinase inhibition assays (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a> Compound <b>52</b> (GSK’840) was shown to have an FP binding IC<sub>50</sub> value of 0.9 nM as determined by the ATP-competitive fluorescent probe <b>55</b> (GSK’657), which was confirmed by an ADP-Glo RIPK3 kinase assay (IC<sub>50</sub> = 0.3 nM). Compounds <b>53</b> (GSK’843) and <b>54</b> (GSK’872) bound RIPK3 with FP IC<sub>50</sub> values of 8.6 nM and 1.8 nM and ADP-Glo kinase IC<sub>50</sub> values of 6.5 nM and 1.3 nM, respectively. These molecules also had decent kinase selectivity profiles against a 300-human kinase panel at 1 μM. In human HT-29 cell models, they could dose-dependently block TNF-induced necroptosis. Compounds <b>53</b> and <b>54</b> were also active in murine cells, but compound <b>52</b> was inactive in mouse cells. However, these compounds showed high cytotoxicity and induced RIPK3-dependent apoptosis, which represented a major challenge to the development of anti-inflammatory therapies targeting RIPK3. Green et al. reported <b>56</b> (GW’39B) as a RIPK3 inhibitor with an IC<sub>50</sub> of 73.6 nM from 8904 bioactive compounds.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This molecule could specifically block necroptosis in different cell lines, including SVEC, WT MEF, L929, HeLa, and HT-29 but not NIH-3T3 with RIPK3 lacking the RIP homotypic interaction motif (RHIM) domain. The compound did not block TNF-mediated apoptosis in L929 cells but potentially induced apoptosis. In 2018, Kim et al. discovered compound <b>57</b> (namely, HS-1371) as a potent RIPK3 inhibitor (IC<sub>50</sub> = 20.8 nM) from an in-house kinase-targeted chemical library.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> This compound was predicted to bind to the ATP binding pocket of RIPK3 and could protect cells from RIPK3-mediated necroptosis. However, the in vivo efficacy of these compounds has not been reported.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of <b>52</b>–<b>57</b> as RIPK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The drug-repurposing approach was also applied to discover that the B-Raf inhibitor <b>58</b> (dabrafenib) inhibited necroptosis by targeting RIPK3 with IC<sub>50</sub> values of 250 nM and 2 nM in the luminescent and radioactive assays and showed high selectivity toward RIPK1, RIPK2, and RIPK5 (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> This molecule inhibited RIPK3-dependent necrosis induced by acetaminophen in human hepatocytes. Importantly, <b>58</b> was first reported as a RIPK3 inhibitor to protect mice from hepatotoxicity. Another B-Raf inhibitor, <b>59</b> (sorafenib), a poor RIPK3 inhibitor (luminescent IC<sub>50</sub> = 14.52 μM), also targeted RIPK1 with an IC<sub>50</sub> of 1.5 μM and inhibited in vitro and in vivo necroptosis.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure optimization workflow of RIPK3 inhibitors from Raf inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, another pan-Raf inhibitor, <b>60</b> (TAK-632), was identified from an in-house fluorinated compound library generated by our group.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> This inhibitor was shown to specifically protect against necroptosis in human (HT-29, U937, THP-1) and mouse (L929, J774A.1) cells and did not protect cells from apoptosis. Target identification by drug affinity responsive target stability (DARTS) assays using <b>60</b> and a pull-down assay using the less potent biotinylated analogue <b>61</b> demonstrated that this inhibitor could bind with RIPK1 and RIPK3 and inhibit their kinase activity with IC<sub>50</sub> values of 480 nM and 105 nM, respectively. The results also showed 70% protection at 100 mg/kg and 25% protection at 25 mg/kg against a necroptosis-associated SIRS mouse model. Further SAR analysis led to analogue <b>62</b>, with only the cyano group removed, which exhibited ∼8-fold better antinecroptotic activity in human HT-29 cells (EC<sub>50</sub> = 170 nM) and ∼4-fold and ∼2-fold better in vitro RIPK1 (<i>K</i><sub>d</sub> = 97 nM) and RIPK3 (<i>K</i><sub>d</sub> = 77 nM) kinase inhibition than those of the parent compound.<a onclick="showRef(event, 'ref62 ref108'); return false;" href="javascript:void(0);" class="ref ref62 ref108">(62,108)</a> Although this molecule showed slight cytotoxicity (CC<sub>50</sub> = 36.50 μM), the in vivo anti-SIRS efficacy was markedly improved to 90% and 70% protection at low doses of 50 mg/kg and 25 mg/kg.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The SAR also indicated that the carbamide replacement of the amide group led to compound <b>63</b> with good antinecroptotic activity and high selectivity for RIPK3 (<i>K</i><sub>d</sub> = 81 nM) over RIPK1 (<i>K</i><sub>d</sub> > 5000 nM).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Consistent with the in vitro kinase assay, compound <b>63</b> blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells. Notably, 90% protection of mice from hypothermia and death was observed at a very low dose of 5 mg/kg, and a favorable and drug-like PK property was observed in rats with an oral bioavailability of 25%. However, the Raf inhibitory activity is still a major challenge of these compounds that requires further optimizations.</div><div class="NLM_p">Interestingly, the Raf inhibitors (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) were discovered to possess potential inhibitory activity against RIPK1/3. This finding was believed to result from their strong structural homology.<a onclick="showRef(event, 'ref64 ref106 ref109'); return false;" href="javascript:void(0);" class="ref ref64 ref106 ref109">(64,106,109)</a> In addition to the above-mentioned Raf inhibitors, Raf inhibitors such as AZ628, regorafenib, PLX4720, and vemurafenib were reported to inhibit RIPK3 activity with submicromolar IC<sub>50</sub> values, but GDC-0879 and SB590885 did not show this activity.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> However, these compounds, except <b>58</b>–<b>60</b>, did not rescue TSZ-induced cell death in human HT-29. Thus, more studies are required to investigate the relationships between the Raf and RIP family as well as the in vivo efficacy. Selective inhibitors of RIPK3 targeting the Raf-like compound <b>63</b> series may be useful in this aspect.</div><div class="NLM_p">Bristol-Myers Squibb identified a series of RIPK3 type II inhibitors by the HTS method (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Among the hits, compound <b>64</b>, a type II c-Met inhibitor, possessed RIPK3 inhibitory activity with an IC<sub>50</sub> of 180 nM and good selectivity toward RIPK1 (IC<sub>50</sub> = 1.5 μM) and RIPK2 (IC<sub>50</sub> > 15 μM). The cocrystal of murine RIPK3 with <b>64</b> revealed a DFG-out binding mode. The chemical structure of <b>64</b> was rigidified by locking the conformation of pyridone oxygen with the amide. The DFG motif was flipped to form a distal pocket to locate the pyridone and its substituent and form a hydrogen bond with the pyridone oxygen at D161. The azaindole core formed hydrogen-bonding interactions with M98 at the hinge. On the basis of the crystal complex, further linker and hinge binder optimizations led to compound <b>65</b> with increased kinase inhibitory activity and selectivity. The RIPK3 potency was improved to 9.1 nM, and c-Met activity was decreased to 1100 nM. However, the activity in human or murine cells and animal models has not been determined yet.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of <b>64</b>–<b>65</b> and the cocrystal complex of <b>64</b> with murine RIPK3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OKO">6OKO</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.3.  MLKL Inhibitors</h3><div class="NLM_p">Compound <b>66</b> (named NSA) was identified to block necroptosis in HT-29 cells by screening a chemical library of ∼200 000 compounds.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Biotinylated NSA pulled down human MLKL as the binding target and covalently modified the Michael acceptor at Cys86 (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). This compound was not active in mouse L929 fibrosarcoma cells because mouse MLKL lacked the corresponding cysteine residue, confirming the target of this compound. Further development of a drug candidate was limited due to the narrow SAR and moderate potency.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> In the same screening, Wang et al. investigated another hit compound, <b>67</b>, with good antinecroptosis activity in HT-29 cells (EC<sub>50</sub> = 390 nM).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> This compound did not block the phosphorylation of MLKL but blocked the binding of MLKL to NSA according to the binding competitive experiment. Then, the SAR study led to the highly potent analogue <b>68</b> (also termed TC13172, EC<sub>50</sub> = 2 nM) with the LC–MS/MS method showing that it covalently bound at Cys86 of MLKL as well. Similarly, this compound was not active in mouse or rat cells. In addition, high cytotoxicity is a major concern when using these covalent inhibitors.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of <b>66</b>–<b>71</b> as MLKL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Silke et al. identified compound <b>69</b> (GW806742X) against the recombinant mouse MLKL pseudokinase domain using a thermal stability shift assay of a library of 367 small molecules.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> This compound showed only a moderate binding affinity with MLKL (<i>K</i><sub>d</sub> = 9.3 μM) and blocked necroptosis in wild-type mouse dermal fibroblasts (MDFs) with an IC<sub>50</sub> < 50 nM. A subsequent study disclosed the binding affinity (K<sub>d</sub> = 116 nM) and crystal complex with human MLKL (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> The molecule bound to the ATP-binding site of MLKL, and the amino pyrimidine showed hydrogen-bonding interactions with C286 of the hinge. Hydrogen bonds of the sulfonamide with E293 and urea with G349 and E250 were observed, suggesting a type II binding mode (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>A). However, the compound had an obvious off-target effect against VEGFR2, RIPK1, and RIPK3 (highly nonselective in which 56 out of 403 kinases were inhibited at 1 μM),<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> indicating that MLKL might not be the on-target effect of necroptosis. For identification of compounds that bind to MLKL but not to RIPK1 or RIPK3, compounds <b>70</b> (named crizotinib) and <b>71</b> were identified.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Compound <b>70</b> inhibited MLKL (<i>K</i><sub>d</sub> = 210 nM) with 6- to 30-fold selectivity toward RIPK1 or RIPK3. Compound <b>71</b> was found to bind to MLKL with high selectivity and no inhibition against RIPK1 and RIPK3 at 30 μM. The cocrystal structure of <b>71</b> with the human MLKL pseudokinase domain showed a different binding mode compared with that of <b>69</b>, indicating a type I MLKL binder (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>B). The compound was located at the ATP binding pocket of MLKL and formed two hydrogen bonds with the hinge C286 and E284 residue. The 4-fluorophenyl formed stacking with R210, and the nonsubstituted phenyl pointed toward the GFE (G349-F350-E351) motif of MLKL but did not displace F350 from its pocket. However, <b>70</b> and <b>71</b> are limited due to their inactivity against necroptosis in FADD-deficient Jurkat cells. The above information seems reasonable to conclude that pseudokinase-ATP binding pocket may not be necessary for necroptotic activity of MLKL.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Cocrystal complexes of the human MLKL pseudokinase domain with (A) <b>69</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KNJ">5KNJ</a>) and (B) <b>71</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KO1">5KO1</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">3.  Necroptosis Inhibitors in Clinical Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, there are at least three necroptosis inhibitors in clinical trials. Compound <b>10</b> (GSK2982772) has been advanced into phase I trials (NCT02302404) to test the safety, tolerability, PK, RIPK1 target engagement, and exploratory pharmacodynamics (PD) of single (0.1–120 mg) and repeat (20 mg once daily [q.d.] to up to 120 mg twice daily [b.i.d.]) oral doses for up to 14 days in healthy male subjects.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The most common adverse effects were mild contact dermatitis and headache. No deaths or serious adverse effects were identified through vital signs or during physical examinations, neurological examinations, or respiratory assessments. An approximately linear PK was observed over doses up to 120 mg b.i.d. with no apparent accumulation upon repeat dosing. The RIPK1 target engagement achieved >90% over a 24 h period, and a concentration-dependent relationship between the drug candidate and target engagement was observed. No CYP3A4 induction following 14 days of dosing was detected. Phase I/II trials to determine the safety and tolerability, PK, PD, and its efficacy of repeat doses in subjects with moderate to severe rheumatoid arthritis (NCT02858492) and psoriasis (NCT02776033) have been completed, but the results have not been posted. Another phase I study to investigate the PK of modified release (MR) prototype-coated tablet formulations of GSK2982772 is recruiting healthy male and female subjects (NCT03649412). Compound <b>11</b> (GSK3145095) has been advanced to phase I/II trials alone and in combination with other anticancer agents, including pembrolizumab, in subjects with PDAC and other selected tumors (NCT03681951).</div><div class="NLM_p last">DNL747, a RIPK1 inhibitor with an undisclosed structure, was reported to show a brain to blood ratio of ∼0.8, which was significantly higher than a benchmark periphery-restricted RIPK1 inhibitor of ∼0.05.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Considering the activation of RIPK1 in human AD patient and AD mouse models,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> DNL747 has been advanced to a phase I trial to evaluate the safety, tolerability, PK, and PD of multiple oral doses in subjects with AD (NCT03757325) and ALS (NCT03757351). DNL758, a non-brain-penetrating RIPK1 inhibitor, is in preclinical evaluation for autoimmune diseases such as rheumatoid arthritis and psoriasis.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">4.  Outlook and Future Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The RIPK family contains seven members (RIPK1–7), among which RIPK1, RIPK2, and RIPK3 are largely superimposable with subtle differences in their pharmacologic specificity.<a onclick="showRef(event, 'ref116 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref116 ref117 ref118">(116−118)</a> RIPK1 is the only member of the RIPK family with a C-terminal domain that recruits RIPK1 to signaling complexes to initiate different pathways, including necroptosis, apoptosis, and inflammation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref117 ref119'); return false;" href="javascript:void(0);" class="ref ref117 ref119">(117,119)</a> Thus, in recent years, RIPK1 has become an important target for drug development not only in the pharmaceutical industry but also in academic research due to its key roles in TNF signaling responses and its highly amenable kinase structure. The type III RIPK1 inhibitors are uniquely selective toward RIPK1.<a onclick="showRef(event, 'ref116 ref118'); return false;" href="javascript:void(0);" class="ref ref116 ref118">(116,118)</a> The GSK benzoxazepinone and dihydropyrazole compounds showed high selectivity for targeting RIPK1 in the treatment of multiple human diseases in clinical trials.<a onclick="showRef(event, 'ref71 ref72 ref74 ref75 ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref74 ref75 ref76 ref77 ref78">(71,72,74−78)</a> Compounds <b>1</b> (Nec-1) and <b>4</b> (Nec-1s) have been widely used to define the role of necroptosis and RIPK1 in a few human disease animal models.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> However, the application of Nec compounds is limited by the moderate potency, stability, and potential off-target effect against IDO.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> Nec-1 only inhibited necroptosis in RIPK1-expressing cells but was inactive against RIPK1-independent necroptosis.<a onclick="showRef(event, 'ref68 ref121'); return false;" href="javascript:void(0);" class="ref ref68 ref121">(68,121)</a> Compound <b>60</b> (TAK-632), a RIPK1 and RIPK3 dual-targeting agent, inhibited RIPK1-independent necroptosis induced by Poly(I:C) plus z-VAD-FMK in RIPK1<sup>–/–</sup> MEF cells.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Mechanistically, RIPK3 can induce necroptosis without RIPK1 in some cases, and in these cases, RIPK1 inhibitors will not work.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Thus, selectively targeting RIPK3 has recently attracted attention in the development of inhibitors. However, two concerns are raised in these reported RIPK3 inhibitors. (i) Most of the RIPK3 inhibitors, such as <b>52</b>–<b>54</b> and <b>56</b>, were shown to induce RIPK1-dependent apoptosis.<a onclick="showRef(event, 'ref103 ref122'); return false;" href="javascript:void(0);" class="ref ref103 ref122">(103,122)</a> (ii) The RIPK family members, especially RIPK2, were reported to be targeted by some RIPK3 inhibitors.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> For instance, <b>37</b> (ponatinib) and <b>58</b> (dabrafenib) were shown to be potent inhibitors of RIPK2.<a onclick="showRef(event, 'ref87 ref106'); return false;" href="javascript:void(0);" class="ref ref87 ref106">(87,106)</a> RIPK2 regulates proinflammatory signaling as a part of nucleotide-binding oligomerization domain (NOD) signaling.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> A series of RIPK3 type II inhibitors (e.g., compound <b>65</b>) abolished the RIPK2 activity. However, the developability profiles of the type II kinase inhibitors were challenging due to high molecular weight, high lipophilicity, low aqueous solubility, and a range of off-target kinase activities. Generally, a drug repurposing strategy screened compounds and potentially led to off-target effects, such as pan-Raf inhibitors,<a onclick="showRef(event, 'ref62 ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref62 ref106 ref107 ref108">(62,106−108)</a> pan-AurK inhibitors,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> PERK inhibitors,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> BCR-Abl inhibitors,<a onclick="showRef(event, 'ref57 ref87'); return false;" href="javascript:void(0);" class="ref ref57 ref87">(57,87)</a> which nonselectively inhibited necroptotic targets. Thus, the target selectivity of necroptosis inhibitors, including that for the whole kinome and RIPK family, must be taken into consideration in the current stage.</div><div class="NLM_p">Many studies have determined the role of necroptosis in various diseases, especially inflammatory-related diseases.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, the rationale for targeting RIPK1 in cancer, especially pancreatic cancer, is still questionable. Different studies have examined the relationship between necroptosis and tumor metastasis. Yang et al. reported a series of type II RIPK1 inhibitors with the pyrrolopyrimidine amine scaffold (e.g., <b>33</b>, <b>34</b>) possessing inhibitory activity against tumor metastasis in a B16 melanoma cell intravenously injected lung metastasis mouse model.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> GSK reported the RIPK1 inhibitor dihydropyrazole analogue <b>25</b> inhibiting PDAC in KPC mice.<a onclick="showRef(event, 'ref77 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref79">(77,79)</a> Another mechanistic study also revealed that the necrosome promoted the progression of pancreatic cancer via CXCL1 and Mincle-induced immune suppression.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> However, a research result from Genentech reported an absolutely different result in which RIPK1 inhibition by small molecules did not block tumor growth or metastases.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The Genentech researchers applied two RIPK1 inhibitors, <b>4</b> (Nec-1s) and <b>17</b> (GNE684), in two autochthonous Kras mutant PDAC models (KPP and KPR) and observed no impact on overall survival or tumor growth and no reduction of lung metastases in a B16 melanoma model. However, pancreatic tumor cell implantation model was used in Yang’s and GSK’s studies, and tumor growth inhibition results were obtained.<a onclick="showRef(event, 'ref77 ref79 ref85'); return false;" href="javascript:void(0);" class="ref ref77 ref79 ref85">(77,79,85)</a> Therefore, the difference in these models needs to be further characterized to provide more insight into the relationship between RIPK1 inhibition and tumor growth and metastasis and real effect of RIPK1 on cancer treatment.</div><div class="NLM_p">As a key target in the necroptotic pathway, MLKL has attracted increased attention.<a onclick="showRef(event, 'ref35 ref111 ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref35 ref111 ref112 ref113 ref114">(35,111−114)</a> Current inhibitors, such as <b>66</b>–<b>69</b>, were shown to covalently modify MLKL, which might have a high risk of cytotoxicity. Compounds <b>70</b> and <b>71</b> were shown to bind to MLKL in a type I mode with an obvious off-target effect. In addition, the contribution of MLKL inhibitors in vivo has not been well-defined.</div><div class="NLM_p">Collectively, the target specificity of necroptosis inhibitors and whether RIPK1 or RIPK3 represents a priority target for potential intervention are important. The development of animal models with the knock-in of kinase-dead mutants of both RIPK1 and RIPK3 and highly specific chemical tools targeting RIPK1 and/or RIPK3 may help elucidate the exact roles of RIPK1 and RIPK3 in vitro and in vivo. For inhibitor development, the structural biology of RIP kinases, especially that of human RIPK3, which has not been disclosed, and MLKL is critical to SBDD. The catalytic lysines in RIPK1 were proposed to be an alternative site of a reactive cysteine for covalent modification to improve the target selectivity.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Natural products are valuable sources with strong biocompatibility.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> To date, only three cases with unique chemical structures have been reported (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). Compounds <b>72</b> and <b>73</b> (named geldanamycins) were reported to protect against neuronal injury induced by oxygen glucose deprivation (OGD)/zVAD treatment and to decrease RIPK1 and Hsp90 protein levels.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Shen et al. found a noncanonical Hsp90 inhibitor (<b>74</b>) to block RIPK3-dependent necroptosis in HT-29 cells (IC<sub>50</sub> = 200 nM). This molecule was demonstrated to covalently modify Cys420 of Hsp90, leading to the dissociation of Hsp90 from the cochaperone CDC37 to inhibit necroptosis.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Compound <b>75</b> (known as 6E11) was shown to inhibit necroptosis in Jurkat T cells by selective targeting of RIPK1 (<i>K</i><sub>D</sub> = 130 nM).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Thus, further analyses of botanical sources, marine sources, microorganism, and other natural sources may provide novel chemical structures and useful biological activities and specificities.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of <b>72</b>–<b>75</b> from natural sources.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Combinatorial therapy is a potential area of focus. A RIPK1 inhibitor, GSK3145095, in combination with other anticancer agents, including pembrolizumab, has been proposed in a recent clinical trial (NCT03681951). In addition, combination with other agents targeting different nodes (RIPK1, RIPK3, MLKL) in the necroptotic pathway could also be examined. Alternatively, the development of dual-targeting or multitargeting strategies of the three known targets is a kind of combinatorial therapy that might have clinical advantages.<a onclick="showRef(event, 'ref57 ref61 ref62 ref130'); return false;" href="javascript:void(0);" class="ref ref57 ref61 ref62 ref130">(57,61,62,130)</a> Finally, according to the molecular mechanism of necroptosis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), degradation of the targets of necroptosis by the ubiquitin–proteasome system is a reasonable strategy to inhibit the formation of necrosomes.</div><div class="NLM_p last">In summary, the inhibition of necroptosis has the exciting potential to improve the outcome in a number of inflammatory and degenerative human diseases, as well as possibly a role in oncology. To some extent, the science of necroptosis and its therapeutic targets, as well as the functions and relationships of RIPK1, RIPK3, and MLKL, remains in its infancy. With additional investigations related to structural biology, medicinal chemistry, and mechanisms and preclinical and clinical evaluations of necroptosis-related fields, the clinical future is promising for necroptosis inhibitors.</div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e2266-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01317" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01317" class="ext-link">10.1021/acs.jmedchem.9b01317</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01317/suppl_file/jm9b01317_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01317/suppl_file/jm9b01317_si_001.csv">jm9b01317_si_001.csv (5.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01317" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunlin Zhuang</span> - <span class="hlFld-Affiliation affiliation">Engineering
Center of Catalysis and Synthesis for Chiral Molecules, Department
of Chemistry, Fudan University, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e399808f8d82978b828da3d2d5d0cd808c8e"><span class="__cf_email__" data-cfemail="97edf4fbf9f6e3fff6f9d7a6a1a4b9f4f8fa">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fener Chen</span> - <span class="hlFld-Affiliation affiliation">Engineering
Center of Catalysis and Synthesis for Chiral Molecules, Department
of Chemistry, Fudan University, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6734-3388" title="Orcid link">http://orcid.org/0000-0002-6734-3388</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f48692979c919ab4928190959ada919081da979a"><span class="__cf_email__" data-cfemail="b8cadedbd0ddd6f8decddcd9d696dddccd96dbd6">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Chunlin Zhuang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=BIO-d7e2572-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chunlin Zhuang</b> received his Bachelor’s degree from Nanjing Medical University, China (2009), and a Ph.D. in Medicinal Chemistry from Second Military Medical University (2014). In 2012–2013, he worked at the University of Minnesota as an exchange Ph.D. candidate. He has worked as a faculty member at the School of Pharmacy, Second Military Medical University from 2014 and in Prof. Fener Chen’s group at Fudan University from 2019 as a professor. He has held a joint professorship at Ningxia Medical University. His research interests have recently focused on programmed cell death inhibitors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Fener Chen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=BIO-d7e2577-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fener Chen</b> received a M.S. in Pharmacy and a Ph.D. in Organic Chemistry from Sichuan University. He joined Wuhan Institute of Technology in 1988 and was promoted to Professor in 1996. In 1998, he moved to Fudan University as a full professor. His current research focuses on the development of new asymmetric catalysis, asymmetric total synthesis of natural products, process chemistry, and computer assisted based drug design. He has been a visiting professor at numerous prestigious universities, including Washington University, King’s College London, etc. He is currently a member of Academician of Chinese Academy of Engineering.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Nicholas Meanwell for the kind invitation to write this Perspective. We also acknowledge Prof. Chengguo Xing from University of Florida for comments on the manuscript. This work was funded by grants from the National Natural Science Foundation of China (Grant 81872791), the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (Grant 2017QNRC061), the Shanghai Municipal Commission of Health and Family Planning (Grant 2017YQ052), and the Key Research and Development Program of Ningxia (Grants 2018BFH02001 and 2019BFG02017).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACD</td><td class="NLM_def"><p class="first last">accidental cell death</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">AurK</td><td class="NLM_def"><p class="first last">Aurora kinase</p></td></tr><tr><td class="NLM_term">cIAP1/2</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis proteins 1/2</p></td></tr><tr><td class="NLM_term">DAMP</td><td class="NLM_def"><p class="first last">damage-associated molecular pattern</p></td></tr><tr><td class="NLM_term">DARTS</td><td class="NLM_def"><p class="first last">drug affinity responsive target stability</p></td></tr><tr><td class="NLM_term">DEL</td><td class="NLM_def"><p class="first last">DNA-encoded library</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">FADD</td><td class="NLM_def"><p class="first last">Fas associated death domain protein</p></td></tr><tr><td class="NLM_term">FAS</td><td class="NLM_def"><p class="first last">CD95</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen-bonding donor</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">IDO</td><td class="NLM_def"><p class="first last">indoleamine 2,3-dioxygenase</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">MLKL</td><td class="NLM_def"><p class="first last">mixed lineage kinase domain-like protein</p></td></tr><tr><td class="NLM_term">MR</td><td class="NLM_def"><p class="first last">modified release</p></td></tr><tr><td class="NLM_term">MTH-Trp</td><td class="NLM_def"><p class="first last">methyl-thiohydantoin-tryptophan</p></td></tr><tr><td class="NLM_term">Nec-1</td><td class="NLM_def"><p class="first last">necrostatin-1</p></td></tr><tr><td class="NLM_term">NOD</td><td class="NLM_def"><p class="first last">nucleotide-binding oligomerization domain</p></td></tr><tr><td class="NLM_term">OGD</td><td class="NLM_def"><p class="first last">oxygen glucose deprivation</p></td></tr><tr><td class="NLM_term">PCD</td><td class="NLM_def"><p class="first last">programmed cell death</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma cancer</p></td></tr><tr><td class="NLM_term">PERK</td><td class="NLM_def"><p class="first last">PKR-like ER kinase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">RHIM</td><td class="NLM_def"><p class="first last">RIP homotypic interaction motif</p></td></tr><tr><td class="NLM_term">RIPK1</td><td class="NLM_def"><p class="first last">receptor-interacting protein kinase 1</p></td></tr><tr><td class="NLM_term">RIPK3</td><td class="NLM_def"><p class="first last">receptor-interacting protein kinase 3</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">SIRS</td><td class="NLM_def"><p class="first last">systemic inflammatory response syndrome</p></td></tr><tr><td class="NLM_term">SMAC</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspase</p></td></tr><tr><td class="NLM_term">TAK1</td><td class="NLM_def"><p class="first last">transforming growth factor-β-activated kinase 1</p></td></tr><tr><td class="NLM_term">TLR3/4</td><td class="NLM_def"><p class="first last">Toll-like receptors 3/4</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TNFR1</td><td class="NLM_def"><p class="first last">TNF receptor 1</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">TRADD</td><td class="NLM_def"><p class="first last">TNFR1-associated death domain protein</p></td></tr><tr><td class="NLM_term">TRAF2</td><td class="NLM_def"><p class="first last">TNF receptor 2</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">TNF-related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">TSZ</td><td class="NLM_def"><p class="first last">TNFα-SMAC-z-VAD-FMK</p></td></tr><tr><td class="NLM_term">z-VAD-FMK</td><td class="NLM_def"><p class="first last">z-Val-Ala-Asp-(OMe)-fluoromethyl ketone</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 130 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, A. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/bjc.1972.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+a+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics&doi=10.1038%2Fbjc.1972.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2ebnmmMaT6tr_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520a%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257%26doi%3D10.1038%2Fbjc.1972.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueydan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane changes during programmed cell deaths</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcr.2017.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29076500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=9-21&author=Y.+Zhangauthor=X.+Chenauthor=C.+Gueydanauthor=J.+Han&title=Plasma+membrane+changes+during+programmed+cell+deaths&doi=10.1038%2Fcr.2017.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane changes during programmed cell deaths</span></div><div class="casAuthors">Zhang, Yingying; Chen, Xin; Gueydan, Cyril; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-21</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Ruptured and intact plasma membranes are classically considered as hallmarks of necrotic and apoptotic cell death, resp.  As such, apoptosis is usually considered a non-inflammatory process while necrosis triggers inflammation.  Recent studies on necroptosis and pyroptosis, two types of programmed necrosis, revealed that plasma membrane rupture is mediated by MLKL channels during necroptosis but depends on non-selective gasdermin D (GSDMD) pores during pyroptosis.  Importantly, the morphol. of dying cells executed by MLKL channels can be distinguished from that executed by GSDMD pores.  Interestingly, it was found recently that secondary necrosis of apoptotic cells, a previously believed non-regulated form of cell lysis that occurs after apoptosis, can be programmed and executed by plasma membrane pore formation like that of pyroptosis.  In addn., pyroptosis is assocd. with pyroptotic bodies, which have some similarities to apoptotic bodies.  Therefore, different cell death programs induce distinctive reshuffling processes of the plasma membrane.  Given the fact that the nature of released intracellular contents plays a crucial role in dying/dead cell-induced immunogenicity, not only membrane rupture or integrity but also the nature of plasma membrane breakdown would det. the fate of a cell as well as its ability to elicit an immune response.  In this review, we will discuss recent advances in the field of apoptosis, necroptosis and pyroptosis, with an emphasis on the mechanisms underlying plasma membrane changes obsd. on dying cells and their implication in cell death-elicited immunogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSQjLMNOfh3LVg90H21EOLACvtfcHk0ljaSAWxnTewig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7zL&md5=798a8a152aef6f8df5ee2c3356d3f761</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.133%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGueydan%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DPlasma%2520membrane%2520changes%2520during%2520programmed%2520cell%2520deaths%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26spage%3D9%26epage%3D21%26doi%3D10.1038%2Fcr.2017.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span> <span> </span><span class="NLM_article-title">How dying cells alert the immune system to danger</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1038/nri2215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnri2215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18340345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=279-289&author=H.+Konoauthor=K.+L.+Rock&title=How+dying+cells+alert+the+immune+system+to+danger&doi=10.1038%2Fnri2215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">How dying cells alert the immune system to danger</span></div><div class="casAuthors">Kono, Hajime; Rock, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-289</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  When a cell dies in vivo, the event does not go unnoticed.  The host has evolved mechanisms to detect the death of cells and rapidly investigate the nature of their demise.  If cell death is a result of natural causes - i.e., it is part of normal physiol. processes - then there is little threat to the organism.  In this situation, little else is done other than to remove the corpse.  However, if cells have died as the consequence of some violence or disease, then both defense and repair mechanisms are mobilized in the host.  The importance of these processes to host defense and disease pathogenesis has only been appreciated relatively recently.  This article reviews our current knowledge of these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFG8Y7PNySq7Vg90H21EOLACvtfcHk0ljaSAWxnTewig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1antLs%253D&md5=7eff34d3d5edb5fa16e9d9939739f9be</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2215%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRock%26aufirst%3DK.%2BL.%26atitle%3DHow%2520dying%2520cells%2520alert%2520the%2520immune%2520system%2520to%2520danger%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D279%26epage%3D289%26doi%3D10.1038%2Fnri2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanden
Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouan-Lanhouet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Regulated necrosis: the expanding network of non-apoptotic cell death pathways</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrm3737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrm3737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24452471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=135-147&author=T.+Vanden%0ABergheauthor=A.+Linkermannauthor=S.+Jouan-Lanhouetauthor=H.+Walczakauthor=P.+Vandenabeele&title=Regulated+necrosis%3A+the+expanding+network+of+non-apoptotic+cell+death+pathways&doi=10.1038%2Fnrm3737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated necrosis: the expanding network of non-apoptotic cell death pathways</span></div><div class="casAuthors">Vanden Berghe, Tom; Linkermann, Andreas; Jouan-Lanhouet, Sandrine; Walczak, Henning; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-147</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell death research was revitalized by the understanding that necrosis can occur in a highly regulated and genetically controlled manner.  Although RIPK1 (receptor-interacting protein kinase 1)- and RIPK3-MLKL (mixed lineage kinase domain-like)-mediated necroptosis is the most understood form of regulated necrosis, other examples of this process are emerging, including cell death mechanisms known as parthanatos, oxytosis, ferroptosis, NETosis, pyronecrosis and pyroptosis.  Elucidating how these pathways of regulated necrosis are interconnected at the mol. level should enable this process to be therapeutically targeted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZtCEnuIUd7Vg90H21EOLACvtfcHk0litVla45oHgoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7w%253D&md5=8e5e201e06e98cb9d0f780748ca19e04</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm3737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3737%26sid%3Dliteratum%253Aachs%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DJouan-Lanhouet%26aufirst%3DS.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRegulated%2520necrosis%253A%2520the%2520expanding%2520network%2520of%2520non-apoptotic%2520cell%2520death%2520pathways%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D135%26epage%3D147%26doi%3D10.1038%2Fnrm3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of necroptosis: an ordered cellular explosion</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1038/nrm2970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrm2970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20823910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=700-714&author=P.+Vandenabeeleauthor=L.+Galluzziauthor=T.+Vanden+Bergheauthor=G.+Kroemer&title=Molecular+mechanisms+of+necroptosis%3A+an+ordered+cellular+explosion&doi=10.1038%2Fnrm2970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of necroptosis: an ordered cellular explosion</span></div><div class="casAuthors">Vandenabeele, Peter; Galluzzi, Lorenzo; Vanden Berghe, Tom; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">700-714</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For a long time, apoptosis was considered the sole form of programmed cell death during development, homeostasis and disease, whereas necrosis was regarded as an unregulated and uncontrollable process.  Evidence now reveals that necrosis can also occur in a regulated manner.  The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumor necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3), and its execution involves the active disintegration of mitochondrial, lysosomal and plasma membranes.  Necroptosis participates in the pathogenesis of diseases, including ischemic injury, neurodegeneration and viral infection, thereby representing an attractive target for the avoidance of unwarranted cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEe8vjo9AoLVg90H21EOLACvtfcHk0litVla45oHgoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P&md5=bc7798f807de31771d8e620acf754b92</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm2970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2970%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520ordered%2520cellular%2520explosion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D700%26epage%3D714%26doi%3D10.1038%2Fnrm2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laster, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooding, L. R.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">2629</span>– <span class="NLM_lpage">2634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=3171180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaL1cXmtV2ntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1988&pages=2629-2634&author=S.+M.+Lasterauthor=J.+G.+Woodauthor=L.+R.+Gooding&title=Tumor+necrosis+factor+can+induce+both+apoptic+and+necrotic+forms+of+cell+lysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis</span></div><div class="casAuthors">Laster, Scott M.; Wood, John G.; Gooding, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2629-34</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">The mechansim of lysis by tumor necrosis factor (TNF) is not well understood.  The goal of this investigation was to det. whether TNF caused one of the classic forms of cell death, i.e., apoptosis, which is characterized  by nuclear disintegration and cytoplasmic boiling, or necrosis, which is characterized by the formation of a balloon-like plasma membrane and a lack of nuclear disintegration.  To distinguish apoptosis from necrosis, time-lapse video microscopy was used to observe the death of several TNF-sensitive target cell lines while measuring the release of Na251CrO4 and [3H]TdR from cytoplasmic and nuclear compartments, resp.  The targets were 2 spontaneously sensitive cell lines, F17 and L-M, and one resistant cell line, C3HA, which was sensitized by treatment with cycloheximide or by infection  with the adeno-SV40 hybrid virus Ad2+ND2.  The type of cell death obsd. depends on the cell being tested.  In F17 cells TNF treatment induced a classical form of apoptosis.  In contrast, TNF induced a necrotic form of cell death in L-M cells, similar to the lysis induced by antibody in complement.  Sensitized C3HA cells displayed a novel cytolytic phenotype which resembled apoptosis but did not include DNA fragmentation.  These results emphasize the complex nature of the TNF-induced cytotoxic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlGgyf3t9917Vg90H21EOLACvtfcHk0litVla45oHgoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtV2ntrs%253D&md5=7fe9cfb1ccbab963b585e083c53dbdc3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaster%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BG.%26aulast%3DGooding%26aufirst%3DL.%2BR.%26atitle%3DTumor%2520necrosis%2520factor%2520can%2520induce%2520both%2520apoptic%2520and%2520necrotic%2520forms%2520of%2520cell%2520lysis%26jtitle%3DJ.%2520Immunol.%26date%3D1988%26volume%3D141%26spage%3D2629%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercammen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grooten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1485</span>, <span class="refDoi"> DOI: 10.1084/jem.187.9.1477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1084%2Fjem.187.9.1477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=9565639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaK1cXivVGjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1998&pages=1477-1485&author=D.+Vercammenauthor=R.+Beyaertauthor=G.+Deneckerauthor=V.+Goossensauthor=G.+Van+Looauthor=W.+Declercqauthor=J.+Grootenauthor=W.+Fiersauthor=P.+Vandenabeele&title=Inhibition+of+caspases+increases+the+sensitivity+of+L929+cells+to+necrosis+mediated+by+tumor+necrosis+factor&doi=10.1084%2Fjem.187.9.1477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor</span></div><div class="casAuthors">Vercammen, Dominique; Beyaert, Rudi; Denecker, Geertrui; Goossens, Vera; Van Loo, Geert; Declercq, Wim; Grooten, Johan; Fiers, Walter; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1477-1485</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates.  We investigated the role of caspases in the necrotic cell death pathway.  When the cytokine response modifier A (CrmA), a serpin-like caspase inhibitor of viral origin, was stably overexpressed in L929 cells, the latter became 1,000-fold more sensitive to TNF-mediated cell death.  In addn., TNF sensitization was also obsd. when the cells were pretreated with Ac-YVAD-cmk or zDEVD-fmk, which inhibits caspase-1-and caspase-3-like proteases, resp.  ZVAD-fmk and zD-fmk, two broad-spectrum inhibitors of caspases, also rendered the cells more sensitive, since the half-maximal dose for TNF-mediated necrosis decreased by a factor of 1,000.  The presence of zVAD-fmk also resulted in a more rapid increase of TNF-mediated prodn. of oxygen radicals.  ZVAD-fmk-dependent sensitization of TNF cytotoxicity could be completely inhibited by the oxygen radical scavenger butylated hydroxyanisole.  These results indicate an involvement of caspases in protection against TNF-induced formation of oxygen radicals and necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7woIo0pkZo7Vg90H21EOLACvtfcHk0lgqWMXL4eLiGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVGjur8%253D&md5=90368ab3d4749831c6b4605225ef3607</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.187.9.1477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.187.9.1477%26sid%3Dliteratum%253Aachs%26aulast%3DVercammen%26aufirst%3DD.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DDenecker%26aufirst%3DG.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVan%2BLoo%26aufirst%3DG.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DGrooten%26aufirst%3DJ.%26aulast%3DFiers%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520caspases%2520increases%2520the%2520sensitivity%2520of%2520L929%2520cells%2520to%2520necrosis%2520mediated%2520by%2520tumor%2520necrosis%2520factor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D187%26spage%3D1477%26epage%3D1485%26doi%3D10.1084%2Fjem.187.9.1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1038/nchembio711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16408008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=112-119&author=A.+Degterevauthor=Z.+Huangauthor=M.+Boyceauthor=Y.+Liauthor=P.+Jagtapauthor=N.+Mizushimaauthor=G.+D.+Cunyauthor=T.+J.+Mitchisonauthor=M.+A.+Moskowitzauthor=J.+Yuan&title=Chemical+inhibitor+of+nonapoptotic+cell+death+with+therapeutic+potential+for+ischemic+brain+injury&doi=10.1038%2Fnchembio711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span></div><div class="casAuthors">Degterev, Alexei; Huang, Zhihong; Boyce, Michael; Li, Yaqiao; Jagtap, Prakash; Mizushima, Noboru; Cuny, Gregory D.; Mitchison, Timothy J.; Moskowitz, Michael A.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death.  Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, the authors demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which the authors term necroptosis.  The authors showed that necroptosis is characterized by necrotic cell death morphol. and activation of autophagy.  The authors identified a specific and potent small-mol. inhibitor of necroptosis, necrostatin-1, which blocks a crit. step in necroptosis.  The authors demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection.  Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiBDVRJkdUbVg90H21EOLACvtfcHk0lgqWMXL4eLiGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D&md5=83f8c363ffb73ccc14bf11ec02577336</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio711%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DChemical%2520inhibitor%2520of%2520nonapoptotic%2520cell%2520death%2520with%2520therapeutic%2520potential%2520for%2520ischemic%2520brain%2520injury%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26spage%3D112%26epage%3D119%26doi%3D10.1038%2Fnchembio711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zong, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Necrotic death as a cell fate</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1101/gad.1376506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1101%2Fgad.1376506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16391229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Omu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1-15&author=W.+X.+Zongauthor=C.+B.+Thompson&title=Necrotic+death+as+a+cell+fate&doi=10.1101%2Fgad.1376506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Necrotic death as a cell fate</span></div><div class="casAuthors">Zong, Wei-Xing; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Organismal homeostasis depends on an intricate balance between cell death and renewal.  Early pathologists recognized that this balance could be disrupted by the extensive damage obsd. in internal organs during the course of certain diseases.  This form of tissue damage was termed "necrosis", derived from the Greek "nekros" for corpse.  As it became clear that the essential building block of tissue was the cell, necrosis came to be used to describe pathol. cell death.  Until recently, necrotic cell death was believed to result from injuries that caused an irreversible bioenergetic compromise.  The cell dying by necrosis has been viewed as a victim of extrinsic events beyond its control.  However, recent evidence suggests that a cell can initiate its own demise by necrosis in a manner that initiates both inflammatory and/or reparative responses in the host.  By initiating these adaptive responses, programmed cell necrosis may serve to maintain tissue and organismal integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAyl0ut3xEQrVg90H21EOLACvtfcHk0ljidnEXXV4JOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Omu7o%253D&md5=6166f1f7c5782df62093676669d26474</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.1376506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1376506%26sid%3Dliteratum%253Aachs%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DNecrotic%2520death%2520as%2520a%2520cell%2520fate%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D1%26epage%3D15%26doi%3D10.1101%2Fgad.1376506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valitutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1038/82732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2F82732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=11101870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslyru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=489-495&author=N.+Hollerauthor=R.+Zaruauthor=O.+Micheauauthor=M.+Thomeauthor=A.+Attingerauthor=S.+Valituttiauthor=J.+L.+Bodmerauthor=P.+Schneiderauthor=B.+Seedauthor=J.+Tschopp&title=Fas+triggers+an+alternative%2C+caspase-8-independent+cell+death+pathway+using+the+kinase+RIP+as+effector+molecule&doi=10.1038%2F82732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule</span></div><div class="casAuthors">Holler, Nils; Zaru, Rossana; Micheau, Olivier; Thome, Margot; Attinger, Antoine; Valitutti, Salvatore; Bodmer, Jean-Luc; Schneider, Pascal; Seed, Brian; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-495</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Cell death is achieved by two fundamentally different mechanisms: apoptosis and necrosis.  Apoptosis is dependent on caspase activation, whereas the caspase-independent necrotic signaling pathway remains largely uncharacterized.  We show here that Fas kills activated primary T cells efficiently in the absence of active caspases, which results in necrotic morphol. changes and late mitochondrial damage but no cytochrome c release.  This Fas ligand-induced caspase-independent death is absent in T cells that are deficient in either Fas-assocd. death domain (FADD) or receptor-interacting protein (RIP).  RIP is also required for necrotic death induced by tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand (TRAIL).  In contrast to its role in nuclear factor κB activation, RIP requires its own kinase activity for death signaling.  Thus, Fas, TRAIL and TNF receptors can initiate cell death by two alternative pathways, one relying on caspase-8 and the other dependent on the kinase RIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBFtIFdBNfVbVg90H21EOLACvtfcHk0ljidnEXXV4JOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslyru74%253D&md5=224004595782f9d5f3954c3a57b3c496</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F82732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F82732%26sid%3Dliteratum%253Aachs%26aulast%3DHoller%26aufirst%3DN.%26aulast%3DZaru%26aufirst%3DR.%26aulast%3DMicheau%26aufirst%3DO.%26aulast%3DThome%26aufirst%3DM.%26aulast%3DAttinger%26aufirst%3DA.%26aulast%3DValitutti%26aufirst%3DS.%26aulast%3DBodmer%26aufirst%3DJ.%2BL.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DFas%2520triggers%2520an%2520alternative%252C%2520caspase-8-independent%2520cell%2520death%2520pathway%2520using%2520the%2520kinase%2520RIP%2520as%2520effector%2520molecule%26jtitle%3DNat.%2520Immunol.%26date%3D2000%26volume%3D1%26spage%3D489%26epage%3D495%26doi%3D10.1038%2F82732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedospasov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">10822</span>– <span class="NLM_lpage">10828</span>, <span class="refDoi"> DOI: 10.1074/jbc.M313141200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1074%2Fjbc.M313141200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=14701813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10822-10828&author=Y.+Linauthor=S.+Choksiauthor=H.+M.+Shenauthor=Q.+F.+Yangauthor=G.+M.+Hurauthor=Y.+S.+Kimauthor=J.+H.+Tranauthor=S.+A.+Nedospasovauthor=Z.+G.+Liu&title=Tumor+necrosis+factor-induced+nonapoptotic+cell+death+requires+receptor-interacting+protein-mediated+cellular+reactive+oxygen+species+accumulation&doi=10.1074%2Fjbc.M313141200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Necrosis Factor-induced Nonapoptotic Cell Death Requires Receptor-interacting Protein-mediated Cellular Reactive Oxygen Species Accumulation</span></div><div class="casAuthors">Lin, Yong; Choksi, Swati; Shen, Han-Ming; Yang, Qing-Feng; Hur, Gang Min; Kim, You Sun; Tran, Jamie Hong; Nedospasov, Sergei A.; Liu, Zheng-gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10822-10828</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism of tumor necrosis factor (TNF)-induced nonapoptotic cell death is largely unknown, although the mechanism of TNF-induced apoptosis has been studied extensively.  In wild-type mouse embryonic fibroblast cells under a caspase-inhibited condition, TNF effectively induced cell death that morphol. resembled necrosis.  In this study, the authors utilized gene knockout mouse embryonic fibroblasts cells and found that tumor necrosis factor receptor (TNFR) I mediates TNF-induced necrotic cell death, and that RIP, FADD, and TRAF2 are crit. components of the signaling cascade of this TNF-induced necrotic cell death.  Inhibitors of NF-κB facilitated TNF-induced necrotic cell death, suggesting that NF-κB suppresses the necrotic cell death pathway.  JNK, p38, and ERK activation seem not to be required for this type of cell death because mitogen-activated protein kinase inhibitors did not significantly affect TNF-induced necrotic cell death.  In agreement with the previous reports that the reactive oxygen species (ROS) may play an important role in this type of cell death, the ROS scavenger butylated hydroxyanisole efficiently blocked TNF-induced necrotic cell death.  Interestingly, during TNF-induced necrotic cell death, the cellular ROS level was significantly elevated in wild type, but not in RIP-/-, TRAF2-/-, and FADD-/- cells.  These results suggest that RIP, TRAF2, and FADD are crucial in mediating ROS accumulation in TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcGfyYn42grVg90H21EOLACvtfcHk0ljidnEXXV4JOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCht7o%253D&md5=704ded34f09a6899cee7073d3a0ebdba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M313141200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M313141200%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DYang%26aufirst%3DQ.%2BF.%26aulast%3DHur%26aufirst%3DG.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DTran%26aufirst%3DJ.%2BH.%26aulast%3DNedospasov%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DTumor%2520necrosis%2520factor-induced%2520nonapoptotic%2520cell%2520death%2520requires%2520receptor-interacting%2520protein-mediated%2520cellular%2520reactive%2520oxygen%2520species%2520accumulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10822%26epage%3D10828%26doi%3D10.1074%2Fjbc.M313141200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span> <span> </span><span class="NLM_article-title">The role of necroptosis in cancer: a double-edged sword?</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1871</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2019.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bbcan.2019.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30716362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1WksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1871&publication_year=2019&pages=259-266&author=X.+Qinauthor=D.+Maauthor=Y.+X.+Tanauthor=H.+Y.+Wangauthor=Z.+Cai&title=The+role+of+necroptosis+in+cancer%3A+a+double-edged+sword%3F&doi=10.1016%2Fj.bbcan.2019.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of necroptosis in cancer: A double-edged sword?</span></div><div class="casAuthors">Qin, Xia; Ma, Dan; Tan, Ye-xiong; Wang, Hong-yang; Cai, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1871</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-266</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a programmed, caspase-independent cell death that is morphol. similar to necrosis.  Unlike apoptosis, necroptosis evokes inflammatory responses by releasing damage-assocd. mol. patterns.  Recent studies suggest that tumor undergoes necroptosis in vivo and necroptosis has pro- or anti-tumoral effects in cancer development and progression.  Furthermore, triggering necroptosis in tumor cells has been explored as a potential therapeutic strategy against cancer.  Here, we will review the recent research progress of necroptosis in conferring anti- or pro-tumoral effects and its potential application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6U2ziHSQLjbVg90H21EOLACvtfcHk0lgSyciqxPbQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1WksL0%253D&md5=891b09640690f0c01297912486ed1642</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2019.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2019.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DCai%26aufirst%3DZ.%26atitle%3DThe%2520role%2520of%2520necroptosis%2520in%2520cancer%253A%2520a%2520double-edged%2520sword%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2019%26volume%3D1871%26spage%3D259%26epage%3D266%26doi%3D10.1016%2Fj.bbcan.2019.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">20054</span>– <span class="NLM_lpage">20059</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116302108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1116302108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22123964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12gtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20054-20059&author=S.+Heauthor=Y.+Liangauthor=F.+Shaoauthor=X.+Wang&title=Toll-like+receptors+activate+programmed+necrosis+in+macrophages+through+a+receptor-interacting+kinase-3-mediated+pathway&doi=10.1073%2Fpnas.1116302108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway</span></div><div class="casAuthors">He, Sudan; Liang, Yuqiong; Shao, Feng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20054-20059, S20054/1-S20054/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report here that mouse macrophages undergo receptor-interacting kinase-3 (RIP3)-dependent but TNFα-independent necrosis when Toll-like receptors (TLR) 3 and 4 are activated by poly(I:C) and LPS, resp.  An adaptor protein, Toll/IL-1 receptor domain-contg. adapter inducing IFN-β (TRIF/TICAM-1), which is dispensable for TNF-α-induced necrosis, forms a complex with RIP3 upon TLR3/ TLR4 activation and is essential for TLR3/TLR4-induced necrosis.  Mice without RIP3 or functional TRIF did not show macrophage loss and elevation of inflammatory cytokines when they were exposed to LPS.  Necrosis in mouse macrophages induced by either TNFR or TLR3/TLR4 is executed by reactive oxygen species.  Taken together, these data indicate that there are multiple upstream necrosis-initiating signaling pathways converging on the RIP3 during an innate immune response to viral and bacterial infections in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlZgMAgWomJ7Vg90H21EOLACvtfcHk0lgSyciqxPbQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12gtbbI&md5=984418c7e649a485303167662eff6745</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116302108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116302108%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DToll-like%2520receptors%2520activate%2520programmed%2520necrosis%2520in%2520macrophages%2520through%2520a%2520receptor-interacting%2520kinase-3-mediated%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D20054%26epage%3D20059%26doi%3D10.1073%2Fpnas.1116302108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sad, S.</span></span> <span> </span><span class="NLM_article-title">Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/ni.2397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fni.2397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22922364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=954-962&author=N.+Robinsonauthor=S.+McCombauthor=R.+Mulliganauthor=R.+Dudaniauthor=L.+Krishnanauthor=S.+Sad&title=Type+I+interferon+induces+necroptosis+in+macrophages+during+infection+with+Salmonella+enterica+serovar+Typhimurium&doi=10.1038%2Fni.2397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</span></div><div class="casAuthors">Robinson, Nirmal; McComb, Scott; Mulligan, Rebecca; Dudani, Renu; Krishnan, Lakshmi; Sad, Subash</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">954-962</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Salmonella enterica serovar Typhimurium (S. Typhimurium) is a virulent pathogen that induces rapid host death.  Here we obsd. t.hat host survival after infection with S. Typhimurium was enhanced in the absence of type I interferon signaling, with improved survival of mice deficient in the receptor for type I interferons (Ifnar1-/- mice) that was attributed to macrophages.  Although there was no impairment in cytokine expression or inflammasome activation in Ifnar1-/- macrophages, they were highly resistant to S.  Typhimurium-induced cell death.  Specific inhibition of the kinase RIP1 or knockdown of the gene encoding the kinase RIP3 prevented the death of wild-type macrophages, which indicated that necroptosis was a mechanism of cell death.  Finally, RIP3-deficient macrophages, which cannot undergo necroptosis, had similarly less death and enhanced control of S. Typhimurium in vivo.  Thus, we propose that S. Typhimurium induces the prodn. of type I interferon, which drives necroptosis of macrophages and allows them to evade the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSo_COBES0hbVg90H21EOLACvtfcHk0lgSyciqxPbQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbzK&md5=401914c5d80d813e4982062e4b97edf5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fni.2397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2397%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DDudani%26aufirst%3DR.%26aulast%3DKrishnan%26aufirst%3DL.%26aulast%3DSad%26aufirst%3DS.%26atitle%3DType%2520I%2520interferon%2520induces%2520necroptosis%2520in%2520macrophages%2520during%2520infection%2520with%2520Salmonella%2520enterica%2520serovar%2520Typhimurium%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D954%26epage%3D962%26doi%3D10.1038%2Fni.2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rall, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span> <span> </span><span class="NLM_article-title">Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E3109</span>– <span class="NLM_lpage">3118</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301218110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1301218110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23898178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCrtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E3109-3118&author=R.+J.+Thapaauthor=S.+Nogusaauthor=P.+Chenauthor=J.+L.+Makiauthor=A.+Lerroauthor=M.+Andrakeauthor=G.+F.+Rallauthor=A.+Degterevauthor=S.+Balachandran&title=Interferon-induced+RIP1%2FRIP3-mediated+necrosis+requires+PKR+and+is+licensed+by+FADD+and+caspases&doi=10.1073%2Fpnas.1301218110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases</span></div><div class="casAuthors">Thapa, Roshan J.; Nogusa, Shoko; Chen, Peirong; Maki, Jenny L.; Lerro, Anthony; Andrake, Mark; Rall, Glenn F.; Degterev, Alexei; Balachandran, Siddharth</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E3109-E3118,SE3109/1-SE3109/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Interferons (IFNs) are cytokines with powerful immunomodulatory and antiviral properties, but less is known about how they induce cell death.  Here, we show that both type I (α/β) and type II (γ) IFNs induce precipitous receptor-interacting protein (RIP)1/RIP3 kinase-mediated necrosis when the adaptor protein Fas-assocd. death domain (FADD) is lost or disabled by phosphorylation, or when caspases (e.g., caspase 8) are inactivated.  IFN-induced necrosis proceeds via progressive assembly of a RIP1-RIP3 "necrosome" complex that requires Jak1/STAT1-dependent transcription, but does not need the kinase activity of RIP1.  Instead, IFNs transcriptionally activate the RNA-responsive protein kinase PKR, which then interacts with RIP1 to initiate necrosome formation and trigger necrosis.  Although IFNs are powerful activators of necrosis when FADD is absent, these cytokines are likely not the dominant inducers of RIP kinase-driven embryonic lethality in FADD-deficient mice.  We also identify phosphorylation on serine 191 as a mechanism that disables FADD and collaborates with caspase inactivation to allow IFN-activated necrosis.  Collectively, these findings outline a mechanism of IFN-induced RIP kinase-dependent necrotic cell death and identify FADD and caspases as neg. regulators of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3zqxFs-plYLVg90H21EOLACvtfcHk0lgPDamKltQmLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCrtbfI&md5=c6cafc37a78608324a899c8c2842953c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301218110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301218110%26sid%3Dliteratum%253Aachs%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DLerro%26aufirst%3DA.%26aulast%3DAndrake%26aufirst%3DM.%26aulast%3DRall%26aufirst%3DG.%2BF.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DBalachandran%26aufirst%3DS.%26atitle%3DInterferon-induced%2520RIP1%252FRIP3-mediated%2520necrosis%2520requires%2520PKR%2520and%2520is%2520licensed%2520by%2520FADD%2520and%2520caspases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE3109%26epage%3D3118%26doi%3D10.1073%2Fpnas.1301218110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Herreweghe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Festjens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1567</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1007/s00018-010-0283-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1007%2Fs00018-010-0283-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20198502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC3c3otF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=1567-1579&author=F.+Van%0AHerrewegheauthor=N.+Festjensauthor=W.+Declercqauthor=P.+Vandenabeele&title=Tumor+necrosis+factor-mediated+cell+death%3A+to+break+or+to+burst%2C+that%E2%80%99s+the+question&doi=10.1007%2Fs00018-010-0283-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor-mediated cell death: to break or to burst, that's the question</span></div><div class="casAuthors">Van Herreweghe Franky; Festjens Nele; Declercq Wim; Vandenabeele Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular life sciences : CMLS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1567-79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In this review, we discuss the signal-transduction pathways of three major cellular responses induced by tumor necrosis factor (TNF): cell survival through NF-kappaB activation, apoptosis, and necrosis.  Recruitment and activation of caspases plays a crucial role in the initiation and execution of TNF-induced apoptosis.  However, experimental inhibition of caspases reveals an alternative cell death pathway, namely necrosis, also called necroptosis, suggesting that caspases actively suppress the latter outcome.  TNF-induced necrotic cell death crucially depends on the kinase activity of receptor interacting protein serine-threonine kinase 1 (RIP1) and RIP3.  It was recently demonstrated that ubiquitination of RIP1 determines whether it will function as a pro-survival or pro-cell death molecule.  Deeper insight into the mechanisms that control the molecular switches between cell survival and cell death will help us to understand why TNF can exert so many different biological functions in the etiology and pathogenesis of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa7ys_p93Q3QvupmecNw_lfW6udTcc2eYXcPdaLoKL47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3otF2iug%253D%253D&md5=74266f51bb7352373156d395d5205e7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00018-010-0283-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-010-0283-0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHerreweghe%26aufirst%3DF.%26aulast%3DFestjens%26aufirst%3DN.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DTumor%2520necrosis%2520factor-mediated%2520cell%2520death%253A%2520to%2520break%2520or%2520to%2520burst%252C%2520that%25E2%2580%2599s%2520the%2520question%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D1567%26epage%3D1579%26doi%3D10.1007%2Fs00018-010-0283-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeddel, D. V.</span></span> <span> </span><span class="NLM_article-title">TNF-R1 signaling: a beautiful pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1126/science.1071924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1071924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12040173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1634-1635&author=G.+Chenauthor=D.+V.+Goeddel&title=TNF-R1+signaling%3A+a+beautiful+pathway&doi=10.1126%2Fscience.1071924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">TNF-R1 signaling: A beautiful pathway</span></div><div class="casAuthors">Chen, Guoqing; Goeddel, David V.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1634-1635</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Tumor necrosis factor (TNF) is a major mediator of apoptosis as well as inflammation and immunity, and it has been implicated in the pathogenesis of a wide spectrum of human diseases, including sepsis, diabetes, cancer, osteoporosis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel diseases.  The interaction of TNF with TNF receptor-1 (TNF-R1) activates several signal transduction pathways.  A common feature of each pathway is the TNF-induced formation of a multiprotein signaling complex at the cell membrane.  Over the past decade, many of the components and mechanisms of these signaling pathways have been elucidated.  We provide an overview of current knowledge of TNF signaling and introduce an STKE Connections Map that depicts a canonical view of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9BE_4FwgPrVg90H21EOLACvtfcHk0lgPDamKltQmLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChtrg%253D&md5=af1ad93413869caabf70ed256a4c070a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1071924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1071924%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGoeddel%26aufirst%3DD.%2BV.%26atitle%3DTNF-R1%2520signaling%253A%2520a%2520beautiful%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1634%26epage%3D1635%26doi%3D10.1126%2Fscience.1071924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wajant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfizenmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurich, P.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor signaling</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fsj.cdd.4401189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12655295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=45-65&author=H.+Wajantauthor=K.+Pfizenmaierauthor=P.+Scheurich&title=Tumor+necrosis+factor+signaling&doi=10.1038%2Fsj.cdd.4401189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor signaling</span></div><div class="casAuthors">Wajant, H.; Pfizenmaier, K.; Scheurich, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-65</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A single mouse click on the topic tumor necrosis factor (TNF) in PubMed reveals about 50,000 articles providing one or the other information about this pleiotropic cytokine or its relatives.  This demonstrates the enormous scientific and clin. interest in elucidating the biol. of a mol. (or rather a large family of mols.), which began now almost 30 yr ago with the description of a cytokine able to exert antitumoral effects in mouse models.  Although our understanding of the multiple functions of TNF in vivo and of the resp. underlying mechanisms at a cellular and mol. level has made enormous progress since then, new aspects are steadily uncovered and it appears that still much needs to be learned before we can conclude that we have a full comprehension of TNF biol.  This review shortly covers some general aspects of this fascinating mol. and then concs. on the mol. mechanisms of TNF signal transduction.  In particular, the multiple facets of crosstalk between the various signalling pathways engaged by TNF will be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVf0tpPhPSQbVg90H21EOLACvtfcHk0lizHly1ejdsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12mu7s%253D&md5=5a4d49fe31e636183b49dff642e59662</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401189%26sid%3Dliteratum%253Aachs%26aulast%3DWajant%26aufirst%3DH.%26aulast%3DPfizenmaier%26aufirst%3DK.%26aulast%3DScheurich%26aufirst%3DP.%26atitle%3DTumor%2520necrosis%2520factor%2520signaling%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D45%26epage%3D65%26doi%3D10.1038%2Fsj.cdd.4401189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofferson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Control of life-or-death decisions by RIP1 kinase</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-021113-170259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1146%2Fannurev-physiol-021113-170259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24079414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVCmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=129-150&author=D.+E.+Christoffersonauthor=Y.+Liauthor=J.+Yuan&title=Control+of+life-or-death+decisions+by+RIP1+kinase&doi=10.1146%2Fannurev-physiol-021113-170259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Control of life-or-death decisions by RIP1 kinase</span></div><div class="casAuthors">Christofferson, Dana E.; Li, Ying; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-150</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  RIP1 kinase, a multifunctional protein that contains an N-terminal Ser/Thr kinase and a C-terminal death domain, has emerged as a key regulatory mol. involved in regulating both cell death and cell survival.  When the proinflammatory cytokine TNFα stimulates its receptor, TNFR1, RIP1 regulates whether the cell lives by activating NF-κB or dies by apoptosis or necroptosis, two distinct pathways of programmed cell death that may be activated to eliminate unwanted cells.  The kinase domain of RIP1 is involved in regulating necroptosis, and the death domain regulates RIP1 recruitment to the intracellular domain of TNFR1.  The intermediate domain of RIP1 activates NF-κB and also interacts with RIP3 kinase, a downstream mediator of RIP1 in the execution of necroptosis.  This review focuses on the functional roles of RIP1 in regulating multiple cellular mechanisms, the dynamic regulation of RIP1, and the physiol. and pathol. roles of RIP1 kinase in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNS3xlVU5PLVg90H21EOLACvtfcHk0lizHly1ejdsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVCmsLg%253D&md5=4386c6498ec70f897b4a6e2a1e8ad010</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-021113-170259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-021113-170259%26sid%3Dliteratum%253Aachs%26aulast%3DChristofferson%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DControl%2520of%2520life-or-death%2520decisions%2520by%2520RIP1%2520kinase%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2014%26volume%3D76%26spage%3D129%26epage%3D150%26doi%3D10.1146%2Fannurev-physiol-021113-170259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00521-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2FS0092-8674%2803%2900521-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12887920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2003&pages=181-190&author=O.+Micheauauthor=J.+Tschopp&title=Induction+of+TNF+receptor+I-mediated+apoptosis+via+two+sequential+signaling+complexes&doi=10.1016%2FS0092-8674%2803%2900521-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes</span></div><div class="casAuthors">Micheau, Olivier; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis induced by TNF-receptor I (TNFR1) is thought to proceed via recruitment of the adaptor FADD and caspase-8 to the receptor complex.  TNFR1 signaling is also known to activate the transcription factor NF-κB and promote survival.  The mechanism by which this decision between cell death and survival is arbitrated is not clear.  The authors report that TNFR1-induced apoptosis involves two sequential signaling complexes.  The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1, and TRAF2 and rapidly signals activation of NF-κB.  In a second step, TRADD and RIP1 assoc. with FADD and caspase-8, forming a cytoplasmic complex (complex II).  When NF-κB is activated by complex I, complex II harbors the caspase-8 inhibitor FLIPL and the cell survives.  Thus, TNFR1-mediated-signal transduction includes a checkpoint, resulting in cell death (via complex II) in instances where the initial signal (via complex I, NF-κB) fails to be activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvD_hEcCU4rrVg90H21EOLACvtfcHk0lizHly1ejdsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFCgu7Y%253D&md5=9aae140d4da012f1ba51ec5f3ac6e934</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900521-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900521-X%26sid%3Dliteratum%253Aachs%26aulast%3DMicheau%26aufirst%3DO.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520TNF%2520receptor%2520I-mediated%2520apoptosis%2520via%2520two%2520sequential%2520signaling%2520complexes%26jtitle%3DCell%26date%3D2003%26volume%3D114%26spage%3D181%26epage%3D190%26doi%3D10.1016%2FS0092-8674%2803%2900521-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Jimenez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massoumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. T.</span></span> <span> </span><span class="NLM_article-title">Caspase 8 inhibits programmed necrosis by processing CYLD</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1038/ncb2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fncb2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22037414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1437-1442&author=M.+A.+O%E2%80%99Donnellauthor=E.+Perez-Jimenezauthor=A.+Oberstauthor=A.+Ngauthor=R.+Massoumiauthor=R.+Xavierauthor=D.+R.+Greenauthor=A.+T.+Ting&title=Caspase+8+inhibits+programmed+necrosis+by+processing+CYLD&doi=10.1038%2Fncb2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase 8 inhibits programmed necrosis by processing CYLD</span></div><div class="casAuthors">O'Donnell, Marie Anne; Perez-Jimenez, Eva; Oberst, Andrew; Ng, Aylwin; Massoumi, Ramin; Xavier, Ramnik; Green, Douglas R.; Ting, Adrian T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1437-1442</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase 8 initiates apoptosis downstream of TNF death receptors by undergoing autocleavage and processing the executioner caspase 3 (ref. ).  However, the dominant function of caspase 8 is to transmit a pro-survival signal that suppresses programmed necrosis (or necroptosis) mediated by RIPK1 and RIPK3 (refs , , , , ) during embryogenesis and hematopoiesis.  Suppression of necrotic cell death by caspase 8 requires its catalytic activity but not the autocleavage essential for apoptosis; however, the key substrate processed by caspase 8 to block necrosis has been elusive.  A key substrate must meet three criteria: it must be essential for programmed necrosis; it must be cleaved by caspase 8 in situations where caspase 8 is blocking necrosis; and mutation of the caspase 8 processing site on the substrate should convert a pro-survival response to necrotic death without the need for caspase 8 inhibition.  We now identify CYLD as a substrate for caspase 8 that satisfies these criteria.  Following TNF stimulation, caspase 8 cleaves CYLD to generate a survival signal.  In contrast, loss of caspase 8 prevented CYLD degrdn., resulting in necrotic death.  A CYLD substitution mutation at Asp 215 that cannot be cleaved by caspase 8 switches cell survival to necrotic cell death in response to TNF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CASDRvG6a7Vg90H21EOLACvtfcHk0lglQDguy8jj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrL&md5=72d1e19c0fd92d5e9692b1a54b4f90dd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fncb2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2362%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BA.%26aulast%3DPerez-Jimenez%26aufirst%3DE.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DMassoumi%26aufirst%3DR.%26aulast%3DXavier%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DTing%26aufirst%3DA.%2BT.%26atitle%3DCaspase%25208%2520inhibits%2520programmed%2520necrosis%2520by%2520processing%2520CYLD%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1437%26epage%3D1442%26doi%3D10.1038%2Fncb2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feoktistova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geserick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrova, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span> <span> </span><span class="NLM_article-title">cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2011.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21737330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=449-463&author=M.+Feoktistovaauthor=P.+Geserickauthor=B.+Kellertauthor=D.+P.+Dimitrovaauthor=C.+Langlaisauthor=M.+Hupeauthor=K.+Cainauthor=M.+MacFarlaneauthor=G.+Hackerauthor=M.+Leverkus&title=cIAPs+block+Ripoptosome+formation%2C+a+RIP1%2Fcaspase-8+containing+intracellular+cell+death+complex+differentially+regulated+by+cFLIP+isoforms&doi=10.1016%2Fj.molcel.2011.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms</span></div><div class="casAuthors">Feoktistova, Maria; Geserick, Peter; Kellert, Beate; Dimitrova, Diana Panayotova; Langlais, Claudia; Hupe, Mike; Cain, Kelvin; MacFarlane, Marion; Haecker, Georg; Leverkus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The intracellular regulation of cell death pathways by cIAPs has been enigmatic.  Here we show that loss of cIAPs promotes the spontaneous formation of an intracellular platform that activates either apoptosis or necroptosis.  This 2 MDa intracellular complex that we designate "Ripoptosome" is necessary but not sufficient for cell death.  It contains RIP1, FADD, caspase-8, caspase-10, and caspase inhibitor cFLIP isoforms. cFLIPL prevents Ripoptosome formation, whereas, intriguingly, cFLIPS promotes Ripoptosome assembly.  When cIAPs are absent, caspase activity is the "rheostat" that is controlled by cFLIP isoforms in the Ripoptosome and decides if cell death occurs by RIP3-dependent necroptosis or caspase-dependent apoptosis.  RIP1 is the core component of the complex.  As exemplified by our studies for TLR3 activation, our data argue that the Ripoptosome critically influences the outcome of membrane-bound receptor triggering.  The differential quality of cell death mediated by the Ripoptosome may cause important pathophysiol. consequences during inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhfGgsTTImLVg90H21EOLACvtfcHk0lglQDguy8jj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrY%253D&md5=6e61d717861960c0ecbad7ae84e7ad62</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DFeoktistova%26aufirst%3DM.%26aulast%3DGeserick%26aufirst%3DP.%26aulast%3DKellert%26aufirst%3DB.%26aulast%3DDimitrova%26aufirst%3DD.%2BP.%26aulast%3DLanglais%26aufirst%3DC.%26aulast%3DHupe%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DHacker%26aufirst%3DG.%26aulast%3DLeverkus%26aufirst%3DM.%26atitle%3DcIAPs%2520block%2520Ripoptosome%2520formation%252C%2520a%2520RIP1%252Fcaspase-8%2520containing%2520intracellular%2520cell%2520death%2520complex%2520differentially%2520regulated%2520by%2520cFLIP%2520isoforms%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D43%26spage%3D449%26epage%3D463%26doi%3D10.1016%2Fj.molcel.2011.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachariou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2011.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21737329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=432-448&author=T.+Tenevauthor=K.+Bianchiauthor=M.+Dardingauthor=M.+Broemerauthor=C.+Langlaisauthor=F.+Wallbergauthor=A.+Zachariouauthor=J.+Lopezauthor=M.+MacFarlaneauthor=K.+Cainauthor=P.+Meier&title=The+Ripoptosome%2C+a+signaling+platform+that+assembles+in+response+to+genotoxic+stress+and+loss+of+IAPs&doi=10.1016%2Fj.molcel.2011.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs</span></div><div class="casAuthors">Tenev, Tencho; Bianchi, Katiuscia; Darding, Maurice; Broemer, Meike; Langlais, Claudia; Wallberg, Fredrik; Zachariou, Anna; Lopez, Juanita; MacFarlane, Marion; Cain, Kelvin; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-448</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A better understanding of the mechanisms through which anticancer drugs exert their effects is essential to improve combination therapies.  While studying how genotoxic stress kills cancer cells, we discovered a large ∼2MDa cell death-inducing platform, referred to as "Ripoptosome." It contains the core components RIP1, FADD, and caspase-8, and assembles in response to genotoxic stress-induced depletion of XIAP, cIAP1 and cIAP2.  Importantly, it forms independently of TNF, CD95L/FASL, TRAIL, death-receptors, and mitochondrial pathways.  It also forms upon Smac-mimetic (SM) treatment without involvement of autocrine TNF.  Ripoptosome assembly requires RIP1's kinase activity and can stimulate caspase-8-mediated apoptosis as well as caspase-independent necrosis.  It is neg. regulated by FLIP, cIAP1, cIAP2, and XIAP.  Mechanistically, IAPs target components of this complex for ubiquitylation and inactivation.  Moreover, we find that etoposide-stimulated Ripoptosome formation converts proinflammatory cytokines into prodeath signals.  Together, our observations shed new light on fundamental mechanisms by which chemotherapeutics may kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIDpVuGme2BbVg90H21EOLACvtfcHk0lglQDguy8jj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrs%253D&md5=efd6febf43090282226e5d0ffc3a72ae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DBroemer%26aufirst%3DM.%26aulast%3DLanglais%26aufirst%3DC.%26aulast%3DWallberg%26aufirst%3DF.%26aulast%3DZachariou%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DJ.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DThe%2520Ripoptosome%252C%2520a%2520signaling%2520platform%2520that%2520assembles%2520in%2520response%2520to%2520genotoxic%2520stress%2520and%2520loss%2520of%2520IAPs%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D43%26spage%3D432%26epage%3D448%26doi%3D10.1016%2Fj.molcel.2011.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e76841</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0076841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0076841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24098568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76841&author=D.+M.+Moquinauthor=T.+McQuadeauthor=F.+K.+Chan&title=CYLD+deubiquitinates+RIP1+in+the+TNFalpha-induced+necrosome+to+facilitate+kinase+activation+and+programmed+necrosis&doi=10.1371%2Fjournal.pone.0076841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis</span></div><div class="casAuthors">Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e76841</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Necroptosis/programmed necrosis is initiated by a macromol. protein complex termed the necrosome.  Receptor interacting protein kinase 1 (RIPK1/RIP1) and RIP3 are key components of the necrosome.  TNFα is a prototypic inducer of necrosome activation, and it is widely believed that deubiquitination of RIP1 at the TNFR-1 signaling complex precedes transition of RIP1 into the cytosol where it forms the RIP1-RIP3 necrosome.  Cylindromatosis (CYLD) is believed to promote programmed necrosis by facilitating RIP1 deubiquitination at this membrane receptor complex.  We demonstrate that RIP1 is indeed the primary target of CYLD in TNFα-induced programmed necrosis.  We obsd. that CYLD does not regulate RIP1 ubiquitination at the TNF receptor.  TNF and zVAD-induced programmed necrosis was highly attenuated in CYLD-/- cells.  However, in the presence of cycloheximide or SMAC mimetics, programmed necrosis was only moderately reduced in CYLD-/- cells.  Under the latter conditions, RIP1-RIP3 necrosome formation is only delayed, but not abolished in CYLD-/- cells.  We further demonstrate that RIP1 within the NP-40 insol. necrosome is ubiquitinated and that CYLD regulates RIP1 ubiquitination in this compartment.  Hence, RIP1 ubiquitination in this late-forming complex is greatly increased in CYLD-/- cells.  Increased RIP1 ubiquitination impairs RIP1 and RIP3 phosphorylation, a signature of kinase activation.  Our results show that CYLD regulates RIP1 ubiquitination in the TNFα-induced necrosome, but not in the TNFR-1 signaling complex.  In cells sensitized to programmed necrosis with SMAC mimetics, CYLD is not essential for necrosome assembly.  Since SMAC mimetics induces the loss of the E3 ligases cIAP1 and cIAP2, reduced RIP1 ubiquitination could lead to reduced requirement for CYLD to remove ubiquitin chains from RIP1 in the TNFR-1 complex.  As increased RIP1 ubiquitination in the necrosome correlates with impaired RIP1 and RIP3 phosphorylation and function, these results suggest that CYLD controls RIP1 kinase activity during necrosome assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc0d2j3EJAfbVg90H21EOLACvtfcHk0lgMsNSFXZhZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrurzK&md5=0385f6fa8152b657bccaa5739b010536</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076841%26sid%3Dliteratum%253Aachs%26aulast%3DMoquin%26aufirst%3DD.%2BM.%26aulast%3DMcQuade%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DCYLD%2520deubiquitinates%2520RIP1%2520in%2520the%2520TNFalpha-induced%2520necrosome%2520to%2520facilitate%2520kinase%2520activation%2520and%2520programmed%2520necrosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De76841%26doi%3D10.1371%2Fjournal.pone.0076841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span> <span> </span><span class="NLM_article-title">Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2056</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2007.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cellsig.2007.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17644308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=2056-2067&author=S.+Fengauthor=Y.+Yangauthor=Y.+Meiauthor=L.+Maauthor=D.+E.+Zhuauthor=N.+Hotiauthor=M.+Castanaresauthor=M.+Wu&title=Cleavage+of+RIP3+inactivates+its+caspase-independent+apoptosis+pathway+by+removal+of+kinase+domain&doi=10.1016%2Fj.cellsig.2007.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain</span></div><div class="casAuthors">Feng, Shanshan; Yang, Yonghui; Mei, Yide; Ma, Li; Zhu, De-e; Hoti, Naseruddin; Castanares, Mark; Wu, Mian</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2056-2067</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RIP3 (Receptor Interacting Protein 3), a member of the Ser/Thr kinase family, is able to induce apoptosis and activate NF-κB in various cell types.  However, the detailed mechanism of RIP3-induced apoptosis is largely unknown.  In this study, we show that RIP3 is cleaved at Asp328 by caspase-8 under apoptotic stimuli, which is blocked by pan-caspase inhibitor Z-VAD-FMK.  In addn., full-length RIP3 induces both caspase-dependent and-independent apoptosis, as well as activates NF-κB.  However, after cleavage, the C-terminus of RIP3 (aa 329-518) that lacks the kinase domain can form punctuate or filaments-like structures in cytoplasm, which induces only caspase-dependent apoptosis and exhibits a markedly higher NF-κB-activating activity than full-length RIP3.  More importantly, the cleaved product of RIP3 (aa 329-518) displays better stability than wild type RIP3.  Addnl., RIP3(K50A), a kinase-dead RIP3 mutant, also induces only caspase-dependent apoptosis along with an increased NF-κB-activating activity compared to RIP3, which further demonstrates that kinase activity of RIP3 is essential for its caspase-independent apoptotic activity.  These results will help us to understand the mechanism underlying RIP3-induced apoptosis and the different roles of kinase domain and unique domain of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQchn1imoRa7Vg90H21EOLACvtfcHk0liS6S1bjdz2gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFylsb4%253D&md5=79b356b6e84a0086b411deaee17abab9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DD.%2BE.%26aulast%3DHoti%26aufirst%3DN.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DM.%26atitle%3DCleavage%2520of%2520RIP3%2520inactivates%2520its%2520caspase-independent%2520apoptosis%2520pathway%2520by%2520removal%2520of%2520kinase%2520domain%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D2056%26epage%3D2067%26doi%3D10.1016%2Fj.cellsig.2007.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondelinger, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montessuit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggeman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulpiau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24813885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=971-981&author=Y.+Dondelingerauthor=W.+Declercqauthor=S.+Montessuitauthor=R.+Roelandtauthor=A.+Goncalvesauthor=I.+Bruggemanauthor=P.+Hulpiauauthor=K.+Weberauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Goughauthor=S.+Savvidesauthor=J.+C.+Martinouauthor=M.+J.+Bertrandauthor=P.+Vandenabeele&title=MLKL+compromises+plasma+membrane+integrity+by+binding+to+phosphatidylinositol+phosphates&doi=10.1016%2Fj.celrep.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates</span></div><div class="casAuthors">Dondelinger, Yves; Declercq, Wim; Montessuit, Sylvie; Roelandt, Ria; Goncalves, Amanda; Bruggeman, Inge; Hulpiau, Paco; Weber, Kathrin; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Gough, Peter J.; Savvides, Savvas; Martinou, Jean-Claude; Bertrand, Mathieu J. M.; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although mixed lineage kinase domain-like (MLKL) protein has emerged as a specific and crucial protein for necroptosis induction, how MLKL transduces the death signal remains poorly understood.  Here, we demonstrate that the full four-helical bundle domain (4HBD) in the N-terminal region of MLKL is required and sufficient to induce its oligomerization and trigger cell death.  Moreover, we found that a patch of pos. charged amino acids on the surface of the 4HBD binds to phosphatidylinositol phosphates (PIPs) and allows recruitment of MLKL to the plasma membrane.  Importantly, we found that recombinant MLKL, but not a mutant lacking these pos. charges, induces leakage of PIP-contg. liposomes as potently as BAX, supporting a model in which MLKL induces necroptosis by directly permeabilizing the plasma membrane.  Accordingly, we found that inhibiting the formation of PI(5)P and PI(4,5)P2 specifically inhibits tumor necrosis factor (TNF)-mediated necroptosis but not apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRumZDmhVGLVg90H21EOLACvtfcHk0liS6S1bjdz2gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D&md5=42d9a43216f884c12bd4288658563873</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DDondelinger%26aufirst%3DY.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DMontessuit%26aufirst%3DS.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DGoncalves%26aufirst%3DA.%26aulast%3DBruggeman%26aufirst%3DI.%26aulast%3DHulpiau%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSavvides%26aufirst%3DS.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DMLKL%2520compromises%2520plasma%2520membrane%2520integrity%2520by%2520binding%2520to%2520phosphatidylinositol%2520phosphates%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D971%26epage%3D981%26doi%3D10.1016%2Fj.celrep.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/ncb2883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fncb2883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24316671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=55-65&author=Z.+Caiauthor=S.+Jitkaewauthor=J.+Zhaoauthor=H.+C.+Chiangauthor=S.+Choksiauthor=J.+Liuauthor=Y.+Wardauthor=L.+G.+Wuauthor=Z.+G.+Liu&title=Plasma+membrane+translocation+of+trimerized+MLKL+protein+is+required+for+TNF-induced+necroptosis&doi=10.1038%2Fncb2883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span></div><div class="casAuthors">Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Chiang, Hsueh-Cheng; Choksi, Swati; Liu, Jie; Ward, Yvona; Wu, Ling-gang; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumor necrosis factor (TNF)-induced necroptosis.  MLKL is phosphorylated by RIP3 and is recruited to the necrosome through its interaction with RIP3.  However, it is still unknown how MLKL mediates TNF-induced necroptosis.  Here, we report that MLKL forms a homotrimer through its amino-terminal coiled-coil domain and locates to the cell plasma membrane during TNF-induced necroptosis.  By generating different MLKL mutants, we demonstrated that the plasma membrane localization of trimerized MLKL is crit. for mediating necroptosis.  Importantly, we found that the membrane localization of MLKL is essential for Ca2+ influx, which is an early event of TNF-induced necroptosis.  Furthermore, we identified that TRPM7 (transient receptor potential melastatin related 7) is a MLKL downstream target for the mediation of Ca2+ influx and TNF-induced necroptosis.  Hence, our study reveals a crucial mechanism of MLKL-mediated TNF-induced necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjJZlohdKsLVg90H21EOLACvtfcHk0liS6S1bjdz2gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E&md5=95e4468ee729b5a3bd8ab8ce49af8f25</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncb2883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2883%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DH.%2BC.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DPlasma%2520membrane%2520translocation%2520of%2520trimerized%2520MLKL%2520protein%2520is%2520required%2520for%2520TNF-induced%2520necroptosis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D55%26epage%3D65%26doi%3D10.1038%2Fncb2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24703947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=133-146&author=H.+Wangauthor=L.+Sunauthor=L.+Suauthor=J.+Rizoauthor=L.+Liuauthor=L.+F.+Wangauthor=F.+S.+Wangauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+MLKL+causes+necrotic+membrane+disruption+upon+phosphorylation+by+RIP3&doi=10.1016%2Fj.molcel.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3</span></div><div class="casAuthors">Wang, Huayi; Sun, Liming; Su, Lijing; Rizo, Josep; Liu, Lei; Wang, Li-Feng; Wang, Fu-Sheng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Programmed necrotic cell death induced by the tumor necrosis factor alpha (TNF-α) family of cytokines is dependent on a kinase cascade consisting of receptor-interacting kinases RIP1 and RIP3.  How these kinase activities cause cells to die by necrosis is not known.  The mixed lineage kinase domain-like protein MLKL is a functional RIP3 substrate that binds to RIP3 through its kinase-like domain but lacks kinase activity of its own.  RIP3 phosphorylates MLKL at the T357 and S358 sites.  Reported here is the development of a monoclonal antibody that specifically recognizes phosphorylated MLKL in cells dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced liver injury.  The phosphorylated MLKL forms an oligomer that binds to phosphatidylinositol lipids and cardiolipin.  This property allows MLKL to move from the cytosol to the plasma and intracellular membranes, where it directly disrupts membrane integrity, resulting in necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1gUpKITrVg90H21EOLACvtfcHk0lgzcdxQlp9TaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D&md5=8e4ab8e0a49933201ed49b147b6b189e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DF.%2BS.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520MLKL%2520causes%2520necrotic%2520membrane%2520disruption%2520upon%2520phosphorylation%2520by%2520RIP3%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D133%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/cr.2013.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcr.2013.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24366341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=105-121&author=X.+Chenauthor=W.+Liauthor=J.+Renauthor=D.+Huangauthor=W.+T.+Heauthor=Y.+Songauthor=C.+Yangauthor=W.+Liauthor=X.+Zhengauthor=P.+Chenauthor=J.+Han&title=Translocation+of+mixed+lineage+kinase+domain-like+protein+to+plasma+membrane+leads+to+necrotic+cell+death&doi=10.1038%2Fcr.2013.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span></div><div class="casAuthors">Chen, Xin; Li, Wenjuan; Ren, Junming; Huang, Deli; He, Wan-ting; Song, Yunlong; Yang, Chao; Li, Wanyun; Zheng, Xinru; Chen, Pengda; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like protein (MLKL) was identified to function downstream of receptor interacting protein 3 (RIP3) in tumor necrosis factor-α (TNF)-induced necrosis (also called necroptosis).  However, how MLKL functions to mediate necroptosis is unknown.  By reconstitution of MLKL function in MLKL-knockout cells, we showed that the N-terminus of MLKL is required for its function in necroptosis.  The oligomerization of MLKL in TNF-treated cells is essential for necroptosis, as artificially forcing MLKL together by using the hormone-binding domain (HBD*) triggers necroptosis.  Notably, forcing together the N-terminal domain (ND) but not the C-terminal kinase domain of MLKL causes necroptosis.  Further deletion anal. showed that the four-α-helix bundle of MLKL (1-130 amino acids) is sufficient to trigger necroptosis.  Both the HBD*-mediated and TNF-induced complexes of MLKL(ND) or MLKL are tetramers, and translocation of these complexes to lipid rafts of the plasma membrane precedes cell death.  The homo-oligomerization is required for MLKL translocation and the signal sequence for plasma membrane location is located in the junction of the first and second α-helixes of MLKL.  The plasma membrane translocation of MLKL or MLKL(ND) leads to sodium influx, and depletion of sodium from the cell culture medium inhibits necroptosis.  All of the above phenomena were not seen in apoptosis.  Thus, the MLKL oligomerization leads to translocation of MLKL to lipid rafts of plasma membrane, and the plasma membrane MLKL complex acts either by itself or via other proteins to increase the sodium influx, which increases osmotic pressure, eventually leading to membrane rupture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3gKfH7oX77Vg90H21EOLACvtfcHk0lgzcdxQlp9TaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVyr&md5=16ac2183df16e01d3555e4a099540aae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fcr.2013.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2013.171%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%2BT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DTranslocation%2520of%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%2520to%2520plasma%2520membrane%2520leads%2520to%2520necrotic%2520cell%2520death%26jtitle%3DCell%2520Res.%26date%3D2014%26volume%3D24%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fcr.2013.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span> <span> </span><span class="NLM_article-title">Necroptosis: the release of damage-associated molecular patterns and its physiological relevance</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.immuni.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23438821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVeht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=209-223&author=A.+Kaczmarekauthor=P.+Vandenabeeleauthor=D.+V.+Krysko&title=Necroptosis%3A+the+release+of+damage-associated+molecular+patterns+and+its+physiological+relevance&doi=10.1016%2Fj.immuni.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance</span></div><div class="casAuthors">Kaczmarek, Agnieszka; Vandenabeele, Peter; Krysko, Dmitri V.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-223</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Regulated necrosis, termed necroptosis, is neg. regulated by caspase-8 and is dependent on the kinase activity of RIPK1 and RIPK3.  Necroptosis leads to rapid plasma membrane permeabilization and to the release of cell contents and exposure of damage-assocd. mol. patterns (DAMPs).  We are only beginning to identify the necroptotic DAMPs, their modifications, and their potential role in the regulation of inflammation.  In this review, we discuss the physiol. relevance of necroptosis and its role in the modulation of inflammation.  For example, during viral infection, RIPK3-mediated necroptosis acts as a backup mechanism to clear pathogens.  Necroptosis is also involved in apparently immunol. silent maintenance of T cell homeostasis.  In contrast, the induction of necroptosis in skin, intestine, systemic inflammatory response syndrome, and ischemia reperfusion injury provoke a strong inflammatory response, which might be triggered by emission of DAMPs from necroptotic cells, showing the detrimental side of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwzS_R6I-CZ7Vg90H21EOLACvtfcHk0ljsDCKJ5CP-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVeht7k%253D&md5=899783987a1bb878995ed7d0b30d2daa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaczmarek%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26atitle%3DNecroptosis%253A%2520the%2520release%2520of%2520damage-associated%2520molecular%2520patterns%2520and%2520its%2520physiological%2520relevance%26jtitle%3DImmunity%26date%3D2013%26volume%3D38%26spage%3D209%26epage%3D223%26doi%3D10.1016%2Fj.immuni.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and inflammation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060815-014830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1146%2Fannurev-biochem-060815-014830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26865533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVGitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2016&pages=743-763&author=K.+Newtonauthor=G.+Manning&title=Necroptosis+and+inflammation&doi=10.1146%2Fannurev-biochem-060815-014830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and Inflammation</span></div><div class="casAuthors">Newton, Kim; Manning, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">743-763</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Necroptosis is a regulated form of necrosis, with the dying cell rupturing and releasing intracellular components that can trigger an innate immune response.  Toll-like receptor 3 and 4 agonists, tumor necrosis factor, certain viral infections, or the T cell receptor can trigger necroptosis if the activity of the protease caspase-8 is compromised.  Necroptosis signaling is modulated by the kinase RIPK1 and requires the kinase RIPK3 and the pseudokinase MLKL.  Either RIPK3 deficiency or RIPK1 inhibition confers resistance in various animal disease models, suggesting that inflammation caused by necroptosis contributes to tissue damage and that inhibitors of these kinases could have therapeutic potential.  Recent studies have revealed unexpected complexity in the regulation of cell death programs by RIPK1 and RIPK3 with the possibility that necroptosis is but one mechanism by which these kinases promote inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDHlIAqcEKR7Vg90H21EOLACvtfcHk0ljsDCKJ5CP-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVGitLw%253D&md5=ee7ea0c14e45d52158f7b9e50e338789</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060815-014830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060815-014830%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DG.%26atitle%3DNecroptosis%2520and%2520inflammation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2016%26volume%3D85%26spage%3D743%26epage%3D763%26doi%3D10.1146%2Fannurev-biochem-060815-014830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and its role in inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature14191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25592536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=311-320&author=M.+Pasparakisauthor=P.+Vandenabeele&title=Necroptosis+and+its+role+in+inflammation&doi=10.1038%2Fnature14191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and its role in inflammation</span></div><div class="casAuthors">Pasparakis, Manolis; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7534</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulated cell death has essential functions in development and in adult tissue homeostasis.  Necroptosis is a newly discovered pathway of regulated necrosis that requires the proteins RIPK3 and MLKL and is induced by death receptors, interferons, toll-like receptors, intracellular RNA and DNA sensors, and probably other mediators.  RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis.  Mouse-model studies have revealed important functions for necroptosis in inflammation and suggested that it could be implicated in the pathogenesis of many human inflammatory diseases.  We discuss the mechanisms regulating necroptosis and its potential role in inflammation and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA9_ozm2Tq27Vg90H21EOLACvtfcHk0ljsDCKJ5CP-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D&md5=3acc43a5a345c231eb47ba079211783e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature14191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14191%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecroptosis%2520and%2520its%2520role%2520in%2520inflammation%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D311%26epage%3D320%26doi%3D10.1038%2Fnature14191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1126/science.1172308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1172308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19498109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Sqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=332-336&author=D.+W.+Zhangauthor=J.+Shaoauthor=J.+Linauthor=N.+Zhangauthor=B.+J.+Luauthor=S.+C.+Linauthor=M.+Q.+Dongauthor=J.+Han&title=RIP3%2C+an+energy+metabolism+regulator+that+switches+TNF-induced+cell+death+from+apoptosis+to+necrosis&doi=10.1126%2Fscience.1172308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis</span></div><div class="casAuthors">Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lu, Bao-Ju; Lin, Sheng-Cai; Dong, Meng-Qiu; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5938</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Necrosis can be induced by stimulating death receptors with tumor necrosis factor (TNF) or other agonists; however, the underlying mechanism differentiating necrosis from apoptosis is largely unknown.  The authors identified the protein kinase receptor-interacting protein 3 (RIP3) as a mol. switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells.  RIP3 did not affect RIP1-mediated apoptosis but was required for RIP1-mediated necrosis and the enhancement of necrosis by the caspase inhibitor zVAD.  By activating key enzymes of metabolic pathways, RIP3 regulates TNF-induced reactive oxygen species prodn., which partially accounts for RIP3's ability to promote necrosis.  The authors' data suggest that modulation of energy metab. in response to death stimuli has an important role in the choice between apoptosis and necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOqRfzL9nh47Vg90H21EOLACvtfcHk0liil1pqnRH44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Sqt7Y%253D&md5=f30f0c410243ca8a71616fb6718b8612</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1172308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1172308%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BW.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DB.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DRIP3%252C%2520an%2520energy%2520metabolism%2520regulator%2520that%2520switches%2520TNF-induced%2520cell%2520death%2520from%2520apoptosis%2520to%2520necrosis%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D332%26epage%3D336%26doi%3D10.1126%2Fscience.1172308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19524512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1100-1111&author=S.+Heauthor=L.+Wangauthor=L.+Miaoauthor=T.+Wangauthor=F.+Duauthor=L.+Zhaoauthor=X.+Wang&title=Receptor+interacting+protein+kinase-3+determines+cellular+necrotic+response+to+TNF-alpha&doi=10.1016%2Fj.cell.2009.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α</span></div><div class="casAuthors">He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1111</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Smac mimetics induce apoptosis synergistically with TNF-α by triggering the formation of a caspase-8-activating complex contg. receptor interacting protein kinase-1 (RIPK1).  Caspase inhibitors block this form of apoptosis in many types of cells.  However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis.  A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis.  The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction.  The kinase activity of RIP3 is essential for necrosis execution.  Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex.  Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model.  These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-α family of death-inducing cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymGY6l3d1LbVg90H21EOLACvtfcHk0liil1pqnRH44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D&md5=6397b34b896f8fe36c726f6d2ab39933</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DReceptor%2520interacting%2520protein%2520kinase-3%2520determines%2520cellular%2520necrotic%2520response%2520to%2520TNF-alpha%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1100%26epage%3D1111%26doi%3D10.1016%2Fj.cell.2009.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2011.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22265413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=213-227&author=L.+Sunauthor=H.+Wangauthor=Z.+Wangauthor=S.+Heauthor=S.+Chenauthor=D.+Liaoauthor=L.+Wangauthor=J.+Yanauthor=W.+Liuauthor=X.+Leiauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+mediates+necrosis+signaling+downstream+of+RIP3+kinase&doi=10.1016%2Fj.cell.2011.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span></div><div class="casAuthors">Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The receptor-interacting serine-threonine kinase 3 (RIP3) is a key signaling mol. in the programmed necrosis (necroptosis) pathway.  This pathway plays important roles in a variety of physiol. and pathol. conditions, including development, tissue damage response, and antiviral immunity.  Here, we report the identification of a small mol. called (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide-hereafter referred to as necrosulfonamide-that specifically blocks necrosis downstream of RIP3 activation.  An affinity probe derived from necrosulfonamide and coimmunopptn. using anti-RIP3 antibodies both identified the mixed lineage kinase domain-like protein (MLKL) as the interacting target.  MLKL was phosphorylated by RIP3 at the threonine 357 and serine 358 residues, and these phosphorylation events were crit. for necrosis.  Treating cells with necrosulfonamide or knocking down MLKL expression arrested necrosis at a specific step at which RIP3 formed discrete punctae in cells.  These findings implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.  MLKL connects RIP1 and RIP3 with its downstream targets.  In response to necrosis induction, activated RIP3 binds and phosphorylates MLKL, allowing downstream necrosis signaling to proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTbwLFup35LVg90H21EOLACvtfcHk0liil1pqnRH44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D&md5=c3301ecd27c6892817e18b42c56bd97e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520mediates%2520necrosis%2520signaling%2520downstream%2520of%2520RIP3%2520kinase%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D213%26epage%3D227%26doi%3D10.1016%2Fj.cell.2011.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5327</span>, <span class="refDoi"> DOI: 10.1073/pnas.1200012109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1200012109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22421439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5322-5327&author=J.+Zhaoauthor=S.+Jitkaewauthor=Z.+Caiauthor=S.+Choksiauthor=Q.+Liauthor=J.+Luoauthor=Z.+G.+Liu&title=Mixed+lineage+kinase+domain-like+is+a+key+receptor+interacting+protein+3+downstream+component+of+TNF-induced+necrosis&doi=10.1073%2Fpnas.1200012109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span></div><div class="casAuthors">Zhao, Jie; Jitkaew, Siriporn; Cai, Zhenyu; Choksi, Swati; Li, Qiuning; Luo, Ji; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5322-5327, S5322/1-S5322/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is an important inflammatory cytokine and induces many cellular responses, including inflammation, cell proliferation, apoptosis, and necrosis.  It is known that receptor interacting protein (RIP) kinases, RIP1 and RIP3, are key effectors of TNF-induced necrosis, but little is known about how these two RIP kinases mediate this process, although reactive oxygen species (ROS) generation and JNK activation have been suggested to be two downstream events of RIP kinases.  Here we report the identification of mixed lineage kinase domain-like, MLKL, as a key RIP3 downstream component of TNF-induced necrosis.  Through screening a kinase/phosphatase shRNA library in human colon adenocarcinoma HT-29 cells, we found that knockdown of MLKL blocked TNF-induced necrosis.  Our data suggest that MLKL functions downstream of R1P1 and RIP3 and is recruited to the necrosome through its interaction with RIP3.  Finally, we found that MLKL is required for the generation of ROS and the late-phase activation of JNK during TNF-induced necrosis.  However, because these two events are not involved in TNF-induced necrosis in HT-29 cells, the target of MLKL during TNF-induced necrosis remains elusive.  Taken together, our study suggests that MLKL is a key RIP3 downstream component of TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA3gnnPnZluLVg90H21EOLACvtfcHk0lgcpXYaQUhOGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D&md5=74fd138fd18afacf677003f41d6be280</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1200012109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1200012109%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520is%2520a%2520key%2520receptor%2520interacting%2520protein%25203%2520downstream%2520component%2520of%2520TNF-induced%2520necrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5322%26epage%3D5327%26doi%3D10.1073%2Fpnas.1200012109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0lgcpXYaQUhOGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guildford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2009.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19524513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1112-1123&author=Y.+S.+Choauthor=S.+Challaauthor=D.+Moquinauthor=R.+Gengaauthor=T.+D.+Rayauthor=M.+Guildfordauthor=F.+K.+Chan&title=Phosphorylation-driven+assembly+of+the+RIP1-RIP3+complex+regulates+programmed+necrosis+and+virus-induced+inflammation&doi=10.1016%2Fj.cell.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span></div><div class="casAuthors">Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Dutta Ray, Tathagat; Guildford, Melissa; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1112-1123</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Programmed necrosis is a form of caspase-independent cell death whose mol. regulation is poorly understood.  The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-κB.  The authors postulated that addnl. mols. are required to specifically activate programmed necrosis.  Using a RNA interference screen, the authors identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection.  RIP3 regulates necrosis-specific RIP1 phosphorylation.  The phosphorylation of RIP1 and RIP3 stabilizes their assocn. within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species prodn.  The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection.  Consequently, RIP3-/- mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication.  The authors' findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmgsGJGayANrVg90H21EOLACvtfcHk0lgcpXYaQUhOGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D&md5=6c158081daa49222becf864ac4a23885</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DMoquin%26aufirst%3DD.%26aulast%3DGenga%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DT.%2BD.%26aulast%3DGuildford%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DPhosphorylation-driven%2520assembly%2520of%2520the%2520RIP1-RIP3%2520complex%2520regulates%2520programmed%2520necrosis%2520and%2520virus-induced%2520inflammation%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1112%26epage%3D1123%26doi%3D10.1016%2Fj.cell.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlic, M.</span></span> <span> </span><span class="NLM_article-title">The diverse role of RIP kinases in necroptosis and inflammation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1038/ni.3206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fni.3206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26086143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=689-697&author=J.+Silkeauthor=J.+A.+Rickardauthor=M.+Gerlic&title=The+diverse+role+of+RIP+kinases+in+necroptosis+and+inflammation&doi=10.1038%2Fni.3206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse role of RIP kinases in necroptosis and inflammation</span></div><div class="casAuthors">Silke, John; Rickard, James A.; Gerlic, Motti</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a healthy response to infection or danger and should be rapid, specific and terminated once the threat has passed.  Inflammatory diseases, where this regulation fails, cause considerable human suffering.  Treatments have successfully targeted pro-inflammatory cytokines, such as tumor-necrosis factor (TNF), that directly induce genes encoding inflammatory products.  Inflammatory signals, including TNF, may also directly induce caspase-independent cell death (necroptosis), which can also elicit inflammation.  Necroptosis was originally defined as being dependent on the kinase RIPK1 but is now known to be dependent on RIPK3 and the pseudo-kinase MLKL.  Therefore, RIPK1, RIPK3 and MLKL are potential therapeutic targets.  RIPK1 and RIPK3 also directly regulate inflammatory signaling, which complicates interpretation of their function but might alter their therapeutic utility.  This Review examines the role of cell death, particularly necroptosis, in inflammation, in the context of recent insights into the roles of the key necroptosis effector mols. RIPK1, RIPK3 and MLKL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwQIKren3X7Vg90H21EOLACvtfcHk0lhhAL50pZji1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E&md5=124026d3c7caa25e1d416c6cb2bd8d87</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fni.3206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3206%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DJ.%2BA.%26aulast%3DGerlic%26aufirst%3DM.%26atitle%3DThe%2520diverse%2520role%2520of%2520RIP%2520kinases%2520in%2520necroptosis%2520and%2520inflammation%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26spage%3D689%26epage%3D697%26doi%3D10.1038%2Fni.3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1038/s41583-018-0093-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41583-018-0093-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30467385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=19-33&author=J.+Yuanauthor=P.+Aminauthor=D.+Ofengeim&title=Necroptosis+and+RIPK1-mediated+neuroinflammation+in+CNS+diseases&doi=10.1038%2Fs41583-018-0093-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span></div><div class="casAuthors">Yuan, Junying; Amin, Palak; Ofengeim, Dimitry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death.  However, under pathol. conditions, upregulation of death receptor family ligands, such as tumor necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL).  Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease.  In this Review, we outline the evidence implicating necroptosis in these neurol. diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SkNdlkg47rVg90H21EOLACvtfcHk0lhhAL50pZji1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O&md5=935fd7ac622d04317a9f7c2c21f40717</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41583-018-0093-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41583-018-0093-1%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DOfengeim%26aufirst%3DD.%26atitle%3DNecroptosis%2520and%2520RIPK1-mediated%2520neuroinflammation%2520in%2520CNS%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2019%26volume%3D20%26spage%3D19%26epage%3D33%26doi%3D10.1038%2Fs41583-018-0093-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Necroptosis in health and diseases</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2014.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.semcdb.2014.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25087983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=14-23&author=W.+Zhouauthor=J.+Yuan&title=Necroptosis+in+health+and+diseases&doi=10.1016%2Fj.semcdb.2014.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis in health and diseases</span></div><div class="casAuthors">Zhou, Wen; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14-23</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Necroptosis is a form of regulated necrosis that can be activated by ligands of death receptors and stimuli that induce the expression of death receptor ligands under apoptotic deficient conditions.  Activation of necroptosis by ligands of death receptors requires the kinase activity of RIP1, which mediates the activation of RIP3 and MLKL, two crit. downstream mediators of necroptosis.  Blocking the kinase activity of RIP1, a key druggable target in the necroptosis pathway, by necrostatins inhibits the activation of necroptosis and allows cell survival and proliferation in the presence of death receptor ligands.  The activation of necroptosis is modulated by different forms of ubiquitination, including K63, linear and K48 ubiquitination, as well as phosphorylation of RIP1, RIP3 and MLKL.  Necroptosis is suppressed by caspase-8/FADD-mediated apoptosis.  Deficiency in caspase-8 and FADD leads to embryonic lethality, tissue degeneration and inflammation which can be suppressed by inhibition of RIP1 kinase and RIP3.  On the other hand, the lack of RIP3 kinase activity leads to early embryonic lethality which can be suppressed by the loss of caspase-8, suggesting that although the kinase activity of RIP3 is involved in mediating necroptosis, the basal activity of RIP3 kinase may be required for suppressing caspase-8 mediated apoptosis.  Necroptosis as well as RIP1- and RIP3-mediated inflammatory response have been implicated in mediating multiple human diseases including TNF-mediated hypothermia and systemic inflammation, ischemic reperfusion injury, neurodegeneration, Gaucher's disease, progressive atherosclerotic lesions, etc.  Targeting RIP1 kinase may provide therapeutic benefits for the treatment of human diseases characterized by necrosis and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8_BPfzp_ambVg90H21EOLACvtfcHk0lhhAL50pZji1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClurzO&md5=fd986c50bf0c1ef8b247f221b67d4cb1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2014.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DNecroptosis%2520in%2520health%2520and%2520diseases%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D14%26epage%3D23%26doi%3D10.1016%2Fj.semcdb.2014.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitz, S. I.</span></span> <span> </span><span class="NLM_article-title">Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1576</span>, <span class="refDoi"> DOI: 10.1002/jnr.22314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1002%2Fjnr.22314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=1569-1576&author=D.+M.+Rosenbaumauthor=A.+Degterevauthor=J.+Davidauthor=P.+S.+Rosenbaumauthor=S.+Rothauthor=J.+C.+Grottaauthor=G.+D.+Cunyauthor=J.+Yuanauthor=S.+I.+Savitz&title=Necroptosis%2C+a+novel+form+of+caspase-independent+cell+death%2C+contributes+to+neuronal+damage+in+a+retinal+ischemia-reperfusion+injury+model&doi=10.1002%2Fjnr.22314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22314%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DP.%2BS.%26aulast%3DRoth%26aufirst%3DS.%26aulast%3DGrotta%26aufirst%3DJ.%2BC.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSavitz%26aufirst%3DS.%2BI.%26atitle%3DNecroptosis%252C%2520a%2520novel%2520form%2520of%2520caspase-independent%2520cell%2520death%252C%2520contributes%2520to%2520neuronal%2520damage%2520in%2520a%2520retinal%2520ischemia-reperfusion%2520injury%2520model%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D88%26spage%3D1569%26epage%3D1576%26doi%3D10.1002%2Fjnr.22314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. M.</span></span> <span> </span><span class="NLM_article-title">Necroptosis in neurodegenerative diseases: a potential therapeutic target</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2905</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2017.286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28661482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e2905&author=S.+Zhangauthor=M.+B.+Tangauthor=H.+Y.+Luoauthor=C.+H.+Shiauthor=Y.+M.+Xu&title=Necroptosis+in+neurodegenerative+diseases%3A+a+potential+therapeutic+target&doi=10.1038%2Fcddis.2017.286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis in neurodegenerative diseases: a potential therapeutic target</span></div><div class="casAuthors">Zhang, Shuo; Tang, Mi-bo; Luo, Hai-yang; Shi, Chang-he; Xu, Yu-ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2905</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurodegenerative diseases are a group of chronic progressive disorders characterized by neuronal loss.  Necroptosis, a recently discovered form of programmed cell death, is a cell death mechanism that has necrosis-like morphol. characteristics.  Necroptosis activation relies on the receptor-interacting protein (RIP) homol. interaction motif (RHIM).  A variety of RHIM-contg. proteins transduce necroptotic signals from the cell trigger to the cell death mediators RIP3 and mixed lineage kinase domain-like protein (MLKL).  RIP1 plays a particularly important and complex role in necroptotic cell death regulation ranging from cell death activation to inhibition, and these functions are often cell type and context dependent.  Increasing evidence suggests that necroptosis plays an important role in the pathogenesis of neurodegenerative diseases.  Moreover, small mols. such as necrostatin-1 are thought inhibit necroptotic signaling pathway.  Understanding the precise mechanisms underlying necroptosis and its interactions with other cell death pathways in neurodegenerative diseases could provide significant therapeutic insights.  The present review is aimed at summarizing the mol. mechanisms of necroptosis and highlighting the emerging evidence on necroptosis as a major driver of neuron cell death in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZy6uU_ivijrVg90H21EOLACvtfcHk0lg6-jfmGUE_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7jM&md5=ba20c4fb8e82c7d99da7d5bba4291344</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.286%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DM.%2BB.%26aulast%3DLuo%26aufirst%3DH.%2BY.%26aulast%3DShi%26aufirst%3DC.%2BH.%26aulast%3DXu%26aufirst%3DY.%2BM.%26atitle%3DNecroptosis%2520in%2520neurodegenerative%2520diseases%253A%2520a%2520potential%2520therapeutic%2520target%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De2905%26doi%3D10.1038%2Fcddis.2017.286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saberi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouchida, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1126/science.aaf6803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.aaf6803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27493188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oks7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2016&pages=603-608&author=Y.+Itoauthor=D.+Ofengeimauthor=A.+Najafovauthor=S.+Dasauthor=S.+Saberiauthor=Y.+Liauthor=J.+Hitomiauthor=H.+Zhuauthor=H.+Chenauthor=L.+Mayoauthor=J.+Gengauthor=P.+Aminauthor=J.+P.+DeWittauthor=A.+K.+Mookhtiarauthor=M.+Florezauthor=A.+T.+Ouchidaauthor=J.+B.+Fanauthor=M.+Pasparakisauthor=M.+A.+Kelliherauthor=J.+Ravitsauthor=J.+Yuan&title=RIPK1+mediates+axonal+degeneration+by+promoting+inflammation+and+necroptosis+in+ALS&doi=10.1126%2Fscience.aaf6803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS</span></div><div class="casAuthors">Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Das, Sudeshna; Saberi, Shahram; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Mayo, Lior; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Fan, Jian-bing; Pasparakis, Manolis; Kelliher, Michelle A.; Ravits, John; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6299</span>),
    <span class="NLM_cas:pages">603-608</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mutations in the optineurin (OPTN) gene have been implicated in both familial and sporadic amyotrophic lateral sclerosis (ALS).  However, the role of this protein in the central nervous system (CNS) and how it may contribute to ALS pathol. are unclear.  Here, we found that optineurin actively suppressed receptor-interacting kinase 1 (RIPK1)-dependent signaling by regulating its turnover.  Loss of OPTN led to progressive dysmyelination and axonal degeneration through engagement of necroptotic machinery in the CNS, including RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL).  Furthermore, RIPK1- and RIPK3-mediated axonal pathol. was commonly obsd. in SOD1G93A transgenic mice and pathol. samples from human ALS patients.  Thus, RIPK1 and RIPK3 play a crit. role in mediating progressive axonal degeneration.  Furthermore, inhibiting RIPK1 kinase may provide an axonal protective strategy for the treatment of ALS and other human degenerative diseases characterized by axonal degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo120pi55BWcLVg90H21EOLACvtfcHk0lg6-jfmGUE_7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oks7jO&md5=6145b22849aa523b5dc1200dc8610c1c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf6803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf6803%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DNajafov%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DSaberi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DL.%26aulast%3DGeng%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DDeWitt%26aufirst%3DJ.%2BP.%26aulast%3DMookhtiar%26aufirst%3DA.%2BK.%26aulast%3DFlorez%26aufirst%3DM.%26aulast%3DOuchida%26aufirst%3DA.%2BT.%26aulast%3DFan%26aufirst%3DJ.%2BB.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DRavits%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRIPK1%2520mediates%2520axonal%2520degeneration%2520by%2520promoting%2520inflammation%2520and%2520necroptosis%2520in%2520ALS%26jtitle%3DScience%26date%3D2016%26volume%3D353%26spage%3D603%26epage%3D608%26doi%3D10.1126%2Fscience.aaf6803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzitelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mifflin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adiconis, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E8788</span>– <span class="NLM_lpage">E8797</span>, <span class="refDoi"> DOI: 10.1073/pnas.1714175114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1714175114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28904096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2jtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E8788-E8797&author=D.+Ofengeimauthor=S.+Mazzitelliauthor=Y.+Itoauthor=J.+P.+DeWittauthor=L.+Mifflinauthor=C.+Zouauthor=S.+Dasauthor=X.+Adiconisauthor=H.+Chenauthor=H.+Zhuauthor=M.+A.+Kelliherauthor=J.+Z.+Levinauthor=J.+Yuan&title=RIPK1+mediates+a+disease-associated+microglial+response+in+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.1714175114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 mediates a disease-associated microglial response in Alzheimer's disease</span></div><div class="casAuthors">Ofengeim, Dimitry; Mazzitelli, Sonia; Ito, Yasushi; DeWitt, Judy Park; Mifflin, Lauren; Zou, Chengyu; Das, Sudeshna; Adiconis, Xian; Chen, Hongbo; Zhu, Hong; Kelliher, Michelle A.; Levin, Joshua Z.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">E8788-E8797</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Dysfunction of microglia is known to play an important role in Alzheimer's disease (AD).  Here, we investigated the role of RIPK1 in microglia mediating the pathogenesis of AD.  RIPK1 is highly expressed by microglial cells in human AD brains.  Using the amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model, we found that inhibition of RIPK1, using both pharmacol. and genetic means, reduced amyloid burden, the levels of inflammatory cytokines, and memory deficits.  Furthermore, inhibition of RIPK1 promoted microglial degrdn. of Aβ in vitro.  We characterized the transcriptional profiles of adult microglia from APP/PS1 mice and identified a role for RIPK1 in regulating the microglial expression of CH25H and Cst7, a marker for disease-assocd. microglia (DAM), which encodes an endosomal/lysosomal cathepsin inhibitor named Cystatin F.  We present evidence that RIPK1-mediated induction of Cst7 leads to an impairment in the lysosomal pathway.  These data suggest that RIPK1 may mediate a crit. checkpoint in the transition to the DAM state.  Together, our study highlights a non-cell death mechanism by which the activation of RIPK1 mediates the induction of a DAM phenotype, including an inflammatory response and a redn. in phagocytic activity, and connects RIPK1-mediated transcription in microglia to the etiol. of AD.  Our results support that RIPK1 is an important therapeutic target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv0lO0A81cirVg90H21EOLACvtfcHk0li-AGemZedOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2jtLrF&md5=01538404affc3d5fd19b09cf95911933</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1714175114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1714175114%26sid%3Dliteratum%253Aachs%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DMazzitelli%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DDeWitt%26aufirst%3DJ.%2BP.%26aulast%3DMifflin%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DAdiconis%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DLevin%26aufirst%3DJ.%2BZ.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRIPK1%2520mediates%2520a%2520disease-associated%2520microglial%2520response%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE8788%26epage%3DE8797%26doi%3D10.1073%2Fpnas.1714175114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piras, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huentelman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Readhead, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winslow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddo, S.</span></span> <span> </span><span class="NLM_article-title">Necroptosis activation in Alzheimer’s disease</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1038/nn.4608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnn.4608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28758999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=1236-1246&author=A.+Caccamoauthor=C.+Brancaauthor=I.+S.+Pirasauthor=E.+Ferreiraauthor=M.+J.+Huentelmanauthor=W.+S.+Liangauthor=B.+Readheadauthor=J.+T.+Dudleyauthor=E.+E.+Spangenbergauthor=K.+N.+Greenauthor=R.+Belfioreauthor=W.+Winslowauthor=S.+Oddo&title=Necroptosis+activation+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnn.4608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis activation in Alzheimer's disease</span></div><div class="casAuthors">Caccamo, Antonella; Branca, Caterina; Piras, Ignazio S.; Ferreira, Eric; Huentelman, Matthew J.; Liang, Winnie S.; Readhead, Ben; Dudley, Joel T.; Spangenberg, Elizabeth E.; Green, Kim N.; Belfiore, Ramona; Winslow, Wendy; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1236-1246</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by severe neuronal loss; however, the mechanisms by which neurons die remain elusive.  Necroptosis, a programmed form of necrosis, is executed by the mixed lineage kinase domain-like (MLKL) protein, which is triggered by receptor-interactive protein kinases (RIPK) 1 and 3.  We found that necroptosis was activated in postmortem human AD brains, pos. correlated with Braak stage, and inversely correlated with brain wt. and cognitive scores.  In addn., we found that the set of genes regulated by RIPK1 overlapped significantly with multiple independent AD transcriptomic signatures, indicating that RIPK1 activity could explain a substantial portion of transcriptomic changes in AD.  Furthermore, we obsd. that lowering necroptosis activation reduced cell loss in a mouse model of AD.  We anticipate that our findings will spur a new area of research in the AD field focused on developing new therapeutic strategies aimed at blocking its activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA07yeNmfVubVg90H21EOLACvtfcHk0li-AGemZedOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wrtb7M&md5=ccacc427ebeca196e23197779abc4bde</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnn.4608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4608%26sid%3Dliteratum%253Aachs%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBranca%26aufirst%3DC.%26aulast%3DPiras%26aufirst%3DI.%2BS.%26aulast%3DFerreira%26aufirst%3DE.%26aulast%3DHuentelman%26aufirst%3DM.%2BJ.%26aulast%3DLiang%26aufirst%3DW.%2BS.%26aulast%3DReadhead%26aufirst%3DB.%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DSpangenberg%26aufirst%3DE.%2BE.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DBelfiore%26aufirst%3DR.%26aulast%3DWinslow%26aufirst%3DW.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DNecroptosis%2520activation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Neurosci.%26date%3D2017%26volume%3D20%26spage%3D1236%26epage%3D1246%26doi%3D10.1038%2Fnn.4608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2011.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.immuni.2011.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22195746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=908-918&author=L.+Duprezauthor=N.+Takahashiauthor=F.+Van+Hauwermeirenauthor=B.+Vandendriesscheauthor=V.+Goossensauthor=T.+Vanden+Bergheauthor=W.+Declercqauthor=C.+Libertauthor=A.+Cauwelsauthor=P.+Vandenabeele&title=RIP+kinase-dependent+necrosis+drives+lethal+systemic+inflammatory+response+syndrome&doi=10.1016%2Fj.immuni.2011.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death.  An addnl. switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis.  We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS).  Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS.  However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amts. of circulating damage-assocd. mol. patterns.  Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect.  These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS.  RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clin. relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiE2quF2rmSLVg90H21EOLACvtfcHk0lgEZOJ2nhdGiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ&md5=191d5b38562d315da4dd18e267da5246</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2011.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2011.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DVandendriessche%26aufirst%3DB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIP%2520kinase-dependent%2520necrosis%2520drives%2520lethal%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DImmunity%26date%3D2011%26volume%3D35%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.immuni.2011.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e93944</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0093944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0093944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24714696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ans7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93944&author=T.+Panauthor=S.+Wuauthor=X.+Heauthor=H.+Luoauthor=Y.+Zhangauthor=M.+Fanauthor=G.+Gengauthor=V.+C.+Ruizauthor=J.+Zhangauthor=L.+Millsauthor=C.+Baiauthor=H.+Zhang&title=Necroptosis+takes+place+in+human+immunodeficiency+virus+type-1+%28HIV-1%29-infected+CD4%2B+T+lymphocytes&doi=10.1371%2Fjournal.pone.0093944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes</span></div><div class="casAuthors">Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Ruiz, Vivian Clarke; Zhang, Jim; Mills, Lisa; Bai, Chuan; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e93944/1-e93944/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) infection is characterized by progressive depletion of CD4+ T lymphocytes and dysfunction of the immune system.  The nos. of CD4+ T lymphocytes in the human body are maintained constantly by homeostatic mechanisms that failed during HIV-1 infection, resulting in progressive loss of CD4+ T cells mainly via apoptosis.  Recently, a non-apoptotic form of necrotic programmed cell death, named necroptosis, has been investigated in many biol. and pathol. processes.  We then det. whether HIV-1-infected cells also undergo necroptosis.  In this report, we demonstrate that HIV-1 not only induces apoptosis, but also mediates necroptosis in the infected primary CD4+ T lymphocytes and CD4+ T-cell lines.  Necroptosis-dependent cytopathic effects are significantly increased in HIV-1-infected Jurkat cells that is lack of Fas-assocd. protein-contg. death domain (FADD), indicating that necroptosis occurs as an alternative cell death mechanism in the absence of apoptosis.  Unlike apoptosis, necroptosis mainly occurs in HIV-infected cells and spares bystander damage.  Treatment with necrostatin-1(Nec-1), a RIP1 inhibitor that specifically blocks the necroptosis pathway, potently restrains HIV-1-induced cytopathic effect and interestingly, inhibits the formation of HIV-induced syncytia in CD4+ T-cell lines.  This suggests that syncytia formation is mediated, at least partially, by necroptosis-related processes.  Furthermore, we also found that the HIV-1 infection-augmented tumor necrosis factor-alpha (TNF-α) plays a key role in inducing necroptosis and HIV-1 Envelope and Tat proteins function as its co-factors.  Taken together, necroptosis can function as an alternative cell death pathway in lieu of apoptosis during HIV-1 infection, thereby also contributing to HIV-1-induced cytopathic effects.  Our results reveal that in addn. to apoptosis, necroptosis also plays an important role in HIV-1-induced pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsm9SFldtsA7Vg90H21EOLACvtfcHk0lgEZOJ2nhdGiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ans7nL&md5=1abfb6f677d34c1a15df25f1bb21a395</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093944%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DG.%26aulast%3DRuiz%26aufirst%3DV.%2BC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DNecroptosis%2520takes%2520place%2520in%2520human%2520immunodeficiency%2520virus%2520type-1%2520%2528HIV-1%2529-infected%2520CD4%252B%2520T%2520lymphocytes%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93944%26doi%3D10.1371%2Fjournal.pone.0093944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span> <span> </span><span class="NLM_article-title">Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">15438</span>– <span class="NLM_lpage">15443</span>, <span class="refDoi"> DOI: 10.1073/pnas.1412767111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1412767111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25316792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKmtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15438-15443&author=X.+Wangauthor=Y.+Liauthor=S.+Liuauthor=X.+Yuauthor=L.+Liauthor=C.+Shiauthor=W.+Heauthor=J.+Liauthor=L.+Xuauthor=Z.+Huauthor=L.+Yuauthor=Z.+Yangauthor=Q.+Chenauthor=L.+Geauthor=Z.+Zhangauthor=B.+Zhouauthor=X.+Jiangauthor=S.+Chenauthor=S.+He&title=Direct+activation+of+RIP3%2FMLKL-dependent+necrosis+by+herpes+simplex+virus+1+%28HSV-1%29+protein+ICP6+triggers+host+antiviral+defense&doi=10.1073%2Fpnas.1412767111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense</span></div><div class="casAuthors">Wang, Xing; Li, Yun; Liu, Shan; Yu, Xiaoliang; Li, Lin; Shi, Cuilin; He, Wenhui; Li, Jun; Xu, Lei; Hu, Zhilin; Yu, Lu; Yang, Zhongxu; Chen, Qin; Ge, Lin; Zhang, Zili; Zhou, Biqi; Jiang, Xuejun; Chen, She; He, Sudan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15438-15443</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The receptor-interacting kinase-3 (RIP3) and its downstream substrate mixed lineage kinase domain-like protein (MLKL) have emerged as the key cellular components in programmed necrotic cell death.  Receptors for the cytokines of tumor necrosis factor (TNF) family and Toll-like receptors (TLR) 3 and 4 are able to activate RIP3 through receptor-interacting kinase-1 and Toll/IL-1 receptor domain-contg. adapter inducing IFN-β, resp.  This form of cell death has been implicated in the host-defense system.  However, the mol. mechanisms that drive the activation of RIP3 by a variety of pathogens, other than the above-mentioned receptors, are largely unknown.  Here, we report that human herpes simplex virus 1 (HSV-1) infection triggers RIP3-dependent necrosis.  This process requires MLKL but is independent of TNF receptor, TLR3, cylindromatosis, and host RIP homotypic interaction motif-contg. protein DNA-dependent activator of IFN regulatory factor.  After HSV-1 infection, the viral ribonucleotide reductase large subunit (ICP6) interacts with RIP3.  The formation of the ICP6-RIP3 complex requires the RHIM domains of both proteins.  An HSV-1 ICP6 deletion mutant failed to cause effective necrosis of HSV-1-infected cells.  Furthermore, ectopic expression of ICP6, but not RHIM mutant ICP6, directly activated RIP3/MLKL-mediated necrosis.  Mice lacking RIP3 exhibited severely impaired control of HSV-1 replication and pathogenesis.  Therefore, this study reveals a previously uncharacterized host antipathogen mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUpcOI635iSLVg90H21EOLACvtfcHk0lh_MJElOa9qsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKmtbzP&md5=e9afc1a54c5297b0069df7f9c5abf438</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1412767111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1412767111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DDirect%2520activation%2520of%2520RIP3%252FMLKL-dependent%2520necrosis%2520by%2520herpes%2520simplex%2520virus%25201%2520%2528HSV-1%2529%2520protein%2520ICP6%2520triggers%2520host%2520antiviral%2520defense%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D15438%26epage%3D15443%26doi%3D10.1073%2Fpnas.1412767111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmerkus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ki.2011.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fki.2011.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22237751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=751-761&author=A.+Linkermannauthor=J.+H.+Brasenauthor=N.+Himmerkusauthor=S.+Liuauthor=T.+B.+Huberauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Rip1+%28receptor-interacting+protein+kinase+1%29+mediates+necroptosis+and+contributes+to+renal+ischemia%2Freperfusion+injury&doi=10.1038%2Fki.2011.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; Himmerkus, Nina; Liu, Shuya; Huber, Tobias B.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-761</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of kidney function in renal ischemia/reperfusion injury is due to programmed cell death, but the contribution of necroptosis, a newly discovered form of programmed necrosis, has not been evaluated.  Here, we identified the presence of death receptor-mediated but caspase-independent cell death in murine tubular cells and characterized it as necroptosis by the addn. of necrostatin-1, a highly specific receptor-interacting protein kinase 1 inhibitor.  The detection of receptor-interacting protein kinase 1 and 3 in whole-kidney lysates and freshly isolated murine proximal tubules led us to investigate the contribution of necroptosis in a mouse model of renal ischemia/reperfusion injury.  Treatment with necrostatin-1 reduced organ damage and renal failure, even when administered after reperfusion, resulting in a significant survival benefit in a model of lethal renal ischemia/reperfusion injury.  Unexpectedly, specific blockade of apoptosis by zVAD, a pan-caspase inhibitor, did not prevent the organ damage or the increase in urea and creatinine in vivo in renal ischemia/reperfusion injury.  Thus, necroptosis is present and has functional relevance in the pathophysiol. course of ischemic kidney injury and shows the predominance of necroptosis over apoptosis in this setting.  Necrostatin-1 may have therapeutic potential to prevent and treat renal ischemia/reperfusion injury.  Kidney International (2012) 81, 751-761; doi:10.1038/ki.2011.450; published online 11 Jan. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdkP2OeYjeLVg90H21EOLACvtfcHk0lh_MJElOa9qsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D&md5=5eea0d0e70f6a604223d5a8eb848ae5e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fki.2011.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2011.450%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DHimmerkus%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DT.%2BB.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DRip1%2520%2528receptor-interacting%2520protein%2520kinase%25201%2529%2520mediates%2520necroptosis%2520and%2520contributes%2520to%2520renal%2520ischemia%252Freperfusion%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2012%26volume%3D81%26spage%3D751%26epage%3D761%26doi%3D10.1038%2Fki.2011.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonso, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borralho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez-Pinto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M.</span></span> <span> </span><span class="NLM_article-title">Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1042/CS20140732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1042%2FCS20140732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26201023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKqtLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2015&pages=721-739&author=M.+B.+Afonsoauthor=P.+M.+Rodriguesauthor=T.+Carvalhoauthor=M.+Caridadeauthor=P.+Borralhoauthor=H.+Cortez-Pintoauthor=R.+E.+Castroauthor=C.+M.+Rodrigues&title=Necroptosis+is+a+key+pathogenic+event+in+human+and+experimental+murine+models+of+non-alcoholic+steatohepatitis&doi=10.1042%2FCS20140732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis</span></div><div class="casAuthors">Afonso, Marta B.; Rodrigues, Pedro M.; Carvalho, Tania; Caridade, Marta; Borralho, Paula; Cortez-Pinto, Helena; Castro, Rui E.; Rodrigues, Cecilia M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">721-739</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocyte cell death, inflammation and oxidative stress constitute key pathogenic mechanisms underlying non-alc. fatty liver disease (NAFLD).  We aimed to investigate the role of necroptosis in human and exptl. NAFLD and its assocn. with tumor necrosis factor α (TNF-α) and oxidative stress.  Serum markers of necrosis, liver receptor-interacting protein 3 (RIP3) and phosphorylated mixed lineage kinase domain-like (MLKL) were evaluated in control individuals and patients with NAFLD.  C57BL/6 wild-type (WT) or RIP3-deficient (RIP3-/-) mice were fed a high-fat choline-deficient (HFCD) or methionine and choline-deficient (MCD) diet, with subsequent histol. and biochem. anal. of hepatic damage.  In primary murine hepatocytes, necroptosis and oxidative stress were also assessed after necrostatin-1 (Nec-1) treatment or RIP3 silencing.  We show that circulating markers of necrosis and TNF-α, as well as liver RIP3 and MLKL phosphorylation were increased in NAFLD.  Likewise, RIP3 and MLKL protein levels and TNF-α expression were increased in the liver of HFCD and MCD diet-fed mice.  Moreover, RIP3 and MLKL sequestration in the insol. protein fraction of NASH (non-alc. steatohepatitis) mice liver lysates represented an early event during stetatohepatitis progression.  Functional studies in primary murine hepatocytes established the assocn. between TNF-α-induced RIP3 expression, activation of necroptosis and oxidative stress.  Strikingly, RIP3 deficiency attenuated MCD diet-induced liver injury, steatosis, inflammation, fibrosis and oxidative stress.  In conclusion, necroptosis is increased in the liver of NAFLD patients and in exptl. models of NASH.  Further, TNF-α triggers RIP3-dependent oxidative stress during hepatocyte necroptosis.  As such, targeting necroptosis appears to arrest or at least impair NAFLD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzcqywp1nMLVg90H21EOLACvtfcHk0lh_MJElOa9qsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKqtLjJ&md5=186aa82572cc6ecf015743d96b2c2b9d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FCS20140732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20140732%26sid%3Dliteratum%253Aachs%26aulast%3DAfonso%26aufirst%3DM.%2BB.%26aulast%3DRodrigues%26aufirst%3DP.%2BM.%26aulast%3DCarvalho%26aufirst%3DT.%26aulast%3DCaridade%26aufirst%3DM.%26aulast%3DBorralho%26aufirst%3DP.%26aulast%3DCortez-Pinto%26aufirst%3DH.%26aulast%3DCastro%26aufirst%3DR.%2BE.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%26atitle%3DNecroptosis%2520is%2520a%2520key%2520pathogenic%2520event%2520in%2520human%2520and%2520experimental%2520murine%2520models%2520of%2520non-alcoholic%2520steatohepatitis%26jtitle%3DClin.%2520Sci.%26date%3D2015%26volume%3D129%26spage%3D721%26epage%3D739%26doi%3D10.1042%2FCS20140732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1038/s41422-018-0058-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41422-018-0058-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29941926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eku73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=868-870&author=D.+Jiaoauthor=Z.+Caiauthor=S.+Choksiauthor=D.+Maauthor=M.+Choeauthor=H.+J.+Kwonauthor=J.+Y.+Baikauthor=B.+G.+Rowanauthor=C.+Liuauthor=Z.+G.+Liu&title=Necroptosis+of+tumor+cells+leads+to+tumor+necrosis+and+promotes+tumor+metastasis&doi=10.1038%2Fs41422-018-0058-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis</span></div><div class="casAuthors">Jiao, Delong; Cai, Zhenyu; Choksi, Swati; Ma, Dan; Choe, Moran; Kwon, Hyung-Joon; Baik, Jin Young; Rowan, Brian G.; Liu, Chengyu; Liu, Zheng-gang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">868-870</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLjobNhhVTbVg90H21EOLACvtfcHk0li8vwusFbtPeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eku73F&md5=d9f2c1f9d28386ccf909cf521c18675b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41422-018-0058-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-018-0058-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26aulast%3DBaik%26aufirst%3DJ.%2BY.%26aulast%3DRowan%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DNecroptosis%2520of%2520tumor%2520cells%2520leads%2520to%2520tumor%2520necrosis%2520and%2520promotes%2520tumor%2520metastasis%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26spage%3D868%26epage%3D870%26doi%3D10.1038%2Fs41422-018-0058-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strilic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran-Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachsmuth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>536</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nature19076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature19076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27487218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1yqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=536&publication_year=2016&pages=215-218&author=B.+Strilicauthor=L.+Yangauthor=J.+Albarran-Juarezauthor=L.+Wachsmuthauthor=K.+Hanauthor=U.+C.+Mullerauthor=M.+Pasparakisauthor=S.+Offermanns&title=Tumour-cell-induced+endothelial+cell+necroptosis+via+death+receptor+6+promotes+metastasis&doi=10.1038%2Fnature19076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis</span></div><div class="casAuthors">Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Wachsmuth, Laurens; Han, Kang; Mueller, Ulrike C.; Pasparakis, Manolis; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">536</span>
        (<span class="NLM_cas:issue">7615</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is the leading cause of cancer-related death in humans.  It is a complex multistep process during which individual tumor cells spread primarily through the circulatory system to colonize distant organs.  Once in the circulation, tumor cells remain vulnerable, and their metastatic potential largely depends on a rapid and efficient way to escape from the blood stream by passing the endothelial barrier.  Evidence has been provided that tumor cell extravasation resembles leukocyte transendothelial migration.  However, it remains unclear how tumor cells interact with endothelial cells during extravasation and how these processes are regulated on a mol. level.  Here we show that human and murine tumor cells induce programmed necrosis (necroptosis) of endothelial cells, which promotes tumor cell extravasation and metastasis.  Treatment of mice with the receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-inhibitor necrostatin-1 or endothelial-cell-specific deletion of RIPK3 reduced tumor-cell-induced endothelial necroptosis, tumor cell extravasation and metastasis.  In contrast, pharmacol. caspase inhibition or endothelial-cell-specific loss of caspase-8 promoted these processes.  We furthermore show in vitro and in vivo that tumor-cell-induced endothelial necroptosis leading to extravasation and metastasis requires amyloid precursor protein expressed by tumor cells and its receptor, death receptor 6 (DR6), on endothelial cells as the primary mediators of these effects.  Our data identify a new mechanism underlying tumor cell extravasation and metastasis, and suggest endothelial DR6-mediated necroptotic signalling pathways as targets for anti-metastatic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2mtgcDEIwXrVg90H21EOLACvtfcHk0li8vwusFbtPeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1yqsbzF&md5=2c01e1fee7e4f9bab4c290a4b470c978</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnature19076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19076%26sid%3Dliteratum%253Aachs%26aulast%3DStrilic%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DAlbarran-Juarez%26aufirst%3DJ.%26aulast%3DWachsmuth%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DU.%2BC.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DTumour-cell-induced%2520endothelial%2520cell%2520necroptosis%2520via%2520death%2520receptor%25206%2520promotes%2520metastasis%26jtitle%3DNature%26date%3D2016%26volume%3D536%26spage%3D215%26epage%3D218%26doi%3D10.1038%2Fnature19076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span>; <span class="NLM_string-name">Webster, J. D.</span>; <span class="NLM_string-name">Varfolomeev, E.</span>; <span class="NLM_string-name">Kwon, Y. C.</span>; <span class="NLM_string-name">Cheng, J. H.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Dugger, D. L.</span>; <span class="NLM_string-name">Wickliffe, K. E.</span>; <span class="NLM_string-name">Maltzman, A.</span>; <span class="NLM_string-name">Sujatha-Bhaskar, S.</span>; <span class="NLM_string-name">Bir Kohli, P.</span>; <span class="NLM_string-name">Ramaswamy, S.</span>; <span class="NLM_string-name">Deshmukh, G.</span>; <span class="NLM_string-name">Liederer, B. M.</span>; <span class="NLM_string-name">Fong, R.</span>; <span class="NLM_string-name">Hamilton, G.</span>; <span class="NLM_string-name">Lupardus, P.</span>; <span class="NLM_string-name">Caplazi, P.</span>; <span class="NLM_string-name">Lee, W. P.</span>; <span class="NLM_string-name">van Lookeren Campagne, M.</span>; <span class="NLM_string-name">Johnson, A.</span>; <span class="NLM_string-name">McKenzie, B. S.</span>; <span class="NLM_string-name">Junttila, M. R.</span>; <span class="NLM_string-name">Newton, K.</span>; <span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases</span>.  <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1038/s41418-019-0347-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41418-019-0347-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31101885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=S.+Patel&author=J.+D.+Webster&author=E.+Varfolomeev&author=Y.+C.+Kwon&author=J.+H.+Cheng&author=J.+Zhang&author=D.+L.+Dugger&author=K.+E.+Wickliffe&author=A.+Maltzman&author=S.+Sujatha-Bhaskar&author=P.+Bir+Kohli&author=S.+Ramaswamy&author=G.+Deshmukh&author=B.+M.+Liederer&author=R.+Fong&author=G.+Hamilton&author=P.+Lupardus&author=P.+Caplazi&author=W.+P.+Lee&author=M.+van+Lookeren+Campagne&author=A.+Johnson&author=B.+S.+McKenzie&author=M.+R.+Junttila&author=K.+Newton&author=D.+Vucic&title=RIP1+inhibition+blocks+inflammatory+diseases+but+not+tumor+growth+or+metastases&doi=10.1038%2Fs41418-019-0347-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0347-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0347-0%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DRIP1%2520inhibition%2520blocks%2520inflammatory%2520diseases%2520but%2520not%2520tumor%2520growth%2520or%2520metastases%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26doi%3D10.1038%2Fs41418-019-0347-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaes, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Herde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leybaert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span> <span> </span><span class="NLM_article-title">Necroptotic cell death in anti-cancer therapy</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1111/imr.12583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fimr.12583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29027225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Cit7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2017&pages=207-219&author=O.+Kryskoauthor=T.+L.+Aaesauthor=V.+E.+Kaganauthor=K.+D%E2%80%99Herdeauthor=C.+Bachertauthor=L.+Leybaertauthor=P.+Vandenabeeleauthor=D.+V.+Krysko&title=Necroptotic+cell+death+in+anti-cancer+therapy&doi=10.1111%2Fimr.12583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptotic cell death in anti-cancer therapy</span></div><div class="casAuthors">Krysko, Olga; Aaes, Tania Love; Kagan, Valerian E.; D'Herde, Katharina; Bachert, Claus; Leybaert, Luc; Vandenabeele, Peter; Krysko, Dmitri V.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Necroptosis is one the best-characterized forms of regulated necrosis.  Necroptosis is mediated by the kinase activities of receptor interacting protein kinase-1 and receptor interacting protein kinase-3, which eventually lead to the activation of mixed lineage kinase domain-like.  Necroptosis is characterized by rapid permeabilization of the plasma membrane, which is assocd. with the release of the cell content and subsequent exposure of damage-assocd. mol. patterns (DAMPs) and cytokines/chemokines.  This release underlies the immunogenic nature of necroptotic cancer cells and their ability to induce efficient anti-tumor immunity.  Triggering necroptosis has become esp. important in exptl. cancer treatments as an alternative to triggering apoptosis because one of the hallmarks of cancer is the blockade or evasion of apoptosis.  In this review, we discuss recent advances in necroptosis research and the functional consequences of necroptotic cancer cell death, with focus on its immunogenicity and its role in the activation of anti-tumor immunity.  Next, we discuss the mol. mechanisms of phosphatidylserine exposure during necroptosis and its role in the recognition of necroptotic cells.  We also highlight the complex role of the necroptotic pathway in tumor promotion and suppression and in metastasis.  Future studies will show whether necroptosis is truly a better strategy to overcome apoptosis resistance and provide the insights needed for development of novel treatment strategies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2k39pvTdlULVg90H21EOLACvtfcHk0lhDaxbz13q22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Cit7zO&md5=12b615cea748b0dc3f1288d765df8990</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fimr.12583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12583%26sid%3Dliteratum%253Aachs%26aulast%3DKrysko%26aufirst%3DO.%26aulast%3DAaes%26aufirst%3DT.%2BL.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DD%25E2%2580%2599Herde%26aufirst%3DK.%26aulast%3DBachert%26aufirst%3DC.%26aulast%3DLeybaert%26aufirst%3DL.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26atitle%3DNecroptotic%2520cell%2520death%2520in%2520anti-cancer%2520therapy%26jtitle%3DImmunol%2520Rev.%26date%3D2017%26volume%3D280%26spage%3D207%26epage%3D219%26doi%3D10.1111%2Fimr.12583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Methodology of drug screening and target identification for new necroptosis inhibitors</span>. <i>J. Pharm. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jpha.2018.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.jpha.2018.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31011462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FotVOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=71-76&author=P.+Panauthor=Z.+Caiauthor=C.+Zhuangauthor=X.+Chenauthor=Y.+Chai&title=Methodology+of+drug+screening+and+target+identification+for+new+necroptosis+inhibitors&doi=10.1016%2Fj.jpha.2018.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Methodology of drug screening and target identification for new necroptosis inhibitors</span></div><div class="casAuthors">Pan Pengchao; Chen Xiaofei; Chai Yifeng; Cai Zhenyu; Zhuang Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical analysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Apoptosis has been considered as the only form of regulated cell death for a long time.  However, a novel form of programmed cell death called necroptosis was recently reported.  The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases.  Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers.  Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years.  In addition, the identification of the critical drug targets of the necroptosis is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwHAkIZy4YwhpyrDyM_m9cfW6udTcc2eaWclu-PYP6V7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FotVOjtg%253D%253D&md5=21fd3cc590a27ed14021cccd1d4c988c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jpha.2018.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpha.2018.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DP.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DMethodology%2520of%2520drug%2520screening%2520and%2520target%2520identification%2520for%2520new%2520necroptosis%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Anal.%26date%3D2019%26volume%3D9%26spage%3D71%26epage%3D76%26doi%3D10.1016%2Fj.jpha.2018.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1767</span>, <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1767&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1767%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">15279</span>– <span class="NLM_lpage">15294</span>, <span class="refDoi"> DOI: 10.1021/ja074725f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.+Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+Smac+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP&doi=10.1021%2Fja074725f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Meagher, Jennifer L.; Yang, Chao-Yie; Qiu, Su; Tomita, York; Ueda, Yumi; Jiang, Sheng; Krajewski, Krzysztof; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15279-15294</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, resp.  Smac protein in its dimeric form effectively antagonizes XIAP by concurrently targeting both its BIR2 and BIR3 domains.  We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-mol. (SM-164) which mimics Smac protein for targeting XIAP.  Our study shows that SM-164 binds to XIAP contg. both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, resp.  SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays.  SM-164 targets cellular XIAP and effectively induces apoptosis at concns. as low as 1 nM in the HL-60 leukemia cell line.  The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGBGUOFcArLVg90H21EOLACvtfcHk0liQltSFsBBCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI&md5=11b7028aa71b875e07b80f7a3d952b46</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294%26doi%3D10.1021%2Fja074725f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callus, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koentgen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2007.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18022363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">682-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIABLO.  IAP antagonist compds. (IACs) have therefore been designed to inhibit XIAP to kill tumor cells.  Because XIAP inhibits postmitochondrial caspases, caspase 8 inhibitors should not block killing by IACs.  Instead, the authors show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-κB signaling via inhibition of cIAP1.  In sensitive tumor lines, IAP antagonist induced NF-κB-stimulated prodn. of TNFα that killed cells in an autocrine fashion.  Inhibition of NF-κB reduced TNFα prodn., and blocking NF-κB activation or TNFα allowed tumor cells to survive IAC-induced apoptosis.  Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNFα, suggesting novel uses of these compds. in treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNa8nssRGeLVg90H21EOLACvtfcHk0lh8svcCHgKpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N&md5=9e973670c472d0612d947a2ffe688d20</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693%26doi%3D10.1016%2Fj.cell.2007.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fonc.2016.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27869161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1487-1502&author=C.+Safferthalauthor=K.+Rohdeauthor=S.+Fulda&title=Therapeutic+targeting+of+necroptosis+by+Smac+mimetic+bypasses+apoptosis+resistance+in+acute+myeloid+leukemia+cells&doi=10.1038%2Fonc.2016.310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span></div><div class="casAuthors">Safferthal, C.; Rohde, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1487-1502</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is assocd. with poor prognosis in acute myeloid leukemia (AML).  Here, we identify that Smac mimetics such as BV6, which antagonizes IAP proteins, elicit necroptosis in AML cells, in which apoptosis is inhibited pharmacol. by caspase inhibitors or genetically by caspase-8 knockdown.  Importantly, BV6 triggers necroptosis also in apoptosis-resistant patient-derived AML blasts, underlining the clin. relevance of our findings.  Mechanistically, we show that BV6-induced cell death depends on key components of necroptosis signaling such as RIP1, RIP3 and MLKL, since pharmacol. or genetic inhibition of these proteins significantly protects AML cells from BV6-mediated cell death, whereas PGAM5 is dispensable.  Interestingly, we identify constitutive tumor necrosis factor-alpha (TNFα) secretion and an autocrine/paracrine TNFα loop as crit. mediators of BV6-induced necroptosis in AML cell lines and patient-derived blasts, as the TNFα-blocking antibody Enbrel or tumor necrosis factor-alpha receptor 1 (TNFR1) knockdown significantly rescue cell death.  Notably, AML cells exhibit high basal levels of TNFα compared to non-malignant CD34+ cells, which is further increased by BV6.  In conclusion, this is the first report showing that Smac mimetics circumvent apoptosis resistance in AML cells by inducing necroptosis in a TNFα-dependent manner, which has important implications for the development of new strategies to overcome treatment resistance in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3FlE4mhKWHLVg90H21EOLACvtfcHk0lh8svcCHgKpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE&md5=f5e560e534db4acf5c098c48d53a70bc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.310%26sid%3Dliteratum%253Aachs%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTherapeutic%2520targeting%2520of%2520necroptosis%2520by%2520Smac%2520mimetic%2520bypasses%2520apoptosis%2520resistance%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1487%26epage%3D1502%26doi%3D10.1038%2Fonc.2016.310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: current status and perspectives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5750</span>– <span class="NLM_lpage">5772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5750-5772&author=H.+Congauthor=L.+Xuauthor=Y.+Wuauthor=Z.+Quauthor=T.+Bianauthor=W.+Zhangauthor=C.+Xingauthor=C.+Zhuang&title=Inhibitor+of+apoptosis+protein+%28IAP%29+antagonists+in+anticancer+agent+discovery%3A+current+status+and+perspectives&doi=10.1021%2Facs.jmedchem.8b01668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: current status and perspectives</span></div><div class="casAuthors">Cong, Hui; Xu, Lijuan; Wu, Yougen; Qu, Zhuo; Bian, Tengfei; Zhang, Wannian; Xing, Chengguo; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5750-5772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells.  Resistance of apoptosis is a hallmark of cancer cells.  Inhibitor of apoptosis proteins (IAPs) is a class of key apoptosis regulators that promote cancer cell resistant to apoptosis, particularly in cancer treatment.  Disrupting the binding of IAPs with their functional partners therefore is a promising strategy to restore the apoptotic response to proapoptotic stimuli, particularly those introduced by std. cancer therapies.  The most successful example is the use of small mols. to mimic the IAP-binding motif of an endogenous IAP antagonist, second mitochondria-derived activator of caspase (SMAC).  Here we will review the functions of IAPs, the structural interactions of IAPs with SMAC, four generations of SMAC-mimetic IAP antagonists, and representative antagonists in clin. evaluations, focusing on research articles over the past 15 years.  Outlooks and perspectives on the assocd. challenges are provided as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxBHQlIfyQrVg90H21EOLACvtfcHk0lh8svcCHgKpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWksrY%253D&md5=e3a0daceb7979f37d994f55b2323995e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26aulast%3DCong%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DZ.%26aulast%3DBian%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DInhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520antagonists%2520in%2520anticancer%2520agent%2520discovery%253A%2520current%2520status%2520and%2520perspectives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5750%26epage%3D5772%26doi%3D10.1021%2Facs.jmedchem.8b01668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2108</span>, <span class="refDoi"> DOI: 10.1111/bph.14653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fbph.14653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30825190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosl2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=2095-2108&author=X.+Chenauthor=C.+Zhuangauthor=Y.+Renauthor=H.+Zhangauthor=X.+Qinauthor=L.+Huauthor=J.+Fuauthor=Z.+Miaoauthor=Y.+Chaiauthor=Z.+G.+Liuauthor=H.+Zhangauthor=Z.+Caiauthor=H.+Y.+Wang&title=Identification+of+the+Raf+kinase+inhibitor+TAK-632+and+its+analogues+as+potent+inhibitors+of+necroptosis+by+targeting+RIPK1+and+RIPK3&doi=10.1111%2Fbph.14653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span></div><div class="casAuthors">Chen, Xiaofei; Zhuang, Chunlin; Ren, Yibin; Zhang, Hao; Qin, Xia; Hu, Longmiao; Fu, Jing; Miao, Zhenyuan; Chai, Yifeng; Liu, Zheng-gang; Zhang, Haibing; Cai, Zhenyu; Wang, Hong-yang</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2095-2108</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Necroptosis is a form of programmed, caspase-independent, cell death, mediated by receptor-interacting protein kinases, RIPK1 and RIPK3, and the mixed lineage kinase domain-like (MLKL).  Necroptosis contributes to the pathophysiol. of various inflammatory, infectious, and degenerative diseases.  Thus, identification of low MW inhibitors for necroptosis has broad therapeutic relevance.  Here, we identified that the pan-Raf inhibitor TAK-632 was also an inhibitor of necroptosis.  We have further generated a more selective, highly potent analog of TAK-632 by targeting RIPK1 and RIPK3.  Exptl. Approach : Cell viability was measured by MTT, propidium staining, or CellTiter-Glo luminescent assays.  Effects of TAK-632 on necroptosis signalling pathways were investigated by western blotting, immunopptn., and in vitro kinase assays.  Downstream targets of TAK-632 were identified by a drug affinity responsive target stability assay and a pull-down assay with biotinylated TAK-632.  A mouse model of TNF-α-induced systemic inflammatory response syndrome (SIRS) was further used to explore the role of TAK-632 in protecting against necroptosis-assocd. inflammation in vivo.  Key Results : TAK-632 protected against necroptosis in human and mouse cells but did not protect cells from apoptosis.  TAK-632 directly bound with RIPK1 and RIPK3 to inhibit kinase activities of both enzymes.  In vivo, TAK-632 alleviated TNF-induced SIRS.  Furthermore, we performed a structure-activity relationship anal. of TAK-632 analogs and generated SZM594, a highly potent inhibitor of RIPK1/3.  Conclusions and Implications : TAK-632 is an inhibitor of necroptosis and represents a new lead compd. in the development of highly potent inhibitors of RIPK1 and RIPK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvb-w5Nn5QV7Vg90H21EOLACvtfcHk0lizrk4mKRRc1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosl2lsLs%253D&md5=42bad0990a0998b25a2cce3d4117401f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fbph.14653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14653%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BY.%26atitle%3DIdentification%2520of%2520the%2520Raf%2520kinase%2520inhibitor%2520TAK-632%2520and%2520its%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520necroptosis%2520by%2520targeting%2520RIPK1%2520and%2520RIPK3%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D2095%26epage%3D2108%26doi%3D10.1111%2Fbph.14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of novel necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5044</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2005.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16153840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5039-5044&author=X.+Tengauthor=A.+Degterevauthor=P.+Jagtapauthor=X.+Xingauthor=S.+Choiauthor=R.+Denuauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+novel+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2005.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of novel necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Degterev, Alexei; Jagtap, Prakash; Xing, Xuechao; Choi, Sungwoon; Denu, Regine; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5039-5044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling necrosis.  It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-α.  5-(1H-Indol-3-ylmethyl)-2-thiohydantoin derivs. and 5-(1H-indol-3-ylmethyl)hydantoin derivs. were found to be potent necroptosis inhibitors (called necrostatins).  A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity.  The hydantoin ring was also quite sensitive to structural modifications.  A representative member of this compd. class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkqj1HWHSSLVg90H21EOLACvtfcHk0lizrk4mKRRc1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O&md5=5a2b77e2d0461c24eaef8182ab7d4cdf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520novel%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5039%26epage%3D5044%26doi%3D10.1016%2Fj.bmcl.2005.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of RIP1 inhibition by necrostatins</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.str.2013.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23473668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVOqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=493-499&author=T.+Xieauthor=W.+Pengauthor=Y.+Liuauthor=C.+Yanauthor=J.+Makiauthor=A.+Degterevauthor=J.+Yuanauthor=Y.+Shi&title=Structural+basis+of+RIP1+inhibition+by+necrostatins&doi=10.1016%2Fj.str.2013.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of RIP1 Inhibition by Necrostatins</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Liu, Yexing; Yan, Chuangye; Maki, Jenny; Degterev, Alexei; Yuan, Junying; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">493-499</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism that mediates necrotic cell death.  The receptor-interacting serine/threonine protein kinase 1 (RIP1) is an essential upstream signaling mol. in tumor-necrosis-factor-α-induced necroptosis.  Necrostatins, a series of small-mol. inhibitors, suppress necroptosis by specifically inhibiting RIP1 kinase activity.  Both RIP1 structure and the mechanisms by which necrostatins inhibit RIP1 remain unknown.  Here, we report the crystal structures of the RIP1 kinase domain individually bound to necrostatin-1 analog, necrostatin-3 analog, and necrostatin-4.  Necrostatin, caged in a hydrophobic pocket between the N- and C-lobes of the kinase domain, stabilizes RIP1 in an inactive conformation through interactions with highly conserved amino acids in the activation loop and the surrounding structural elements.  Structural comparison of RIP1 with the inhibitor-bound oncogenic kinase B-RAF reveals partially overlapping binding sites for necrostatin and for the anticancer compd. PLX4032.  Our study provides a structural basis for RIP1 inhibition by necrostatins and offers insights into potential structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtw_1OVLFe4rVg90H21EOLACvtfcHk0lizrk4mKRRc1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVOqsLk%253D&md5=42a3f8951b390358b9068bb1b885445e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DMaki%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520RIP1%2520inhibition%2520by%2520necrostatins%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D493%26epage%3D499%26doi%3D10.1016%2Fj.str.2013.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Eyck, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuong, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowadski, J. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1126/science.1862342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1862342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1862342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaK3MXmsFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=407-414&author=D.+R.+Knightonauthor=J.+H.+Zhengauthor=L.+F.+Ten+Eyckauthor=V.+A.+Ashfordauthor=N.+H.+Xuongauthor=S.+S.+Taylorauthor=J.+M.+Sowadski&title=Crystal+structure+of+the+catalytic+subunit+of+cyclic+adenosine+monophosphate-dependent+protein+kinase&doi=10.1126%2Fscience.1862342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</span></div><div class="casAuthors">Knighton, Daniel R.; Zheng, Jianhua; Ten Eyck, Lynn F.; Ashford, Victor A.; Nguyen Huu Xuong; Taylor, Susan S.; Sowadski, Janusz M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">5018</span>),
    <span class="NLM_cas:pages">407-14</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase complexed with a 20-amino acid substrate analog inhibitor has been solved and partially refined at 2.7 Å resoln. to an R factor of 0.212.  The magnesium ATP (MgATP) binding site was located by difference Fourier synthesis.  The enzyme structure is bilobal with a deep cleft between the lobes.  The cleft is filled by MgATP and a portion of the inhibitor peptide.  The smaller lobe, consisting mostly of amino-terminal sequence, is assocd. with nucleotide binding, and its largely antiparallel β sheet architecture constitutes an unusual nucleotide binding motif.  The large lobe is dominated by helical structure with a single β sheet at the domain interface.  This lobe is primarily involved in peptide binding and catalysis.  Residues 40 through 280 constitute a conserved catalytic core that is shared by more than 100 protein kinases.  Most of the invariant amino acids in this conserved catalytic core are clustered at the site of nucleotide binding and catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BPvdNuboTbVg90H21EOLACvtfcHk0lhel4NZSRyUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsFSqsLw%253D&md5=1b1dc6aaa1a63fc665b81f8967e143b1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1862342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1862342%26sid%3Dliteratum%253Aachs%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DZheng%26aufirst%3DJ.%2BH.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26aulast%3DAshford%26aufirst%3DV.%2BA.%26aulast%3DXuong%26aufirst%3DN.%2BH.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DSowadski%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520subunit%2520of%2520cyclic%2520adenosine%2520monophosphate-dependent%2520protein%2520kinase%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D407%26epage%3D414%26doi%3D10.1126%2Fscience.1862342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">366</span>, <span class="refDoi"> DOI: 10.1038/cdd.2012.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2012.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23197295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=366&author=A.+Degterevauthor=J.+L.+Makiauthor=J.+Yuan&title=Activity+and+specificity+of+necrostatin-1%2C+small-molecule+inhibitor+of+RIP1+kinase&doi=10.1038%2Fcdd.2012.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase</span></div><div class="casAuthors">Degterev, A.; Maki, J. L.; Yuan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This paper describes activity and specificity of necrostatin-1, small-mol. inhibitor of RIP1 kinase.  RIP3 and IDO-deficient animals and/or short hairpin RNA knockdowns, can help further distinguish between these two pathways.  Perfect correlation between inhibition of RIP1 kinase and cellular necroptosis by Nec-1 analogs was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpv-luvvc_57Vg90H21EOLACvtfcHk0lhel4NZSRyUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVygtw%253D%253D&md5=33f5ef417c17d93bb6214aa8aebd96a7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2012.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2012.133%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DActivity%2520and%2520specificity%2520of%2520necrostatin-1%252C%2520small-molecule%2520inhibitor%2520of%2520RIP1%2520kinase%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D366%26doi%3D10.1038%2Fcdd.2012.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e437</span>, <span class="refDoi"> DOI: 10.1038/cddis.2012.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2012.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23190609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e437&author=N.+Takahashiauthor=L.+Duprezauthor=S.+Grootjansauthor=A.+Cauwelsauthor=W.+Nerinckxauthor=J.+B.+DuHadawayauthor=V.+Goossensauthor=R.+Roelandtauthor=F.+Van+Hauwermeirenauthor=C.+Libertauthor=W.+Declercqauthor=N.+Callewaertauthor=G.+C.+Prendergastauthor=A.+Degterevauthor=J.+Yuanauthor=P.+Vandenabeele&title=Necrostatin-1+analogues%3A+critical+issues+on+the+specificity%2C+activity+and+in+vivo+use+in+experimental+disease+models&doi=10.1038%2Fcddis.2012.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span></div><div class="casAuthors">Takahashi, N.; Duprez, L.; Grootjans, S.; Cauwels, A.; Nerinckx, W.; DuHadaway, J. B.; Goossens, V.; Roelandt, R.; Van Hauwermeiren, F.; Libert, C.; Declercq, W.; Callewaert, N.; Prendergast, G. C.; Degterev, A.; Yuan, J.; Vandenabeele, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e437, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation.  We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Nec-1s), its more stable variant.  We report that Nec-1 is identical to methyl-thiohydantoin-tryptophan, an inhibitor of the potent immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO).  Both Nec-1 and Nec-1i inhibited human IDO, but Nec-1s did not, as predicted by mol. modeling.  Therefore, Nec-1s is a more specific RIPK1 inhibitor lacking the IDO-targeting effect.  Next, although Nec-1i was ∼100 × less effective than Nec-1 in inhibiting human RIPK1 kinase activity in vitro, it was only 10 times less potent than Nec-1 and Nec-1s in a mouse necroptosis assay and became even equipotent at high concns.  Along the same line, in vivo, high doses of Nec-1, Nec-1i and Nec-1s prevented tumor necrosis factor (TNF)-induced mortality equally well, excluding the use of Nec-1i as an inactive control.  Paradoxically, low doses of Nec-1 or Nec-1i, but not Nec-1s, even sensitized mice to TNF-induced mortality.  Importantly, Nec-1s did not exhibit this low dose toxicity, stressing again the preferred use of Nec-1s in vivo.  Our findings have important implications for the interpretation of Nec-1-based data in exptl. disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2yIQ4UD-yb7Vg90H21EOLACvtfcHk0lgTX9cGmulLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D&md5=2d4f57016d88e474cbfe00dee540b8fa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.176%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecrostatin-1%2520analogues%253A%2520critical%2520issues%2520on%2520the%2520specificity%252C%2520activity%2520and%2520in%2520vivo%2520use%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De437%26doi%3D10.1038%2Fcddis.2012.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofferson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upperman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">A novel role for RIP1 kinase in mediating TNFalpha production</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e320</span>, <span class="refDoi"> DOI: 10.1038/cddis.2012.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2012.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22695613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGgur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e320&author=D.+E.+Christoffersonauthor=Y.+Liauthor=J.+Hitomiauthor=W.+Zhouauthor=C.+Uppermanauthor=H.+Zhuauthor=S.+A.+Gerberauthor=S.+Gygiauthor=J.+Yuan&title=A+novel+role+for+RIP1+kinase+in+mediating+TNFalpha+production&doi=10.1038%2Fcddis.2012.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A novel role for RIP1 kinase in mediating TNFα production</span></div><div class="casAuthors">Christofferson, D. E.; Li, Y.; Hitomi, J.; Zhou, W.; Upperman, C.; Zhu, H.; Gerber, S. A.; Gygi, S.; Yuan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">E320/1-E320/10</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein 1 (RIP1) is a Ser/Thr kinase with both kinase-dependent and kinase-independent roles in death receptor signaling.  The kinase activity of RIP1 is required for necroptosis, a caspase-independent pathway of programmed cell death.  In some cell types, the inhibition of caspases leads to autocrine prodn. of TNFα, which then activates necroptosis.  Here, we describe a novel role for RIP1 kinase in regulating TNFα prodn. after caspase inhibition.  Caspase inhibitors activate RIP1 kinase and another protein, EDD, to mediate JNK signaling, which stimulates Sp1-dependent transcription of TNFα.  This pathway is independent of nuclear factor κB and also occurs after Smac mimetic/IAP antagonist treatment or the loss of TNF receptor-assocd. factor 2 (Traf2).  These findings implicate cIAP1/2 and Traf2 as neg. regulators of this RIP1 kinasedependent TNFα prodn. pathway and suggest a novel role for RIP1 kinase in mediating TNFα prodn. under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooeT4tCLMEOrVg90H21EOLACvtfcHk0lgTX9cGmulLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGgur3L&md5=7164220279f3d57ec7a3ecdeb4f82a17</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.64%26sid%3Dliteratum%253Aachs%26aulast%3DChristofferson%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DUpperman%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DGygi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DA%2520novel%2520role%2520for%2520RIP1%2520kinase%2520in%2520mediating%2520TNFalpha%2520production%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De320%26doi%3D10.1038%2Fcddis.2012.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0lgTX9cGmulLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzen, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gefter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavarana, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliff, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and selection of DNA-encoded small-molecule libraries</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1038/nchembio.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19648931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Ogtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=647-654&author=M.+A.+Clarkauthor=R.+A.+Acharyaauthor=C.+C.+Arico-Muendelauthor=S.+L.+Belyanskayaauthor=D.+R.+Benjaminauthor=N.+R.+Carlsonauthor=P.+A.+Centrellaauthor=C.+H.+Chiuauthor=S.+P.+Creaserauthor=J.+W.+Cuozzoauthor=C.+P.+Davieauthor=Y.+Dingauthor=G.+J.+Franklinauthor=K.+D.+Franzenauthor=M.+L.+Gefterauthor=S.+P.+Haleauthor=N.+J.+Hansenauthor=D.+I.+Israelauthor=J.+Jiangauthor=M.+J.+Kavaranaauthor=M.+S.+Kelleyauthor=C.+S.+Kollmannauthor=F.+Liauthor=K.+Lindauthor=S.+Mataruseauthor=P.+F.+Medeirosauthor=J.+A.+Messerauthor=P.+Myersauthor=H.+O%E2%80%99Keefeauthor=M.+C.+Oliffauthor=C.+E.+Riseauthor=A.+L.+Satzauthor=S.+R.+Skinnerauthor=J.+L.+Svendsenauthor=L.+Tangauthor=K.+van+Vlotenauthor=R.+W.+Wagnerauthor=G.+Yaoauthor=B.+Zhaoauthor=B.+A.+Morgan&title=Design%2C+synthesis+and+selection+of+DNA-encoded+small-molecule+libraries&doi=10.1038%2Fnchembio.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and selection of DNA-encoded small-molecule libraries</span></div><div class="casAuthors">Clark, Matthew A.; Acharya, Raksha A.; Arico-Muendel, Christopher C.; Belyanskaya, Svetlana L.; Benjamin, Dennis R.; Carlson, Neil R.; Centrella, Paolo A.; Chiu, Cynthia H.; Creaser, Steffen P.; Cuozzo, John W.; Davie, Christopher P.; Ding, Yun; Franklin, G. Joseph; Franzen, Kurt D.; Gefter, Malcolm L.; Hale, Steven P.; Hansen, Nils J. V.; Israel, David I.; Jiang, Jinwei; Kavarana, Malcolm J.; Kelley, Michael S.; Kollmann, Christopher S.; Li, Fan; Lind, Kenneth; Mataruse, Sibongile; Medeiros, Patricia F.; Messer, Jeffrey A.; Myers, Paul; O'Keefe, Heather; Oliff, Matthew C.; Rise, Cecil E.; Satz, Alexander L.; Skinner, Steven R.; Svendsen, Jennifer L.; Tang, Lujia; van Vloten, Kurt; Wagner, Richard W.; Yao, Gang; Zhao, Baoguang; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">647-654</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biochem. combinatorial techniques such as phage display, RNA display and oligonucleotide aptamers have proven to be reliable methods for generation of ligands to protein targets.  Adapting these techniques to small synthetic mols. has been a long-sought goal.  We report the synthesis and interrogation of an 800-million-member DNA-encoded library in which small mols. are covalently attached to an encoding oligonucleotide.  The library was assembled by a combination of chem. and enzymic synthesis, and interrogated by affinity selection.  We describe methods for the selection and deconvolution of the chem. display library, and the discovery of inhibitors for two enzymes: Aurora A kinase and p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp32j3MHOgNurVg90H21EOLACvtfcHk0li9uR1vcbtgOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Ogtbo%253D&md5=8a40148f5fca24ecf912ed360802e19d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.211%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBenjamin%26aufirst%3DD.%2BR.%26aulast%3DCarlson%26aufirst%3DN.%2BR.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DChiu%26aufirst%3DC.%2BH.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DFranzen%26aufirst%3DK.%2BD.%26aulast%3DGefter%26aufirst%3DM.%2BL.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DHansen%26aufirst%3DN.%2BJ.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKavarana%26aufirst%3DM.%2BJ.%26aulast%3DKelley%26aufirst%3DM.%2BS.%26aulast%3DKollmann%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DLind%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DMedeiros%26aufirst%3DP.%2BF.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DOliff%26aufirst%3DM.%2BC.%26aulast%3DRise%26aufirst%3DC.%2BE.%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DSvendsen%26aufirst%3DJ.%2BL.%26aulast%3DTang%26aufirst%3DL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DR.%2BW.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520selection%2520of%2520DNA-encoded%2520small-molecule%2520libraries%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D647%26epage%3D654%26doi%3D10.1038%2Fnchembio.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lhEPXWZLYGXRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0li0UFA7WJ1Veg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolstenholme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards-Peterson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verticelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. L.</span></span> <span> </span><span class="NLM_article-title">Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00365</span>, <span class="refDoi"> DOI: 10.1002/prp2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1002%2Fprp2.365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=e00365&author=K.+Weiselauthor=N.+E.+Scottauthor=D.+J.+Tompsonauthor=B.+J.+Vottaauthor=S.+Madhavanauthor=K.+Poveyauthor=A.+Wolstenholmeauthor=M.+Simeoniauthor=T.+Rudoauthor=L.+Richards-Petersonauthor=T.+Sahotaauthor=J.+G.+Wangauthor=J.+Lichauthor=J.+Fingerauthor=A.+Verticelliauthor=M.+Reillyauthor=P.+J.+Goughauthor=P.+A.+Harrisauthor=J.+Bertinauthor=M.+L.+Wang&title=Randomized+clinical+study+of+safety%2C+pharmacokinetics%2C+and+pharmacodynamics+of+RIPK1+inhibitor+GSK2982772+in+healthy+volunteers&doi=10.1002%2Fprp2.365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fprp2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.365%26sid%3Dliteratum%253Aachs%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DTompson%26aufirst%3DD.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DMadhavan%26aufirst%3DS.%26aulast%3DPovey%26aufirst%3DK.%26aulast%3DWolstenholme%26aufirst%3DA.%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DRudo%26aufirst%3DT.%26aulast%3DRichards-Peterson%26aufirst%3DL.%26aulast%3DSahota%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%2BG.%26aulast%3DLich%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DVerticelli%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%2BL.%26atitle%3DRandomized%2520clinical%2520study%2520of%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520RIPK1%2520inhibitor%2520GSK2982772%2520in%2520healthy%2520volunteers%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26spage%3De00365%26doi%3D10.1002%2Fprp2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a RIP1 kinase inhibitor clinical candidate (gsk3145095) for the treatment of pancreatic cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFymu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=857-862&author=P.+A.+Harrisauthor=J.+M.+Marinisauthor=J.+D.+Lichauthor=S.+B.+Bergerauthor=A.+Chiralaauthor=J.+A.+Coxauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=P.+J.+Goughauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=L.+K.+Leisterauthor=M.+K.+Mahajanauthor=G.+Millerauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=H.+H.+Sunauthor=J.+H.+Thorpeauthor=R.+D.+Totoritisauthor=W.+Wangauthor=D.+Wuauthor=D.+Zhangauthor=J.+Bertinauthor=R.+W.+Marquis&title=Identification+of+a+RIP1+kinase+inhibitor+clinical+candidate+%28gsk3145095%29+for+the+treatment+of+pancreatic+cancer&doi=10.1021%2Facsmedchemlett.9b00108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer</span></div><div class="casAuthors">Harris, Philip A.; Marinis, Jill M.; Lich, John D.; Berger, Scott B.; Chirala, Anirudh; Cox, Julie A.; Eidam, Patrick M.; Finger, Joshua N.; Gough, Peter J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Leister, Lara K.; Mahajan, Mukesh K.; Miller, George; Nagilla, Rakesh; Ouellette, Michael T.; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Sun, Helen H.; Thorpe, James H.; Totoritis, Rachel D.; Wang, Wei; Wu, Dongling; Zhang, Daohua; Bertin, John; Marquis, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-862</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates cell death and inflammation and is believed to play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases and cancer.  While small-mol. inhibitors of RIP1 kinase have been advanced to the clinic for inflammatory diseases and CNS indications, RIP1 inhibitors for oncol. indications have yet to be described.  Herein we report on the discovery and profile of GSK3145095 (compd. 6).  Compd. 6 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinase-dependent cellular responses.  Highlighting its potential as a novel cancer therapy, the inhibitor was also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures.  Compd. 6 is currently in phase 1 clin. studies for pancreatic adenocarcinoma and other selected solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24k3UrtmbXbVg90H21EOLACvtfcHk0lhhMYfDB1TTzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFymu7g%253D&md5=3e4783b47ed7240e15ae537749f20f2f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00108%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DChirala%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DMiller%26aufirst%3DG.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DIdentification%2520of%2520a%2520RIP1%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528gsk3145095%2529%2520for%2520the%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D857%26epage%3D862%26doi%3D10.1021%2Facsmedchemlett.9b00108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakariya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogo, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-oxo-2,4,5,7-tetrahydro-6 h-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2384-2409&author=M.+Yoshikawaauthor=M.+Saitohauthor=T.+Katohauthor=T.+Sekiauthor=S.+V.+Bigiauthor=Y.+Shimizuauthor=T.+Ishiiauthor=T.+Okaiauthor=M.+Kunoauthor=H.+Hattoriauthor=E.+Watanabeauthor=K.+S.+Saikatenduauthor=H.+Zouauthor=M.+Nakakariyaauthor=T.+Tatamiyaauthor=Y.+Nakadaauthor=T.+Yogo&title=Discovery+of+7-oxo-2%2C4%2C5%2C7-tetrahydro-6+h-pyrazolo%5B3%2C4-+c%5Dpyridine+derivatives+as+potent%2C+orally+available%2C+and+brain-penetrating+receptor+interacting+protein+1+%28RIP1%29+kinase+inhibitors%3A+analysis+of+structure-kinetic+relationships&doi=10.1021%2Facs.jmedchem.7b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships</span></div><div class="casAuthors">Yoshikawa, Masato; Saitoh, Morihisa; Katoh, Taisuke; Seki, Tomohiro; Bigi, Simone V.; Shimizu, Yuji; Ishii, Tsuyoshi; Okai, Takuro; Kuno, Masako; Hattori, Harumi; Watanabe, Etsuro; Saikatendu, Kumar S.; Zou, Hua; Nakakariya, Masanori; Tatamiya, Takayuki; Nakada, Yoshihisa; Yogo, Takatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2384-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery of 7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine derivs. as a novel class of receptor interacting protein 1 (RIP1) kinase inhibitors.  On the basis of the overlay study between HTS hit 10 and GSK2982772 in RIP1 kinase, the authors designed and synthesized a novel class of RIP1 kinase inhibitor (11, (3S)-3-(2-Benzyl-4-oxo-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one trifluoroacetic acid) possessing moderate RIP1 kinase inhibitory activity and P-gp mediated efflux.  The optimization of the core structure and the exploration of appropriate substituents utilizing SBDD approach led to the discovery of (22, (3S)-3-(2-Benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile), a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with excellent PK profiles.  Compd. 22 significantly suppressed necroptotic cell death both in mouse and human cells.  Oral administration of 22 (10 mg/kg, bid) attenuated disease progression in the mouse exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS).  Moreover, anal. of structure-kinetic relationship (SKR) for the authors' novel chem. series was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8rRmbdh7w7Vg90H21EOLACvtfcHk0lhhMYfDB1TTzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D&md5=a76ab7f12af03e277ba37d7ea08274c9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01647%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DNakakariya%26aufirst%3DM.%26aulast%3DTatamiya%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DY.%26aulast%3DYogo%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25207-oxo-2%252C4%252C5%252C7-tetrahydro-6%2520h-pyrazolo%255B3%252C4-%2520c%255Dpyridine%2520derivatives%2520as%2520potent%252C%2520orally%2520available%252C%2520and%2520brain-penetrating%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520inhibitors%253A%2520analysis%2520of%2520structure-kinetic%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2384%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.7b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1497</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2019.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31000154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVSqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1497-1501&author=G.+L.+Hamiltonauthor=H.+Chenauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=R.+Fongauthor=A.+Johnsonauthor=P.+B.+Kohliauthor=P.+J.+Lupardusauthor=B.+M.+Liedererauthor=S.+Ramaswamyauthor=H.+Wangauthor=J.+Wangauthor=Z.+Xuauthor=Y.+Zhuauthor=D.+Vucicauthor=S.+Patel&title=Potent+and+selective+inhibitors+of+receptor-interacting+protein+kinase+1+that+lack+an+aromatic+back+pocket+group&doi=10.1016%2Fj.bmcl.2019.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group</span></div><div class="casAuthors">Hamilton, Gregory L.; Chen, Huifen; Deshmukh, Gauri; Eigenbrot, Charles; Fong, Rina; Johnson, Adam; Kohli, Pawan Bir; Lupardus, Patrick J.; Liederer, Bianca M.; Ramaswamy, Sreemathy; Wang, Haowei; Wang, Jian; Xu, Zhaowu; Zhu, Yunliang; Vucic, Domagoj; Patel, Snahel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1497-1501</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1), a key component of the cellular necroptosis pathway, has gained recognition as an important therapeutic target.  Pharmacol. inhibition or genetic inactivation of RIPK1 has shown promise in animal models of disease ranging from acute ischemic conditions, chronic inflammation, and neurodegeneration.  We present here a class of RIPK1 inhibitors that is distinguished by a lack of a lipophilic arom. group present in most literature inhibitors that typically occupies a hydrophobic back pocket of the protein active site.  Despite not having this ubiquitous feature of many known RIPK1 inhibitors, we were able to obtain compds. with good potency, kinase selectivity, and pharmacokinetic properties in rats (e.g., I).  The use of the lipophilic yet metabolically stable pentafluoroethyl group was crit. to balancing the potency and properties of optimized analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8Y4EUFlsAbVg90H21EOLACvtfcHk0liiyZ2JIpkWuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVSqsLo%253D&md5=c6e65988cf17060faaf7615ede8b6304</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%2BL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520receptor-interacting%2520protein%2520kinase%25201%2520that%2520lack%2520an%2520aromatic%2520back%2520pocket%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1497%26epage%3D1501%26doi%3D10.1016%2Fj.bmcl.2019.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigorel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meslamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasikanti, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolven, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and lead-optimization of 4,5-dihydropyrazoles as mono-kinase selective, orally bioavailable and efficacious inhibitors of receptor interacting protein 1 (RIP1) kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5096</span>– <span class="NLM_lpage">5110</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00318</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1Sgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5096-5110&author=P.+A.+Harrisauthor=N.+Faucherauthor=N.+Georgeauthor=P.+M.+Eidamauthor=B.+W.+Kingauthor=G.+V.+Whiteauthor=N.+A.+Andersonauthor=D.+Bandyopadhyayauthor=A.+M.+Bealauthor=V.+Benetonauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=S.+Camposauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=A.+Dauganauthor=F.+Doncheauthor=M.+H.+Fouchetauthor=J.+N.+Fingerauthor=B.+Geddesauthor=P.+J.+Goughauthor=P.+Grondinauthor=B.+L.+Hoffmanauthor=S.+J.+Hoffmanauthor=S.+E.+Hutchinsonauthor=J.+U.+Jeongauthor=E.+Jigorelauthor=P.+Lamoureuxauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=M.+K.+Mahajanauthor=J.+Meslamaniauthor=J.+E.+Mosleyauthor=R.+Nagillaauthor=P.+M.+Nassauauthor=S.+L.+Ngauthor=M.+T.+Ouelletteauthor=K.+K.+Pasikantiauthor=F.+Potvainauthor=M.+A.+Reillyauthor=E.+J.+Riveraauthor=S.+Sautetauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=H.+Sunauthor=J.+H.+Thorpeauthor=R.+D.+Totoritisauthor=P.+Wardauthor=N.+Wellawayauthor=D.+D.+Wisnoskiauthor=J.+M.+Woolvenauthor=J.+Bertinauthor=R.+W.+Marquis&title=Discovery+and+lead-optimization+of+4%2C5-dihydropyrazoles+as+mono-kinase+selective%2C+orally+bioavailable+and+efficacious+inhibitors+of+receptor+interacting+protein+1+%28RIP1%29+kinase&doi=10.1021%2Facs.jmedchem.9b00318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase</span></div><div class="casAuthors">Harris, Philip A.; Faucher, Nicolas; George, Nicolas; Eidam, Patrick M.; King, Bryan W.; White, Gemma V.; Anderson, Niall A.; Bandyopadhyay, Deepak; Beal, Allison M.; Beneton, Veronique; Berger, Scott B.; Campobasso, Nino; Campos, Sebastien; Capriotti, Carol A.; Cox, Julie A.; Daugan, Alain; Donche, Frederic; Fouchet, Marie-Helene; Finger, Joshua N.; Geddes, Brad; Gough, Peter J.; Grondin, Pascal; Hoffman, Bonnie L.; Hoffman, Sandra J.; Hutchinson, Susan E.; Jeong, Jae U.; Jigorel, Emilie; Lamoureux, Pauline; Leister, Lara K.; Lich, John D.; Mahajan, Mukesh K.; Meslamani, Jamel; Mosley, Julie E.; Nagilla, Rakesh; Nassau, Pamela M.; Ng, Sze-Ling; Ouellette, Michael T.; Pasikanti, Kishore K.; Potvain, Florent; Reilly, Michael A.; Rivera, Elizabeth J.; Sautet, Stephane; Schaeffer, Michelle C.; Sehon, Clark A.; Sun, Helen; Thorpe, James H.; Totoritis, Rachel D.; Ward, Paris; Wellaway, Natalie; Wisnoski, David D.; Woolven, James M.; Bertin, John; Marquis, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5096-5110</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 kinase regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including inflammatory and neurol. diseases.  Currently, RIP1 kinase inhibitors have advanced into early clin. trials for evaluation in inflammatory diseases such as psoriasis, rheumatoid arthritis, and ulcerative colitis and neurol. diseases such as amyotrophic lateral sclerosis and Alzheimer's disease.  In this paper, we report on the design of potent and highly selective dihydropyrazole (DHP) RIP1 kinase inhibitors starting from a high-throughput screen and the lead-optimization of this series from a lead with minimal rat oral exposure to the identification of dihydropyrazole 77 with good pharmacokinetic profiles in multiple species.  Addnl., we identified a potent murine RIP1 kinase inhibitor 76 as a valuable in vivo tool mol. suitable for evaluating the role of RIP1 kinase in chronic models of disease.  DHP 76 showed efficacy in mouse models of both multiple sclerosis and human retinitis pigmentosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3idrD-dQkF7Vg90H21EOLACvtfcHk0liiyZ2JIpkWuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1Sgsb8%253D&md5=eb3cdf239442f7364f51a79a56d43cbd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00318%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DFaucher%26aufirst%3DN.%26aulast%3DGeorge%26aufirst%3DN.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWhite%26aufirst%3DG.%2BV.%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGeddes%26aufirst%3DB.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHoffman%26aufirst%3DB.%2BL.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DHutchinson%26aufirst%3DS.%2BE.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DJigorel%26aufirst%3DE.%26aulast%3DLamoureux%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNassau%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPasikanti%26aufirst%3DK.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSautet%26aufirst%3DS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWellaway%26aufirst%3DN.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DDiscovery%2520and%2520lead-optimization%2520of%25204%252C5-dihydropyrazoles%2520as%2520mono-kinase%2520selective%252C%2520orally%2520bioavailable%2520and%2520efficacious%2520inhibitors%2520of%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5096%26epage%3D5110%26doi%3D10.1021%2Facs.jmedchem.9b00318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of GSK’963: a structurally distinct, potent and selective inhibitor of RIP1 kinase</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15009</span>, <span class="refDoi"> DOI: 10.1038/cddiscovery.2015.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddiscovery.2015.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27551444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ais7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15009&author=S.+B.+Bergerauthor=P.+Harrisauthor=R.+Nagillaauthor=V.+Kasparcovaauthor=S.+Hoffmanauthor=B.+Swiftauthor=L.+Dareauthor=M.+Schaefferauthor=C.+Capriottiauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=J.+Coxauthor=M.+Reillyauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Characterization+of+GSK%E2%80%99963%3A+a+structurally+distinct%2C+potent+and+selective+inhibitor+of+RIP1+kinase&doi=10.1038%2Fcddiscovery.2015.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase</span></div><div class="casAuthors">Berger, S. B.; Harris, P.; Nagilla, R.; Kasparcova, V.; Hoffman, S.; Swift, B.; Dare, L.; Schaeffer, M.; Capriotti, C.; Ouellette, M.; King, B. W.; Wisnoski, D.; Cox, J.; Reilly, M.; Marquis, R. W.; Bertin, J.; Gough, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15009</span>CODEN:
                <span class="NLM_cas:coden">CDDEB5</span>;
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis and signaling regulated by RIP1 kinase activity is emerging as a key driver of inflammation in a variety of disease settings.  A significant amt. has been learned about how RIP1 regulates necrotic cell death through the use of the RIP1 kinase inhibitor Necrostatin-1 (Nec-1).  Nec-1 has been a transformational tool for exploring the function of RIP1 kinase activity; however, its utility is somewhat limited by moderate potency, off-target activity against indoleamine-2,3-dioxygenase (IDO), and poor pharmacokinetic properties.  These limitations of Nec-1 have driven an effort to identify next-generation tools to study RIP1 function, and have led to the identification of 7-Cl-O-Nec-1 (Nec-1s), which has improved pharmacokinetic properties and lacks IDO inhibitory activity.  Here we describe the characterization of GSK'963, a chiral small-mol. inhibitor of RIP1 kinase that is chem. distinct from both Nec-1 and Nec-1s.  GSK'963 is significantly more potent than Nec-1 in both biochem. and cellular assays, inhibiting RIP1-dependent cell death with an IC50 of between 1 and 4 nM in human and murine cells.  GSK'963 is >10 000-fold selective for RIP1 over 339 other kinases, lacks measurable activity against IDO and has an inactive enantiomer, GSK'962, which can be used to confirm on-target effects.  The increased in vitro potency of GSK'963 also translates in vivo, where GSK'963 provides much greater protection from hypothermia at matched doses to Nec-1, in a model of TNF-induced sterile shock.  Together, we believe GSK'963 represents a next-generation tool for examg. the function of RIP1 in vitro and in vivo, and should help to clarify our current understanding of the role of RIP1 in contributing to disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtMEuOlAairrVg90H21EOLACvtfcHk0lg48ZKYt9bgNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ais7%252FJ&md5=c1424386e8dcb6d4e3c2df92f142220f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fcddiscovery.2015.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddiscovery.2015.9%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DS.%26aulast%3DSwift%26aufirst%3DB.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DSchaeffer%26aufirst%3DM.%26aulast%3DCapriotti%26aufirst%3DC.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520GSK%25E2%2580%2599963%253A%2520a%2520structurally%2520distinct%252C%2520potent%2520and%2520selective%2520inhibitor%2520of%2520RIP1%2520kinase%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2015%26volume%3D1%26spage%3D15009%26doi%3D10.1038%2Fcddiscovery.2015.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savadkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaboh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinwand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochen Rossi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aykut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glacken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevaraja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeegbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdatlioglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.ccell.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30423296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=757-774&author=W.+Wangauthor=J.+M.+Marinisauthor=A.+M.+Bealauthor=S.+Savadkarauthor=Y.+Wuauthor=M.+Khanauthor=P.+S.+Taunkauthor=N.+Wuauthor=W.+Suauthor=J.+Wuauthor=A.+Ahsanauthor=E.+Kurzauthor=T.+Chenauthor=I.+Yabohauthor=F.+Liauthor=J.+Gutierrezauthor=B.+Diskinauthor=M.+Hundeyinauthor=M.+Reillyauthor=J.+D.+Lichauthor=P.+A.+Harrisauthor=M.+K.+Mahajanauthor=J.+H.+Thorpeauthor=P.+Nassauauthor=J.+E.+Mosleyauthor=J.+Leinwandauthor=J.+A.+Kochen+Rossiauthor=A.+Mishraauthor=B.+Aykutauthor=M.+Glackenauthor=A.+Ochiauthor=N.+Vermaauthor=J.+I.+Kimauthor=V.+Vasudevarajaauthor=D.+Adeegbeauthor=C.+Almonteauthor=E.+Bagdatliogluauthor=D.+J.+Cohenauthor=K.+K.+Wongauthor=J.+Bertinauthor=G.+Miller&title=RIP1+kinase+drives+macrophage-mediated+adaptive+immune+tolerance+in+pancreatic+cancer&doi=10.1016%2Fj.ccell.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer</span></div><div class="casAuthors">Wang, Wei; Marinis, Jill M.; Beal, Allison M.; Savadkar, Shivraj; Wu, Yue; Khan, Mohammed; Taunk, Pardeep S.; Wu, Nan; Su, Wenyu; Wu, Jingjing; Ahsan, Aarif; Kurz, Emma; Chen, Ting; Yaboh, Inedouye; Li, Fei; Gutierrez, Johana; Diskin, Brian; Hundeyin, Mautin; Reilly, Michael; Lich, John D.; Harris, Philip A.; Mahajan, Mukesh K.; Thorpe, James H.; Nassau, Pamela; Mosley, Julie E.; Leinwand, Joshua; Kochen Rossi, Juan A.; Mishra, Ankita; Aykut, Berk; Glacken, Michael; Ochi, Atsuo; Verma, Narendra; Kim, Jacqueline I.; Vasudevaraja, Varshini; Adeegbe, Dennis; Almonte, Christina; Bagdatlioglu, Ece; Cohen, Deirdre J.; Wong, Kwok-Kin; Bertin, John; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-774.e7</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and immunotherapeutic resistance.  We discovered upregulation of receptor-interacting serine/threonine protein kinase 1 (RIP1) in tumor-assocd. macrophages (TAMs) in PDA.  To study its role in oncogenic progression, we developed a selective small-mol. RIP1 inhibitor with high in vivo exposure.  Targeting RIP1 reprogrammed TAMs toward an MHCIIhiTNFα+IFNγ+ immunogenic phenotype in a STAT1-dependent manner.  RIP1 inhibition in TAMs resulted in cytotoxic T cell activation and T helper cell differentiation toward a mixed Th1/Th17 phenotype, leading to tumor immunity in mice and in organotypic models of human PDA.  Targeting RIP1 synergized with PD1-and inducible co-stimulator-based immunotherapies.  Tumor-promoting effects of RIP1 were independent of its co-assocn. with RIP3.  Collectively, our work describes RIP1 as a checkpoint kinase governing tumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOuua4gAvrLVg90H21EOLACvtfcHk0lhE3MpGTc_KYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO&md5=9210358fa2dbb4da0d0981e84ac696f9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DSavadkar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DTaunk%26aufirst%3DP.%2BS.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAhsan%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYaboh%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DDiskin%26aufirst%3DB.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DNassau%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DLeinwand%26aufirst%3DJ.%26aulast%3DKochen%2BRossi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DAykut%26aufirst%3DB.%26aulast%3DGlacken%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DVasudevaraja%26aufirst%3DV.%26aulast%3DAdeegbe%26aufirst%3DD.%26aulast%3DAlmonte%26aufirst%3DC.%26aulast%3DBagdatlioglu%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DRIP1%2520kinase%2520drives%2520macrophage-mediated%2520adaptive%2520immune%2520tolerance%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D757%26epage%3D774%26doi%3D10.1016%2Fj.ccell.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) for the treatment of systemic inflammatory response syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaitbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=972-986&author=Y.+Renauthor=Y.+Suauthor=L.+Sunauthor=S.+Heauthor=L.+Mengauthor=D.+Liaoauthor=X.+Liuauthor=Y.+Maauthor=C.+Liuauthor=S.+Liauthor=H.+Ruanauthor=X.+Leiauthor=X.+Wangauthor=Z.+Zhang&title=Discovery+of+a+highly+potent%2C+selective%2C+and+metabolically+stable+inhibitor+of+receptor-interacting+protein+1+%28RIP1%29+for+the+treatment+of+systemic+inflammatory+response+syndrome&doi=10.1021%2Facs.jmedchem.6b01196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Ren, Yan; Su, Yaning; Sun, Liming; He, Sudan; Meng, Lingjun; Liao, Daohong; Liu, Xiao; Ma, Yongfen; Liu, Chunyan; Li, Sisi; Ruan, Hanying; Lei, Xiaoguang; Wang, Xiaodong; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">972-986</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on its essential role in driving inflammation and disease pathol., cell necrosis has gradually been verified as a promising therapeutic target for treating atherosclerosis, systemic inflammatory response syndrome (SIRS), and ischemia injury, among other diseases.  Most necrosis inhibitors targeting receptor-interacting protein 1 (RIP1) still require further optimization because of weak potency or poor metabolic stability.  The authors conducted a phenotypic screen and identified a micromolar hit with novel amide structure.  Medicinal chem. efforts yielded a highly-potent, selective, and metabolically stable drug candidate - compd. 56 (RIPA-56, N-benzyl-N-hydroxy-2,2-dimethylbutanamide).  Biochem. studies and mol. docking revealed that RIP1 is the direct target of this new series of type III kinase inhibitors.  In the SIRS mice disease model, 56 efficiently reduced tumor necrosis factor alpha (TNFα)-induced mortality and multi-organ damage.  Compared to known RIP1 inhibitors, 56 is potent in both human and murine cells, is much more stable in vivo, and is efficacious in animal model studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqos-N-fJJ4vbVg90H21EOLACvtfcHk0lhE3MpGTc_KYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaitbfO&md5=6e7045a9646be5f9dc9559d90efe8aed</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01196%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRuan%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520metabolically%2520stable%2520inhibitor%2520of%2520receptor-interacting%2520protein%25201%2520%2528RIP1%2529%2520for%2520the%2520treatment%2520of%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D972%26epage%3D986%26doi%3D10.1021%2Facs.jmedchem.6b01196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e27692</span>, <span class="refDoi"> DOI: 10.7554/eLife.27692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.7554%2FeLife.27692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28807105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGrtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=e27692&author=D.+Liauthor=L.+Mengauthor=T.+Xuauthor=Y.+Suauthor=X.+Liuauthor=Z.+Zhangauthor=X.+Wang&title=RIPK1-RIPK3-MLKL-dependent+necrosis+promotes+the+aging+of+mouse+male+reproductive+system&doi=10.7554%2FeLife.27692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system</span></div><div class="casAuthors">Li, Dianrong; Meng, Lingjun; Xu, Tao; Su, Yaning; Liu, Xiao; Zhang, Zhiyuan; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e27692/1-e27692/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">A pair of kinases, RIPK1 and RIPK3, as well as the RIPK3 substrate MLKL cause a form of programmed necrotic cell death in mammals termed necroptosis.  We report here that male reproductive organs of both Ripk3- and Mlkl-knockout mice retain 'youthful' morphol. and function into advanced age, while those of age-matched wild-type mice deteriorate.  The RIPK3 phosphorylation of MLKL, the activation marker of necroptosis, is detected in spermatogonial stem cells in the testes of old but not in young wild-type mice.  When the testes of young wild-type mice are given a local necroptotic stimulus, their reproductive organs showed accelerated aging.  Feeding of wild-type mice with an RIPK1 inhibitor prior to the normal onset of age-related changes in their reproductive organs blocked the appearance of signs of aging.  Thus, necroptosis in testes promotes the aging-assocd. deterioration of the male reproductive system in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbVNZyGgYXLVg90H21EOLACvtfcHk0ljp3YS23EpBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGrtrvI&md5=31babcdb3fee62f7ab2c327f3d4fa0b5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.7554%2FeLife.27692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.27692%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DRIPK1-RIPK3-MLKL-dependent%2520necrosis%2520promotes%2520the%2520aging%2520of%2520mouse%2520male%2520reproductive%2520system%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26spage%3De27692%26doi%3D10.7554%2FeLife.27692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koytiger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeskind, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laifenfeld, D.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing from the perspective of pharmaceutical companies</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1111/bph.13798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fbph.13798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28369768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvF2rt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=168-180&author=Y.+Chaauthor=T.+Erezauthor=I.+J.+Reynoldsauthor=D.+Kumarauthor=J.+Rossauthor=G.+Koytigerauthor=R.+Kuskoauthor=B.+Zeskindauthor=S.+Rissoauthor=E.+Kaganauthor=S.+Papapetropoulosauthor=I.+Grossmanauthor=D.+Laifenfeld&title=Drug+repurposing+from+the+perspective+of+pharmaceutical+companies&doi=10.1111%2Fbph.13798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Drug repurposing from the perspective of pharmaceutical companies</span></div><div class="casAuthors">Cha, Y.; Erez, T.; Reynolds, I. J.; Kumar, D.; Ross, J.; Koytiger, G.; Kusko, R.; Zeskind, B.; Risso, S.; Kagan, E.; Papapetropoulos, S.; Grossman, I.; Laifenfeld, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-180</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Drug repurposing holds the potential to bring medications with known safety profiles to new patient populations.  Numerous examples exist for the identification of new indications for existing mols., most stemming from serendipitous findings or focused recent efforts specifically limited to the mode of action of a specific drug.  In recent years, the need for new approaches to drug research and development, combined with the advent of big data repositories and assocd. anal. methods, has generated interest in developing systematic approaches to drug repurposing.  A variety of innovative computational methods to enable systematic repurposing screens, exptl. as well as through in silico approaches, have emerged.  An efficient drug repurposing pipeline requires the combination of access to mol. data, appropriate anal. expertise to enable robust insights, expertise and exptl. set-up for validation and clin. development know-how.  In this review, we describe some of the main approaches to systematic repurposing and discuss the various players in this field and the need for strategic collaborations to increase the likelihood of success in bringing existing mols. to new indications, as well as the current advantages, considerations and challenges in repurposing as a drug development strategy pursued by pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pikAVXcZSbVg90H21EOLACvtfcHk0ljp3YS23EpBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvF2rt7g%253D&md5=1aec5588b3eeac7724d3fcaf6371961f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fbph.13798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13798%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DY.%26aulast%3DErez%26aufirst%3DT.%26aulast%3DReynolds%26aufirst%3DI.%2BJ.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DJ.%26aulast%3DKoytiger%26aufirst%3DG.%26aulast%3DKusko%26aufirst%3DR.%26aulast%3DZeskind%26aufirst%3DB.%26aulast%3DRisso%26aufirst%3DS.%26aulast%3DKagan%26aufirst%3DE.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DGrossman%26aufirst%3DI.%26aulast%3DLaifenfeld%26aufirst%3DD.%26atitle%3DDrug%2520repurposing%2520from%2520the%2520perspective%2520of%2520pharmaceutical%2520companies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D168%26epage%3D180%26doi%3D10.1111%2Fbph.13798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.1021/ml400382p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1238-1243&author=P.+A.+Harrisauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=K.+M.+Kahlerauthor=R.+Lehrauthor=J.+D.+Lichauthor=R.+Nagillaauthor=R.+T.+Nolteauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=M.+C.+Schaefferauthor=A.+Smallwoodauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Discovery+of+small+molecule+RIP1+kinase+inhibitors+for+the+treatment+of+pathologies+associated+with+necroptosis&doi=10.1021%2Fml400382p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis</span></div><div class="casAuthors">Harris, Philip A.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Finger, Joshua N.; Hoffman, Sandra J.; Kahler, Kirsten M.; Lehr, Ruth; Lich, John D.; Nagilla, Rakesh; Nolte, Robert T.; Ouellette, Michael T.; Pao, Christina S.; Schaeffer, Michelle C.; Smallwood, Angela; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1238-1243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent inhibitors of RIP1 kinase from three distinct series, 1-aminoisoquinolines, pyrrolo-[2,3-b]-pyridines, and furo-[2,3-d]-pyrimidines, all of the type II class recognizing a DLG-out inactive conformation, were identified from screening of our inhouse kinase focused sets.  An exemplar from the furo-[2,3-d]-pyrimidine series showed a dose proportional response in protection from hypothermia in a mouse model of TNFα induced lethal shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN6cNcMjIyjrVg90H21EOLACvtfcHk0ljp3YS23EpBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrnF&md5=818a831f7083f7f17767daf02992ba55</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fml400382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400382p%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520RIP1%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pathologies%2520associated%2520with%2520necroptosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1238%26epage%3D1243%26doi%3D10.1021%2Fml400382p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nchembio799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations&doi=10.1038%2Fnchembio799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lgyr8I7UcLmfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Identification of 5-(2,3-dihydro-1 h-indol-5-yl)-7 h-pyrrolo[2,3- d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11398</span>– <span class="NLM_lpage">11414</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01652</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01652" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlalsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11398-11414&author=Y.+Liauthor=Y.+Xiongauthor=G.+Zhangauthor=L.+Zhangauthor=W.+Yangauthor=J.+Yangauthor=L.+Huangauthor=Z.+Qiaoauthor=Z.+Miaoauthor=G.+Linauthor=Q.+Sunauthor=T.+Niuauthor=L.+Chenauthor=D.+Niuauthor=L.+Liauthor=S.+Yang&title=Identification+of+5-%282%2C3-dihydro-1+h-indol-5-yl%29-7+h-pyrrolo%5B2%2C3-+d%5Dpyrimidin-4-amine+derivatives+as+a+new+class+of+receptor-interacting+protein+kinase+1+%28RIPK1%29+inhibitors%2C+which+showed+potent+activity+in+a+tumor+metastasis+model&doi=10.1021%2Facs.jmedchem.8b01652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 5-(2,3-Dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model</span></div><div class="casAuthors">Li, Yueshan; Xiong, Yu; Zhang, Guo; Zhang, Liting; Yang, Wei; Yang, Jiao; Huang, Luyi; Qiao, Zeen; Miao, Zhuang; Lin, Guifeng; Sun, Qiu; Niu, Ting; Chen, Lijuan; Niu, Dawen; Li, Linli; Yang, Shengyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11398-11414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We herein report the structural optimization and structure-activity relationship studies of 5-(2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivs. as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors.  Among all obtained RIPK1 inhibitors, I is the most active one.  This compd. potently inhibited RIPK1 with a binding affinity (KD) of 0.004 μM and an enzymic IC50 value of 0.011 μM and also showed good kinase selectivity.  It could efficiently protect cells from necroptosis and attenuate the necrotic cell death of vascular endothelial cells induced by tumor cells both in vitro and in vivo.  Importantly, I exhibited excellent antimetastasis activity in the exptl. B16 melanoma lung metastasis model.  It also displayed favorable pharmacokinetic properties.  Collectively, I could be a promising agent for preventing tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-ByDgYrec7Vg90H21EOLACvtfcHk0lgyr8I7UcLmfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlalsLrM&md5=fcaa76f5196c502cca35c6733c6b2371</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01652%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DNiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DIdentification%2520of%25205-%25282%252C3-dihydro-1%2520h-indol-5-yl%2529-7%2520h-pyrrolo%255B2%252C3-%2520d%255Dpyrimidin-4-amine%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520receptor-interacting%2520protein%2520kinase%25201%2520%2528RIPK1%2529%2520inhibitors%252C%2520which%2520showed%2520potent%2520activity%2520in%2520a%2520tumor%2520metastasis%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11398%26epage%3D11414%26doi%3D10.1021%2Facs.jmedchem.8b01652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">493</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-1735-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41419-019-1735-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31235688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3MzgtlyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=493&author=J.+Houauthor=J.+Juauthor=Z.+Zhangauthor=C.+Zhaoauthor=Z.+Liauthor=J.+Zhengauthor=T.+Shengauthor=H.+Zhangauthor=L.+Huauthor=X.+Yuauthor=W.+Zhangauthor=Y.+Liauthor=M.+Wuauthor=H.+Maauthor=X.+Zhangauthor=S.+He&title=Discovery+of+potent+necroptosis+inhibitors+targeting+RIPK1+kinase+activity+for+the+treatment+of+inflammatory+disorder+and+cancer+metastasis&doi=10.1038%2Fs41419-019-1735-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis</span></div><div class="casAuthors">Hou Jue; Ju Jie; Zhang Zili; Zhao Cong; Yu Xiaoliang; Zhang Wei; Wu Meng; Ma Haikuo; He Sudan; Hou Jue; Ju Jie; Zhang Zili; Zhao Cong; Yu Xiaoliang; Zhang Wei; Wu Meng; He Sudan; Li Zhanhui; Zheng Jiyue; Sheng Tian; Zhang Hongjian; Ma Haikuo; Zhang Xiaohu; Hu Linkun; Yu Xiaoliang; Zhang Wei; He Sudan; Yu Xiaoliang; Zhang Wei; He Sudan; Li Yangxin</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a form of regulated necrosis controlled by receptor-interacting kinase 1 (RIPK1 or RIP1), RIPK3 (RIP3), and pseudokinase mixed lineage kinase domain-like protein (MLKL).  Increasing evidence suggests that necroptosis is closely associated with pathologies including inflammatory diseases, neurodegenerative diseases, and cancer metastasis.  Herein, we discovered the small-molecule PK6 and its derivatives as a novel class of necroptosis inhibitors that directly block the kinase activity of RIPK1.  Optimization of PK6 led to PK68, which has improved efficacy for the inhibition of RIPK1-dependent necroptosis, with an EC50 of around 14-22 nM in human and mouse cells.  PK68 efficiently blocks cellular activation of RIPK1, RIPK3, and MLKL upon necroptosis stimuli.  PK68 displays reasonable selectivity for inhibition of RIPK1 kinase activity and favorable pharmacokinetic properties.  Importantly, PK68 provides strong protection against TNF-α-induced systemic inflammatory response syndrome in vivo.  Moreover, pre-treatment of PK68 significantly represses metastasis of both melanoma cells and lung carcinoma cells in mice.  Together, our study demonstrates that PK68 is a potent and selective inhibitor of RIPK1 and also highlights its great potential for use in the treatment of inflammatory disorders and cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnOsV83il4N8vLc4ARHEmzfW6udTcc2eYhyYY_Pg4PErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzgtlyrtA%253D%253D&md5=a5b78fdb3739cd1785335fa6e94c59e8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1735-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1735-6%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520necroptosis%2520inhibitors%2520targeting%2520RIPK1%2520kinase%2520activity%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disorder%2520and%2520cancer%2520metastasis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D493%26doi%3D10.1038%2Fs41419-019-1735-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suebsuwong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1860</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2015.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25801024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1850-1860&author=M.+Najjarauthor=C.+Suebsuwongauthor=S.+S.+Rayauthor=R.+J.+Thapaauthor=J.+L.+Makiauthor=S.+Nogusaauthor=S.+Shahauthor=D.+Salehauthor=P.+J.+Goughauthor=J.+Bertinauthor=J.+Yuanauthor=S.+Balachandranauthor=G.+D.+Cunyauthor=A.+Degterev&title=Structure+guided+design+of+potent+and+selective+ponatinib-based+hybrid+inhibitors+for+RIPK1&doi=10.1016%2Fj.celrep.2015.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1</span></div><div class="casAuthors">Najjar, Malek; Suebsuwong, Chalada; Ray, Soumya S.; Thapa, Roshan J.; Maki, Jenny L.; Nogusa, Shoko; Shah, Saumil; Saleh, Danish; Gough, Peter J.; Bertin, John; Yuan, Junying; Balachandran, Siddharth; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1860</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIPK1 and RIPK3, two closely related RIPK family members, have emerged as important regulators of pathol. cell death and inflammation.  In the current work, we report that the Bcr-Abl inhibitor and anti-leukemia agent ponatinib is also a first-in-class dual inhibitor of RIPK1 and RIPK3.  Ponatinib potently inhibited multiple paradigms of RIPK1- and RIPK3-dependent cell death and inflammatory tumor necrosis factor alpha (TNF-α) gene transcription.  We further describe design strategies that utilize the ponatinib scaffold to develop two classes of inhibitors (CS and PN series), each with greatly improved selectivity for RIPK1.  In particular, we detail the development of PN10, a highly potent and selective "hybrid" RIPK1 inhibitor, capturing the best properties of two different allosteric RIPK1 inhibitors, ponatinib and necrostatin-1.  Finally, we show that RIPK1 inhibitors from both classes are powerful blockers of TNF-induced injury in vivo.  Altogether, these findings outline promising candidate mols. and design approaches for targeting RIPK1- and RIPK3-driven inflammatory pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQJThkEIWBbVg90H21EOLACvtfcHk0li4VnF_CWdAqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D&md5=c13215958ddcca5a685a4d1e82a96560</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DNajjar%26aufirst%3DM.%26aulast%3DSuebsuwong%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBalachandran%26aufirst%3DS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DStructure%2520guided%2520design%2520of%2520potent%2520and%2520selective%2520ponatinib-based%2520hybrid%2520inhibitors%2520for%2520RIPK1%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D10%26spage%3D1850%26epage%3D1860%26doi%3D10.1016%2Fj.celrep.2015.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Rivera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvaeye, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span> <span> </span><span class="NLM_article-title">When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1110</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2017.58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28452996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1100-1110&author=D.+Rojas-Riveraauthor=T.+Delvaeyeauthor=R.+Roelandtauthor=W.+Nerinckxauthor=K.+Augustynsauthor=P.+Vandenabeeleauthor=M.+J.+M.+Bertrand&title=When+PERK+inhibitors+turn+out+to+be+new+potent+RIPK1+inhibitors%3A+critical+issues+on+the+specificity+and+use+of+GSK2606414+and+GSK2656157&doi=10.1038%2Fcdd.2017.58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157</span></div><div class="casAuthors">Rojas-Rivera, Diego; Delvaeye, Tinneke; Roelandt, Ria; Nerinckx, Wim; Augustyns, Koen; Vandenabeele, Peter; Bertrand, Mathieu J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1110</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes a state of cellular stress known as ER stress.  The cells respond to ER stress by activating the unfolded protein response (UPR), a signaling network emerging from the ER-anchored receptors IRE1α, PERK and ATF6.  The UPR aims at restoring ER protein-folding homeostasis, but turns into a toxic signal when the stress is too severe or prolonged.  Recent studies have demonstrated links between the UPR and inflammation.  Consequently, small mol. inhibitors of IRE1α and PERK have become attractive tools for the potential therapeutic manipulation of the UPR in inflammatory conditions.  TNF is a master pro-inflammatory cytokine that drives inflammation either directly by promoting gene activation, or indirectly by inducing RIPK1 kinase-dependent cell death, in the form of apoptosis or necroptosis.  To evaluate the potential contribution of the UPR to TNF-induced cell death, we tested the effects of two commonly used PERK inhibitors, GSK2606414 and GSK2656157.  Surprisingly, we obsd. that both compds. completely repressed TNF-mediated RIPK1 kinase-dependent death, but found that this effect was independent of PERK inactivation.  Indeed, these two compds. turned out to be direct RIPK1 inhibitors, with comparable potency to the recently developed RIPK1 inhibitor GSK'963 (about 100 times more potent than NEC-1s).  Importantly, these compds. completely inhibited TNF-mediated RIPK1-dependent cell death at a concn. that did not affect PERK activity in cells.  In vivo, GSK2656157 administration protected mice from LDs of TNF independently of PERK inhibition and as efficiently as GSK'963.  Together, our results not only report on new and very potent RIPK1 inhibitors but also highlight the risk of misinterpretation when using these two PERK inhibitors in the context of ER stress, cell death and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1y3OTFwAv3LVg90H21EOLACvtfcHk0li4VnF_CWdAqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOks7s%253D&md5=174d131f4a17be95a3c9459d35d18f98</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.58%26sid%3Dliteratum%253Aachs%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DDelvaeye%26aufirst%3DT.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26atitle%3DWhen%2520PERK%2520inhibitors%2520turn%2520out%2520to%2520be%2520new%2520potent%2520RIPK1%2520inhibitors%253A%2520critical%2520issues%2520on%2520the%2520specificity%2520and%2520use%2520of%2520GSK2606414%2520and%2520GSK2656157%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1100%26epage%3D1110%26doi%3D10.1038%2Fcdd.2017.58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rompaey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span> <span> </span><span class="NLM_article-title">Tozasertib analogues as inhibitors of necroptotic cell death</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1895</span>– <span class="NLM_lpage">1920</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01449</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01449" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1895-1920&author=S.+Hofmansauthor=L.+Devisscherauthor=S.+Martensauthor=D.+Van+Rompaeyauthor=K.+Goossensauthor=T.+Divertauthor=W.+Nerinckxauthor=N.+Takahashiauthor=H.+De+Winterauthor=P.+Van+Der+Vekenauthor=V.+Goossensauthor=P.+Vandenabeeleauthor=K.+Augustyns&title=Tozasertib+analogues+as+inhibitors+of+necroptotic+cell+death&doi=10.1021%2Facs.jmedchem.7b01449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Tozasertib Analogues as Inhibitors of Necroptotic Cell Death</span></div><div class="casAuthors">Hofmans, Sam; Devisscher, Lars; Martens, Sofie; Van Rompaey, Dries; Goossens, Kenneth; Divert, Tatyana; Nerinckx, Wim; Takahashi, Nozomi; De Winter, Hans; Van Der Veken, Pieter; Goossens, Vera; Vandenabeele, Peter; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1895-1920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor interacting protein kinase 1 (RIPK1) plays a crucial role in tumor necrosis factor (TNF)-induced necroptosis, suggesting that this pathway might be druggable.  Most inhibitors of RIPK1 are classified as either type II or type III kinase inhibitors.  This opened up some interesting perspectives for the discovery of novel inhibitors that target the active site of RIPK1.  Tozasertib, a type I pan-aurora kinase (AurK) inhibitor, was found to show a very high affinity for RIPK1.  Because tozasertib presents the typical structural elements of a type I kinase inhibitor, the development of structural analogs of tozasertib is a good starting point for identifying novel type I RIPK1 inhibitors.  In this paper, we identified interesting inhibitors of mTNF-induced necroptosis with no significant effect on AurK A and B, resulting in no nuclear abnormalities as is the case for tozasertib.  Compds. 71 and 72 outperformed tozasertib in an in vivo TNF-induced systemic inflammatory response syndrome (SIRS) mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS01GQAzqRfLVg90H21EOLACvtfcHk0lg4KhUW3Q3-jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gurY%253D&md5=46878ea604761962a7663c2db7bc9cfa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01449%26sid%3Dliteratum%253Aachs%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DVan%2BRompaey%26aufirst%3DD.%26aulast%3DGoossens%26aufirst%3DK.%26aulast%3DDivert%26aufirst%3DT.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDe%2BWinter%26aufirst%3DH.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DTozasertib%2520analogues%2520as%2520inhibitors%2520of%2520necroptotic%2520cell%2520death%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1895%26epage%3D1920%26doi%3D10.1021%2Facs.jmedchem.7b01449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuylsteke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">211</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0245-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41419-017-0245-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29434255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=211&author=S.+Martensauthor=V.+Goossensauthor=L.+Devisscherauthor=S.+Hofmansauthor=P.+Claeysauthor=M.+Vuylstekeauthor=N.+Takahashiauthor=K.+Augustynsauthor=P.+Vandenabeele&title=RIPK1-dependent+cell+death%3A+a+novel+target+of+the+Aurora+kinase+inhibitor+Tozasertib+%28VX-680%29&doi=10.1038%2Fs41419-017-0245-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)</span></div><div class="casAuthors">Martens Sofie; Goossens Vera; Claeys Polien; Vuylsteke Marnik; Takahashi Nozomi; Vandenabeele Peter; Martens Sofie; Goossens Vera; Claeys Polien; Vuylsteke Marnik; Takahashi Nozomi; Vandenabeele Peter; Devisscher Lars; Hofmans Sam; Augustyns Koen; Vuylsteke Marnik</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Aurora kinase family (Aurora A, B and C) are crucial regulators of several mitotic events, including cytokinesis.  Increased expression of these kinases is associated with tumorigenesis and several compounds targeting Aurora kinase are under evaluation in clinical trials (a.o.  AT9283, AZD1152, Danusertib, MLN8054).  Here, we demonstrate that the pan-Aurora kinase inhibitor Tozasertib (VX-680 and MK-0457) not only causes cytokinesis defects through Aurora kinase inhibition, but is also a potent inhibitor of necroptosis, a cell death process regulated and executed by the RIPK1, RIPK3 and MLKL signalling axis.  Tozasertib's potency to inhibit RIPK1-dependent necroptosis and to block cytokinesis in cells is in the same concentration range, with an IC50 of 1.06 μM and 0.554 μM, respectively.  A structure activity relationship (SAR) analysis of 67 Tozasertib analogues, modified at 4 different positions, allowed the identification of analogues that showed increased specificity for either cytokinesis inhibition or for necroptosis inhibition, reflecting more specific inhibition of Aurora kinase or RIPK1, respectively.  These results also suggested that RIPK1 and Aurora kinases are functionally non-interacting targets of Tozasertib and its analogues.  Indeed, more specific Aurora kinase inhibitors did not show any effect in necroptosis and Necrostatin-1s treatment did not result in cytokinesis defects, demonstrating that both cellular processes are not interrelated.  Finally, Tozasertib inhibited recombinant human RIPK1, human Aurora A and human Aurora B kinase activity, but not RIPK3.  The potency ranking of the newly derived Tozasertib analogues and their specificity profile, as observed in cellular assays, coincide with ADP-Glo recombinant kinase activity assays.  Overall, we show that Tozasertib not only targets Aurora kinases but also RIPK1 independently, and that we could generate analogues with increased selectivity to RIPK1 or Aurora kinases, respectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CXO4gDb7JggCfW6udTcc2eZhaDZwEsmJArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSltQ%253D%253D&md5=13f5c240129319d6d469eedb005d3cdc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0245-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0245-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DClaeys%26aufirst%3DP.%26aulast%3DVuylsteke%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIPK1-dependent%2520cell%2520death%253A%2520a%2520novel%2520target%2520of%2520the%2520Aurora%2520kinase%2520inhibitor%2520Tozasertib%2520%2528VX-680%2529%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D211%26doi%3D10.1038%2Fs41419-017-0245-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. M.</span></span> <span> </span><span class="NLM_article-title">RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1609</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1042/CS20190599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1042%2FCS20190599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31315969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWgsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=1609-1627&author=J.+N.+Wangauthor=M.+M.+Liuauthor=F.+Wangauthor=B.+Weiauthor=Q.+Yangauthor=Y.+T.+Caiauthor=X.+Chenauthor=X.+Q.+Liuauthor=L.+Jiangauthor=C.+Liauthor=X.+W.+Huauthor=J.+T.+Yuauthor=T.+T.+Maauthor=J.+Jinauthor=Y.+G.+Wuauthor=J.+Liauthor=X.+M.+Meng&title=RIPK1+inhibitor+Cpd-71+attenuates+renal+dysfunction+in+cisplatin-treated+mice+via+attenuating+necroptosis%2C+inflammation+and+oxidative+stress&doi=10.1042%2FCS20190599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress</span></div><div class="casAuthors">Wang, Jia-nan; Liu, Ming-ming; Wang, Fang; Wei, Biao; Yang, Qin; Cai, Yu-ting; Chen, Xin; Liu, Xue-qi; Jiang, Ling; Li, Chao; Hu, Xiao-wei; Yu, Ju-tao; Ma, Tao-tao; Jin, Juan; Wu, Yong-gui; Li, Jun; Meng, Xiao-ming</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1609-1627</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Acute kidney injury (AKI) is a destructive clin. condition induced by multiple insults including ischemic reperfusion, nephrotoxic drugs and sepsis.  It is characterized by a sudden decline in renal function, in addn. to excessive inflammation, oxidative stress and programmed cell death of renal tubular epithelial cells.  RIPK1-mediated necroptosis plays an important role in AKI.  In the present study, we evaluated the treatment effects of Compd.-71 (Cpd-71), a novel RIPK1 inhibitor, by comparing with Necrostatin-1 (Nec-1), a classic RIPK1 inhibitor, which has several drawbacks like the narrow structure-activity relationship (SAR) profile, moderate potency and non-ideal pharmacokinetic properties, in vivo and in vitro.  Our results showed that pretreatment of Cpd-71 attenuated cisplatin-induced renal injury, restored renal function and suppressed renal inflammation, oxidative stress and cell necroptosis.  In addn., Cpd-71 inhibited renal damage while reducing the up-regulated serum creatinine (Cr) and blood urea nitrogen (BUN) levels in established AKI mice model.  Consistently, we confirmed that Cpd-71 exhibited more effectively suppressive effect on cisplatin-induced renal tubular cell necroptosis than Nec-1, by phys. binding to the allosteric type III ligand binding site of RIPK1, thereby reduced RIPK1 kinase activity, RIPK1/RIPK3 complex formation and phosphor-MLKL membrane translocation by mol. docking, Western blot, co-immunopptn. and cellular thermal shift assay (CETSA).  Taken together, we currently showed that targeting RIPK1 with Cpd-71 may serve as a promising clin. candidate for AKI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAFqnJD8kOrVg90H21EOLACvtfcHk0lgtrqI8xeLYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWgsrvE&md5=1ac5b5e21e5d8663a107ba99e7c55ad2</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1042%2FCS20190599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20190599%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DY.%2BT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DX.%2BW.%26aulast%3DYu%26aufirst%3DJ.%2BT.%26aulast%3DMa%26aufirst%3DT.%2BT.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%2BG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DX.%2BM.%26atitle%3DRIPK1%2520inhibitor%2520Cpd-71%2520attenuates%2520renal%2520dysfunction%2520in%2520cisplatin-treated%2520mice%2520via%2520attenuating%2520necroptosis%252C%2520inflammation%2520and%2520oxidative%2520stress%26jtitle%3DClin.%2520Sci.%26date%3D2019%26volume%3D133%26spage%3D1609%26epage%3D1627%26doi%3D10.1042%2FCS20190599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Aurora kinase A induces necroptosis in pancreatic carcinoma</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2017.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1053%2Fj.gastro.2017.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28764929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2017&pages=1429-1443&author=Y.+Xieauthor=S.+Zhuauthor=M.+Zhongauthor=M.+Yangauthor=X.+Sunauthor=J.+Liuauthor=G.+Kroemerauthor=M.+Lotzeauthor=H.+J.+Zehauthor=R.+Kangauthor=D.+Tang&title=Inhibition+of+Aurora+kinase+A+induces+necroptosis+in+pancreatic+carcinoma&doi=10.1053%2Fj.gastro.2017.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma</span></div><div class="casAuthors">Xie, Yangchun; Zhu, Shan; Zhong, Meizuo; Yang, Manhua; Sun, Xiaofan; Liu, Jinbao; Kroemer, Guido; Lotze, Michael; Zeh, Herbert J., III; Kang, Rui; Tang, Daolin</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1429-1443.e5</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Induction of nonapoptotic cell death could be an approach to eliminate apoptosis-resistant tumors.  We investigated necroptosis-based therapies in mouse models of pancreatic ductal adenocarcinoma cancer (PDAC).  We screened 273 com. available kinase inhibitors for cytotoxicity against a human PDAC cell line (PANC1).  We evaluated the ability of the aurora kinase inhibitor CCT137690 to stimulate necroptosis in PDAC cell lines (PANC1, PANC2.03, CFPAC1, MiaPaCa2, BxPc3, and PANC02) and the HEK293 cell line, measuring loss of plasma membrane integrity, gain in cell vol., swollen organelles, and cytoplasmic vacuoles.  We tested the effects of CCT137690 in colon formation assays, and the effects of the necroptosis (necrostatin-1 and necrosulfonamide), apoptosis, autophagy, and ferroptosis inhibitors.  We derived cells from tumors that developed in Pdx1-Cre;K-RasG12D/+;p53R172H/+ (KPC) mice.  Genes encoding proteins in cell death pathways were knocked out, knocked down, or expressed from transgenes in PDAC cell lines.  Athymic nude or B6 mice were given s.c. injections of PDAC cells or tail-vein injections of KPC tumor cells.  Mice were given CCT137690 (80 mg/kg) or vehicle and tumor growth was monitored; tumor tissues were collected and analyzed by immunohistochem.  We compared gene expression levels between human pancreatic cancer tissues (n = 130) with patient survival times using the online R2 genomics anal. and visualization platform.  CCT137690 induced necrosis-like death in PDAC cell lines and reduced colony formation; these effects required RIPK1, RIPK3, and MLKL, as well as inhibition of aurora kinase A (AURKA).  AURKA interacted directly with RIPK1 and RIPK3 to reduce necrosome activation.  AURKA-mediated phosphorylation of glycogen synthase kinase 3 beta (GSK3β) at serine 9 inhibited activation of the RIPK3 and MLKL necrosome.  Mutations in AURKA (D274A) or GSK3β (S9A), or pharmacol. inhibitors of RIPK1 signaling via RIPK3 and MLKL, reduced the cytotoxic activity of CCT137690 in PDAC cells.  Oral administration of CCT137690 induced necroptosis and immunogenic cell death in s.c. and orthotopic tumors in mice, and reduced tumor growth and tumor cell phosphorylation of AURKA and GSK3β.  CCT137690 increased survival times of mice with orthotopic KPC PDACs and reduced tumor growth, stroma, and metastasis.  Increased expression of AURKA and GSK3β mRNAs assocd. with shorter survival times of patients with pancreatic cancer.  We identified the aurora kinase inhibitor CCT137690 as an agent that induces necrosis-like death in PDAC cells, via RIPK1, RIPK3, and MLKL.  CCT137690 slowed growth of orthotopic tumors from PDAC cells in mice, and expression of AURKA and GSK3β assoc. with patient survival times.  AURKA might be targeted for treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYB2PQImwQrVg90H21EOLACvtfcHk0lgtrqI8xeLYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChtr%252FK&md5=80b9c6315e08861e348a2ab49abf7238</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DLotze%26aufirst%3DM.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520Aurora%2520kinase%2520A%2520induces%2520necroptosis%2520in%2520pancreatic%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2017%26volume%3D153%26spage%3D1429%26epage%3D1443%26doi%3D10.1053%2Fj.gastro.2017.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staples, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2012.06.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22832318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5685-5688&author=S.+Choiauthor=H.+Keysauthor=R.+J.+Staplesauthor=J.+Yuanauthor=A.+Degterevauthor=G.+D.+Cuny&title=Optimization+of+tricyclic+Nec-3+necroptosis+inhibitors+for+in+vitro+liver+microsomal+stability&doi=10.1016%2Fj.bmcl.2012.06.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability</span></div><div class="casAuthors">Choi, Sungwoon; Keys, Heather; Staples, Richard J.; Yuan, Junying; Degterev, Alexei; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5685-5688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death pathway with morphol. features resembling passive non-regulated necrosis.  Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of 3,3a,4,5-tetrahydro-2H-benz[g]indazoles (referred to as the Nec-3 series) displaying potent activity in cellular assays.  However, evaluation of the tricyclic necroptosis inhibitor's stability in mouse liver microsomes indicated that they were rapidly degraded.  A structure-activity relation (SAR) study of this compd. series revealed that increased liver microsomal stability could be accomplished by modification of the pendent Ph ring and by introduction of a hydrophilic substituent (i.e., α-hydroxyl) to the acetamide at the 2-position of the tricyclic ring without significantly compromising necroptosis inhibitory activity.  Further increases in microsomal stability could be achieved by utilizing the 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro-[1]benzothiopyrano[4,3-c]pyrazoles.  However, in this case necroptosis inhibitory activity was not maintained.  Overall, these results provide a strategy for generating potent and metabolically stable tricyclic necrostatin analogs (e.g., 33, LDN-193191) potentially suitable for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xFVUiAnFqbVg90H21EOLACvtfcHk0lgtrqI8xeLYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqtb3K&md5=dc04b5305081d8f75c8c22488cb3ef63</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.098%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DStaples%26aufirst%3DR.%2BJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DOptimization%2520of%2520tricyclic%2520Nec-3%2520necroptosis%2520inhibitors%2520for%2520in%2520vitro%2520liver%2520microsomal%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5685%26epage%3D5688%26doi%3D10.1016%2Fj.bmcl.2012.06.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of tricyclic necroptosis inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1895</span>, <span class="refDoi"> DOI: 10.1021/jm061016o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061016o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVKhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1886-1895&author=P.+G.+Jagtapauthor=A.+Degterevauthor=S.+Choiauthor=H.+Keysauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+tricyclic+necroptosis+inhibitors&doi=10.1021%2Fjm061016o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Study of Tricyclic Necroptosis Inhibitors</span></div><div class="casAuthors">Jagtap, Prakash G.; Degterev, Alexei; Choi, Sungwoon; Keys, Heather; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1886-1895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that can be induced in multiple cell types and is characterized by morphol. features resembling necrosis.  Here we describe a series of tricyclic heterocycles (i.e., 3-phenyl-3,3a,4,5-tetrahydro-2H-benz[g]indazoles, 3-phenyl-2,3,3a,4-tetrahydro[1]benzopyrano[4,3-c]pyrazoles, 3-phenyl-2,3,3a,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazoles, and 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazoles), collectively termed Nec-3, that can potently inhibit necroptosis.  For example, compds. 8, 22, 41, 53, and 55 inhibit necroptosis in an FADD-deficient variant of human Jurkat T cells treated for 24 h with TNF-α with EC50 values in the range 0.15-0.29 μM.  Distinct from the previously described series of hydantoin-contg. indole derivs. (Nec-1), the Nec-3 series exhibits specificity in inhibiting TNF-α-induced necroptosis.  A structure-activity relationship (SAR) study revealed that the (3R,3aR)-rel-diastereomers were more active than the (3R,3aS)-rel-diastereomers for all four ring systems.  Introduction of fluorine or methoxy to the 8-position of the tricyclic ring and a methoxy to the 4-position of the pendent Ph ring increased activity.  Amides at the 2-position of the tricyclic ring were best.  The Nec-3 series provides new tools for elucidating caspase-independent cell death pathways and potentially lead compds. for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLywsvKF2dbVg90H21EOLACvtfcHk0lgQdK2m4-vZ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVKhsLo%253D&md5=94689677b48230d8cc775673a1eb76a6</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm061016o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061016o%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%2BG.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520tricyclic%2520necroptosis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1886%26epage%3D1895%26doi%3D10.1021%2Fjm061016o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeevanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6836</span>– <span class="NLM_lpage">6840</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2007.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17964153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6836-6840&author=X.+Tengauthor=H.+Keysauthor=A.+Jeevanandamauthor=J.+A.+Porcoauthor=A.+Degterevauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+%5B1%2C2%2C3%5Dthiadiazole+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2007.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Keys, Heather; Jeevanandam, Arumugasamy; Porco, John A., Jr.; Degterev, Alexei; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6836-6840</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling non-regulated necrosis.  This form of cell death can be induced in an array of cell types in apoptotic deficient conditions with death receptor family ligands.  A series of [1,2,3]thiadiazole benzylamides was found to be potent necroptosis inhibitors (called necrostatins).  A structure-activity relationship study revealed that small cyclic alkyl groups (i.e. cyclopropyl) and 2,6-dihalobenzylamides at the 4- and 5-positions of the [1,2,3]thiadiazole, resp., were optimal.  In addn., when a small alkyl group (i.e. methyl) was present on the benzylic position all the necroptosis inhibitory activity resided with the (S)-enantiomer.  Finally, replacement of the [1,2,3]thiadiazole with a variety of thiophene derivs. was tolerated, although some erosion of potency was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2f7iOQs6QnLVg90H21EOLACvtfcHk0lgQdK2m4-vZ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL7E&md5=3e0da099adbfbe07217adef2771b5c25</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DJeevanandam%26aufirst%3DA.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520%255B1%252C2%252C3%255Dthiadiazole%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6836%26epage%3D6840%26doi%3D10.1016%2Fj.bmcl.2007.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3219</span>– <span class="NLM_lpage">3223</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2008.04.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18467094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1yiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3219-3223&author=X.+Tengauthor=H.+Keysauthor=J.+Yuanauthor=A.+Degterevauthor=G.+D.+Cuny&title=Structure-activity+relationship+and+liver+microsome+stability+studies+of+pyrrole+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Keys, Heather; Yuan, Junying; Degterev, Alexei; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3219-3223</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death pathway resulting in morphol. reminiscent of passive nonregulated necrosis.  Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of [1,2,3]thiadiazole benzylamide derivs.  However, initial evaluation of mouse liver microsome stability indicated that this series of compds. was rapidly degraded.  A structure-activity relationship (SAR) study of the [1,2,3]thiadiazole benzylamide series revealed that increased mouse liver microsome stability and increased necroptosis inhibitory activity could be accomplished by replacement of the 4-cyclopropyl-[1,2,3]thiadiazole with a 5-cyano-1-methylpyrrole.  In addn., the SAR and the cellular activity profiles, utilizing different cell types and necroptosis-inducing stimuli, of representative [1,2,3]thiadiazole and pyrrole derivs. were very similar suggesting that the two compd. series inhibit necroptosis in the same manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3pYcZsdMo4bVg90H21EOLACvtfcHk0lgQdK2m4-vZ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1yiu7o%253D&md5=ef94e23fda4b78eab1b53c3ed22565bb</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.048%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520and%2520liver%2520microsome%2520stability%2520studies%2520of%2520pyrrole%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3219%26epage%3D3223%26doi%3D10.1016%2Fj.bmcl.2008.04.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1465</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2006.11.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17270434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1455-1465&author=K.+Wangauthor=J.+Liauthor=A.+Degterevauthor=E.+Hsuauthor=J.+Yuanauthor=C.+Yuan&title=Structure-activity+relationship+analysis+of+a+novel+necroptosis+inhibitor%2C+necrostatin-5&doi=10.1016%2Fj.bmcl.2006.11.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5</span></div><div class="casAuthors">Wang, Ke; Li, Jinfeng; Degterev, Alexei; Hsu, Emily; Yuan, Junying; Yuan, Chengye</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1455-1465</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necrostatin-5 (Nec-5) is a novel potent small-mol. inhibitor of necroptosis structurally distinct from previously described Necrostatin-1 (Nec-1), and therefore, represents a new direction for the inhibition of this cellular caspase-independent necrotic cell death mechanism.  Here, the authors describe a series of structural modifications of Nec-5 and the structure-activity relationship (SAR) of Nec-5 series in inhibiting necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbt5G1OwRibVg90H21EOLACvtfcHk0lgXnHTH4RkWrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtLY%253D&md5=fd40143368ccf1df86cebfe52fcc074a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520a%2520novel%2520necroptosis%2520inhibitor%252C%2520necrostatin-5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1455%26epage%3D1465%26doi%3D10.1016%2Fj.bmcl.2006.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.yexcr.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28803066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCltrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&pages=30-38&author=Y.+J.+Doauthor=J.+W.+Sulauthor=K.+H.+Jangauthor=N.+S.+Kangauthor=Y.+H.+Kimauthor=Y.+G.+Kimauthor=E.+Kim&title=A+novel+RIPK1+inhibitor+that+prevents+retinal+degeneration+in+a+rat+glaucoma+model&doi=10.1016%2Fj.yexcr.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model</span></div><div class="casAuthors">Do, Yun-Ju; Sul, Jee-Won; Jang, Ki-Hong; Kang, Nam Sook; Kim, Young-Hoon; Kim, Young-Gwan; Kim, Eunhee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-38</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In glaucoma, retinal ganglion cells (RGCs) are exposed to ischemic stress with elevation of the intraocular pressure and are subsequently lost.  Necroptosis, a type of regulated necrosis, is known to play a pivotal role in this loss.  We obsd. that receptor-interacting protein kinase 1 (RIPK1), the key player of necroptosis, was activated by diverse ischemic stresses, including TCZ, chem. hypoxia (CH), and oxygen glucose deprivation (OGD).  In this study, we introduce a RIPK1-inhibitory compd. (RIC) with a novel scaffold.  RIC inhibited downstream events following RIPK1 activation, including necrosome formation and mitochondrial dysfunction in RGC5 cells.  Moreover, RIC protected RGCs against ischemic injury in the rat glaucoma model, which was induced by acute high intraocular pressure.  However, RIC displayed biochem. characteristics that are distinct from those of previous RIPK1 inhibitors (necrostatin-1; Nec-1 and Compd. 27; Cpd27).  RIC protected RGCs against OGD insult, while Nec-1 and Cpd27 did not.  Conversely, Nec-1 and Cpd27 protected RGCs from TNF-stimulated death, while RIC failed to inhibit the death of RGCs.  This implies that RIPK1 activates alternative pathways depending on the context of the ischemic insults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrQPQIQ65XpLVg90H21EOLACvtfcHk0lgXnHTH4RkWrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCltrfM&md5=7edf4033beccc888c20d93fb47681bf5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DY.%2BJ.%26aulast%3DSul%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DK.%2BH.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DA%2520novel%2520RIPK1%2520inhibitor%2520that%2520prevents%2520retinal%2520degeneration%2520in%2520a%2520rat%2520glaucoma%2520model%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D359%26spage%3D30%26epage%3D38%26doi%3D10.1016%2Fj.yexcr.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Cann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehouze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier-Penna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalande, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piquet-Pellorce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faurez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettey, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goekjian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimanche-Boitrel, M. T.</span></span> <span> </span><span class="NLM_article-title">Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3050</span>– <span class="NLM_lpage">3068</span>, <span class="refDoi"> DOI: 10.1111/febs.14176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Ffebs.14176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28715128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSgsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=3050-3068&author=F.+Le%0ACannauthor=C.+Delehouzeauthor=S.+Leverrier-Pennaauthor=A.+Filliolauthor=A.+Comteauthor=O.+Delalandeauthor=N.+Desbanauthor=B.+Baratteauthor=I.+Gallaisauthor=C.+Piquet-Pellorceauthor=F.+Faurezauthor=M.+Bonnetauthor=Y.+Metteyauthor=P.+Goekjianauthor=M.+Samsonauthor=P.+Vandenabeeleauthor=S.+Bachauthor=M.+T.+Dimanche-Boitrel&title=Sibiriline%2C+a+new+small+chemical+inhibitor+of+receptor-interacting+protein+kinase+1%2C+prevents+immune-dependent+hepatitis&doi=10.1111%2Ffebs.14176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis</span></div><div class="casAuthors">Le Cann, Fabienne; Delehouze, Claire; Leverrier-Penna, Sabrina; Filliol, Aveline; Comte, Arnaud; Delalande, Olivier; Desban, Nathalie; Baratte, Blandine; Gallais, Isabelle; Piquet-Pellorce, Claire; Faurez, Florence; Bonnet, Marion; Mettey, Yvette; Goekjian, Peter; Samson, Michel; Vandenabeele, Peter; Bach, Stephane; Dimanche-Boitrel, Marie-Therese</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3050-3068</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Necroptosis is a regulated form of cell death involved in several disease models including in particular liver diseases.  Receptor-interacting protein kinases, RIPK1 and RIPK3, are the main serine/threonine kinases driving this cell death pathway.  We screened a noncommercial, kinase-focused chem. library which allowed us to identify Sibiriline as a new inhibitor of necroptosis induced by tumor necrosis factor (TNF) in Fas-assocd. protein with death domain (FADD)-deficient Jurkat cells.  Moreover, Sib inhibits necroptotic cell death induced by various death ligands in human or mouse cells while not protecting from caspase-dependent apoptosis.  By using competition binding assay and recombinant kinase assays, we demonstrated that Sib is a rather specific competitive RIPK1 inhibitor.  Mol. docking anal. shows that Sib is trapped closed to human RIPK1 ATP-binding site in a relatively hydrophobic pocket locking RIPK1 in an inactive conformation.  In agreement with its RIPK1 inhibitory property, Sib inhibits both TNF-induced RIPK1-dependent necroptosis and RIPK1-dependent apoptosis.  Finally, Sib protects mice from Con A-induced hepatitis.  These results reveal the small-mol. Sib as a new RIPK1 inhibitor potentially of interest for the treatment of immune-dependent hepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOShDtyIUxXrVg90H21EOLACvtfcHk0lgXnHTH4RkWrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSgsbnO&md5=08b7e21652891c30728f969681c162ae</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14176%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BCann%26aufirst%3DF.%26aulast%3DDelehouze%26aufirst%3DC.%26aulast%3DLeverrier-Penna%26aufirst%3DS.%26aulast%3DFilliol%26aufirst%3DA.%26aulast%3DComte%26aufirst%3DA.%26aulast%3DDelalande%26aufirst%3DO.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGallais%26aufirst%3DI.%26aulast%3DPiquet-Pellorce%26aufirst%3DC.%26aulast%3DFaurez%26aufirst%3DF.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DMettey%26aufirst%3DY.%26aulast%3DGoekjian%26aufirst%3DP.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DDimanche-Boitrel%26aufirst%3DM.%2BT.%26atitle%3DSibiriline%252C%2520a%2520new%2520small%2520chemical%2520inhibitor%2520of%2520receptor-interacting%2520protein%2520kinase%25201%252C%2520prevents%2520immune-dependent%2520hepatitis%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D3050%26epage%3D3068%26doi%3D10.1111%2Ffebs.14176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2012.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.ab.2012.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22658960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVekur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=164-174&author=J.+L.+Makiauthor=E.+E.+Smithauthor=X.+Tengauthor=S.+S.+Rayauthor=G.+D.+Cunyauthor=A.+Degterev&title=Fluorescence+polarization+assay+for+inhibitors+of+the+kinase+domain+of+receptor+interacting+protein+1&doi=10.1016%2Fj.ab.2012.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1</span></div><div class="casAuthors">Maki, Jenny L.; Smith, Elizabeth E.; Teng, Xin; Ray, Soumya S.; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necrotic cell death is prevalent in many different pathol. disease states and in traumatic injury.  Necroptosis is a form of necrosis that stems from specific signaling pathways, with the key regulator being receptor interacting protein 1 (RIP1), a serine/threonine kinase.  Specific inhibitors of RIP1, termed necrostatins, are potent inhibitors of necroptosis.  Necrostatins are structurally distinct from one another yet still possess the ability to inhibit RIP1 kinase activity.  To further understand the differences in the binding of the various necrostatins to RIP1 and to develop a robust high-throughput screening (HTS) assay, which can be used to identify new classes of RIP1 inhibitors, we synthesized fluorescein derivs. of Necrostatin-1 (Nec-1) and Nec-3.  These compds. were used to establish a fluorescence polarization (FP) assay to directly measure the binding of necrostatins to RIP1 kinase.  The fluorescein-labeled compds. are well suited for HTS because the assays have a DMSO (DMSO) tolerance up to 5% and Z' scores of 0.62 (fluorescein-Nec-1) and 0.57 (fluorescein-Nec-3).  In addn., results obtained from the FP assays and ligand docking studies provide insights into the putative binding sites of Nec-1, Nec-3, and Nec-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRs-1l1HAXBLVg90H21EOLACvtfcHk0lirD4DnhFIFZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVekur%252FP&md5=459d3cad4920efb0000a06c6b452b028</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2012.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2012.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BE.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DFluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520the%2520kinase%2520domain%2520of%2520receptor%2520interacting%2520protein%25201%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D427%26spage%3D164%26epage%3D174%26doi%3D10.1016%2Fj.ab.2012.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Execution of RIPK3-regulated necrosis</span>. <i>Mol. Cell Oncol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e960759</span>, <span class="refDoi"> DOI: 10.4161/23723548.2014.960759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.4161%2F23723548.2014.960759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27308332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=e960759&author=Z.+Caiauthor=Z.+G.+Liu&title=Execution+of+RIPK3-regulated+necrosis&doi=10.4161%2F23723548.2014.960759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Execution of RIPK3-regulated necrosis</span></div><div class="casAuthors">Cai, Zhenyu; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e960759/1-e960759/7</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated necrotic cell death that is mediated by receptor-interacting protein 1 (RIP1) and RIP3 kinases.  Diverse receptors, including death receptors, Toll-like receptors, interferon receptors, and DAI DNA receptors are able to trigger necroptosis.  The newly identified MLKL protein functions downstream of RIP1/RIP3 and is essential for the execution of necroptosis.  Studies also indicate involvement of reactive oxygen species and calcium and sodium ions.  Identification of the key mediators of necroptosis is crit. for understanding the mol. mechanisms of the necroptotic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt35ztg1n-rrVg90H21EOLACvtfcHk0lirD4DnhFIFZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN&md5=65d7f10e73fc3e518584c01f9ded2975</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.960759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.960759%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DExecution%2520of%2520RIPK3-regulated%2520necrosis%26jtitle%3DMol.%2520Cell%2520Oncol%26date%3D2014%26volume%3D1%26spage%3De960759%26doi%3D10.4161%2F23723548.2014.960759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">31268</span>– <span class="NLM_lpage">31279</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.462341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1074%2Fjbc.M113.462341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24019532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yhsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=31268-31279&author=W.+J.+Kaiserauthor=H.+Sridharanauthor=C.+Huangauthor=P.+Mandalauthor=J.+W.+Uptonauthor=P.+J.+Goughauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=E.+S.+Mocarski&title=Toll-like+receptor+3-mediated+necrosis+via+TRIF%2C+RIP3%2C+and+MLKL&doi=10.1074%2Fjbc.M113.462341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL</span></div><div class="casAuthors">Kaiser, William J.; Sridharan, Haripriya; Huang, Chunzi; Mandal, Pratyusha; Upton, Jason W.; Gough, Peter J.; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Mocarski, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">31268-31279</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) signaling is triggered by pathogen-assocd. mol. patterns that mediate well established cytokine-driven pathways, activating NF-κB together with IRF3/IRF7.  In addn., TLR3 drives caspase 8-regulated programmed cell death pathways reminiscent of TNF family death receptor signaling.  We find that inhibition or elimination of caspase 8 during stimulation of TLR2, TLR3, TLR4, TLR5, or TLR9 results in receptor interacting protein (RIP) 3 kinase-dependent programmed necrosis that occurs through either TIR domain-contg. adapter-inducing interferon-β (TRIF) or MyD88 signal transduction.  TLR3 or TLR4 directly activates programmed necrosis through a RIP homotypic interaction motif-dependent assocn. of TRIF with RIP3 kinase (also called RIPK3).  In fibroblasts, this pathway proceeds independent of RIP1 or its kinase activity, but it remains dependent on mixed lineage kinase domain-like protein (MLKL) downstream of RIP3 kinase.  Here, we describe two small mol. RIP3 kinase inhibitors and employ them to demonstrate the common requirement for RIP3 kinase in programmed necrosis induced by RIP1-RIP3, DAI-RIP3, and TRIF-RIP3 complexes.  Cell fate decisions following TLR signaling parallel death receptor signaling and rely on caspase 8 to suppress RIP3-dependent programmed necrosis whether initiated directly by a TRIF-RIP3-MLKL pathway or indirectly via TNF activation and the RIP1-RIP3-MLKL necroptosis pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNB5p5-dbMrVg90H21EOLACvtfcHk0lirD4DnhFIFZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yhsL%252FL&md5=b31c4a29d6e0fd1b5e72fdafe208a9cb</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.462341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.462341%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DSridharan%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DUpton%26aufirst%3DJ.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26atitle%3DToll-like%2520receptor%25203-mediated%2520necrosis%2520via%2520TRIF%252C%2520RIP3%252C%2520and%2520MLKL%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D31268%26epage%3D31279%26doi%3D10.1074%2Fjbc.M113.462341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley-Bauer, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roback, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span> <span> </span><span class="NLM_article-title">RIP3 induces apoptosis independent of pronecrotic kinase activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25459880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=481-495&author=P.+Mandalauthor=S.+B.+Bergerauthor=S.+Pillayauthor=K.+Moriwakiauthor=C.+Huangauthor=H.+Guoauthor=J.+D.+Lichauthor=J.+Fingerauthor=V.+Kasparcovaauthor=B.+Vottaauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=A.+S.+Lakdawalaauthor=M.+P.+DeMartinoauthor=L.+N.+Casillasauthor=P.+A.+Haileauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Uptonauthor=L.+P.+Daley-Bauerauthor=L.+Robackauthor=N.+Ramiaauthor=C.+M.+Doveyauthor=J.+E.+Caretteauthor=F.+K.+Chanauthor=J.+Bertinauthor=P.+J.+Goughauthor=E.+S.+Mocarskiauthor=W.+J.+Kaiser&title=RIP3+induces+apoptosis+independent+of+pronecrotic+kinase+activity&doi=10.1016%2Fj.molcel.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity</span></div><div class="casAuthors">Mandal, Pratyusha; Berger, Scott B.; Pillay, Sirika; Moriwaki, Kenta; Huang, Chunzi; Guo, Hongyan; Lich, John D.; Finger, Joshua; Kasparcova, Viera; Votta, Bart; Ouellette, Michael; King, Bryan W.; Wisnoski, David; Lakdawala, Ami S.; DeMartino, Michael P.; Casillas, Linda N.; Haile, Pamela A.; Sehon, Clark A.; Marquis, Robert W.; Upton, Jason; Daley-Bauer, Lisa P.; Roback, Linda; Ramia, Nancy; Dovey, Cole M.; Carette, Jan E.; Chan, Francis Ka-Ming; Bertin, John; Gough, Peter J.; Mocarski, Edward S.; Kaiser, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-495</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease.  Here, three selective small-mol. compds. are shown to inhibit RIP3 kinase-dependent necroptosis, although their therapeutic value is undermined by a surprising, concn.-dependent induction of apoptosis.  These compds. interact with RIP3 to activate caspase 8 (Casp8) via RHIM-driven recruitment of RIP1 (RIPK1) to assemble a Casp8-FADD-cFLIP complex completely independent of pronecrotic kinase activities and MLKL.  RIP3 kinase-dead D161N mutant induces spontaneous apoptosis independent of compd., whereas D161G, D143N, and K51A mutants, like wild-type, only trigger apoptosis when compd. is present.  Accordingly, RIP3-K51A mutant mice (Rip3K51A/K51A) are viable and fertile, in stark contrast to the perinatal lethality of Rip3D161N/D161N mice.  RIP3 therefore holds both necroptosis and apoptosis in balance through a Ripoptosome-like platform.  This work highlights a common mechanism unveiling RHIM-driven apoptosis by therapeutic or genetic perturbation of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaOmUttaymrVg90H21EOLACvtfcHk0lgk3_2X6_JnvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK&md5=43567ddc4cb1b78b17294118acb8a951</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DPillay%26aufirst%3DS.%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DDeMartino%26aufirst%3DM.%2BP.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DUpton%26aufirst%3DJ.%26aulast%3DDaley-Bauer%26aufirst%3DL.%2BP.%26aulast%3DRoback%26aufirst%3DL.%26aulast%3DRamia%26aufirst%3DN.%26aulast%3DDovey%26aufirst%3DC.%2BM.%26aulast%3DCarette%26aufirst%3DJ.%2BE.%26aulast%3DChan%26aufirst%3DF.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26atitle%3DRIP3%2520induces%2520apoptosis%2520independent%2520of%2520pronecrotic%2520kinase%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D481%26epage%3D495%26doi%3D10.1016%2Fj.molcel.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cripps, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2015.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26024392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSiurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=76-88&author=D.+A.+Rodriguezauthor=R.+Weinlichauthor=S.+Brownauthor=C.+Guyauthor=P.+Fitzgeraldauthor=C.+P.+Dillonauthor=A.+Oberstauthor=G.+Quaratoauthor=J.+Lowauthor=J.+G.+Crippsauthor=T.+Chenauthor=D.+R.+Green&title=Characterization+of+RIPK3-mediated+phosphorylation+of+the+activation+loop+of+MLKL+during+necroptosis&doi=10.1038%2Fcdd.2015.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis</span></div><div class="casAuthors">Rodriguez, D. A.; Weinlich, R.; Brown, S.; Guy, C.; Fitzgerald, P.; Dillon, C. P.; Oberst, A.; Quarato, G.; Low, J.; Cripps, J. G.; Chen, T.; Green, D. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like pseudokinase (MLKL) mediates necroptosis by translocating to the plasma membrane and inducing its rupture.  The activation of MLKL occurs in a multimol. complex (the 'necrosome'), which is comprised of MLKL, receptor-interacting serine/threonine kinase (RIPK)-3 (RIPK3) and, in some cases, RIPK1.  Within this complex, RIPK3 phosphorylates the activation loop of MLKL, promoting conformational changes and allowing the formation of MLKL oligomers, which migrate to the plasma membrane.  Previous studies suggested that RIPK3 could phosphorylate the murine MLKL activation loop at Ser345, Ser347 and Thr349.  Moreover, substitution of the Ser345 for an aspartic acid creates a constitutively active MLKL, independent of RIPK3 function.  Here we examine the role of each of these residues and found that the phosphorylation of Ser345 is crit. for RIPK3-mediated necroptosis, Ser347 has a minor accessory role and Thr349 seems to be irrelevant.  We generated a specific monoclonal antibody to detect phospho-Ser345 in murine cells.  Using this antibody, a series of MLKL mutants and a novel RIPK3 inhibitor, we demonstrate that the phosphorylation of Ser345 is not required for the interaction between RIPK3 and MLKL in the necrosome, but is essential for MLKL translocation, accumulation in the plasma membrane, and consequent necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjrS_O0spUN7Vg90H21EOLACvtfcHk0lgk3_2X6_JnvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSiurjF&md5=85f1eb0ff4ddaf746855d456f6ee6f6e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.70%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DFitzgerald%26aufirst%3DP.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DQuarato%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DJ.%26aulast%3DCripps%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520RIPK3-mediated%2520phosphorylation%2520of%2520the%2520activation%2520loop%2520of%2520MLKL%2520during%2520necroptosis%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D76%26epage%3D88%26doi%3D10.1038%2Fcdd.2015.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">125</span>, <span class="refDoi"> DOI: 10.1038/s12276-018-0152-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs12276-018-0152-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30237400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3czhtVWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=125&author=H.+H.+Parkauthor=S.+Y.+Parkauthor=S.+Mahauthor=J.+H.+Parkauthor=S.+S.+Hongauthor=S.+Hongauthor=Y.+S.+Kim&title=HS-1371%2C+a+novel+kinase+inhibitor+of+RIP3-mediated+necroptosis&doi=10.1038%2Fs12276-018-0152-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis</span></div><div class="casAuthors">Park Han-Hee; Park Se-Yeon; Kim You-Sun; Park Han-Hee; Park Se-Yeon; Kim You-Sun; Mah Shinmee; Hong Sungwoo; Mah Shinmee; Hong Sungwoo; Park Jung-Hee; Hong Soon-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & molecular medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">125</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a type of programmed cell death that usually occurs under apoptosis-deficient conditions.  Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is a central player in necroptosis, and its kinase activity is essential for downstream necroptotic signaling events.  Since RIP3 kinase activity has been associated with various diseases, the development of specific RIP3 inhibitors is an attractive strategy for therapeutic application.  In this study, we identified a potent RIP3 inhibitor, HS-1371, by the extensive screening of chemical libraries focused on kinases.  HS-1371 directly binds to RIP3 in an ATP-competitive and time-independent manner, providing a mechanism of action.  Moreover, the compound inhibited TNF-induced necroptosis but did not inhibit TNF-induced apoptosis, indicating that this novel inhibitor has a specific inhibitory effect on RIP3-mediated necroptosis via the suppression of RIP3 kinase activity.  Our results suggest that HS-1371 could serve as a potential preventive or therapeutic agent for diseases involving RIP3 hyperactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPh9ctMIKK5Oqrn-c4Of3KfW6udTcc2eYwLTRbmyZWBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhtVWmtA%253D%253D&md5=9b064775dbc9415b930d2654e06f5971</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fs12276-018-0152-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-018-0152-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DMah%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DHS-1371%252C%2520a%2520novel%2520kinase%2520inhibitor%2520of%2520RIP3-mediated%2520necroptosis%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2018%26volume%3D50%26spage%3D125%26doi%3D10.1038%2Fs12276-018-0152-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span> <span> </span><span class="NLM_article-title">The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1278</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2014.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24901049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1278&author=J.+X.+Liauthor=J.+M.+Fengauthor=Y.+Wangauthor=X.+H.+Liauthor=X.+X.+Chenauthor=Y.+Suauthor=Y.+Y.+Shenauthor=Y.+Chenauthor=B.+Xiongauthor=C.+H.+Yangauthor=J.+Dingauthor=Z.+H.+Miao&title=The+B-Raf%28V600E%29+inhibitor+dabrafenib+selectively+inhibits+RIP3+and+alleviates+acetaminophen-induced+liver+injury&doi=10.1038%2Fcddis.2014.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span></div><div class="casAuthors">Li, J.-X.; Feng, J-.M.; Wang, Y.; Li, X.-H.; Chen, X.-X.; Su, Y.; Shen, Y.-Y.; Chen, Y.; Xiong, B.; Yang, C.-H.; Ding, J.; Miao, Z.-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1278</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein (RIP)3 is a crit. regulator of necroptosis and has been demonstrated to be assocd. with various diseases, suggesting that its inhibitors are promising in the clinic.  However, there have been few RIP3 inhibitors reported as yet.  B-RafV600E inhibitors are an important anticancer drug class for metastatic melanoma therapy.  In this study, we found that 6 B-Raf inhibitors could inhibit RIP3 enzymic activity in vitro.  Among them, dabrafenib showed the most potent inhibition on RIP3, which was achieved by its ATP-competitive binding to the enzyme.  Dabrafenib displayed highly selective inhibition on RIP3 over RIP1, RIP2 and RIP5.  Moreover, only dabrafenib rescued cells from RIP3-mediated necroptosis induced by the necroptosis-induced combinations, i.e., tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand or Fas ligand plus Smac mimetic and the caspase inhibitor z-VAD.  Dabrafenib decreased the RIP3-mediated Ser358 phosphorylation of mixed lineage kinase domain-like protein (MLKL) and disrupted the interaction between RIP3 and MLKL.  Notably, RIP3 inhibition of dabrafenib appeared to be independent of its B-Raf inhibition.  Dabrafenib was further revealed to prevent acetaminophen-induced necrosis in normal human hepatocytes, which is considered to be mediated by RIP3.  In acetaminophen-overdosed mouse models, dabrafenib was found to apparently ease the acetaminophen-caused liver damage.  The results indicate that the anticancer B-RafV600E inhibitor dabrafenib is a RIP3 inhibitor, which could serve as a sharp tool for probing the RIP3 biol. and as a potential preventive or therapeutic agent for RIP3-involved necroptosis-related diseases such as acetaminophen-induced liver damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40b524L_pOLVg90H21EOLACvtfcHk0lhF89Vp17a76Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D&md5=a425dc91c461e5725d553428187db972</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DX.%2BX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26atitle%3DThe%2520B-Raf%2528V600E%2529%2520inhibitor%2520dabrafenib%2520selectively%2520inhibits%2520RIP3%2520and%2520alleviates%2520acetaminophen-induced%2520liver%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1278%26doi%3D10.1038%2Fcddis.2014.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2904</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2017.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28661484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e2904&author=S.+Martensauthor=M.+Jeongauthor=W.+Tonnusauthor=F.+Feldmannauthor=S.+Hofmansauthor=V.+Goossensauthor=N.+Takahashiauthor=J.+H.+Brasenauthor=E.+W.+Leeauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Fuldaauthor=A.+Linkermannauthor=J.+Songauthor=P.+Vandenabeele&title=Sorafenib+tosylate+inhibits+directly+necrosome+complex+formation+and+protects+in+mouse+models+of+inflammation+and+tissue+injury&doi=10.1038%2Fcddis.2017.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span></div><div class="casAuthors">Martens, Sofie; Jeong, Manhyung; Tonnus, Wulf; Feldmann, Friederike; Hofmans, Sam; Goossens, Vera; Takahashi, Nozomi; Brasen, Jan Hinrich; Lee, Eun-Woo; Van der Veken, Pieter; Joossens, Jurgen; Augustyns, Koen; Fulda, Simone; Linkermann, Andreas; Song, Jaewhan; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2904</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis contributes to the pathophysiol. of several inflammatory, infectious and degenerative disorders.  TNF-induced necroptosis involves activation of the receptor-interacting protein kinases 1 and 3 (RIPK1/3) in a necrosome complex, eventually leading to the phosphorylation and relocation of mixed lineage kinase domain like protein (MLKL).  Using a high-content screening of small compds. and FDA-approved drug libraries, we identified the anti-cancer drug Sorafenib tosylate as a potent inhibitor of TNF-dependent necroptosis.  Interestingly, Sorafenib has a dual activity spectrum depending on its concn.  In murine and human cell lines it induces cell death, while at lower concns. it inhibits necroptosis, without affecting NF-κB activation.  Pull down expts. with biotinylated Sorafenib show that it binds independently RIPK1, RIPK3 and MLKL.  Moreover, it inhibits RIPK1 and RIPK3 kinase activity.  In vivo Sorafenib protects against TNF-induced systemic inflammatory response syndrome (SIRS) and renal ischemia-reperfusion injury (IRI).  Altogether, we show that Sorafenib can, next to the reported Braf/Mek/Erk and VEGFR pathways, also target the necroptotic pathway and that it can protect in an acute inflammatory RIPK1/3-mediated pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfswPD82jd67Vg90H21EOLACvtfcHk0lhF89Vp17a76Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO&md5=bb4e411a5d4a9a76e2a52d84075ddb3c</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.298%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DM.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DSorafenib%2520tosylate%2520inhibits%2520directly%2520necrosome%2520complex%2520formation%2520and%2520protects%2520in%2520mouse%2520models%2520of%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De2904%26doi%3D10.1038%2Fcddis.2017.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d] thiazol-2-yl)cyclopropanecarboxamide (TAK-632) analogues as novel necroptosis inhibitors by targeting receptor-interacting protein kinase 3 (RIPK3): synthesis, structure-activity relationships, and in vivo efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6665</span>– <span class="NLM_lpage">6681</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6665-6681&author=H.+Zhangauthor=L.+Xuauthor=X.+Qinauthor=X.+Chenauthor=H.+Congauthor=L.+Huauthor=L.+Chenauthor=Z.+Miaoauthor=W.+Zhangauthor=Z.+Caiauthor=C.+Zhuang&title=N-%287-cyano-6-%284-fluoro-3-%282-%283-%28trifluoromethyl%29phenyl%29acetamido%29phenoxy%29benzo%5Bd%5D+thiazol-2-yl%29cyclopropanecarboxamide+%28TAK-632%29+analogues+as+novel+necroptosis+inhibitors+by+targeting+receptor-interacting+protein+kinase+3+%28RIPK3%29%3A+synthesis%2C+structure-activity+relationships%2C+and+in+vivo+efficacy&doi=10.1021%2Facs.jmedchem.9b00611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure-Activity Relationships, and in Vivo Efficacy</span></div><div class="casAuthors">Zhang, Hao; Xu, Lijuan; Qin, Xia; Chen, Xiaofei; Cong, Hui; Hu, Longmiao; Chen, Long; Miao, Zhenyuan; Zhang, Wannian; Cai, Zhenyu; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6665-6681</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Necroptosis, a form of programmed cell death, plays a crit. role in various diseases, including inflammatory, infectious, and degenerative diseases.  We previously identified N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (6) as a potent inhibitor of necroptosis by targeting both receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) kinases.  Herein, we performed three rounds of structural optimizations of TAK-632 and elucidated structure-activity relationships to generate more potent inhibitors by targeting RIPK3.  The analogs with carbamide groups exhibited great antinecroptotic activities, and compd. 42 showed >60-fold selectivity for RIPK3 than RIPK1.  It blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells.  In a tumor necrosis factor-induced systemic inflammatory response syndrome model, it significantly protected mice from hypothermia and death at a dose of 5 mg/kg, which was much more effective than TAK-632.  Moreover, it showed favorable and druglike pharmacokinetic properties in rats with an oral bioavailability of 25.2%.  Thus, these RIPK3-targeting small mols. represent promising lead structures for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1wo_oM-kczbVg90H21EOLACvtfcHk0lguFkS9NEDB_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOkurs%253D&md5=a854b3004c4055a47a3935756f49cc55</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00611%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCong%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DN-%25287-cyano-6-%25284-fluoro-3-%25282-%25283-%2528trifluoromethyl%2529phenyl%2529acetamido%2529phenoxy%2529benzo%255Bd%255D%2520thiazol-2-yl%2529cyclopropanecarboxamide%2520%2528TAK-632%2529%2520analogues%2520as%2520novel%2520necroptosis%2520inhibitors%2520by%2520targeting%2520receptor-interacting%2520protein%2520kinase%25203%2520%2528RIPK3%2529%253A%2520synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6665%26epage%3D6681%26doi%3D10.1021%2Facs.jmedchem.9b00611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural insights into RIP3-mediated necroptotic signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2013.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24095729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=70-78&author=T.+Xieauthor=W.+Pengauthor=C.+Yanauthor=J.+Wuauthor=X.+Gongauthor=Y.+Shi&title=Structural+insights+into+RIP3-mediated+necroptotic+signaling&doi=10.1016%2Fj.celrep.2013.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into RIP3-Mediated Necroptotic Signaling</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Yan, Chuangye; Wu, Jianping; Gong, Xinqi; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3 is an essential upstream kinase in necroptosis.  The pseudokinase MLKL functions as a substrate of RIP3 to mediate downstream signaling.  The mol. mechanism by which RIP3 recognizes and phosphorylates MLKL remains unknown.  Here, we report the crystal structures of the mouse RIP3 kinase domain, the MLKL kinase-like domain, and a binary complex between the two.  Both RIP3 and MLKL adopt the canonical kinase fold.  Free RIP3 exists in an active conformation, whereas MLKL-bound RIP3 is stabilized by AMP-PNP to adopt an inactive conformation.  The formation of the RIP3-MLKL complex, involving their resp. N- and C-lobes, is accompanied by pronounced conformational changes of the αC helix and activation loop in RIP3 and the corresponding structural elements in MLKL.  RIP3-mediated MLKL phosphorylation, though important for downstream signaling, is dispensable for stable complex formation between RIP3 and MLKL.  Our study serves as a framework for mechanistic understanding of RIP3-mediated necroptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7R60YS-0cP7Vg90H21EOLACvtfcHk0lguFkS9NEDB_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL&md5=53fa2aefe1223dfca855a95d28e5d478</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520insights%2520into%2520RIP3-mediated%2520necroptotic%2520signaling%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D5%26spage%3D70%26epage%3D78%26doi%3D10.1016%2Fj.celrep.2013.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A. C.</span>; <span class="NLM_string-name">Abell, L.</span>; <span class="NLM_string-name">Guo, J.</span>; <span class="NLM_string-name">Mertzman, M. E.</span>; <span class="NLM_string-name">Padmanabha, R.</span>; <span class="NLM_string-name">Macor, J. E.</span>; <span class="NLM_string-name">Chaudhry, C.</span>; <span class="NLM_string-name">Lu, H.</span>; <span class="NLM_string-name">O’Malley, K.</span>; <span class="NLM_string-name">Shaw, P. J.</span>; <span class="NLM_string-name">Weigelt, C.</span>; <span class="NLM_string-name">Pokross, M.</span>; <span class="NLM_string-name">Kish, K.</span>; <span class="NLM_string-name">Kim, K. S.</span>; <span class="NLM_string-name">Cornelius, L.</span>; <span class="NLM_string-name">Douglas, A. E.</span>; <span class="NLM_string-name">Calambur, D.</span>; <span class="NLM_string-name">Zhang, P.</span>; <span class="NLM_string-name">Carpenter, B.</span>; <span class="NLM_string-name">Pitts, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIPK3 type II inhibitors using high-throughput mechanistic studies in hit triage</span>.  <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00065</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+C.+Hart&author=L.+Abell&author=J.+Guo&author=M.+E.+Mertzman&author=R.+Padmanabha&author=J.+E.+Macor&author=C.+Chaudhry&author=H.+Lu&author=K.+O%E2%80%99Malley&author=P.+J.+Shaw&author=C.+Weigelt&author=M.+Pokross&author=K.+Kish&author=K.+S.+Kim&author=L.+Cornelius&author=A.+E.+Douglas&author=D.+Calambur&author=P.+Zhang&author=B.+Carpenter&author=W.+J.+Pitts&title=Identification+of+RIPK3+type+II+inhibitors+using+high-throughput+mechanistic+studies+in+hit+triage&doi=10.1021%2Facsmedchemlett.9b00065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00065%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520of%2520RIPK3%2520type%2520II%2520inhibitors%2520using%2520high-throughput%2520mechanistic%2520studies%2520in%2520hit%2520triage%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26doi%3D10.1021%2Facsmedchemlett.9b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span> <span> </span><span class="NLM_article-title">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1039/c3md00278k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1039%2Fc3md00278k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1yls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=333-337&author=D.+Liaoauthor=L.+Sunauthor=W.+Liuauthor=S.+Heauthor=X.+Wangauthor=X.+Lei&title=Necrosulfonamide+inhibits+necroptosis+by+selectively+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2Fc3md00278k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span></div><div class="casAuthors">Liao, Daohong; Sun, Liming; Liu, Weilong; He, Sudan; Wang, Xiaodong; Lei, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-337</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Through high-throughput screening of 200 000 compds. and subsequent structure-activity relationship (SAR) studies we identified necrosulfonamide (NSA) as a potent small mol. inhibitor for necroptosis, induced by a combination of TNF-a, Smac mimetic, and z-VAD-fmk (T/S/Z).  Applying a forward chem. genetic approach, we utilized an NSA based chem. probe to further reveal that NSA selectively targeted the Mixed Lineage Kinase Domain-like Protein (MLKL) to block the necrosome formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Hlqz0b1OmbVg90H21EOLACvtfcHk0lhPoYYPXdCbig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1yls78%253D&md5=a1a32fada660dc22dd208e64e2ecda87</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2Fc3md00278k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00278k%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26atitle%3DNecrosulfonamide%2520inhibits%2520necroptosis%2520by%2520selectively%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D333%26epage%3D337%26doi%3D10.1039%2Fc3md00278k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3637</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1039/C7CC00667E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1039%2FC7CC00667E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28267172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=3637-3640&author=B.+Yanauthor=L.+Liuauthor=S.+Huangauthor=Y.+Renauthor=H.+Wangauthor=Z.+Yaoauthor=L.+Liauthor=S.+Chenauthor=X.+Wangauthor=Z.+Zhang&title=Discovery+of+a+new+class+of+highly+potent+necroptosis+inhibitors+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2FC7CC00667E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein</span></div><div class="casAuthors">Yan, Bo; Liu, Lei; Huang, Shaoqiang; Ren, Yan; Wang, Huayi; Yao, Zhenglin; Li, Lin; Chen, She; Wang, Xiaodong; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3637-3640</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the development of novel Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitors with single nanomolar potency (compd. 15 is also named as TC13172).  Using the converting biochem. to chem. activity-based protein profiling (BTC-ABPP) method, the authors were able to det. that the inhibitors covalently bind to Cysteine 86 (Cys 86) of MLKL.  This is the first example of the use of LC-MS/MS to identify the binding site of an MLKL inhibitor.  The novel MLKL inhibitors provide powerful tools to study the biol. function of MLKL and demonstrate that MLKL should be viewed as a druggable target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9iUTEGlqF7Vg90H21EOLACvtfcHk0lhPoYYPXdCbig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVSgsrk%253D&md5=e3b110a609ce907845d00ca6d7a29cae</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2FC7CC00667E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC00667E%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520highly%2520potent%2520necroptosis%2520inhibitors%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2017%26volume%3D53%26spage%3D3637%26epage%3D3640%26doi%3D10.1039%2FC7CC00667E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucet, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripaydonis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babon, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcair, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">15072</span>– <span class="NLM_lpage">15077</span>, <span class="refDoi"> DOI: 10.1073/pnas.1408987111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1408987111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25288762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15072-15077&author=J.+M.+Hildebrandauthor=M.+C.+Tanzerauthor=I.+S.+Lucetauthor=S.+N.+Youngauthor=S.+K.+Spallauthor=P.+Sharmaauthor=C.+Pierottiauthor=J.+M.+Garnierauthor=R.+C.+Dobsonauthor=A.+I.+Webbauthor=A.+Tripaydonisauthor=J.+J.+Babonauthor=M.+D.+Mulcairauthor=M.+J.+Scanlonauthor=W.+S.+Alexanderauthor=A.+F.+Wilksauthor=P.+E.+Czabotarauthor=G.+Lesseneauthor=J.+M.+Murphyauthor=J.+Silke&title=Activation+of+the+pseudokinase+MLKL+unleashes+the+four-helix+bundle+domain+to+induce+membrane+localization+and+necroptotic+cell+death&doi=10.1073%2Fpnas.1408987111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death</span></div><div class="casAuthors">Hildebrand, Joanne M.; Tanzer, Maria C.; Lucet, Isabelle S.; Young, Samuel N.; Spall, Sukhdeep K.; Sharma, Pooja; Pierotti, Catia; Garnier, Jean-Marc; Dobson, Renwick C. J.; Webb, Andrew I.; Tripaydonis, Anne; Babon, Jeffrey J.; Mulcair, Mark D.; Scanlon, Martin J.; Alexander, Warren S.; Wilks, Andrew F.; Czabotar, Peter E.; Lessene, Guillaume; Murphy, James M.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15072-15077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Necroptosis is considered to be complementary to the classical caspase-dependent programmed cell death pathway, apoptosis.  The pseudokinase Mixed Lineage Kinase Domain-Like (MLKL) is an essential effector protein in the necroptotic cell death pathway downstream of the protein kinase Receptor Interacting Protein Kinase-3 (RIPK3).  How MLKL causes cell death is unclear, however RIPK3-mediated phosphorylation of the activation loop in MLKL trips a mol. switch to induce necroptotic cell death.  Here, we show that the MLKL pseudokinase domain acts as a latch to restrain the N-terminal four-helix bundle (4HB) domain and that unleashing this domain results in formation of a high-mol.-wt., membrane-localized complex and cell death.  Using alanine-scanning mutagenesis, we identified two clusters of residues on opposing faces of the 4HB domain that were required for the 4HB domain to kill cells.  The integrity of one cluster was essential for membrane localization, whereas MLKL mutations in the other cluster did not prevent membrane translocation but prevented killing; this demonstrates that membrane localization is necessary, but insufficient, to induce cell death.  Finally, we identified a small mol. that binds the nucleotide binding site within the MLKL pseudokinase domain and retards MLKL translocation to membranes, thereby preventing necroptosis.  This inhibitor provides a novel tool to investigate necroptosis and demonstrates the feasibility of using small mols. to target the nucleotide binding site of pseudokinases to modulate signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBj_zEe5HYP7Vg90H21EOLACvtfcHk0liQxexBPUXe6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtLnJ&md5=4acef514a3c5a8c3b7fb7dd7b61dc2cd</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1408987111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1408987111%26sid%3Dliteratum%253Aachs%26aulast%3DHildebrand%26aufirst%3DJ.%2BM.%26aulast%3DTanzer%26aufirst%3DM.%2BC.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BN.%26aulast%3DSpall%26aufirst%3DS.%2BK.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DPierotti%26aufirst%3DC.%26aulast%3DGarnier%26aufirst%3DJ.%2BM.%26aulast%3DDobson%26aufirst%3DR.%2BC.%26aulast%3DWebb%26aufirst%3DA.%2BI.%26aulast%3DTripaydonis%26aufirst%3DA.%26aulast%3DBabon%26aufirst%3DJ.%2BJ.%26aulast%3DMulcair%26aufirst%3DM.%2BD.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DW.%2BS.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520pseudokinase%2520MLKL%2520unleashes%2520the%2520four-helix%2520bundle%2520domain%2520to%2520induce%2520membrane%2520localization%2520and%2520necroptotic%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D15072%26epage%3D15077%26doi%3D10.1073%2Fpnas.1408987111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramasivam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolotti-Ciarlet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moree, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L. F.</span></span> <span> </span><span class="NLM_article-title">ATP-competitive MLKL binders have no functional impact on necroptosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0165983</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0165983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0165983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27832137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0165983&author=B.+Maauthor=D.+Marcotteauthor=M.+Paramasivamauthor=K.+Michelsenauthor=T.+Wangauthor=A.+Bertolotti-Ciarletauthor=J.+H.+Jonesauthor=B.+Moreeauthor=M.+Butkoauthor=J.+Salafskyauthor=X.+Sunauthor=T.+McKeeauthor=L.+F.+Silvian&title=ATP-competitive+MLKL+binders+have+no+functional+impact+on+necroptosis&doi=10.1371%2Fjournal.pone.0165983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-competitive MLKL binders have no functional impact on necroptosis</span></div><div class="casAuthors">Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Howard, Jones John; Moree, Ben; Butko, Margaret; Salafsky, Joshua; Sun, Xin; McKee, Timothy; Silvian, Laura F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0165983/1-e0165983/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">MLKL is a pore forming pseudokinase involved in the final stage of necroptosis, a form of programmed cell death.  Its phosphorylation by RIPK3 is necessary for triggering necroptosis but not for triggering apoptosis, which makes it a unique target for pharmacol. inhibition to block necroptotic cell death.  This mechanism has been described as playing a role in disease progression in neurodegenerative and inflammatory diseases.  A type II kinase inhibitor (cpd 1) has been described that reportedly binds to the MLKL pseudokinase domain and prevents necroptosis.  Here we describe five compds. that bind to the MLKL ATP-binding site, however the four MLKL-selective compds. have no activity in rescuing cells from necroptosis.  We use kinase selectivity panels, crystallog. and a new conformationally sensitive method of measuring protein conformational changes (SHG) to confirm that the one previously reported compd. that can rescue cells (cpd 1) is a non-selective type II inhibitor that also inhibits the upstream kinase RIPK1.  Although this compd. can shift the GFE motif of the activation loop to an "out" position, the accessibility of the key residue Ser358 in the MLKL activation loop is not affected by compd. binding to the MLKL active site.  Our studies indicate that an ATP-pocket inhibitor of the MLKL pseudokinase domain does not have any impact on the necroptosis pathway, which is contrary to a previously reported study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg4NB28MjYebVg90H21EOLACvtfcHk0liQxexBPUXe6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlWnur4%253D&md5=2e8429a8d5a591faa411e1515362bf8b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0165983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0165983%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DParamasivam%26aufirst%3DM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBertolotti-Ciarlet%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DMoree%26aufirst%3DB.%26aulast%3DButko%26aufirst%3DM.%26aulast%3DSalafsky%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMcKee%26aufirst%3DT.%26aulast%3DSilvian%26aufirst%3DL.%2BF.%26atitle%3DATP-competitive%2520MLKL%2520binders%2520have%2520no%2520functional%2520impact%2520on%2520necroptosis%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0165983%26doi%3D10.1371%2Fjournal.pone.0165983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span>Denali
Therapeutics. <a href="https://denalitherapeutics.com/pipeline" class="extLink">https://denalitherapeutics.com/pipeline</a> (accessed June 12, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Denali%0ATherapeutics.+https%3A%2F%2Fdenalitherapeutics.com%2Fpipeline+%28accessed+June+12%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moynagh, P. N.</span></span> <span> </span><span class="NLM_article-title">RIP kinases: key decision makers in cell death and innate immunity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2014.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25146926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCrsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=225-236&author=F.+Humphriesauthor=S.+Yangauthor=B.+Wangauthor=P.+N.+Moynagh&title=RIP+kinases%3A+key+decision+makers+in+cell+death+and+innate+immunity&doi=10.1038%2Fcdd.2014.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">RIP kinases: key decision makers in cell death and innate immunity</span></div><div class="casAuthors">Humphries, F.; Yang, S.; Wang, B.; Moynagh, P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-236</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Innate immunity represents the first line of defense against invading pathogens.  It consists of an initial inflammatory response that recruits white blood cells to the site of infection in an effort to destroy and eliminate the pathogen.  Some pathogens replicate within host cells, and cell death by apoptosis is an important effector mechanism to remove the replication niche for such microbes.  However, some microbes have evolved evasive strategies to block apoptosis, and in these cases host cells may employ further countermeasures, including an inflammatory form of cell death know as necroptosis.  This review aims to highlight the importance of the RIP kinase family in controlling these various defense strategies.  RIP1 is initially discussed as a key component of death receptor signalling and in the context of dictating whether a cell triggers a pathway of pro-inflammatory gene expression or cell death by apoptosis.  The mol. and functional interplay of RIP1 and RIP3 is described, esp. with respect to mediating necroptosis and as key mediators of inflammation.  The function of RIP2, with particular emphasis on its role in NOD signalling, is also explored.  Special attention is given to emphasizing the physiol. and pathophysiol. contexts for these various functions of RIP kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPApofbdnkLLVg90H21EOLACvtfcHk0liguHXCdrn44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCrsLnP&md5=f25195c56cf9a7553367a4eed0f1b34a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.126%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMoynagh%26aufirst%3DP.%2BN.%26atitle%3DRIP%2520kinases%253A%2520key%2520decision%2520makers%2520in%2520cell%2520death%2520and%2520innate%2520immunity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26spage%3D225%26epage%3D236%26doi%3D10.1038%2Fcdd.2014.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Receptor-interacting protein (RIP) kinase family</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/cmi.2010.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcmi.2010.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20383176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=243-249&author=D.+Zhangauthor=J.+Linauthor=J.+Han&title=Receptor-interacting+protein+%28RIP%29+kinase+family&doi=10.1038%2Fcmi.2010.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-interacting protein (RIP) kinase family</span></div><div class="casAuthors">Zhang, Duanwu; Lin, Juan; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Receptor-interacting protein (RIP) kinases are a group of threonine/serine protein kinases with a relatively conserved kinase domain but distinct non-kinase regions.  A no. of different domain structures, such as death and caspase activation and recruitment domain (CARD) domains, were found in different RIP family members, and these domains should be keys in detg. the specific function of each RIP kinase.  It is known that RIP kinases participate in different biol. processes, including those in innate immunity, but their downstream substrates are largely unknown.  This review will give an overview of the structures and functions of RIP family members, and an update of recent progress in RIP kinase research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICS9EnND6QLVg90H21EOLACvtfcHk0liguHXCdrn44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSms7w%253D&md5=e110b4cbd223b7ddef4855830c7d4156</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2010.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2010.10%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DReceptor-interacting%2520protein%2520%2528RIP%2529%2520kinase%2520family%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2010%26volume%3D7%26spage%3D243%26epage%3D249%26doi%3D10.1038%2Fcmi.2010.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chirieleison, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kertesy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D. W.</span></span> <span> </span><span class="NLM_article-title">Synthetic biology reveals the uniqueness of the RIP kinase domain</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">4291</span>– <span class="NLM_lpage">4297</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1502631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.4049%2Fjimmunol.1502631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27045108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=4291-4297&author=S.+M.+Chirieleisonauthor=S.+B.+Kertesyauthor=D.+W.+Abbott&title=Synthetic+biology+reveals+the+uniqueness+of+the+RIP+kinase+domain&doi=10.4049%2Fjimmunol.1502631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain</span></div><div class="casAuthors">Chirieleison, Steven M.; Kertesy, Sylvia B.; Abbott, Derek W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4291-4297</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The RIP kinases (RIPKs) play an essential role in inflammatory signaling and inflammatory cell death.  However, the function of their kinase activity has been enigmatic, and only recently has kinase domain activity been shown to be crucial for their signal transduction capacity.  Despite this uncertainty, the RIPKs have been the subject of intense pharmaceutical development with a no. of compds. currently in preclin. testing.  In this work, we seek to det. the functional redundancy between the kinase domains of the four major RIPK family members.  We find that although RIPK1, RIPK2, and RIPK4 are similar in that they can all activate NF-κB and induce NF-κB essential modulator ubiquitination, only RIPK2 is a dual-specificity kinase.  Domain swapping expts. showed that the RIPK4 kinase domain could be converted to a dual-specificity kinase and is essentially indistinct from RIPK2 in biochem. and mol. activity.  Surprisingly, however, replacement of RIPK2's kinase domain with RIPK4's did not complement a nucleotide-binding oligomerization domain 2 signaling or gene expression induction defect in RIPK2-/- macrophages.  These findings suggest that RIPK2's kinase domain is functionally unique compared with other RIPK family members and that pharmacol. targeting of RIPK2 can be sepd. from the other RIPKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BtYagqNBrVg90H21EOLACvtfcHk0liguHXCdrn44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCntLg%253D&md5=b5482ea6e9e0c17c8d097686d208430f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1502631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1502631%26sid%3Dliteratum%253Aachs%26aulast%3DChirieleison%26aufirst%3DS.%2BM.%26aulast%3DKertesy%26aufirst%3DS.%2BB.%26aulast%3DAbbott%26aufirst%3DD.%2BW.%26atitle%3DSynthetic%2520biology%2520reveals%2520the%2520uniqueness%2520of%2520the%2520RIP%2520kinase%2520domain%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26spage%3D4291%26epage%3D4297%26doi%3D10.4049%2Fjimmunol.1502631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-independent signaling by the RIP kinases in inflammation</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2203-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1007%2Fs00018-016-2203-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27048814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2325-2334&author=K.+Moriwakiauthor=F.+K.+Chan&title=Necroptosis-independent+signaling+by+the+RIP+kinases+in+inflammation&doi=10.1007%2Fs00018-016-2203-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-independent signaling by the RIP kinases in inflammation</span></div><div class="casAuthors">Moriwaki, Kenta; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Recent advances have identified a signaling cascade involving receptor interacting protein kinase 1 (RIPK1), RIPK3 and the pseudokinase mixed lineage kinase domain-like (MLKL) that is crucial for induction of necroptosis, a non-apoptotic form of cell death.  RIPK1-RIPK3-MLKL-mediated necroptosis has been attributed to cause many inflammatory diseases through the release of cellular damage-assocd. mol. patterns (DAMPs).  In addn. to necroptosis, emerging evidence suggests that these necroptosis signal adaptors can also facilitate inflammation independent of cell death.  In particular, the RIP kinases can drive NF-κB and inflammasome activation independent of cell death.  In this review, we will discuss recent discoveries that led to this realization and present arguments why cell death-independent signaling by the RIP kinases may have a more important role in inflammation than necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wW0-uJ6xhbVg90H21EOLACvtfcHk0liGtkUYpXjHlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D&md5=8ba1cc7565ca54604626eb5d030dce48</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2203-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2203-4%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DNecroptosis-independent%2520signaling%2520by%2520the%2520RIP%2520kinases%2520in%2520inflammation%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2325%26epage%3D2334%26doi%3D10.1007%2Fs00018-016-2203-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Targeting RIPK1 for the treatment of human diseases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9714</span>– <span class="NLM_lpage">9722</span>, <span class="refDoi"> DOI: 10.1073/pnas.1901179116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1901179116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31048504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Clu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=9714-9722&author=A.+Degterevauthor=D.+Ofengeimauthor=J.+Yuan&title=Targeting+RIPK1+for+the+treatment+of+human+diseases&doi=10.1073%2Fpnas.1901179116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RIPK1 for the treatment of human diseases</span></div><div class="casAuthors">Degterev, Alexei; Ofengeim, Dimitry; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9714-9722</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  RIPK1 kinase has emerged as a promising therapeutic target for the treatment of a wide range of human neurodegenerative, autoimmune, and inflammatory diseases.  This was supported by extensive studies which demonstrated that RIPK1 is a key mediator of apoptotic and necrotic cell death as well as inflammatory pathways.  Furthermore, human genetic evidence has linked the dysregulation of RIPK1 to the pathogenesis of ALS as well as other inflammatory and neurodegenerative diseases.  Importantly, unique allosteric small-mol. inhibitors of RIPK1 that offer high selectivity have been developed.  These mols. can penetrate the blood-brain barrier, thus offering the possibility to target neuroinflammation and cell death which drive various neurol. conditions including Alzheimer's disease, ALS, and multiple sclerosis as well as acute neurol. diseases such as stroke and traumatic brain injuries.  We discuss the current understanding of RIPK1 regulatory mechanisms and emerging evidence for the pathol. roles of RIPK1 in human diseases, esp. in the context of the central nervous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCMIOEQUbM87Vg90H21EOLACvtfcHk0liGtkUYpXjHlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Clu7s%253D&md5=c3c83482fe0621d4775dcd2dd6e36af5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1901179116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1901179116%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DTargeting%2520RIPK1%2520for%2520the%2520treatment%2520of%2520human%2520diseases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D9714%26epage%3D9722%26doi%3D10.1073%2Fpnas.1901179116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cripps, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llambi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janke, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2014.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24813850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=1189-1202&author=C.+P.+Dillonauthor=R.+Weinlichauthor=D.+A.+Rodriguezauthor=J.+G.+Crippsauthor=G.+Quaratoauthor=P.+Gurungauthor=K.+C.+Verbistauthor=T.+L.+Brewerauthor=F.+Llambiauthor=Y.+N.+Gongauthor=L.+J.+Jankeauthor=M.+A.+Kelliherauthor=T.+D.+Kannegantiauthor=D.+R.+Green&title=RIPK1+blocks+early+postnatal+lethality+mediated+by+caspase-8+and+RIPK3&doi=10.1016%2Fj.cell.2014.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3</span></div><div class="casAuthors">Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Janke, Laura J.; Kelliher, Michelle A.; Kanneganti, Thirumala-Devi; Green, Douglas R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1202</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase (RIPK)-1 is involved in RIPK3-dependent and -independent signaling pathways leading to cell death and/or inflammation.  Genetic ablation of ripk1 causes postnatal lethality, which was not prevented by deletion of ripk3, caspase-8, or fadd.  However, animals that lack RIPK1, RIPK3, and either caspase-8 or FADD survived weaning and matured normally.  RIPK1 functions in vitro to limit caspase-8-dependent, TNFR-induced apoptosis, and animals lacking RIPK1, RIPK3, and TNFR1 survive to adulthood.  The role of RIPK3 in promoting lethality in ripk1-/- mice suggests that RIPK3 activation is inhibited by RIPK1 postbirth.  Whereas TNFR-induced RIPK3-dependent necroptosis requires RIPK1, cells lacking RIPK1 were sensitized to necroptosis triggered by poly I:C or interferons.  Disruption of TLR (TRIF) or type I interferon (IFNAR) signaling delayed lethality in ripk1-/-tnfr1-/- mice.  These results clarify the complex roles for RIPK1 in postnatal life and provide insights into the regulation of FADD-caspase-8 and RIPK3-MLKL signaling by RIPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7TSpMVJ47sLVg90H21EOLACvtfcHk0liGtkUYpXjHlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGru74%253D&md5=e1b4cca701a96c7860515fa61ff03552</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DCripps%26aufirst%3DJ.%2BG.%26aulast%3DQuarato%26aufirst%3DG.%26aulast%3DGurung%26aufirst%3DP.%26aulast%3DVerbist%26aufirst%3DK.%2BC.%26aulast%3DBrewer%26aufirst%3DT.%2BL.%26aulast%3DLlambi%26aufirst%3DF.%26aulast%3DGong%26aufirst%3DY.%2BN.%26aulast%3DJanke%26aufirst%3DL.%2BJ.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DRIPK1%2520blocks%2520early%2520postnatal%2520lethality%2520mediated%2520by%2520caspase-8%2520and%2520RIPK3%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D1189%26epage%3D1202%26doi%3D10.1016%2Fj.cell.2014.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickliffe, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almagro, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komuves, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1126/science.1249361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1249361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24557836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=1357-1360&author=K.+Newtonauthor=D.+L.+Duggerauthor=K.+E.+Wickliffeauthor=N.+Kapoorauthor=M.+C.+de+Almagroauthor=D.+Vucicauthor=L.+Komuvesauthor=R.+E.+Ferrandoauthor=D.+M.+Frenchauthor=J.+Websterauthor=M.+Roose-Girmaauthor=S.+Warmingauthor=V.+M.+Dixit&title=Activity+of+protein+kinase+RIPK3+determines+whether+cells+die+by+necroptosis+or+apoptosis&doi=10.1126%2Fscience.1249361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis</span></div><div class="casAuthors">Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; de Almagro, M. Cristina; Vucic, Domagoj; Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua; Roose-Girma, Merone; Warming, Soren; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6177</span>),
    <span class="NLM_cas:pages">1357-1360</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 trigger pro-inflammatory cell death termed "necroptosis.".  Studies with RIPK3-deficient mice or the RIPK1 inhibitor necrostatin-1 suggest that necroptosis exacerbates pathol. in many disease models.  We engineered mice expressing catalytically inactive RIPK3 D161N or RIPK1 D138N to det. the need for the active kinase in the whole animal.  Unexpectedly, RIPK3 D161N promoted lethal RIPK1- and caspase-8-dependent apoptosis.  In contrast, mice expressing RIPK1 D138N were viable and, like RIPK3-deficient mice, resistant to tumor necrosis factor (TNF)-induced hypothermia.  Cells expressing RIPK1 D138N were resistant to TNF-induced necroptosis, whereas TNF-induced signaling pathways promoting gene transcription were unperturbed.  Our data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_ux2V9rge7Vg90H21EOLACvtfcHk0ljd2Vd6hCTLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D&md5=a07b82bee66bdc1fe471b15e3294792b</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249361%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDugger%26aufirst%3DD.%2BL.%26aulast%3DWickliffe%26aufirst%3DK.%2BE.%26aulast%3DKapoor%26aufirst%3DN.%26aulast%3Dde%2BAlmagro%26aufirst%3DM.%2BC.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DKomuves%26aufirst%3DL.%26aulast%3DFerrando%26aufirst%3DR.%2BE.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DWebster%26aufirst%3DJ.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DActivity%2520of%2520protein%2520kinase%2520RIPK3%2520determines%2520whether%2520cells%2520die%2520by%2520necroptosis%2520or%2520apoptosis%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D1357%26epage%3D1360%26doi%3D10.1126%2Fscience.1249361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giao Ly, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alothman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alqunaibit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Hernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambirinis, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pansari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/nature17403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature17403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27049944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=245-249&author=L.+Seifertauthor=G.+Werbaauthor=S.+Tiwariauthor=N.+N.+Giao+Lyauthor=S.+Alothmanauthor=D.+Alqunaibitauthor=A.+Avanziauthor=R.+Barillaauthor=D.+Daleyauthor=S.+H.+Grecoauthor=A.+Torres-Hernandezauthor=M.+Pergamoauthor=A.+Ochiauthor=C.+P.+Zambirinisauthor=M.+Pansariauthor=M.+Rendonauthor=D.+Tippensauthor=M.+Hundeyinauthor=V.+R.+Maniauthor=C.+Hajduauthor=D.+Engleauthor=G.+Miller&title=The+necrosome+promotes+pancreatic+oncogenesis+via+CXCL1+and+Mincle-induced+immune+suppression&doi=10.1038%2Fnature17403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression</span></div><div class="casAuthors">Seifert, Lena; Werba, Gregor; Tiwari, Shaun; Ly, Nancy Ngoc Giao; Alothman, Sara; Alqunaibit, Dalia; Avanzi, Antonina; Barilla, Rocky; Daley, Donnele; Greco, Stephanie H.; Torres-Hernandez, Alejandro; Pergamo, Matthew; Ochi, Atsuo; Zambirinis, Constantinos P.; Pansari, Mridul; Rendon, Mauricio; Tippens, Daniel; Hundeyin, Mautin; Mani, Vishnu R.; Hajdu, Cristina; Engle, Dannielle; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7598</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neoplastic pancreatic epithelial cells are believed to die through caspase 8-dependent apoptotic cell death, and chemotherapy is thought to promote tumor apoptosis.  Conversely, cancer cells often disrupt apoptosis to survive.  Another type of programmed cell death is necroptosis (programmed necrosis), but its role in pancreatic ductal adenocarcinoma (PDA) is unclear.  There are many potential inducers of necroptosis in PDA, including ligation of tumor necrosis factor receptor 1 (TNFR1), CD95, TNF-related apoptosis-inducing ligand (TRAIL) receptors, Toll-like receptors, reactive oxygen species, and chemotherapeutic drugs.  Here we report that the principal components of the necrosome, receptor-interacting protein (RIP)1 and RIP3, are highly expressed in PDA and are further upregulated by the chemotherapy drug gemcitabine.  Blockade of the necrosome in vitro promoted cancer cell proliferation and induced an aggressive oncogenic phenotype.  By contrast, in vivo deletion of RIP3 or inhibition of RIP1 protected against oncogenic progression in mice and was assocd. with the development of a highly immunogenic myeloid and T cell infiltrate.  The immune-suppressive tumor microenvironment assocd. with intact RIP1/RIP3 signalling depended in part on necroptosis-induced expression of the chemokine attractant CXCL1, and CXCL1 blockade protected against PDA.  Moreover, cytoplasmic SAP130 (a subunit of the histone deacetylase complex) was expressed in PDA in a RIP1/RIP3-dependent manner, and Mincle-its cognate receptor-was upregulated in tumor-infiltrating myeloid cells.  Ligation of Mincle by SAP130 promoted oncogenesis, whereas deletion of Mincle protected against oncogenesis and phenocopied the immunogenic reprogramming of the tumor microenvironment that was induced by RIP3 deletion.  Cellular depletion suggested that whereas inhibitory macrophages promote tumorigenesis in PDA, they lose their immune-suppressive effects when RIP3 or Mincle is deleted.  Accordingly, T cells, which are not protective against PDA progression in mice with intact RIP3 or Mincle signalling, are reprogrammed into indispensable mediators of anti-tumor immunity in the absence of RIP3 or Mincle.  Our work describes parallel networks of necroptosis-induced CXCL1 and Mincle signalling that promote macrophage-induced adaptive immune suppression and thereby enable PDA progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpme8FBoik-1LVg90H21EOLACvtfcHk0ljd2Vd6hCTLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gs7s%253D&md5=7c9b5b47993341fdadb9c0983e1eea7b</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnature17403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17403%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DL.%26aulast%3DWerba%26aufirst%3DG.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DGiao%2BLy%26aufirst%3DN.%2BN.%26aulast%3DAlothman%26aufirst%3DS.%26aulast%3DAlqunaibit%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DA.%26aulast%3DBarilla%26aufirst%3DR.%26aulast%3DDaley%26aufirst%3DD.%26aulast%3DGreco%26aufirst%3DS.%2BH.%26aulast%3DTorres-Hernandez%26aufirst%3DA.%26aulast%3DPergamo%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DZambirinis%26aufirst%3DC.%2BP.%26aulast%3DPansari%26aufirst%3DM.%26aulast%3DRendon%26aufirst%3DM.%26aulast%3DTippens%26aufirst%3DD.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DMani%26aufirst%3DV.%2BR.%26aulast%3DHajdu%26aufirst%3DC.%26aulast%3DEngle%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DThe%2520necrosome%2520promotes%2520pancreatic%2520oncogenesis%2520via%2520CXCL1%2520and%2520Mincle-induced%2520immune%2520suppression%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D245%26epage%3D249%26doi%3D10.1038%2Fnature17403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">Assessing lysine and cysteine reactivities for designing targeted covalent kinase inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">6553</span>– <span class="NLM_lpage">6560</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=6553-6560&author=R.+Liuauthor=Z.+Yueauthor=C.+C.+Tsaiauthor=J.+Shen&title=Assessing+lysine+and+cysteine+reactivities+for+designing+targeted+covalent+kinase+inhibitors&doi=10.1021%2Fjacs.8b13248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors</span></div><div class="casAuthors">Liu, Ruibin; Yue, Zhi; Tsai, Cheng-Chieh; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6553-6560</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted covalent inhibitor design is gaining increasing interest and acceptance.  A typical covalent kinase inhibitor design targets a reactive cysteine; however, this strategy is limited by the low abundance of cysteine and acquired drug resistance from point mutations.  Inspired by the recent development of lysine-targeted chem. probes, we asked if nucleophilic (reactive) catalytic lysines are common on the basis of the published crystal structures of the human kinome.  Using a newly developed pKa prediction tool based on continuous const. pH mol. dynamics, the catalytic lysines of eight unique kinases from various human kinase groups were retrospectively and prospectively predicted to be nucleophilic, when kinase is in the rare DFG-out/αC-out type of conformation.  Importantly, other reactive lysines as well as cysteines at various locations were also identified.  On the basis of the findings, we proposed a new strategy in which selective type II reversible kinase inhibitors are modified to design highly selective, lysine-targeted covalent inhibitors.  Traditional covalent drugs were discovered serendipitously; the presented tool, which can assess the reactivities of any potentially targetable residues, may accelerate the rational discovery of new covalent inhibitors.  Another significant finding of the work is that lysines and cysteines in kinases may adopt neutral and charged states at physiol. pH, resp.  This finding may shift the current paradigm of computational studies of kinases, which assume fixed soln. protonation states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXUZJq48FZTLVg90H21EOLACvtfcHk0ljd2Vd6hCTLwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgur8%253D&md5=aab2762e5cbcedae163c38445f48bdd7</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13248%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DTsai%26aufirst%3DC.%2BC.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DAssessing%2520lysine%2520and%2520cysteine%2520reactivities%2520for%2520designing%2520targeted%2520covalent%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D6553%26epage%3D6560%26doi%3D10.1021%2Fjacs.8b13248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0ljIHHSZN4Hucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07526.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fj.1471-4159.2011.07526.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21985437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=70-77&author=W.+W.+Chenauthor=H.+Yuauthor=H.+B.+Fanauthor=C.+C.+Zhangauthor=M.+Zhangauthor=C.+Zhangauthor=Y.+Chengauthor=J.+Kongauthor=C.+F.+Liuauthor=D.+Gengauthor=X.+Xu&title=RIP1+mediates+the+protection+of+geldanamycin+on+neuronal+injury+induced+by+oxygen-glucose+deprivation+combined+with+zVAD+in+primary+cortical+neurons&doi=10.1111%2Fj.1471-4159.2011.07526.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons</span></div><div class="casAuthors">Chen, Wei-Wei; Yu, Hailong; Fan, Hong-Bin; Zhang, Cui-Cui; Zhang, Min; Zhang, Caiyi; Cheng, Yanbo; Kong, Jiming; Liu, Chun-Feng; Geng, Deqin; Xu, Xingshun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Caspase-dependent apoptosis is considered one of the most important cell death pathways.  When the apoptotic process is blocked, a form of programmed necrosis called necroptosis occurs.  Apoptosis and necroptosis may share some regulatory mechanisms.  Recent studies indicated that receptor interacting protein 1 (RIP1), an Hsp90-assocd. kinase, is an important regulatory switch between apoptosis and necroptosis.  In this study, we showed that oxygen-glucose deprivation (OGD) combined with a caspase inhibitor zVAD (OGD/zVAD)-induced RIP1 protein expression in a time-dependent manner.  We found that geldanamycin (GA), a benzoquinone ansamycin, protected against neuronal injury induced by OGD/zVAD treatment in cultured primary neurons.  More importantly, GA decreased RIP1 protein level in a time- and concn.-dependent manner.  In this study, we found that GA also decreased the Hsp90 protein level, which caused instability of RIP1 protein, resulting in decreased RIP1 protein level but not RIP1 mRNA level after GA treatment.  We concluded that the GA-mediated protection against OGD/zVAD-induced neuronal injury was assocd. with enhanced RIP1 protein instability by decreasing Hsp90 protein level.  GA and its derivs. may be promising for the prevention of neuronal injury during ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrackQ7AKU6MLVg90H21EOLACvtfcHk0ljIHHSZN4Hucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtbs%253D&md5=1afb3022b78177cf4c93269a162a943d</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07526.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07526.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%2BF.%26aulast%3DGeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DRIP1%2520mediates%2520the%2520protection%2520of%2520geldanamycin%2520on%2520neuronal%2520injury%2520induced%2520by%2520oxygen-glucose%2520deprivation%2520combined%2520with%2520zVAD%2520in%2520primary%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26spage%3D70%26epage%3D77%26doi%3D10.1111%2Fj.1471-4159.2011.07526.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span> <span> </span><span class="NLM_article-title">Natural product Kongensin A is a non-canonical HSP90 inhibitor that blocks RIP3-dependent necroptosis</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.chembiol.2015.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27028885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=257-266&author=D.+Liauthor=C.+Liauthor=L.+Liauthor=S.+Chenauthor=L.+Wangauthor=Q.+Liauthor=X.+Wangauthor=X.+Leiauthor=Z.+Shen&title=Natural+product+Kongensin+A+is+a+non-canonical+HSP90+inhibitor+that+blocks+RIP3-dependent+necroptosis&doi=10.1016%2Fj.chembiol.2015.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis</span></div><div class="casAuthors">Li, Dianrong; Li, Chao; Li, Lin; Chen, She; Wang, Lei; Li, Qiang; Wang, Xiaodong; Lei, Xiaoguang; Shen, Zhirong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3-dependent necroptosis has recently garnered significant interest because of the unique signaling mechanisms and pathol. functions involved in this process.  Accordingly, a no. of chem. screens have identified several effective small-mol. inhibitors that specifically block necroptosis.  Here, we report the discovery that kongensin A (KA), a natural product isolated from Croton kongensis, is a potent inhibitor of necroptosis and an inducer of apoptosis.  Using a new bioorthogonal ligation method (TQ ligation), we reveal that the direct cellular target of KA is heat shock protein 90 (HSP90).  Further studies demonstrate that KA covalently binds to a previously uncharacterized cysteine 420 in the middle domain of HSP90 and dissocs. HSP90 from its cochaperone CDC37, which leads to inhibition of RIP3-dependent necroptosis and promotion of apoptosis in multiple cancer cell lines.  Collectively, our findings demonstrate that KA is an effective HSP90 inhibitor that has potential anti-necroptosis and anti-inflammation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCEeQjx4di8rVg90H21EOLACvtfcHk0ljIHHSZN4Hucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D&md5=0750612b811f8bd7379feca734ab6014</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DZ.%26atitle%3DNatural%2520product%2520Kongensin%2520A%2520is%2520a%2520non-canonical%2520HSP90%2520inhibitor%2520that%2520blocks%2520RIP3-dependent%2520necroptosis%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D257%26epage%3D266%26doi%3D10.1016%2Fj.chembiol.2015.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delehouze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier-Penna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Cann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquard-Fevai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalande, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faurez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauteville, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goekjian, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuillier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimanche-Boitrel, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span> <span> </span><span class="NLM_article-title">6E11, a highly selective inhibitor of receptor-interacting protein kinase 1, protects cells against cold hypoxia-reoxygenation injury</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12931</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-12788-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41598-017-12788-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29018243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252Fptlahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=12931&author=C.+Delehouzeauthor=S.+Leverrier-Pennaauthor=F.+Le+Cannauthor=A.+Comteauthor=M.+Jacquard-Fevaiauthor=O.+Delalandeauthor=N.+Desbanauthor=B.+Baratteauthor=I.+Gallaisauthor=F.+Faurezauthor=M.+C.+Bonnetauthor=M.+Hautevilleauthor=P.+G.+Goekjianauthor=R.+Thuillierauthor=F.+Favreauauthor=P.+Vandenabeeleauthor=T.+Hauetauthor=M.+T.+Dimanche-Boitrelauthor=S.+Bach&title=6E11%2C+a+highly+selective+inhibitor+of+receptor-interacting+protein+kinase+1%2C+protects+cells+against+cold+hypoxia-reoxygenation+injury&doi=10.1038%2Fs41598-017-12788-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury</span></div><div class="casAuthors">Delehouze C; Desban N; Baratte B; Bach S; Leverrier-Penna S; Le Cann F; Gallais I; Faurez F; Bonnet M C; Dimanche-Boitrel M T; Leverrier-Penna S; Le Cann F; Gallais I; Faurez F; Bonnet M C; Dimanche-Boitrel M T; Le Cann F; Vandenabeele P; Le Cann F; Vandenabeele P; Comte A; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Delalande O; Bonnet M C; Hauteville M; Goekjian P G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12931</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a programmed cell death pathway that has been shown to be of central pathophysiological relevance in multiple disorders (hepatitis, brain and cardiac ischemia, pancreatitis, viral infection and inflammatory diseases).  Necroptosis is driven by two serine threonine kinases, RIPK1 (Receptor Interacting Protein Kinase 1) and RIPK3, and a pseudo-kinase MLKL (Mixed Lineage Kinase domain-Like) associated in a multi-protein complex called necrosome.  In order to find new inhibitors for use in human therapy, a chemical library containing highly diverse chemical structures was screened using a cell-based assay.  The compound 6E11, a natural product derivative, was characterized as a positive hit.  Interestingly, this flavanone compound: inhibits necroptosis induced by death receptors ligands TNF-α (Tumor Necrosis Factor) or TRAIL (TNF-Related Apoptosis-Inducing Ligand); is an extremely selective inhibitor, among kinases, of human RIPK1 enzymatic activity with a nM Kd; has a non-ATP competitive mode of action and a novel putative binding site; is weakly cytotoxic towards human primary blood leukocytes or retinal pigment epithelial cells at effective concentrations; protects human aortic endothelial cells (HAEC) from cold hypoxia/reoxygenation injury more effectively than necrostatin-1 (Nec-1) and Nec-1s.  Altogether, these data demonstrate that 6E11 is a novel potent small molecular inhibitor of RIPK1-driven necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVJKELZUTFBlHFYivNCdPRfW6udTcc2ebdHtaQsKSauLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252Fptlahug%253D%253D&md5=ca9cc681c13af6a490fef52eacecef6a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-12788-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-12788-4%26sid%3Dliteratum%253Aachs%26aulast%3DDelehouze%26aufirst%3DC.%26aulast%3DLeverrier-Penna%26aufirst%3DS.%26aulast%3DLe%2BCann%26aufirst%3DF.%26aulast%3DComte%26aufirst%3DA.%26aulast%3DJacquard-Fevai%26aufirst%3DM.%26aulast%3DDelalande%26aufirst%3DO.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGallais%26aufirst%3DI.%26aulast%3DFaurez%26aufirst%3DF.%26aulast%3DBonnet%26aufirst%3DM.%2BC.%26aulast%3DHauteville%26aufirst%3DM.%26aulast%3DGoekjian%26aufirst%3DP.%2BG.%26aulast%3DThuillier%26aufirst%3DR.%26aulast%3DFavreau%26aufirst%3DF.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DHauet%26aufirst%3DT.%26aulast%3DDimanche-Boitrel%26aufirst%3DM.%2BT.%26aulast%3DBach%26aufirst%3DS.%26atitle%3D6E11%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520receptor-interacting%2520protein%2520kinase%25201%252C%2520protects%2520cells%2520against%2520cold%2520hypoxia-reoxygenation%2520injury%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D12931%26doi%3D10.1038%2Fs41598-017-12788-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, E. A.</span></span> <span> </span><span class="NLM_article-title">Regulated cell death signaling pathways and marine natural products that target them</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">76</span>, <span class="refDoi"> DOI: 10.3390/md17020076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.3390%2Fmd17020076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlakurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=76&author=E.+A.+Guzman&title=Regulated+cell+death+signaling+pathways+and+marine+natural+products+that+target+them&doi=10.3390%2Fmd17020076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated cell death signaling pathways and marine natural products that target them</span></div><div class="casAuthors">Guzman, Esther A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">76</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Our understanding of cell death used to consist in necrosis, an unregulated form, and apoptosis, regulated cell death.  That understanding expanded to acknowledge that apoptosis happens through the intrinsic or extrinsic pathways.  Actually, many other regulated cell death processes exist, including necroptosis, a regulated form of necrosis, and autophagy-dependent cell death.  We also understand that apoptosis occurs beyond the intrinsic and extrinsic pathways with caspase independent forms of apoptosis existing.  Our knowledge of the signaling continues to grow, and with that, so does our ability to target different parts of the pathways with small mols.  Marine natural products co-evolve with their targets, and these unique mols. have complex structures with exquisite biol. activities and specificities.  This article offers a review of our current understanding of the signaling pathways regulating cell death, and highlights marine natural products that can affect these signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo74olq98TXU7Vg90H21EOLACvtfcHk0lg7GXpB2CyHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlakurnM&md5=fe75028159be55334da7275852bbdfa4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3390%2Fmd17020076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17020076%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DE.%2BA.%26atitle%3DRegulated%2520cell%2520death%2520signaling%2520pathways%2520and%2520marine%2520natural%2520products%2520that%2520target%2520them%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D17%26spage%3D76%26doi%3D10.3390%2Fmd17020076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajapaksa, N. S.</span></span> <span> </span><span class="NLM_article-title">Kinase inhibitors for the treatment of immunological disorders: Recent advances</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9030</span>– <span class="NLM_lpage">9058</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9030-9058&author=M.+C.+Bryanauthor=N.+S.+Rajapaksa&title=Kinase+inhibitors+for+the+treatment+of+immunological+disorders%3A+Recent+advances&doi=10.1021%2Facs.jmedchem.8b00667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances</span></div><div class="casAuthors">Bryan, Marian C.; Rajapaksa, Naomi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9030-9058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mol. inhibitors targeting autoimmune and inflammatory processes have been an area of intense focus within academia and industry.  Much of this work has been aimed at key kinases operating as central nodes in inflammatory signaling pathways.  While this focus has led to over 30 FDA-approved small mol. kinase inhibitors, only one is currently approved for autoimmune and inflammatory diseases.  Despite this lack of success, there remains tremendous reason for excitement.  Our growing understanding of the biol. involved in the inflammatory response, the factors that lead to safer small mol. kinase inhibitors, and the availability of selective tool mols. for interrogating specific nodes and pathways are all pushing the field forward.  This article focuses on recent developments requiring novel approaches to create safe and effective small mol. kinase inhibitors and where further work is needed to realize the promise of small mol. kinase inhibitors for patient benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVucOE4LCJALVg90H21EOLACvtfcHk0ljQq72aCPnAMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmsLzI&md5=aff62adff54c9152d2b2156b05d67400</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DRajapaksa%26aufirst%3DN.%2BS.%26atitle%3DKinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520immunological%2520disorders%253A%2520Recent%2520advances%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9030%26epage%3D9058%26doi%3D10.1021%2Facs.jmedchem.8b00667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanon  Piamsiri</span>, <span class="hlFld-ContribAuthor ">Chayodom  Maneechote</span>, <span class="hlFld-ContribAuthor ">Natthaphat  Siri-Angkul</span>, <span class="hlFld-ContribAuthor ">Siriporn C.  Chattipakorn</span>, <span class="hlFld-ContribAuthor ">Nipon  Chattipakorn</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting necroptosis as therapeutic potential in chronic myocardial infarction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-021-00722-w" title="DOI URL">https://doi.org/10.1186/s12929-021-00722-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-021-00722-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-021-00722-w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DTargeting%252Bnecroptosis%252Bas%252Btherapeutic%252Bpotential%252Bin%252Bchronic%252Bmyocardial%252Binfarction%26aulast%3DPiamsiri%26aufirst%3DChanon%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunnian  Xia</span>, <span class="hlFld-ContribAuthor ">Zhengguang  Yao</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Haihu  Chen</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113484. <a href="https://doi.org/10.1016/j.ejmech.2021.113484" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113484%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bbioisosterism%252Bdesign%252Bof%252Bthio-benzoxazepinones%252Bas%252Bnovel%252Bnecroptosis%252Binhibitors%26aulast%3DXia%26aufirst%3DChunnian%26date%3D2021%26volume%3D220%26spage%3D113484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhuo  Qu</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Huang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiomeric profiling of a chiral benzothiazole necroptosis inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128084. <a href="https://doi.org/10.1016/j.bmcl.2021.128084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnantiomeric%252Bprofiling%252Bof%252Ba%252Bchiral%252Bbenzothiazole%252Bnecroptosis%252Binhibitor%26aulast%3DZhu%26aufirst%3DJing%26date%3D2021%26volume%3D43%26spage%3D128084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abigail M.  Shotland</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Fontenot</span>, <span class="hlFld-ContribAuthor ">Amy S.  McKee</span>. </span><span class="cited-content_cbyCitation_article-title">Pulmonary Macrophage Cell Death in Lung Health and Disease. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory Cell and Molecular Biology</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 547-556. <a href="https://doi.org/10.1165/rcmb.2020-0420TR" title="DOI URL">https://doi.org/10.1165/rcmb.2020-0420TR</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1165/rcmb.2020-0420TR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1165%2Frcmb.2020-0420TR%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520Cell%2520and%2520Molecular%2520Biology%26atitle%3DPulmonary%252BMacrophage%252BCell%252BDeath%252Bin%252BLung%252BHealth%252Band%252BDisease%26aulast%3DShotland%26aufirst%3DAbigail%2BM.%26date%3D2021%26volume%3D64%26issue%3D5%26spage%3D547%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Meng  Xin</span>, <span class="hlFld-ContribAuthor ">Congcong  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  He</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>184 </em><a href="https://doi.org/10.1016/j.apsb.2021.05.017" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DLigand-based%252Bsubstituent-anchoring%252Bdesign%252Bof%252Bselective%252Breceptor-interacting%252Bprotein%252Bkinase%252B1%252Bnecroptosis%252Binhibitors%252Bfor%252Bulcerative%252Bcolitis%252Btherapy%26aulast%3DZhu%26aufirst%3DJing%26date%3D2021%26volume%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Ma</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengguang  Yao</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Lichao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113030. <a href="https://doi.org/10.1016/j.ejmech.2020.113030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbardoxolone%252Bderivatives%252Bas%252Bnovel%252Borally%252Bactive%252Bnecroptosis%252Binhibitors%26aulast%3DWang%26aufirst%3DYuanyuan%26date%3D2021%26volume%3D212%26spage%3D113030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luo  Ying</span>, <span class="hlFld-ContribAuthor ">Juthipong  Benjanuwattra</span>, <span class="hlFld-ContribAuthor ">Siriporn C.  Chattipakorn</span>, <span class="hlFld-ContribAuthor ">Nipon  Chattipakorn</span>. </span><span class="cited-content_cbyCitation_article-title">The role of RIPK3‐regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia‐reperfusion injury. </span><span class="cited-content_cbyCitation_journal-name">Acta Physiologica</span><span> <strong>2021,</strong> <em>231 </em>
                                    (2)
                                     <a href="https://doi.org/10.1111/apha.13541" title="DOI URL">https://doi.org/10.1111/apha.13541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/apha.13541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fapha.13541%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Physiologica%26atitle%3DThe%252Brole%252Bof%252BRIPK3%2525E2%252580%252590regulated%252Bcell%252Bdeath%252Bpathways%252Band%252Bnecroptosis%252Bin%252Bthe%252Bpathogenesis%252Bof%252Bcardiac%252Bischaemia%2525E2%252580%252590reperfusion%252Binjury%26aulast%3DYing%26aufirst%3DLuo%26date%3D2021%26date%3D2020%26volume%3D231%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory D.  Cuny</span>, <span class="hlFld-ContribAuthor ">Alexei  Degterev</span>. </span><span class="cited-content_cbyCitation_article-title">RIPK protein kinase family: Atypical lives of typical kinases. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2021,</strong> <em>109 </em>, 96-105. <a href="https://doi.org/10.1016/j.semcdb.2020.06.014" title="DOI URL">https://doi.org/10.1016/j.semcdb.2020.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2020.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2020.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DRIPK%252Bprotein%252Bkinase%252Bfamily%25253A%252BAtypical%252Blives%252Bof%252Btypical%252Bkinases%26aulast%3DCuny%26aufirst%3DGregory%2BD.%26date%3D2021%26volume%3D109%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Rübbelke</span>, <span class="hlFld-ContribAuthor ">Dennis  Fiegen</span>, <span class="hlFld-ContribAuthor ">Margit  Bauer</span>, <span class="hlFld-ContribAuthor ">Florian  Binder</span>, <span class="hlFld-ContribAuthor ">James  Hamilton</span>, <span class="hlFld-ContribAuthor ">Jim  King</span>, <span class="hlFld-ContribAuthor ">Sven  Thamm</span>, <span class="hlFld-ContribAuthor ">Herbert  Nar</span>, <span class="hlFld-ContribAuthor ">Markus  Zeeb</span>. </span><span class="cited-content_cbyCitation_article-title">Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (52)
                                     , 33272-33281. <a href="https://doi.org/10.1073/pnas.2017406117" title="DOI URL">https://doi.org/10.1073/pnas.2017406117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2017406117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2017406117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DLocking%252Bmixed-lineage%252Bkinase%252Bdomain-like%252Bprotein%252Bin%252Bits%252Bauto-inhibited%252Bstate%252Bprevents%252Bnecroptosis%26aulast%3DR%25C3%25BCbbelke%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D52%26spage%3D33272%26epage%3D33281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Ludmila  Ermolenko</span>, <span class="hlFld-ContribAuthor ">Minh Quan  Tran</span>, <span class="hlFld-ContribAuthor ">Agathe  Vagneux</span>, <span class="hlFld-ContribAuthor ">Hristo  Nedev</span>, <span class="hlFld-ContribAuthor ">Claire  Delehouzé</span>, <span class="hlFld-ContribAuthor ">Mohamed  Souab</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Béatrice  Josselin</span>, <span class="hlFld-ContribAuthor ">Bogdan I.  Iorga</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Ali  Al-Mourabit</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112337. <a href="https://doi.org/10.1016/j.ejmech.2020.112337" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112337%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bsimplified%252Bbenzazole%252Bfragments%252Bderived%252Bfrom%252Bthe%252Bmarine%252Bbenzosceptrin%252BB%252Bas%252Bnecroptosis%252Binhibitors%252Binvolving%252Bthe%252Breceptor%252Binteracting%252Bprotein%252BKinase-1%26aulast%3DBenchekroun%26aufirst%3DMohamed%26date%3D2020%26volume%3D201%26spage%3D112337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Baecker</span>, <span class="hlFld-ContribAuthor ">Benjamin N.  Ma</span>, <span class="hlFld-ContribAuthor ">Jessica  Sagasser</span>, <span class="hlFld-ContribAuthor ">Lukas  Schultz</span>, <span class="hlFld-ContribAuthor ">Carina  Hörschläger</span>, <span class="hlFld-ContribAuthor ">Maria  Weinreich</span>, <span class="hlFld-ContribAuthor ">Lucy  Steiner</span>, <span class="hlFld-ContribAuthor ">Brigitte  Kircher</span>, <span class="hlFld-ContribAuthor ">Ronald  Gust</span>. </span><span class="cited-content_cbyCitation_article-title">Amide and ester derivatives of chlorido[4-carboxy-1,2-disalicylideneaminobenzene]iron(
              iii
              ) as necroptosis and ferroptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (20)
                                     , 6842-6853. <a href="https://doi.org/10.1039/D0DT00168F" title="DOI URL">https://doi.org/10.1039/D0DT00168F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT00168F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT00168F%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DAmide%252Band%252Bester%252Bderivatives%252Bof%252Bchlorido%25255B4-carboxy-1%25252C2-disalicylideneaminobenzene%25255Diron%252528%252Biii%252B%252529%252Bas%252Bnecroptosis%252Band%252Bferroptosis%252Binducers%26aulast%3DBaecker%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D20%26spage%3D6842%26epage%3D6853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular mechanism of TNFα-triggered apoptosis and necroptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure optimization workflow of Nec-1 series compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of RIPK1 and <b>4</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITH">4ITH</a>): (A) perpendicular view; (B) close-up view. The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure optimization workflow of benzoxazepine RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal complexes of RIPK1 with (A) <b>6</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HX6">5HX6</a>), (B) <b>10</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TX5">5TX5</a>), (C) <b>11</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RLN">6RLN</a>), (D) <b>12</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C3E">6C3E</a>), (E) <b>14</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C4D">6C4D</a>), and (F) <b>15</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NW2">6NW2</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of <b>17</b> and the cocrystal complex with RIPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NYH">6NYH</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structure optimization workflow of dihydropyrazole RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cocrystal complexes of RIPK1 with (A) <b>23</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OCQ">6OCQ</a>) and (B) <b>26</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6R5F">6R5F</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure optimization workflow of benzylamide RIPK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of <b>30</b>–<b>36</b> and the cocrystal complex of <b>30</b> with RIPK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NEU">4NEU</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of <b>37</b>–<b>43</b> identified by repurposing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical structures of <b>44</b>–<b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of <b>49</b>–<b>51</b> as fluorescent probes. The fluorescent groups are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures of <b>52</b>–<b>57</b> as RIPK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure optimization workflow of RIPK3 inhibitors from Raf inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of <b>64</b>–<b>65</b> and the cocrystal complex of <b>64</b> with murine RIPK3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OKO">6OKO</a>). The figure was generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of <b>66</b>–<b>71</b> as MLKL inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Cocrystal complexes of the human MLKL pseudokinase domain with (A) <b>69</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KNJ">5KNJ</a>) and (B) <b>71</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KO1">5KO1</a>). The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/medium/jm9b01317_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of <b>72</b>–<b>75</b> from natural sources.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01317/20200221/images/large/jm9b01317_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01317&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 130 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, A. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/bjc.1972.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+a+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics&doi=10.1038%2Fbjc.1972.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2eaaAaVnL38ZOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520a%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257%26doi%3D10.1038%2Fbjc.1972.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueydan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane changes during programmed cell deaths</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcr.2017.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29076500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=9-21&author=Y.+Zhangauthor=X.+Chenauthor=C.+Gueydanauthor=J.+Han&title=Plasma+membrane+changes+during+programmed+cell+deaths&doi=10.1038%2Fcr.2017.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane changes during programmed cell deaths</span></div><div class="casAuthors">Zhang, Yingying; Chen, Xin; Gueydan, Cyril; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-21</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Ruptured and intact plasma membranes are classically considered as hallmarks of necrotic and apoptotic cell death, resp.  As such, apoptosis is usually considered a non-inflammatory process while necrosis triggers inflammation.  Recent studies on necroptosis and pyroptosis, two types of programmed necrosis, revealed that plasma membrane rupture is mediated by MLKL channels during necroptosis but depends on non-selective gasdermin D (GSDMD) pores during pyroptosis.  Importantly, the morphol. of dying cells executed by MLKL channels can be distinguished from that executed by GSDMD pores.  Interestingly, it was found recently that secondary necrosis of apoptotic cells, a previously believed non-regulated form of cell lysis that occurs after apoptosis, can be programmed and executed by plasma membrane pore formation like that of pyroptosis.  In addn., pyroptosis is assocd. with pyroptotic bodies, which have some similarities to apoptotic bodies.  Therefore, different cell death programs induce distinctive reshuffling processes of the plasma membrane.  Given the fact that the nature of released intracellular contents plays a crucial role in dying/dead cell-induced immunogenicity, not only membrane rupture or integrity but also the nature of plasma membrane breakdown would det. the fate of a cell as well as its ability to elicit an immune response.  In this review, we will discuss recent advances in the field of apoptosis, necroptosis and pyroptosis, with an emphasis on the mechanisms underlying plasma membrane changes obsd. on dying cells and their implication in cell death-elicited immunogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSQjLMNOfh3LVg90H21EOLACvtfcHk0lh-LJ3ZM5e3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7zL&md5=798a8a152aef6f8df5ee2c3356d3f761</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.133%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGueydan%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DPlasma%2520membrane%2520changes%2520during%2520programmed%2520cell%2520deaths%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26spage%3D9%26epage%3D21%26doi%3D10.1038%2Fcr.2017.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, K. L.</span></span> <span> </span><span class="NLM_article-title">How dying cells alert the immune system to danger</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1038/nri2215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnri2215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18340345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=279-289&author=H.+Konoauthor=K.+L.+Rock&title=How+dying+cells+alert+the+immune+system+to+danger&doi=10.1038%2Fnri2215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">How dying cells alert the immune system to danger</span></div><div class="casAuthors">Kono, Hajime; Rock, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-289</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  When a cell dies in vivo, the event does not go unnoticed.  The host has evolved mechanisms to detect the death of cells and rapidly investigate the nature of their demise.  If cell death is a result of natural causes - i.e., it is part of normal physiol. processes - then there is little threat to the organism.  In this situation, little else is done other than to remove the corpse.  However, if cells have died as the consequence of some violence or disease, then both defense and repair mechanisms are mobilized in the host.  The importance of these processes to host defense and disease pathogenesis has only been appreciated relatively recently.  This article reviews our current knowledge of these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFG8Y7PNySq7Vg90H21EOLACvtfcHk0li30Wde3lFBQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1antLs%253D&md5=7eff34d3d5edb5fa16e9d9939739f9be</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2215%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DH.%26aulast%3DRock%26aufirst%3DK.%2BL.%26atitle%3DHow%2520dying%2520cells%2520alert%2520the%2520immune%2520system%2520to%2520danger%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D279%26epage%3D289%26doi%3D10.1038%2Fnri2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanden
Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouan-Lanhouet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Regulated necrosis: the expanding network of non-apoptotic cell death pathways</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrm3737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrm3737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24452471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=135-147&author=T.+Vanden%0ABergheauthor=A.+Linkermannauthor=S.+Jouan-Lanhouetauthor=H.+Walczakauthor=P.+Vandenabeele&title=Regulated+necrosis%3A+the+expanding+network+of+non-apoptotic+cell+death+pathways&doi=10.1038%2Fnrm3737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated necrosis: the expanding network of non-apoptotic cell death pathways</span></div><div class="casAuthors">Vanden Berghe, Tom; Linkermann, Andreas; Jouan-Lanhouet, Sandrine; Walczak, Henning; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-147</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cell death research was revitalized by the understanding that necrosis can occur in a highly regulated and genetically controlled manner.  Although RIPK1 (receptor-interacting protein kinase 1)- and RIPK3-MLKL (mixed lineage kinase domain-like)-mediated necroptosis is the most understood form of regulated necrosis, other examples of this process are emerging, including cell death mechanisms known as parthanatos, oxytosis, ferroptosis, NETosis, pyronecrosis and pyroptosis.  Elucidating how these pathways of regulated necrosis are interconnected at the mol. level should enable this process to be therapeutically targeted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZtCEnuIUd7Vg90H21EOLACvtfcHk0li30Wde3lFBQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOjt7w%253D&md5=8e5e201e06e98cb9d0f780748ca19e04</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm3737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3737%26sid%3Dliteratum%253Aachs%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DJouan-Lanhouet%26aufirst%3DS.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRegulated%2520necrosis%253A%2520the%2520expanding%2520network%2520of%2520non-apoptotic%2520cell%2520death%2520pathways%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D135%26epage%3D147%26doi%3D10.1038%2Fnrm3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of necroptosis: an ordered cellular explosion</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1038/nrm2970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrm2970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20823910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=700-714&author=P.+Vandenabeeleauthor=L.+Galluzziauthor=T.+Vanden+Bergheauthor=G.+Kroemer&title=Molecular+mechanisms+of+necroptosis%3A+an+ordered+cellular+explosion&doi=10.1038%2Fnrm2970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of necroptosis: an ordered cellular explosion</span></div><div class="casAuthors">Vandenabeele, Peter; Galluzzi, Lorenzo; Vanden Berghe, Tom; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">700-714</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For a long time, apoptosis was considered the sole form of programmed cell death during development, homeostasis and disease, whereas necrosis was regarded as an unregulated and uncontrollable process.  Evidence now reveals that necrosis can also occur in a regulated manner.  The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumor necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3), and its execution involves the active disintegration of mitochondrial, lysosomal and plasma membranes.  Necroptosis participates in the pathogenesis of diseases, including ischemic injury, neurodegeneration and viral infection, thereby representing an attractive target for the avoidance of unwarranted cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEe8vjo9AoLVg90H21EOLACvtfcHk0li30Wde3lFBQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P&md5=bc7798f807de31771d8e620acf754b92</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm2970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2970%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520ordered%2520cellular%2520explosion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D700%26epage%3D714%26doi%3D10.1038%2Fnrm2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laster, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooding, L. R.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">2629</span>– <span class="NLM_lpage">2634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=3171180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaL1cXmtV2ntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=1988&pages=2629-2634&author=S.+M.+Lasterauthor=J.+G.+Woodauthor=L.+R.+Gooding&title=Tumor+necrosis+factor+can+induce+both+apoptic+and+necrotic+forms+of+cell+lysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis</span></div><div class="casAuthors">Laster, Scott M.; Wood, John G.; Gooding, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2629-34</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    </div><div class="casAbstract">The mechansim of lysis by tumor necrosis factor (TNF) is not well understood.  The goal of this investigation was to det. whether TNF caused one of the classic forms of cell death, i.e., apoptosis, which is characterized  by nuclear disintegration and cytoplasmic boiling, or necrosis, which is characterized by the formation of a balloon-like plasma membrane and a lack of nuclear disintegration.  To distinguish apoptosis from necrosis, time-lapse video microscopy was used to observe the death of several TNF-sensitive target cell lines while measuring the release of Na251CrO4 and [3H]TdR from cytoplasmic and nuclear compartments, resp.  The targets were 2 spontaneously sensitive cell lines, F17 and L-M, and one resistant cell line, C3HA, which was sensitized by treatment with cycloheximide or by infection  with the adeno-SV40 hybrid virus Ad2+ND2.  The type of cell death obsd. depends on the cell being tested.  In F17 cells TNF treatment induced a classical form of apoptosis.  In contrast, TNF induced a necrotic form of cell death in L-M cells, similar to the lysis induced by antibody in complement.  Sensitized C3HA cells displayed a novel cytolytic phenotype which resembled apoptosis but did not include DNA fragmentation.  These results emphasize the complex nature of the TNF-induced cytotoxic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlGgyf3t9917Vg90H21EOLACvtfcHk0ljXF0SFguhyFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtV2ntrs%253D&md5=7fe9cfb1ccbab963b585e083c53dbdc3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaster%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BG.%26aulast%3DGooding%26aufirst%3DL.%2BR.%26atitle%3DTumor%2520necrosis%2520factor%2520can%2520induce%2520both%2520apoptic%2520and%2520necrotic%2520forms%2520of%2520cell%2520lysis%26jtitle%3DJ.%2520Immunol.%26date%3D1988%26volume%3D141%26spage%3D2629%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercammen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grooten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiers, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1485</span>, <span class="refDoi"> DOI: 10.1084/jem.187.9.1477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1084%2Fjem.187.9.1477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=9565639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaK1cXivVGjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1998&pages=1477-1485&author=D.+Vercammenauthor=R.+Beyaertauthor=G.+Deneckerauthor=V.+Goossensauthor=G.+Van+Looauthor=W.+Declercqauthor=J.+Grootenauthor=W.+Fiersauthor=P.+Vandenabeele&title=Inhibition+of+caspases+increases+the+sensitivity+of+L929+cells+to+necrosis+mediated+by+tumor+necrosis+factor&doi=10.1084%2Fjem.187.9.1477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor</span></div><div class="casAuthors">Vercammen, Dominique; Beyaert, Rudi; Denecker, Geertrui; Goossens, Vera; Van Loo, Geert; Declercq, Wim; Grooten, Johan; Fiers, Walter; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1477-1485</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates.  We investigated the role of caspases in the necrotic cell death pathway.  When the cytokine response modifier A (CrmA), a serpin-like caspase inhibitor of viral origin, was stably overexpressed in L929 cells, the latter became 1,000-fold more sensitive to TNF-mediated cell death.  In addn., TNF sensitization was also obsd. when the cells were pretreated with Ac-YVAD-cmk or zDEVD-fmk, which inhibits caspase-1-and caspase-3-like proteases, resp.  ZVAD-fmk and zD-fmk, two broad-spectrum inhibitors of caspases, also rendered the cells more sensitive, since the half-maximal dose for TNF-mediated necrosis decreased by a factor of 1,000.  The presence of zVAD-fmk also resulted in a more rapid increase of TNF-mediated prodn. of oxygen radicals.  ZVAD-fmk-dependent sensitization of TNF cytotoxicity could be completely inhibited by the oxygen radical scavenger butylated hydroxyanisole.  These results indicate an involvement of caspases in protection against TNF-induced formation of oxygen radicals and necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7woIo0pkZo7Vg90H21EOLACvtfcHk0ljXF0SFguhyFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVGjur8%253D&md5=90368ab3d4749831c6b4605225ef3607</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.187.9.1477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.187.9.1477%26sid%3Dliteratum%253Aachs%26aulast%3DVercammen%26aufirst%3DD.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DDenecker%26aufirst%3DG.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVan%2BLoo%26aufirst%3DG.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DGrooten%26aufirst%3DJ.%26aulast%3DFiers%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520caspases%2520increases%2520the%2520sensitivity%2520of%2520L929%2520cells%2520to%2520necrosis%2520mediated%2520by%2520tumor%2520necrosis%2520factor%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D187%26spage%3D1477%26epage%3D1485%26doi%3D10.1084%2Fjem.187.9.1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1038/nchembio711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16408008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=112-119&author=A.+Degterevauthor=Z.+Huangauthor=M.+Boyceauthor=Y.+Liauthor=P.+Jagtapauthor=N.+Mizushimaauthor=G.+D.+Cunyauthor=T.+J.+Mitchisonauthor=M.+A.+Moskowitzauthor=J.+Yuan&title=Chemical+inhibitor+of+nonapoptotic+cell+death+with+therapeutic+potential+for+ischemic+brain+injury&doi=10.1038%2Fnchembio711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span></div><div class="casAuthors">Degterev, Alexei; Huang, Zhihong; Boyce, Michael; Li, Yaqiao; Jagtap, Prakash; Mizushima, Noboru; Cuny, Gregory D.; Mitchison, Timothy J.; Moskowitz, Michael A.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death.  Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, the authors demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which the authors term necroptosis.  The authors showed that necroptosis is characterized by necrotic cell death morphol. and activation of autophagy.  The authors identified a specific and potent small-mol. inhibitor of necroptosis, necrostatin-1, which blocks a crit. step in necroptosis.  The authors demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection.  Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiBDVRJkdUbVg90H21EOLACvtfcHk0ljXF0SFguhyFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D&md5=83f8c363ffb73ccc14bf11ec02577336</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio711%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DChemical%2520inhibitor%2520of%2520nonapoptotic%2520cell%2520death%2520with%2520therapeutic%2520potential%2520for%2520ischemic%2520brain%2520injury%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26spage%3D112%26epage%3D119%26doi%3D10.1038%2Fnchembio711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zong, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. B.</span></span> <span> </span><span class="NLM_article-title">Necrotic death as a cell fate</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1101/gad.1376506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1101%2Fgad.1376506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16391229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Omu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1-15&author=W.+X.+Zongauthor=C.+B.+Thompson&title=Necrotic+death+as+a+cell+fate&doi=10.1101%2Fgad.1376506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Necrotic death as a cell fate</span></div><div class="casAuthors">Zong, Wei-Xing; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Organismal homeostasis depends on an intricate balance between cell death and renewal.  Early pathologists recognized that this balance could be disrupted by the extensive damage obsd. in internal organs during the course of certain diseases.  This form of tissue damage was termed "necrosis", derived from the Greek "nekros" for corpse.  As it became clear that the essential building block of tissue was the cell, necrosis came to be used to describe pathol. cell death.  Until recently, necrotic cell death was believed to result from injuries that caused an irreversible bioenergetic compromise.  The cell dying by necrosis has been viewed as a victim of extrinsic events beyond its control.  However, recent evidence suggests that a cell can initiate its own demise by necrosis in a manner that initiates both inflammatory and/or reparative responses in the host.  By initiating these adaptive responses, programmed cell necrosis may serve to maintain tissue and organismal integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAyl0ut3xEQrVg90H21EOLACvtfcHk0ljXF0SFguhyFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Omu7o%253D&md5=6166f1f7c5782df62093676669d26474</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.1376506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1376506%26sid%3Dliteratum%253Aachs%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DNecrotic%2520death%2520as%2520a%2520cell%2520fate%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D1%26epage%3D15%26doi%3D10.1101%2Fgad.1376506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valitutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1038/82732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2F82732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=11101870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslyru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=489-495&author=N.+Hollerauthor=R.+Zaruauthor=O.+Micheauauthor=M.+Thomeauthor=A.+Attingerauthor=S.+Valituttiauthor=J.+L.+Bodmerauthor=P.+Schneiderauthor=B.+Seedauthor=J.+Tschopp&title=Fas+triggers+an+alternative%2C+caspase-8-independent+cell+death+pathway+using+the+kinase+RIP+as+effector+molecule&doi=10.1038%2F82732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule</span></div><div class="casAuthors">Holler, Nils; Zaru, Rossana; Micheau, Olivier; Thome, Margot; Attinger, Antoine; Valitutti, Salvatore; Bodmer, Jean-Luc; Schneider, Pascal; Seed, Brian; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-495</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Cell death is achieved by two fundamentally different mechanisms: apoptosis and necrosis.  Apoptosis is dependent on caspase activation, whereas the caspase-independent necrotic signaling pathway remains largely uncharacterized.  We show here that Fas kills activated primary T cells efficiently in the absence of active caspases, which results in necrotic morphol. changes and late mitochondrial damage but no cytochrome c release.  This Fas ligand-induced caspase-independent death is absent in T cells that are deficient in either Fas-assocd. death domain (FADD) or receptor-interacting protein (RIP).  RIP is also required for necrotic death induced by tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand (TRAIL).  In contrast to its role in nuclear factor κB activation, RIP requires its own kinase activity for death signaling.  Thus, Fas, TRAIL and TNF receptors can initiate cell death by two alternative pathways, one relying on caspase-8 and the other dependent on the kinase RIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBFtIFdBNfVbVg90H21EOLACvtfcHk0lilKDJli7j06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslyru74%253D&md5=224004595782f9d5f3954c3a57b3c496</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F82732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F82732%26sid%3Dliteratum%253Aachs%26aulast%3DHoller%26aufirst%3DN.%26aulast%3DZaru%26aufirst%3DR.%26aulast%3DMicheau%26aufirst%3DO.%26aulast%3DThome%26aufirst%3DM.%26aulast%3DAttinger%26aufirst%3DA.%26aulast%3DValitutti%26aufirst%3DS.%26aulast%3DBodmer%26aufirst%3DJ.%2BL.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DFas%2520triggers%2520an%2520alternative%252C%2520caspase-8-independent%2520cell%2520death%2520pathway%2520using%2520the%2520kinase%2520RIP%2520as%2520effector%2520molecule%26jtitle%3DNat.%2520Immunol.%26date%3D2000%26volume%3D1%26spage%3D489%26epage%3D495%26doi%3D10.1038%2F82732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedospasov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">10822</span>– <span class="NLM_lpage">10828</span>, <span class="refDoi"> DOI: 10.1074/jbc.M313141200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1074%2Fjbc.M313141200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=14701813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10822-10828&author=Y.+Linauthor=S.+Choksiauthor=H.+M.+Shenauthor=Q.+F.+Yangauthor=G.+M.+Hurauthor=Y.+S.+Kimauthor=J.+H.+Tranauthor=S.+A.+Nedospasovauthor=Z.+G.+Liu&title=Tumor+necrosis+factor-induced+nonapoptotic+cell+death+requires+receptor-interacting+protein-mediated+cellular+reactive+oxygen+species+accumulation&doi=10.1074%2Fjbc.M313141200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Necrosis Factor-induced Nonapoptotic Cell Death Requires Receptor-interacting Protein-mediated Cellular Reactive Oxygen Species Accumulation</span></div><div class="casAuthors">Lin, Yong; Choksi, Swati; Shen, Han-Ming; Yang, Qing-Feng; Hur, Gang Min; Kim, You Sun; Tran, Jamie Hong; Nedospasov, Sergei A.; Liu, Zheng-gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10822-10828</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism of tumor necrosis factor (TNF)-induced nonapoptotic cell death is largely unknown, although the mechanism of TNF-induced apoptosis has been studied extensively.  In wild-type mouse embryonic fibroblast cells under a caspase-inhibited condition, TNF effectively induced cell death that morphol. resembled necrosis.  In this study, the authors utilized gene knockout mouse embryonic fibroblasts cells and found that tumor necrosis factor receptor (TNFR) I mediates TNF-induced necrotic cell death, and that RIP, FADD, and TRAF2 are crit. components of the signaling cascade of this TNF-induced necrotic cell death.  Inhibitors of NF-κB facilitated TNF-induced necrotic cell death, suggesting that NF-κB suppresses the necrotic cell death pathway.  JNK, p38, and ERK activation seem not to be required for this type of cell death because mitogen-activated protein kinase inhibitors did not significantly affect TNF-induced necrotic cell death.  In agreement with the previous reports that the reactive oxygen species (ROS) may play an important role in this type of cell death, the ROS scavenger butylated hydroxyanisole efficiently blocked TNF-induced necrotic cell death.  Interestingly, during TNF-induced necrotic cell death, the cellular ROS level was significantly elevated in wild type, but not in RIP-/-, TRAF2-/-, and FADD-/- cells.  These results suggest that RIP, TRAF2, and FADD are crucial in mediating ROS accumulation in TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcGfyYn42grVg90H21EOLACvtfcHk0lilKDJli7j06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCht7o%253D&md5=704ded34f09a6899cee7073d3a0ebdba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M313141200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M313141200%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DH.%2BM.%26aulast%3DYang%26aufirst%3DQ.%2BF.%26aulast%3DHur%26aufirst%3DG.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DTran%26aufirst%3DJ.%2BH.%26aulast%3DNedospasov%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DTumor%2520necrosis%2520factor-induced%2520nonapoptotic%2520cell%2520death%2520requires%2520receptor-interacting%2520protein-mediated%2520cellular%2520reactive%2520oxygen%2520species%2520accumulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10822%26epage%3D10828%26doi%3D10.1074%2Fjbc.M313141200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span> <span> </span><span class="NLM_article-title">The role of necroptosis in cancer: a double-edged sword?</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1871</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2019.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bbcan.2019.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30716362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1WksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1871&publication_year=2019&pages=259-266&author=X.+Qinauthor=D.+Maauthor=Y.+X.+Tanauthor=H.+Y.+Wangauthor=Z.+Cai&title=The+role+of+necroptosis+in+cancer%3A+a+double-edged+sword%3F&doi=10.1016%2Fj.bbcan.2019.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of necroptosis in cancer: A double-edged sword?</span></div><div class="casAuthors">Qin, Xia; Ma, Dan; Tan, Ye-xiong; Wang, Hong-yang; Cai, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1871</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-266</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a programmed, caspase-independent cell death that is morphol. similar to necrosis.  Unlike apoptosis, necroptosis evokes inflammatory responses by releasing damage-assocd. mol. patterns.  Recent studies suggest that tumor undergoes necroptosis in vivo and necroptosis has pro- or anti-tumoral effects in cancer development and progression.  Furthermore, triggering necroptosis in tumor cells has been explored as a potential therapeutic strategy against cancer.  Here, we will review the recent research progress of necroptosis in conferring anti- or pro-tumoral effects and its potential application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6U2ziHSQLjbVg90H21EOLACvtfcHk0lhT4OZS-OVM_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1WksL0%253D&md5=891b09640690f0c01297912486ed1642</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2019.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2019.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DTan%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DCai%26aufirst%3DZ.%26atitle%3DThe%2520role%2520of%2520necroptosis%2520in%2520cancer%253A%2520a%2520double-edged%2520sword%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2019%26volume%3D1871%26spage%3D259%26epage%3D266%26doi%3D10.1016%2Fj.bbcan.2019.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">20054</span>– <span class="NLM_lpage">20059</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116302108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1116302108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22123964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12gtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20054-20059&author=S.+Heauthor=Y.+Liangauthor=F.+Shaoauthor=X.+Wang&title=Toll-like+receptors+activate+programmed+necrosis+in+macrophages+through+a+receptor-interacting+kinase-3-mediated+pathway&doi=10.1073%2Fpnas.1116302108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway</span></div><div class="casAuthors">He, Sudan; Liang, Yuqiong; Shao, Feng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20054-20059, S20054/1-S20054/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We report here that mouse macrophages undergo receptor-interacting kinase-3 (RIP3)-dependent but TNFα-independent necrosis when Toll-like receptors (TLR) 3 and 4 are activated by poly(I:C) and LPS, resp.  An adaptor protein, Toll/IL-1 receptor domain-contg. adapter inducing IFN-β (TRIF/TICAM-1), which is dispensable for TNF-α-induced necrosis, forms a complex with RIP3 upon TLR3/ TLR4 activation and is essential for TLR3/TLR4-induced necrosis.  Mice without RIP3 or functional TRIF did not show macrophage loss and elevation of inflammatory cytokines when they were exposed to LPS.  Necrosis in mouse macrophages induced by either TNFR or TLR3/TLR4 is executed by reactive oxygen species.  Taken together, these data indicate that there are multiple upstream necrosis-initiating signaling pathways converging on the RIP3 during an innate immune response to viral and bacterial infections in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlZgMAgWomJ7Vg90H21EOLACvtfcHk0liLGT8j5Ss1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12gtbbI&md5=984418c7e649a485303167662eff6745</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116302108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116302108%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DToll-like%2520receptors%2520activate%2520programmed%2520necrosis%2520in%2520macrophages%2520through%2520a%2520receptor-interacting%2520kinase-3-mediated%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D20054%26epage%3D20059%26doi%3D10.1073%2Fpnas.1116302108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sad, S.</span></span> <span> </span><span class="NLM_article-title">Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/ni.2397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fni.2397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22922364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=954-962&author=N.+Robinsonauthor=S.+McCombauthor=R.+Mulliganauthor=R.+Dudaniauthor=L.+Krishnanauthor=S.+Sad&title=Type+I+interferon+induces+necroptosis+in+macrophages+during+infection+with+Salmonella+enterica+serovar+Typhimurium&doi=10.1038%2Fni.2397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</span></div><div class="casAuthors">Robinson, Nirmal; McComb, Scott; Mulligan, Rebecca; Dudani, Renu; Krishnan, Lakshmi; Sad, Subash</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">954-962</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Salmonella enterica serovar Typhimurium (S. Typhimurium) is a virulent pathogen that induces rapid host death.  Here we obsd. t.hat host survival after infection with S. Typhimurium was enhanced in the absence of type I interferon signaling, with improved survival of mice deficient in the receptor for type I interferons (Ifnar1-/- mice) that was attributed to macrophages.  Although there was no impairment in cytokine expression or inflammasome activation in Ifnar1-/- macrophages, they were highly resistant to S.  Typhimurium-induced cell death.  Specific inhibition of the kinase RIP1 or knockdown of the gene encoding the kinase RIP3 prevented the death of wild-type macrophages, which indicated that necroptosis was a mechanism of cell death.  Finally, RIP3-deficient macrophages, which cannot undergo necroptosis, had similarly less death and enhanced control of S. Typhimurium in vivo.  Thus, we propose that S. Typhimurium induces the prodn. of type I interferon, which drives necroptosis of macrophages and allows them to evade the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSo_COBES0hbVg90H21EOLACvtfcHk0liLGT8j5Ss1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhsbzK&md5=401914c5d80d813e4982062e4b97edf5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fni.2397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2397%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DDudani%26aufirst%3DR.%26aulast%3DKrishnan%26aufirst%3DL.%26aulast%3DSad%26aufirst%3DS.%26atitle%3DType%2520I%2520interferon%2520induces%2520necroptosis%2520in%2520macrophages%2520during%2520infection%2520with%2520Salmonella%2520enterica%2520serovar%2520Typhimurium%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D954%26epage%3D962%26doi%3D10.1038%2Fni.2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rall, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span> <span> </span><span class="NLM_article-title">Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E3109</span>– <span class="NLM_lpage">3118</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301218110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1301218110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23898178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCrtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E3109-3118&author=R.+J.+Thapaauthor=S.+Nogusaauthor=P.+Chenauthor=J.+L.+Makiauthor=A.+Lerroauthor=M.+Andrakeauthor=G.+F.+Rallauthor=A.+Degterevauthor=S.+Balachandran&title=Interferon-induced+RIP1%2FRIP3-mediated+necrosis+requires+PKR+and+is+licensed+by+FADD+and+caspases&doi=10.1073%2Fpnas.1301218110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases</span></div><div class="casAuthors">Thapa, Roshan J.; Nogusa, Shoko; Chen, Peirong; Maki, Jenny L.; Lerro, Anthony; Andrake, Mark; Rall, Glenn F.; Degterev, Alexei; Balachandran, Siddharth</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">E3109-E3118,SE3109/1-SE3109/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Interferons (IFNs) are cytokines with powerful immunomodulatory and antiviral properties, but less is known about how they induce cell death.  Here, we show that both type I (α/β) and type II (γ) IFNs induce precipitous receptor-interacting protein (RIP)1/RIP3 kinase-mediated necrosis when the adaptor protein Fas-assocd. death domain (FADD) is lost or disabled by phosphorylation, or when caspases (e.g., caspase 8) are inactivated.  IFN-induced necrosis proceeds via progressive assembly of a RIP1-RIP3 "necrosome" complex that requires Jak1/STAT1-dependent transcription, but does not need the kinase activity of RIP1.  Instead, IFNs transcriptionally activate the RNA-responsive protein kinase PKR, which then interacts with RIP1 to initiate necrosome formation and trigger necrosis.  Although IFNs are powerful activators of necrosis when FADD is absent, these cytokines are likely not the dominant inducers of RIP kinase-driven embryonic lethality in FADD-deficient mice.  We also identify phosphorylation on serine 191 as a mechanism that disables FADD and collaborates with caspase inactivation to allow IFN-activated necrosis.  Collectively, these findings outline a mechanism of IFN-induced RIP kinase-dependent necrotic cell death and identify FADD and caspases as neg. regulators of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3zqxFs-plYLVg90H21EOLACvtfcHk0lgSu0tMCNBCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCrtbfI&md5=c6cafc37a78608324a899c8c2842953c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301218110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301218110%26sid%3Dliteratum%253Aachs%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DLerro%26aufirst%3DA.%26aulast%3DAndrake%26aufirst%3DM.%26aulast%3DRall%26aufirst%3DG.%2BF.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DBalachandran%26aufirst%3DS.%26atitle%3DInterferon-induced%2520RIP1%252FRIP3-mediated%2520necrosis%2520requires%2520PKR%2520and%2520is%2520licensed%2520by%2520FADD%2520and%2520caspases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE3109%26epage%3D3118%26doi%3D10.1073%2Fpnas.1301218110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Herreweghe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Festjens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1567</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1007/s00018-010-0283-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1007%2Fs00018-010-0283-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20198502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC3c3otF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=1567-1579&author=F.+Van%0AHerrewegheauthor=N.+Festjensauthor=W.+Declercqauthor=P.+Vandenabeele&title=Tumor+necrosis+factor-mediated+cell+death%3A+to+break+or+to+burst%2C+that%E2%80%99s+the+question&doi=10.1007%2Fs00018-010-0283-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor-mediated cell death: to break or to burst, that's the question</span></div><div class="casAuthors">Van Herreweghe Franky; Festjens Nele; Declercq Wim; Vandenabeele Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular life sciences : CMLS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1567-79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In this review, we discuss the signal-transduction pathways of three major cellular responses induced by tumor necrosis factor (TNF): cell survival through NF-kappaB activation, apoptosis, and necrosis.  Recruitment and activation of caspases plays a crucial role in the initiation and execution of TNF-induced apoptosis.  However, experimental inhibition of caspases reveals an alternative cell death pathway, namely necrosis, also called necroptosis, suggesting that caspases actively suppress the latter outcome.  TNF-induced necrotic cell death crucially depends on the kinase activity of receptor interacting protein serine-threonine kinase 1 (RIP1) and RIP3.  It was recently demonstrated that ubiquitination of RIP1 determines whether it will function as a pro-survival or pro-cell death molecule.  Deeper insight into the mechanisms that control the molecular switches between cell survival and cell death will help us to understand why TNF can exert so many different biological functions in the etiology and pathogenesis of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa7ys_p93Q3QvupmecNw_lfW6udTcc2eZT1wihYZVKErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3otF2iug%253D%253D&md5=74266f51bb7352373156d395d5205e7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00018-010-0283-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-010-0283-0%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHerreweghe%26aufirst%3DF.%26aulast%3DFestjens%26aufirst%3DN.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DTumor%2520necrosis%2520factor-mediated%2520cell%2520death%253A%2520to%2520break%2520or%2520to%2520burst%252C%2520that%25E2%2580%2599s%2520the%2520question%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D1567%26epage%3D1579%26doi%3D10.1007%2Fs00018-010-0283-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeddel, D. V.</span></span> <span> </span><span class="NLM_article-title">TNF-R1 signaling: a beautiful pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1635</span>, <span class="refDoi"> DOI: 10.1126/science.1071924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1071924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12040173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1634-1635&author=G.+Chenauthor=D.+V.+Goeddel&title=TNF-R1+signaling%3A+a+beautiful+pathway&doi=10.1126%2Fscience.1071924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">TNF-R1 signaling: A beautiful pathway</span></div><div class="casAuthors">Chen, Guoqing; Goeddel, David V.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1634-1635</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Tumor necrosis factor (TNF) is a major mediator of apoptosis as well as inflammation and immunity, and it has been implicated in the pathogenesis of a wide spectrum of human diseases, including sepsis, diabetes, cancer, osteoporosis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel diseases.  The interaction of TNF with TNF receptor-1 (TNF-R1) activates several signal transduction pathways.  A common feature of each pathway is the TNF-induced formation of a multiprotein signaling complex at the cell membrane.  Over the past decade, many of the components and mechanisms of these signaling pathways have been elucidated.  We provide an overview of current knowledge of TNF signaling and introduce an STKE Connections Map that depicts a canonical view of this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9BE_4FwgPrVg90H21EOLACvtfcHk0lgSu0tMCNBCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChtrg%253D&md5=af1ad93413869caabf70ed256a4c070a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1071924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1071924%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGoeddel%26aufirst%3DD.%2BV.%26atitle%3DTNF-R1%2520signaling%253A%2520a%2520beautiful%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1634%26epage%3D1635%26doi%3D10.1126%2Fscience.1071924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wajant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfizenmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurich, P.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor signaling</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fsj.cdd.4401189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12655295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=45-65&author=H.+Wajantauthor=K.+Pfizenmaierauthor=P.+Scheurich&title=Tumor+necrosis+factor+signaling&doi=10.1038%2Fsj.cdd.4401189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor signaling</span></div><div class="casAuthors">Wajant, H.; Pfizenmaier, K.; Scheurich, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-65</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A single mouse click on the topic tumor necrosis factor (TNF) in PubMed reveals about 50,000 articles providing one or the other information about this pleiotropic cytokine or its relatives.  This demonstrates the enormous scientific and clin. interest in elucidating the biol. of a mol. (or rather a large family of mols.), which began now almost 30 yr ago with the description of a cytokine able to exert antitumoral effects in mouse models.  Although our understanding of the multiple functions of TNF in vivo and of the resp. underlying mechanisms at a cellular and mol. level has made enormous progress since then, new aspects are steadily uncovered and it appears that still much needs to be learned before we can conclude that we have a full comprehension of TNF biol.  This review shortly covers some general aspects of this fascinating mol. and then concs. on the mol. mechanisms of TNF signal transduction.  In particular, the multiple facets of crosstalk between the various signalling pathways engaged by TNF will be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVf0tpPhPSQbVg90H21EOLACvtfcHk0lhkWwhWsoTG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12mu7s%253D&md5=5a4d49fe31e636183b49dff642e59662</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401189%26sid%3Dliteratum%253Aachs%26aulast%3DWajant%26aufirst%3DH.%26aulast%3DPfizenmaier%26aufirst%3DK.%26aulast%3DScheurich%26aufirst%3DP.%26atitle%3DTumor%2520necrosis%2520factor%2520signaling%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2003%26volume%3D10%26spage%3D45%26epage%3D65%26doi%3D10.1038%2Fsj.cdd.4401189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofferson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Control of life-or-death decisions by RIP1 kinase</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-021113-170259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1146%2Fannurev-physiol-021113-170259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24079414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVCmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=129-150&author=D.+E.+Christoffersonauthor=Y.+Liauthor=J.+Yuan&title=Control+of+life-or-death+decisions+by+RIP1+kinase&doi=10.1146%2Fannurev-physiol-021113-170259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Control of life-or-death decisions by RIP1 kinase</span></div><div class="casAuthors">Christofferson, Dana E.; Li, Ying; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-150</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  RIP1 kinase, a multifunctional protein that contains an N-terminal Ser/Thr kinase and a C-terminal death domain, has emerged as a key regulatory mol. involved in regulating both cell death and cell survival.  When the proinflammatory cytokine TNFα stimulates its receptor, TNFR1, RIP1 regulates whether the cell lives by activating NF-κB or dies by apoptosis or necroptosis, two distinct pathways of programmed cell death that may be activated to eliminate unwanted cells.  The kinase domain of RIP1 is involved in regulating necroptosis, and the death domain regulates RIP1 recruitment to the intracellular domain of TNFR1.  The intermediate domain of RIP1 activates NF-κB and also interacts with RIP3 kinase, a downstream mediator of RIP1 in the execution of necroptosis.  This review focuses on the functional roles of RIP1 in regulating multiple cellular mechanisms, the dynamic regulation of RIP1, and the physiol. and pathol. roles of RIP1 kinase in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNS3xlVU5PLVg90H21EOLACvtfcHk0lhkWwhWsoTG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVCmsLg%253D&md5=4386c6498ec70f897b4a6e2a1e8ad010</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-021113-170259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-021113-170259%26sid%3Dliteratum%253Aachs%26aulast%3DChristofferson%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DControl%2520of%2520life-or-death%2520decisions%2520by%2520RIP1%2520kinase%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2014%26volume%3D76%26spage%3D129%26epage%3D150%26doi%3D10.1146%2Fannurev-physiol-021113-170259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Micheau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00521-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2FS0092-8674%2803%2900521-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=12887920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2003&pages=181-190&author=O.+Micheauauthor=J.+Tschopp&title=Induction+of+TNF+receptor+I-mediated+apoptosis+via+two+sequential+signaling+complexes&doi=10.1016%2FS0092-8674%2803%2900521-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes</span></div><div class="casAuthors">Micheau, Olivier; Tschopp, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis induced by TNF-receptor I (TNFR1) is thought to proceed via recruitment of the adaptor FADD and caspase-8 to the receptor complex.  TNFR1 signaling is also known to activate the transcription factor NF-κB and promote survival.  The mechanism by which this decision between cell death and survival is arbitrated is not clear.  The authors report that TNFR1-induced apoptosis involves two sequential signaling complexes.  The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1, and TRAF2 and rapidly signals activation of NF-κB.  In a second step, TRADD and RIP1 assoc. with FADD and caspase-8, forming a cytoplasmic complex (complex II).  When NF-κB is activated by complex I, complex II harbors the caspase-8 inhibitor FLIPL and the cell survives.  Thus, TNFR1-mediated-signal transduction includes a checkpoint, resulting in cell death (via complex II) in instances where the initial signal (via complex I, NF-κB) fails to be activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvD_hEcCU4rrVg90H21EOLACvtfcHk0lhkWwhWsoTG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFCgu7Y%253D&md5=9aae140d4da012f1ba51ec5f3ac6e934</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900521-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900521-X%26sid%3Dliteratum%253Aachs%26aulast%3DMicheau%26aufirst%3DO.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520TNF%2520receptor%2520I-mediated%2520apoptosis%2520via%2520two%2520sequential%2520signaling%2520complexes%26jtitle%3DCell%26date%3D2003%26volume%3D114%26spage%3D181%26epage%3D190%26doi%3D10.1016%2FS0092-8674%2803%2900521-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Jimenez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massoumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. T.</span></span> <span> </span><span class="NLM_article-title">Caspase 8 inhibits programmed necrosis by processing CYLD</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1038/ncb2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fncb2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22037414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1437-1442&author=M.+A.+O%E2%80%99Donnellauthor=E.+Perez-Jimenezauthor=A.+Oberstauthor=A.+Ngauthor=R.+Massoumiauthor=R.+Xavierauthor=D.+R.+Greenauthor=A.+T.+Ting&title=Caspase+8+inhibits+programmed+necrosis+by+processing+CYLD&doi=10.1038%2Fncb2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase 8 inhibits programmed necrosis by processing CYLD</span></div><div class="casAuthors">O'Donnell, Marie Anne; Perez-Jimenez, Eva; Oberst, Andrew; Ng, Aylwin; Massoumi, Ramin; Xavier, Ramnik; Green, Douglas R.; Ting, Adrian T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1437-1442</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Caspase 8 initiates apoptosis downstream of TNF death receptors by undergoing autocleavage and processing the executioner caspase 3 (ref. ).  However, the dominant function of caspase 8 is to transmit a pro-survival signal that suppresses programmed necrosis (or necroptosis) mediated by RIPK1 and RIPK3 (refs , , , , ) during embryogenesis and hematopoiesis.  Suppression of necrotic cell death by caspase 8 requires its catalytic activity but not the autocleavage essential for apoptosis; however, the key substrate processed by caspase 8 to block necrosis has been elusive.  A key substrate must meet three criteria: it must be essential for programmed necrosis; it must be cleaved by caspase 8 in situations where caspase 8 is blocking necrosis; and mutation of the caspase 8 processing site on the substrate should convert a pro-survival response to necrotic death without the need for caspase 8 inhibition.  We now identify CYLD as a substrate for caspase 8 that satisfies these criteria.  Following TNF stimulation, caspase 8 cleaves CYLD to generate a survival signal.  In contrast, loss of caspase 8 prevented CYLD degrdn., resulting in necrotic death.  A CYLD substitution mutation at Asp 215 that cannot be cleaved by caspase 8 switches cell survival to necrotic cell death in response to TNF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CASDRvG6a7Vg90H21EOLACvtfcHk0lgvOzCLX67iTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrL&md5=72d1e19c0fd92d5e9692b1a54b4f90dd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fncb2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2362%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BA.%26aulast%3DPerez-Jimenez%26aufirst%3DE.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DMassoumi%26aufirst%3DR.%26aulast%3DXavier%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DTing%26aufirst%3DA.%2BT.%26atitle%3DCaspase%25208%2520inhibits%2520programmed%2520necrosis%2520by%2520processing%2520CYLD%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1437%26epage%3D1442%26doi%3D10.1038%2Fncb2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feoktistova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geserick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrova, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span> <span> </span><span class="NLM_article-title">cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2011.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21737330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=449-463&author=M.+Feoktistovaauthor=P.+Geserickauthor=B.+Kellertauthor=D.+P.+Dimitrovaauthor=C.+Langlaisauthor=M.+Hupeauthor=K.+Cainauthor=M.+MacFarlaneauthor=G.+Hackerauthor=M.+Leverkus&title=cIAPs+block+Ripoptosome+formation%2C+a+RIP1%2Fcaspase-8+containing+intracellular+cell+death+complex+differentially+regulated+by+cFLIP+isoforms&doi=10.1016%2Fj.molcel.2011.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms</span></div><div class="casAuthors">Feoktistova, Maria; Geserick, Peter; Kellert, Beate; Dimitrova, Diana Panayotova; Langlais, Claudia; Hupe, Mike; Cain, Kelvin; MacFarlane, Marion; Haecker, Georg; Leverkus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The intracellular regulation of cell death pathways by cIAPs has been enigmatic.  Here we show that loss of cIAPs promotes the spontaneous formation of an intracellular platform that activates either apoptosis or necroptosis.  This 2 MDa intracellular complex that we designate "Ripoptosome" is necessary but not sufficient for cell death.  It contains RIP1, FADD, caspase-8, caspase-10, and caspase inhibitor cFLIP isoforms. cFLIPL prevents Ripoptosome formation, whereas, intriguingly, cFLIPS promotes Ripoptosome assembly.  When cIAPs are absent, caspase activity is the "rheostat" that is controlled by cFLIP isoforms in the Ripoptosome and decides if cell death occurs by RIP3-dependent necroptosis or caspase-dependent apoptosis.  RIP1 is the core component of the complex.  As exemplified by our studies for TLR3 activation, our data argue that the Ripoptosome critically influences the outcome of membrane-bound receptor triggering.  The differential quality of cell death mediated by the Ripoptosome may cause important pathophysiol. consequences during inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhfGgsTTImLVg90H21EOLACvtfcHk0lgprPs60LqpTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrY%253D&md5=6e61d717861960c0ecbad7ae84e7ad62</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DFeoktistova%26aufirst%3DM.%26aulast%3DGeserick%26aufirst%3DP.%26aulast%3DKellert%26aufirst%3DB.%26aulast%3DDimitrova%26aufirst%3DD.%2BP.%26aulast%3DLanglais%26aufirst%3DC.%26aulast%3DHupe%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DHacker%26aufirst%3DG.%26aulast%3DLeverkus%26aufirst%3DM.%26atitle%3DcIAPs%2520block%2520Ripoptosome%2520formation%252C%2520a%2520RIP1%252Fcaspase-8%2520containing%2520intracellular%2520cell%2520death%2520complex%2520differentially%2520regulated%2520by%2520cFLIP%2520isoforms%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D43%26spage%3D449%26epage%3D463%26doi%3D10.1016%2Fj.molcel.2011.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachariou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2011.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21737329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=432-448&author=T.+Tenevauthor=K.+Bianchiauthor=M.+Dardingauthor=M.+Broemerauthor=C.+Langlaisauthor=F.+Wallbergauthor=A.+Zachariouauthor=J.+Lopezauthor=M.+MacFarlaneauthor=K.+Cainauthor=P.+Meier&title=The+Ripoptosome%2C+a+signaling+platform+that+assembles+in+response+to+genotoxic+stress+and+loss+of+IAPs&doi=10.1016%2Fj.molcel.2011.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs</span></div><div class="casAuthors">Tenev, Tencho; Bianchi, Katiuscia; Darding, Maurice; Broemer, Meike; Langlais, Claudia; Wallberg, Fredrik; Zachariou, Anna; Lopez, Juanita; MacFarlane, Marion; Cain, Kelvin; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-448</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A better understanding of the mechanisms through which anticancer drugs exert their effects is essential to improve combination therapies.  While studying how genotoxic stress kills cancer cells, we discovered a large ∼2MDa cell death-inducing platform, referred to as "Ripoptosome." It contains the core components RIP1, FADD, and caspase-8, and assembles in response to genotoxic stress-induced depletion of XIAP, cIAP1 and cIAP2.  Importantly, it forms independently of TNF, CD95L/FASL, TRAIL, death-receptors, and mitochondrial pathways.  It also forms upon Smac-mimetic (SM) treatment without involvement of autocrine TNF.  Ripoptosome assembly requires RIP1's kinase activity and can stimulate caspase-8-mediated apoptosis as well as caspase-independent necrosis.  It is neg. regulated by FLIP, cIAP1, cIAP2, and XIAP.  Mechanistically, IAPs target components of this complex for ubiquitylation and inactivation.  Moreover, we find that etoposide-stimulated Ripoptosome formation converts proinflammatory cytokines into prodeath signals.  Together, our observations shed new light on fundamental mechanisms by which chemotherapeutics may kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIDpVuGme2BbVg90H21EOLACvtfcHk0lgprPs60LqpTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFSqtrs%253D&md5=efd6febf43090282226e5d0ffc3a72ae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DBroemer%26aufirst%3DM.%26aulast%3DLanglais%26aufirst%3DC.%26aulast%3DWallberg%26aufirst%3DF.%26aulast%3DZachariou%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DJ.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DK.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DThe%2520Ripoptosome%252C%2520a%2520signaling%2520platform%2520that%2520assembles%2520in%2520response%2520to%2520genotoxic%2520stress%2520and%2520loss%2520of%2520IAPs%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D43%26spage%3D432%26epage%3D448%26doi%3D10.1016%2Fj.molcel.2011.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e76841</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0076841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0076841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24098568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76841&author=D.+M.+Moquinauthor=T.+McQuadeauthor=F.+K.+Chan&title=CYLD+deubiquitinates+RIP1+in+the+TNFalpha-induced+necrosome+to+facilitate+kinase+activation+and+programmed+necrosis&doi=10.1371%2Fjournal.pone.0076841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis</span></div><div class="casAuthors">Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e76841</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Necroptosis/programmed necrosis is initiated by a macromol. protein complex termed the necrosome.  Receptor interacting protein kinase 1 (RIPK1/RIP1) and RIP3 are key components of the necrosome.  TNFα is a prototypic inducer of necrosome activation, and it is widely believed that deubiquitination of RIP1 at the TNFR-1 signaling complex precedes transition of RIP1 into the cytosol where it forms the RIP1-RIP3 necrosome.  Cylindromatosis (CYLD) is believed to promote programmed necrosis by facilitating RIP1 deubiquitination at this membrane receptor complex.  We demonstrate that RIP1 is indeed the primary target of CYLD in TNFα-induced programmed necrosis.  We obsd. that CYLD does not regulate RIP1 ubiquitination at the TNF receptor.  TNF and zVAD-induced programmed necrosis was highly attenuated in CYLD-/- cells.  However, in the presence of cycloheximide or SMAC mimetics, programmed necrosis was only moderately reduced in CYLD-/- cells.  Under the latter conditions, RIP1-RIP3 necrosome formation is only delayed, but not abolished in CYLD-/- cells.  We further demonstrate that RIP1 within the NP-40 insol. necrosome is ubiquitinated and that CYLD regulates RIP1 ubiquitination in this compartment.  Hence, RIP1 ubiquitination in this late-forming complex is greatly increased in CYLD-/- cells.  Increased RIP1 ubiquitination impairs RIP1 and RIP3 phosphorylation, a signature of kinase activation.  Our results show that CYLD regulates RIP1 ubiquitination in the TNFα-induced necrosome, but not in the TNFR-1 signaling complex.  In cells sensitized to programmed necrosis with SMAC mimetics, CYLD is not essential for necrosome assembly.  Since SMAC mimetics induces the loss of the E3 ligases cIAP1 and cIAP2, reduced RIP1 ubiquitination could lead to reduced requirement for CYLD to remove ubiquitin chains from RIP1 in the TNFR-1 complex.  As increased RIP1 ubiquitination in the necrosome correlates with impaired RIP1 and RIP3 phosphorylation and function, these results suggest that CYLD controls RIP1 kinase activity during necrosome assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc0d2j3EJAfbVg90H21EOLACvtfcHk0lgyFj07bBi92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrurzK&md5=0385f6fa8152b657bccaa5739b010536</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0076841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0076841%26sid%3Dliteratum%253Aachs%26aulast%3DMoquin%26aufirst%3DD.%2BM.%26aulast%3DMcQuade%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DCYLD%2520deubiquitinates%2520RIP1%2520in%2520the%2520TNFalpha-induced%2520necrosome%2520to%2520facilitate%2520kinase%2520activation%2520and%2520programmed%2520necrosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De76841%26doi%3D10.1371%2Fjournal.pone.0076841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span> <span> </span><span class="NLM_article-title">Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2056</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2007.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cellsig.2007.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17644308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=2056-2067&author=S.+Fengauthor=Y.+Yangauthor=Y.+Meiauthor=L.+Maauthor=D.+E.+Zhuauthor=N.+Hotiauthor=M.+Castanaresauthor=M.+Wu&title=Cleavage+of+RIP3+inactivates+its+caspase-independent+apoptosis+pathway+by+removal+of+kinase+domain&doi=10.1016%2Fj.cellsig.2007.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain</span></div><div class="casAuthors">Feng, Shanshan; Yang, Yonghui; Mei, Yide; Ma, Li; Zhu, De-e; Hoti, Naseruddin; Castanares, Mark; Wu, Mian</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2056-2067</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RIP3 (Receptor Interacting Protein 3), a member of the Ser/Thr kinase family, is able to induce apoptosis and activate NF-κB in various cell types.  However, the detailed mechanism of RIP3-induced apoptosis is largely unknown.  In this study, we show that RIP3 is cleaved at Asp328 by caspase-8 under apoptotic stimuli, which is blocked by pan-caspase inhibitor Z-VAD-FMK.  In addn., full-length RIP3 induces both caspase-dependent and-independent apoptosis, as well as activates NF-κB.  However, after cleavage, the C-terminus of RIP3 (aa 329-518) that lacks the kinase domain can form punctuate or filaments-like structures in cytoplasm, which induces only caspase-dependent apoptosis and exhibits a markedly higher NF-κB-activating activity than full-length RIP3.  More importantly, the cleaved product of RIP3 (aa 329-518) displays better stability than wild type RIP3.  Addnl., RIP3(K50A), a kinase-dead RIP3 mutant, also induces only caspase-dependent apoptosis along with an increased NF-κB-activating activity compared to RIP3, which further demonstrates that kinase activity of RIP3 is essential for its caspase-independent apoptotic activity.  These results will help us to understand the mechanism underlying RIP3-induced apoptosis and the different roles of kinase domain and unique domain of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQchn1imoRa7Vg90H21EOLACvtfcHk0lgyFj07bBi92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFylsb4%253D&md5=79b356b6e84a0086b411deaee17abab9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DD.%2BE.%26aulast%3DHoti%26aufirst%3DN.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DM.%26atitle%3DCleavage%2520of%2520RIP3%2520inactivates%2520its%2520caspase-independent%2520apoptosis%2520pathway%2520by%2520removal%2520of%2520kinase%2520domain%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D2056%26epage%3D2067%26doi%3D10.1016%2Fj.cellsig.2007.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondelinger, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montessuit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggeman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulpiau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24813885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=971-981&author=Y.+Dondelingerauthor=W.+Declercqauthor=S.+Montessuitauthor=R.+Roelandtauthor=A.+Goncalvesauthor=I.+Bruggemanauthor=P.+Hulpiauauthor=K.+Weberauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Goughauthor=S.+Savvidesauthor=J.+C.+Martinouauthor=M.+J.+Bertrandauthor=P.+Vandenabeele&title=MLKL+compromises+plasma+membrane+integrity+by+binding+to+phosphatidylinositol+phosphates&doi=10.1016%2Fj.celrep.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates</span></div><div class="casAuthors">Dondelinger, Yves; Declercq, Wim; Montessuit, Sylvie; Roelandt, Ria; Goncalves, Amanda; Bruggeman, Inge; Hulpiau, Paco; Weber, Kathrin; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Gough, Peter J.; Savvides, Savvas; Martinou, Jean-Claude; Bertrand, Mathieu J. M.; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although mixed lineage kinase domain-like (MLKL) protein has emerged as a specific and crucial protein for necroptosis induction, how MLKL transduces the death signal remains poorly understood.  Here, we demonstrate that the full four-helical bundle domain (4HBD) in the N-terminal region of MLKL is required and sufficient to induce its oligomerization and trigger cell death.  Moreover, we found that a patch of pos. charged amino acids on the surface of the 4HBD binds to phosphatidylinositol phosphates (PIPs) and allows recruitment of MLKL to the plasma membrane.  Importantly, we found that recombinant MLKL, but not a mutant lacking these pos. charges, induces leakage of PIP-contg. liposomes as potently as BAX, supporting a model in which MLKL induces necroptosis by directly permeabilizing the plasma membrane.  Accordingly, we found that inhibiting the formation of PI(5)P and PI(4,5)P2 specifically inhibits tumor necrosis factor (TNF)-mediated necroptosis but not apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRumZDmhVGLVg90H21EOLACvtfcHk0lgyFj07bBi92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D&md5=42d9a43216f884c12bd4288658563873</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DDondelinger%26aufirst%3DY.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DMontessuit%26aufirst%3DS.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DGoncalves%26aufirst%3DA.%26aulast%3DBruggeman%26aufirst%3DI.%26aulast%3DHulpiau%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSavvides%26aufirst%3DS.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DMLKL%2520compromises%2520plasma%2520membrane%2520integrity%2520by%2520binding%2520to%2520phosphatidylinositol%2520phosphates%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D971%26epage%3D981%26doi%3D10.1016%2Fj.celrep.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/ncb2883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fncb2883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24316671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=55-65&author=Z.+Caiauthor=S.+Jitkaewauthor=J.+Zhaoauthor=H.+C.+Chiangauthor=S.+Choksiauthor=J.+Liuauthor=Y.+Wardauthor=L.+G.+Wuauthor=Z.+G.+Liu&title=Plasma+membrane+translocation+of+trimerized+MLKL+protein+is+required+for+TNF-induced+necroptosis&doi=10.1038%2Fncb2883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span></div><div class="casAuthors">Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Chiang, Hsueh-Cheng; Choksi, Swati; Liu, Jie; Ward, Yvona; Wu, Ling-gang; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumor necrosis factor (TNF)-induced necroptosis.  MLKL is phosphorylated by RIP3 and is recruited to the necrosome through its interaction with RIP3.  However, it is still unknown how MLKL mediates TNF-induced necroptosis.  Here, we report that MLKL forms a homotrimer through its amino-terminal coiled-coil domain and locates to the cell plasma membrane during TNF-induced necroptosis.  By generating different MLKL mutants, we demonstrated that the plasma membrane localization of trimerized MLKL is crit. for mediating necroptosis.  Importantly, we found that the membrane localization of MLKL is essential for Ca2+ influx, which is an early event of TNF-induced necroptosis.  Furthermore, we identified that TRPM7 (transient receptor potential melastatin related 7) is a MLKL downstream target for the mediation of Ca2+ influx and TNF-induced necroptosis.  Hence, our study reveals a crucial mechanism of MLKL-mediated TNF-induced necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjJZlohdKsLVg90H21EOLACvtfcHk0lhreQ5n2uK8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E&md5=95e4468ee729b5a3bd8ab8ce49af8f25</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fncb2883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2883%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DH.%2BC.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DPlasma%2520membrane%2520translocation%2520of%2520trimerized%2520MLKL%2520protein%2520is%2520required%2520for%2520TNF-induced%2520necroptosis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D55%26epage%3D65%26doi%3D10.1038%2Fncb2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24703947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=133-146&author=H.+Wangauthor=L.+Sunauthor=L.+Suauthor=J.+Rizoauthor=L.+Liuauthor=L.+F.+Wangauthor=F.+S.+Wangauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+MLKL+causes+necrotic+membrane+disruption+upon+phosphorylation+by+RIP3&doi=10.1016%2Fj.molcel.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3</span></div><div class="casAuthors">Wang, Huayi; Sun, Liming; Su, Lijing; Rizo, Josep; Liu, Lei; Wang, Li-Feng; Wang, Fu-Sheng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Programmed necrotic cell death induced by the tumor necrosis factor alpha (TNF-α) family of cytokines is dependent on a kinase cascade consisting of receptor-interacting kinases RIP1 and RIP3.  How these kinase activities cause cells to die by necrosis is not known.  The mixed lineage kinase domain-like protein MLKL is a functional RIP3 substrate that binds to RIP3 through its kinase-like domain but lacks kinase activity of its own.  RIP3 phosphorylates MLKL at the T357 and S358 sites.  Reported here is the development of a monoclonal antibody that specifically recognizes phosphorylated MLKL in cells dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced liver injury.  The phosphorylated MLKL forms an oligomer that binds to phosphatidylinositol lipids and cardiolipin.  This property allows MLKL to move from the cytosol to the plasma and intracellular membranes, where it directly disrupts membrane integrity, resulting in necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1gUpKITrVg90H21EOLACvtfcHk0lhreQ5n2uK8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D&md5=8e4ab8e0a49933201ed49b147b6b189e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DF.%2BS.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520MLKL%2520causes%2520necrotic%2520membrane%2520disruption%2520upon%2520phosphorylation%2520by%2520RIP3%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D133%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/cr.2013.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcr.2013.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24366341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=105-121&author=X.+Chenauthor=W.+Liauthor=J.+Renauthor=D.+Huangauthor=W.+T.+Heauthor=Y.+Songauthor=C.+Yangauthor=W.+Liauthor=X.+Zhengauthor=P.+Chenauthor=J.+Han&title=Translocation+of+mixed+lineage+kinase+domain-like+protein+to+plasma+membrane+leads+to+necrotic+cell+death&doi=10.1038%2Fcr.2013.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span></div><div class="casAuthors">Chen, Xin; Li, Wenjuan; Ren, Junming; Huang, Deli; He, Wan-ting; Song, Yunlong; Yang, Chao; Li, Wanyun; Zheng, Xinru; Chen, Pengda; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like protein (MLKL) was identified to function downstream of receptor interacting protein 3 (RIP3) in tumor necrosis factor-α (TNF)-induced necrosis (also called necroptosis).  However, how MLKL functions to mediate necroptosis is unknown.  By reconstitution of MLKL function in MLKL-knockout cells, we showed that the N-terminus of MLKL is required for its function in necroptosis.  The oligomerization of MLKL in TNF-treated cells is essential for necroptosis, as artificially forcing MLKL together by using the hormone-binding domain (HBD*) triggers necroptosis.  Notably, forcing together the N-terminal domain (ND) but not the C-terminal kinase domain of MLKL causes necroptosis.  Further deletion anal. showed that the four-α-helix bundle of MLKL (1-130 amino acids) is sufficient to trigger necroptosis.  Both the HBD*-mediated and TNF-induced complexes of MLKL(ND) or MLKL are tetramers, and translocation of these complexes to lipid rafts of the plasma membrane precedes cell death.  The homo-oligomerization is required for MLKL translocation and the signal sequence for plasma membrane location is located in the junction of the first and second α-helixes of MLKL.  The plasma membrane translocation of MLKL or MLKL(ND) leads to sodium influx, and depletion of sodium from the cell culture medium inhibits necroptosis.  All of the above phenomena were not seen in apoptosis.  Thus, the MLKL oligomerization leads to translocation of MLKL to lipid rafts of plasma membrane, and the plasma membrane MLKL complex acts either by itself or via other proteins to increase the sodium influx, which increases osmotic pressure, eventually leading to membrane rupture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3gKfH7oX77Vg90H21EOLACvtfcHk0lhK99UV4fmWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVyr&md5=16ac2183df16e01d3555e4a099540aae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fcr.2013.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2013.171%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%2BT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DTranslocation%2520of%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%2520to%2520plasma%2520membrane%2520leads%2520to%2520necrotic%2520cell%2520death%26jtitle%3DCell%2520Res.%26date%3D2014%26volume%3D24%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fcr.2013.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span> <span> </span><span class="NLM_article-title">Necroptosis: the release of damage-associated molecular patterns and its physiological relevance</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.immuni.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23438821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVeht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=209-223&author=A.+Kaczmarekauthor=P.+Vandenabeeleauthor=D.+V.+Krysko&title=Necroptosis%3A+the+release+of+damage-associated+molecular+patterns+and+its+physiological+relevance&doi=10.1016%2Fj.immuni.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance</span></div><div class="casAuthors">Kaczmarek, Agnieszka; Vandenabeele, Peter; Krysko, Dmitri V.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-223</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Regulated necrosis, termed necroptosis, is neg. regulated by caspase-8 and is dependent on the kinase activity of RIPK1 and RIPK3.  Necroptosis leads to rapid plasma membrane permeabilization and to the release of cell contents and exposure of damage-assocd. mol. patterns (DAMPs).  We are only beginning to identify the necroptotic DAMPs, their modifications, and their potential role in the regulation of inflammation.  In this review, we discuss the physiol. relevance of necroptosis and its role in the modulation of inflammation.  For example, during viral infection, RIPK3-mediated necroptosis acts as a backup mechanism to clear pathogens.  Necroptosis is also involved in apparently immunol. silent maintenance of T cell homeostasis.  In contrast, the induction of necroptosis in skin, intestine, systemic inflammatory response syndrome, and ischemia reperfusion injury provoke a strong inflammatory response, which might be triggered by emission of DAMPs from necroptotic cells, showing the detrimental side of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwzS_R6I-CZ7Vg90H21EOLACvtfcHk0lhK99UV4fmWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVeht7k%253D&md5=899783987a1bb878995ed7d0b30d2daa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DKaczmarek%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26atitle%3DNecroptosis%253A%2520the%2520release%2520of%2520damage-associated%2520molecular%2520patterns%2520and%2520its%2520physiological%2520relevance%26jtitle%3DImmunity%26date%3D2013%26volume%3D38%26spage%3D209%26epage%3D223%26doi%3D10.1016%2Fj.immuni.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and inflammation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060815-014830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1146%2Fannurev-biochem-060815-014830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26865533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVGitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2016&pages=743-763&author=K.+Newtonauthor=G.+Manning&title=Necroptosis+and+inflammation&doi=10.1146%2Fannurev-biochem-060815-014830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and Inflammation</span></div><div class="casAuthors">Newton, Kim; Manning, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">743-763</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Necroptosis is a regulated form of necrosis, with the dying cell rupturing and releasing intracellular components that can trigger an innate immune response.  Toll-like receptor 3 and 4 agonists, tumor necrosis factor, certain viral infections, or the T cell receptor can trigger necroptosis if the activity of the protease caspase-8 is compromised.  Necroptosis signaling is modulated by the kinase RIPK1 and requires the kinase RIPK3 and the pseudokinase MLKL.  Either RIPK3 deficiency or RIPK1 inhibition confers resistance in various animal disease models, suggesting that inflammation caused by necroptosis contributes to tissue damage and that inhibitors of these kinases could have therapeutic potential.  Recent studies have revealed unexpected complexity in the regulation of cell death programs by RIPK1 and RIPK3 with the possibility that necroptosis is but one mechanism by which these kinases promote inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDHlIAqcEKR7Vg90H21EOLACvtfcHk0lhK99UV4fmWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVGitLw%253D&md5=ee7ea0c14e45d52158f7b9e50e338789</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060815-014830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060815-014830%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DG.%26atitle%3DNecroptosis%2520and%2520inflammation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2016%26volume%3D85%26spage%3D743%26epage%3D763%26doi%3D10.1146%2Fannurev-biochem-060815-014830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and its role in inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature14191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25592536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=311-320&author=M.+Pasparakisauthor=P.+Vandenabeele&title=Necroptosis+and+its+role+in+inflammation&doi=10.1038%2Fnature14191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and its role in inflammation</span></div><div class="casAuthors">Pasparakis, Manolis; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7534</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulated cell death has essential functions in development and in adult tissue homeostasis.  Necroptosis is a newly discovered pathway of regulated necrosis that requires the proteins RIPK3 and MLKL and is induced by death receptors, interferons, toll-like receptors, intracellular RNA and DNA sensors, and probably other mediators.  RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis.  Mouse-model studies have revealed important functions for necroptosis in inflammation and suggested that it could be implicated in the pathogenesis of many human inflammatory diseases.  We discuss the mechanisms regulating necroptosis and its potential role in inflammation and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA9_ozm2Tq27Vg90H21EOLACvtfcHk0lhK99UV4fmWtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D&md5=3acc43a5a345c231eb47ba079211783e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnature14191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14191%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecroptosis%2520and%2520its%2520role%2520in%2520inflammation%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D311%26epage%3D320%26doi%3D10.1038%2Fnature14191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1126/science.1172308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1172308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19498109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Sqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=332-336&author=D.+W.+Zhangauthor=J.+Shaoauthor=J.+Linauthor=N.+Zhangauthor=B.+J.+Luauthor=S.+C.+Linauthor=M.+Q.+Dongauthor=J.+Han&title=RIP3%2C+an+energy+metabolism+regulator+that+switches+TNF-induced+cell+death+from+apoptosis+to+necrosis&doi=10.1126%2Fscience.1172308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis</span></div><div class="casAuthors">Zhang, Duan-Wu; Shao, Jing; Lin, Juan; Zhang, Na; Lu, Bao-Ju; Lin, Sheng-Cai; Dong, Meng-Qiu; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5938</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Necrosis can be induced by stimulating death receptors with tumor necrosis factor (TNF) or other agonists; however, the underlying mechanism differentiating necrosis from apoptosis is largely unknown.  The authors identified the protein kinase receptor-interacting protein 3 (RIP3) as a mol. switch between TNF-induced apoptosis and necrosis in NIH 3T3 cells and found that RIP3 was required for necrosis in other cells.  RIP3 did not affect RIP1-mediated apoptosis but was required for RIP1-mediated necrosis and the enhancement of necrosis by the caspase inhibitor zVAD.  By activating key enzymes of metabolic pathways, RIP3 regulates TNF-induced reactive oxygen species prodn., which partially accounts for RIP3's ability to promote necrosis.  The authors' data suggest that modulation of energy metab. in response to death stimuli has an important role in the choice between apoptosis and necrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOqRfzL9nh47Vg90H21EOLACvtfcHk0lhshF7sd7FizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Sqt7Y%253D&md5=f30f0c410243ca8a71616fb6718b8612</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1172308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1172308%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BW.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DB.%2BJ.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DRIP3%252C%2520an%2520energy%2520metabolism%2520regulator%2520that%2520switches%2520TNF-induced%2520cell%2520death%2520from%2520apoptosis%2520to%2520necrosis%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D332%26epage%3D336%26doi%3D10.1126%2Fscience.1172308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19524512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1100-1111&author=S.+Heauthor=L.+Wangauthor=L.+Miaoauthor=T.+Wangauthor=F.+Duauthor=L.+Zhaoauthor=X.+Wang&title=Receptor+interacting+protein+kinase-3+determines+cellular+necrotic+response+to+TNF-alpha&doi=10.1016%2Fj.cell.2009.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α</span></div><div class="casAuthors">He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1111</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Smac mimetics induce apoptosis synergistically with TNF-α by triggering the formation of a caspase-8-activating complex contg. receptor interacting protein kinase-1 (RIPK1).  Caspase inhibitors block this form of apoptosis in many types of cells.  However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis.  A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis.  The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction.  The kinase activity of RIP3 is essential for necrosis execution.  Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex.  Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model.  These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-α family of death-inducing cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymGY6l3d1LbVg90H21EOLACvtfcHk0lhshF7sd7FizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D&md5=6397b34b896f8fe36c726f6d2ab39933</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DReceptor%2520interacting%2520protein%2520kinase-3%2520determines%2520cellular%2520necrotic%2520response%2520to%2520TNF-alpha%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1100%26epage%3D1111%26doi%3D10.1016%2Fj.cell.2009.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2011.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22265413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=213-227&author=L.+Sunauthor=H.+Wangauthor=Z.+Wangauthor=S.+Heauthor=S.+Chenauthor=D.+Liaoauthor=L.+Wangauthor=J.+Yanauthor=W.+Liuauthor=X.+Leiauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+mediates+necrosis+signaling+downstream+of+RIP3+kinase&doi=10.1016%2Fj.cell.2011.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span></div><div class="casAuthors">Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The receptor-interacting serine-threonine kinase 3 (RIP3) is a key signaling mol. in the programmed necrosis (necroptosis) pathway.  This pathway plays important roles in a variety of physiol. and pathol. conditions, including development, tissue damage response, and antiviral immunity.  Here, we report the identification of a small mol. called (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide-hereafter referred to as necrosulfonamide-that specifically blocks necrosis downstream of RIP3 activation.  An affinity probe derived from necrosulfonamide and coimmunopptn. using anti-RIP3 antibodies both identified the mixed lineage kinase domain-like protein (MLKL) as the interacting target.  MLKL was phosphorylated by RIP3 at the threonine 357 and serine 358 residues, and these phosphorylation events were crit. for necrosis.  Treating cells with necrosulfonamide or knocking down MLKL expression arrested necrosis at a specific step at which RIP3 formed discrete punctae in cells.  These findings implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.  MLKL connects RIP1 and RIP3 with its downstream targets.  In response to necrosis induction, activated RIP3 binds and phosphorylates MLKL, allowing downstream necrosis signaling to proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTbwLFup35LVg90H21EOLACvtfcHk0lhshF7sd7FizA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D&md5=c3301ecd27c6892817e18b42c56bd97e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520mediates%2520necrosis%2520signaling%2520downstream%2520of%2520RIP3%2520kinase%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D213%26epage%3D227%26doi%3D10.1016%2Fj.cell.2011.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5327</span>, <span class="refDoi"> DOI: 10.1073/pnas.1200012109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1200012109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22421439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5322-5327&author=J.+Zhaoauthor=S.+Jitkaewauthor=Z.+Caiauthor=S.+Choksiauthor=Q.+Liauthor=J.+Luoauthor=Z.+G.+Liu&title=Mixed+lineage+kinase+domain-like+is+a+key+receptor+interacting+protein+3+downstream+component+of+TNF-induced+necrosis&doi=10.1073%2Fpnas.1200012109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span></div><div class="casAuthors">Zhao, Jie; Jitkaew, Siriporn; Cai, Zhenyu; Choksi, Swati; Li, Qiuning; Luo, Ji; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5322-5327, S5322/1-S5322/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is an important inflammatory cytokine and induces many cellular responses, including inflammation, cell proliferation, apoptosis, and necrosis.  It is known that receptor interacting protein (RIP) kinases, RIP1 and RIP3, are key effectors of TNF-induced necrosis, but little is known about how these two RIP kinases mediate this process, although reactive oxygen species (ROS) generation and JNK activation have been suggested to be two downstream events of RIP kinases.  Here we report the identification of mixed lineage kinase domain-like, MLKL, as a key RIP3 downstream component of TNF-induced necrosis.  Through screening a kinase/phosphatase shRNA library in human colon adenocarcinoma HT-29 cells, we found that knockdown of MLKL blocked TNF-induced necrosis.  Our data suggest that MLKL functions downstream of R1P1 and RIP3 and is recruited to the necrosome through its interaction with RIP3.  Finally, we found that MLKL is required for the generation of ROS and the late-phase activation of JNK during TNF-induced necrosis.  However, because these two events are not involved in TNF-induced necrosis in HT-29 cells, the target of MLKL during TNF-induced necrosis remains elusive.  Taken together, our study suggests that MLKL is a key RIP3 downstream component of TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA3gnnPnZluLVg90H21EOLACvtfcHk0liqMZ4v8zdkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D&md5=74fd138fd18afacf677003f41d6be280</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1200012109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1200012109%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520is%2520a%2520key%2520receptor%2520interacting%2520protein%25203%2520downstream%2520component%2520of%2520TNF-induced%2520necrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5322%26epage%3D5327%26doi%3D10.1073%2Fpnas.1200012109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0liqMZ4v8zdkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guildford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2009.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19524513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1112-1123&author=Y.+S.+Choauthor=S.+Challaauthor=D.+Moquinauthor=R.+Gengaauthor=T.+D.+Rayauthor=M.+Guildfordauthor=F.+K.+Chan&title=Phosphorylation-driven+assembly+of+the+RIP1-RIP3+complex+regulates+programmed+necrosis+and+virus-induced+inflammation&doi=10.1016%2Fj.cell.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span></div><div class="casAuthors">Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Dutta Ray, Tathagat; Guildford, Melissa; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1112-1123</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Programmed necrosis is a form of caspase-independent cell death whose mol. regulation is poorly understood.  The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-κB.  The authors postulated that addnl. mols. are required to specifically activate programmed necrosis.  Using a RNA interference screen, the authors identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection.  RIP3 regulates necrosis-specific RIP1 phosphorylation.  The phosphorylation of RIP1 and RIP3 stabilizes their assocn. within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species prodn.  The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection.  Consequently, RIP3-/- mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication.  The authors' findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmgsGJGayANrVg90H21EOLACvtfcHk0lg0AAk3E3hT3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D&md5=6c158081daa49222becf864ac4a23885</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DMoquin%26aufirst%3DD.%26aulast%3DGenga%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DT.%2BD.%26aulast%3DGuildford%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DPhosphorylation-driven%2520assembly%2520of%2520the%2520RIP1-RIP3%2520complex%2520regulates%2520programmed%2520necrosis%2520and%2520virus-induced%2520inflammation%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1112%26epage%3D1123%26doi%3D10.1016%2Fj.cell.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlic, M.</span></span> <span> </span><span class="NLM_article-title">The diverse role of RIP kinases in necroptosis and inflammation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1038/ni.3206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fni.3206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26086143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=689-697&author=J.+Silkeauthor=J.+A.+Rickardauthor=M.+Gerlic&title=The+diverse+role+of+RIP+kinases+in+necroptosis+and+inflammation&doi=10.1038%2Fni.3206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse role of RIP kinases in necroptosis and inflammation</span></div><div class="casAuthors">Silke, John; Rickard, James A.; Gerlic, Motti</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a healthy response to infection or danger and should be rapid, specific and terminated once the threat has passed.  Inflammatory diseases, where this regulation fails, cause considerable human suffering.  Treatments have successfully targeted pro-inflammatory cytokines, such as tumor-necrosis factor (TNF), that directly induce genes encoding inflammatory products.  Inflammatory signals, including TNF, may also directly induce caspase-independent cell death (necroptosis), which can also elicit inflammation.  Necroptosis was originally defined as being dependent on the kinase RIPK1 but is now known to be dependent on RIPK3 and the pseudo-kinase MLKL.  Therefore, RIPK1, RIPK3 and MLKL are potential therapeutic targets.  RIPK1 and RIPK3 also directly regulate inflammatory signaling, which complicates interpretation of their function but might alter their therapeutic utility.  This Review examines the role of cell death, particularly necroptosis, in inflammation, in the context of recent insights into the roles of the key necroptosis effector mols. RIPK1, RIPK3 and MLKL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwQIKren3X7Vg90H21EOLACvtfcHk0lg0AAk3E3hT3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E&md5=124026d3c7caa25e1d416c6cb2bd8d87</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fni.3206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3206%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DJ.%2BA.%26aulast%3DGerlic%26aufirst%3DM.%26atitle%3DThe%2520diverse%2520role%2520of%2520RIP%2520kinases%2520in%2520necroptosis%2520and%2520inflammation%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26spage%3D689%26epage%3D697%26doi%3D10.1038%2Fni.3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1038/s41583-018-0093-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41583-018-0093-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30467385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=19-33&author=J.+Yuanauthor=P.+Aminauthor=D.+Ofengeim&title=Necroptosis+and+RIPK1-mediated+neuroinflammation+in+CNS+diseases&doi=10.1038%2Fs41583-018-0093-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span></div><div class="casAuthors">Yuan, Junying; Amin, Palak; Ofengeim, Dimitry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death.  However, under pathol. conditions, upregulation of death receptor family ligands, such as tumor necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL).  Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease.  In this Review, we outline the evidence implicating necroptosis in these neurol. diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SkNdlkg47rVg90H21EOLACvtfcHk0lg0AAk3E3hT3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O&md5=935fd7ac622d04317a9f7c2c21f40717</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41583-018-0093-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41583-018-0093-1%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DOfengeim%26aufirst%3DD.%26atitle%3DNecroptosis%2520and%2520RIPK1-mediated%2520neuroinflammation%2520in%2520CNS%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2019%26volume%3D20%26spage%3D19%26epage%3D33%26doi%3D10.1038%2Fs41583-018-0093-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Necroptosis in health and diseases</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2014.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.semcdb.2014.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25087983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=14-23&author=W.+Zhouauthor=J.+Yuan&title=Necroptosis+in+health+and+diseases&doi=10.1016%2Fj.semcdb.2014.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis in health and diseases</span></div><div class="casAuthors">Zhou, Wen; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14-23</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Necroptosis is a form of regulated necrosis that can be activated by ligands of death receptors and stimuli that induce the expression of death receptor ligands under apoptotic deficient conditions.  Activation of necroptosis by ligands of death receptors requires the kinase activity of RIP1, which mediates the activation of RIP3 and MLKL, two crit. downstream mediators of necroptosis.  Blocking the kinase activity of RIP1, a key druggable target in the necroptosis pathway, by necrostatins inhibits the activation of necroptosis and allows cell survival and proliferation in the presence of death receptor ligands.  The activation of necroptosis is modulated by different forms of ubiquitination, including K63, linear and K48 ubiquitination, as well as phosphorylation of RIP1, RIP3 and MLKL.  Necroptosis is suppressed by caspase-8/FADD-mediated apoptosis.  Deficiency in caspase-8 and FADD leads to embryonic lethality, tissue degeneration and inflammation which can be suppressed by inhibition of RIP1 kinase and RIP3.  On the other hand, the lack of RIP3 kinase activity leads to early embryonic lethality which can be suppressed by the loss of caspase-8, suggesting that although the kinase activity of RIP3 is involved in mediating necroptosis, the basal activity of RIP3 kinase may be required for suppressing caspase-8 mediated apoptosis.  Necroptosis as well as RIP1- and RIP3-mediated inflammatory response have been implicated in mediating multiple human diseases including TNF-mediated hypothermia and systemic inflammation, ischemic reperfusion injury, neurodegeneration, Gaucher's disease, progressive atherosclerotic lesions, etc.  Targeting RIP1 kinase may provide therapeutic benefits for the treatment of human diseases characterized by necrosis and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8_BPfzp_ambVg90H21EOLACvtfcHk0lgDS184ex8euw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClurzO&md5=fd986c50bf0c1ef8b247f221b67d4cb1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2014.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DNecroptosis%2520in%2520health%2520and%2520diseases%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D14%26epage%3D23%26doi%3D10.1016%2Fj.semcdb.2014.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitz, S. I.</span></span> <span> </span><span class="NLM_article-title">Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1576</span>, <span class="refDoi"> DOI: 10.1002/jnr.22314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1002%2Fjnr.22314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=1569-1576&author=D.+M.+Rosenbaumauthor=A.+Degterevauthor=J.+Davidauthor=P.+S.+Rosenbaumauthor=S.+Rothauthor=J.+C.+Grottaauthor=G.+D.+Cunyauthor=J.+Yuanauthor=S.+I.+Savitz&title=Necroptosis%2C+a+novel+form+of+caspase-independent+cell+death%2C+contributes+to+neuronal+damage+in+a+retinal+ischemia-reperfusion+injury+model&doi=10.1002%2Fjnr.22314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22314%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DP.%2BS.%26aulast%3DRoth%26aufirst%3DS.%26aulast%3DGrotta%26aufirst%3DJ.%2BC.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSavitz%26aufirst%3DS.%2BI.%26atitle%3DNecroptosis%252C%2520a%2520novel%2520form%2520of%2520caspase-independent%2520cell%2520death%252C%2520contributes%2520to%2520neuronal%2520damage%2520in%2520a%2520retinal%2520ischemia-reperfusion%2520injury%2520model%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D88%26spage%3D1569%26epage%3D1576%26doi%3D10.1002%2Fjnr.22314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. M.</span></span> <span> </span><span class="NLM_article-title">Necroptosis in neurodegenerative diseases: a potential therapeutic target</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2905</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2017.286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28661482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e2905&author=S.+Zhangauthor=M.+B.+Tangauthor=H.+Y.+Luoauthor=C.+H.+Shiauthor=Y.+M.+Xu&title=Necroptosis+in+neurodegenerative+diseases%3A+a+potential+therapeutic+target&doi=10.1038%2Fcddis.2017.286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis in neurodegenerative diseases: a potential therapeutic target</span></div><div class="casAuthors">Zhang, Shuo; Tang, Mi-bo; Luo, Hai-yang; Shi, Chang-he; Xu, Yu-ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2905</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurodegenerative diseases are a group of chronic progressive disorders characterized by neuronal loss.  Necroptosis, a recently discovered form of programmed cell death, is a cell death mechanism that has necrosis-like morphol. characteristics.  Necroptosis activation relies on the receptor-interacting protein (RIP) homol. interaction motif (RHIM).  A variety of RHIM-contg. proteins transduce necroptotic signals from the cell trigger to the cell death mediators RIP3 and mixed lineage kinase domain-like protein (MLKL).  RIP1 plays a particularly important and complex role in necroptotic cell death regulation ranging from cell death activation to inhibition, and these functions are often cell type and context dependent.  Increasing evidence suggests that necroptosis plays an important role in the pathogenesis of neurodegenerative diseases.  Moreover, small mols. such as necrostatin-1 are thought inhibit necroptotic signaling pathway.  Understanding the precise mechanisms underlying necroptosis and its interactions with other cell death pathways in neurodegenerative diseases could provide significant therapeutic insights.  The present review is aimed at summarizing the mol. mechanisms of necroptosis and highlighting the emerging evidence on necroptosis as a major driver of neuron cell death in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZy6uU_ivijrVg90H21EOLACvtfcHk0lgDS184ex8euw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7jM&md5=ba20c4fb8e82c7d99da7d5bba4291344</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.286%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DM.%2BB.%26aulast%3DLuo%26aufirst%3DH.%2BY.%26aulast%3DShi%26aufirst%3DC.%2BH.%26aulast%3DXu%26aufirst%3DY.%2BM.%26atitle%3DNecroptosis%2520in%2520neurodegenerative%2520diseases%253A%2520a%2520potential%2520therapeutic%2520target%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De2905%26doi%3D10.1038%2Fcddis.2017.286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saberi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouchida, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1126/science.aaf6803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.aaf6803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27493188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oks7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2016&pages=603-608&author=Y.+Itoauthor=D.+Ofengeimauthor=A.+Najafovauthor=S.+Dasauthor=S.+Saberiauthor=Y.+Liauthor=J.+Hitomiauthor=H.+Zhuauthor=H.+Chenauthor=L.+Mayoauthor=J.+Gengauthor=P.+Aminauthor=J.+P.+DeWittauthor=A.+K.+Mookhtiarauthor=M.+Florezauthor=A.+T.+Ouchidaauthor=J.+B.+Fanauthor=M.+Pasparakisauthor=M.+A.+Kelliherauthor=J.+Ravitsauthor=J.+Yuan&title=RIPK1+mediates+axonal+degeneration+by+promoting+inflammation+and+necroptosis+in+ALS&doi=10.1126%2Fscience.aaf6803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS</span></div><div class="casAuthors">Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Das, Sudeshna; Saberi, Shahram; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Mayo, Lior; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Fan, Jian-bing; Pasparakis, Manolis; Kelliher, Michelle A.; Ravits, John; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6299</span>),
    <span class="NLM_cas:pages">603-608</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mutations in the optineurin (OPTN) gene have been implicated in both familial and sporadic amyotrophic lateral sclerosis (ALS).  However, the role of this protein in the central nervous system (CNS) and how it may contribute to ALS pathol. are unclear.  Here, we found that optineurin actively suppressed receptor-interacting kinase 1 (RIPK1)-dependent signaling by regulating its turnover.  Loss of OPTN led to progressive dysmyelination and axonal degeneration through engagement of necroptotic machinery in the CNS, including RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL).  Furthermore, RIPK1- and RIPK3-mediated axonal pathol. was commonly obsd. in SOD1G93A transgenic mice and pathol. samples from human ALS patients.  Thus, RIPK1 and RIPK3 play a crit. role in mediating progressive axonal degeneration.  Furthermore, inhibiting RIPK1 kinase may provide an axonal protective strategy for the treatment of ALS and other human degenerative diseases characterized by axonal degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo120pi55BWcLVg90H21EOLACvtfcHk0lgDS184ex8euw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oks7jO&md5=6145b22849aa523b5dc1200dc8610c1c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf6803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf6803%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DY.%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DNajafov%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DSaberi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMayo%26aufirst%3DL.%26aulast%3DGeng%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DDeWitt%26aufirst%3DJ.%2BP.%26aulast%3DMookhtiar%26aufirst%3DA.%2BK.%26aulast%3DFlorez%26aufirst%3DM.%26aulast%3DOuchida%26aufirst%3DA.%2BT.%26aulast%3DFan%26aufirst%3DJ.%2BB.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DRavits%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRIPK1%2520mediates%2520axonal%2520degeneration%2520by%2520promoting%2520inflammation%2520and%2520necroptosis%2520in%2520ALS%26jtitle%3DScience%26date%3D2016%26volume%3D353%26spage%3D603%26epage%3D608%26doi%3D10.1126%2Fscience.aaf6803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzitelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWitt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mifflin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adiconis, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E8788</span>– <span class="NLM_lpage">E8797</span>, <span class="refDoi"> DOI: 10.1073/pnas.1714175114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1714175114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28904096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2jtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E8788-E8797&author=D.+Ofengeimauthor=S.+Mazzitelliauthor=Y.+Itoauthor=J.+P.+DeWittauthor=L.+Mifflinauthor=C.+Zouauthor=S.+Dasauthor=X.+Adiconisauthor=H.+Chenauthor=H.+Zhuauthor=M.+A.+Kelliherauthor=J.+Z.+Levinauthor=J.+Yuan&title=RIPK1+mediates+a+disease-associated+microglial+response+in+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.1714175114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 mediates a disease-associated microglial response in Alzheimer's disease</span></div><div class="casAuthors">Ofengeim, Dimitry; Mazzitelli, Sonia; Ito, Yasushi; DeWitt, Judy Park; Mifflin, Lauren; Zou, Chengyu; Das, Sudeshna; Adiconis, Xian; Chen, Hongbo; Zhu, Hong; Kelliher, Michelle A.; Levin, Joshua Z.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">E8788-E8797</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Dysfunction of microglia is known to play an important role in Alzheimer's disease (AD).  Here, we investigated the role of RIPK1 in microglia mediating the pathogenesis of AD.  RIPK1 is highly expressed by microglial cells in human AD brains.  Using the amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model, we found that inhibition of RIPK1, using both pharmacol. and genetic means, reduced amyloid burden, the levels of inflammatory cytokines, and memory deficits.  Furthermore, inhibition of RIPK1 promoted microglial degrdn. of Aβ in vitro.  We characterized the transcriptional profiles of adult microglia from APP/PS1 mice and identified a role for RIPK1 in regulating the microglial expression of CH25H and Cst7, a marker for disease-assocd. microglia (DAM), which encodes an endosomal/lysosomal cathepsin inhibitor named Cystatin F.  We present evidence that RIPK1-mediated induction of Cst7 leads to an impairment in the lysosomal pathway.  These data suggest that RIPK1 may mediate a crit. checkpoint in the transition to the DAM state.  Together, our study highlights a non-cell death mechanism by which the activation of RIPK1 mediates the induction of a DAM phenotype, including an inflammatory response and a redn. in phagocytic activity, and connects RIPK1-mediated transcription in microglia to the etiol. of AD.  Our results support that RIPK1 is an important therapeutic target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv0lO0A81cirVg90H21EOLACvtfcHk0liYx1JIAQDXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2jtLrF&md5=01538404affc3d5fd19b09cf95911933</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1714175114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1714175114%26sid%3Dliteratum%253Aachs%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DMazzitelli%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DDeWitt%26aufirst%3DJ.%2BP.%26aulast%3DMifflin%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DAdiconis%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DLevin%26aufirst%3DJ.%2BZ.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DRIPK1%2520mediates%2520a%2520disease-associated%2520microglial%2520response%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE8788%26epage%3DE8797%26doi%3D10.1073%2Fpnas.1714175114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piras, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huentelman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Readhead, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winslow, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddo, S.</span></span> <span> </span><span class="NLM_article-title">Necroptosis activation in Alzheimer’s disease</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1038/nn.4608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnn.4608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28758999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wrtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=1236-1246&author=A.+Caccamoauthor=C.+Brancaauthor=I.+S.+Pirasauthor=E.+Ferreiraauthor=M.+J.+Huentelmanauthor=W.+S.+Liangauthor=B.+Readheadauthor=J.+T.+Dudleyauthor=E.+E.+Spangenbergauthor=K.+N.+Greenauthor=R.+Belfioreauthor=W.+Winslowauthor=S.+Oddo&title=Necroptosis+activation+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnn.4608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis activation in Alzheimer's disease</span></div><div class="casAuthors">Caccamo, Antonella; Branca, Caterina; Piras, Ignazio S.; Ferreira, Eric; Huentelman, Matthew J.; Liang, Winnie S.; Readhead, Ben; Dudley, Joel T.; Spangenberg, Elizabeth E.; Green, Kim N.; Belfiore, Ramona; Winslow, Wendy; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1236-1246</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by severe neuronal loss; however, the mechanisms by which neurons die remain elusive.  Necroptosis, a programmed form of necrosis, is executed by the mixed lineage kinase domain-like (MLKL) protein, which is triggered by receptor-interactive protein kinases (RIPK) 1 and 3.  We found that necroptosis was activated in postmortem human AD brains, pos. correlated with Braak stage, and inversely correlated with brain wt. and cognitive scores.  In addn., we found that the set of genes regulated by RIPK1 overlapped significantly with multiple independent AD transcriptomic signatures, indicating that RIPK1 activity could explain a substantial portion of transcriptomic changes in AD.  Furthermore, we obsd. that lowering necroptosis activation reduced cell loss in a mouse model of AD.  We anticipate that our findings will spur a new area of research in the AD field focused on developing new therapeutic strategies aimed at blocking its activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA07yeNmfVubVg90H21EOLACvtfcHk0liYx1JIAQDXgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wrtb7M&md5=ccacc427ebeca196e23197779abc4bde</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnn.4608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4608%26sid%3Dliteratum%253Aachs%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBranca%26aufirst%3DC.%26aulast%3DPiras%26aufirst%3DI.%2BS.%26aulast%3DFerreira%26aufirst%3DE.%26aulast%3DHuentelman%26aufirst%3DM.%2BJ.%26aulast%3DLiang%26aufirst%3DW.%2BS.%26aulast%3DReadhead%26aufirst%3DB.%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DSpangenberg%26aufirst%3DE.%2BE.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DBelfiore%26aufirst%3DR.%26aulast%3DWinslow%26aufirst%3DW.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DNecroptosis%2520activation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Neurosci.%26date%3D2017%26volume%3D20%26spage%3D1236%26epage%3D1246%26doi%3D10.1038%2Fnn.4608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2011.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.immuni.2011.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22195746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=908-918&author=L.+Duprezauthor=N.+Takahashiauthor=F.+Van+Hauwermeirenauthor=B.+Vandendriesscheauthor=V.+Goossensauthor=T.+Vanden+Bergheauthor=W.+Declercqauthor=C.+Libertauthor=A.+Cauwelsauthor=P.+Vandenabeele&title=RIP+kinase-dependent+necrosis+drives+lethal+systemic+inflammatory+response+syndrome&doi=10.1016%2Fj.immuni.2011.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death.  An addnl. switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis.  We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS).  Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS.  However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amts. of circulating damage-assocd. mol. patterns.  Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect.  These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS.  RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clin. relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiE2quF2rmSLVg90H21EOLACvtfcHk0lg0py_LrRlSPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ&md5=191d5b38562d315da4dd18e267da5246</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2011.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2011.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DVandendriessche%26aufirst%3DB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIP%2520kinase-dependent%2520necrosis%2520drives%2520lethal%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DImmunity%26date%3D2011%26volume%3D35%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.immuni.2011.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e93944</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0093944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0093944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24714696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ans7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93944&author=T.+Panauthor=S.+Wuauthor=X.+Heauthor=H.+Luoauthor=Y.+Zhangauthor=M.+Fanauthor=G.+Gengauthor=V.+C.+Ruizauthor=J.+Zhangauthor=L.+Millsauthor=C.+Baiauthor=H.+Zhang&title=Necroptosis+takes+place+in+human+immunodeficiency+virus+type-1+%28HIV-1%29-infected+CD4%2B+T+lymphocytes&doi=10.1371%2Fjournal.pone.0093944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes</span></div><div class="casAuthors">Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Ruiz, Vivian Clarke; Zhang, Jim; Mills, Lisa; Bai, Chuan; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e93944/1-e93944/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) infection is characterized by progressive depletion of CD4+ T lymphocytes and dysfunction of the immune system.  The nos. of CD4+ T lymphocytes in the human body are maintained constantly by homeostatic mechanisms that failed during HIV-1 infection, resulting in progressive loss of CD4+ T cells mainly via apoptosis.  Recently, a non-apoptotic form of necrotic programmed cell death, named necroptosis, has been investigated in many biol. and pathol. processes.  We then det. whether HIV-1-infected cells also undergo necroptosis.  In this report, we demonstrate that HIV-1 not only induces apoptosis, but also mediates necroptosis in the infected primary CD4+ T lymphocytes and CD4+ T-cell lines.  Necroptosis-dependent cytopathic effects are significantly increased in HIV-1-infected Jurkat cells that is lack of Fas-assocd. protein-contg. death domain (FADD), indicating that necroptosis occurs as an alternative cell death mechanism in the absence of apoptosis.  Unlike apoptosis, necroptosis mainly occurs in HIV-infected cells and spares bystander damage.  Treatment with necrostatin-1(Nec-1), a RIP1 inhibitor that specifically blocks the necroptosis pathway, potently restrains HIV-1-induced cytopathic effect and interestingly, inhibits the formation of HIV-induced syncytia in CD4+ T-cell lines.  This suggests that syncytia formation is mediated, at least partially, by necroptosis-related processes.  Furthermore, we also found that the HIV-1 infection-augmented tumor necrosis factor-alpha (TNF-α) plays a key role in inducing necroptosis and HIV-1 Envelope and Tat proteins function as its co-factors.  Taken together, necroptosis can function as an alternative cell death pathway in lieu of apoptosis during HIV-1 infection, thereby also contributing to HIV-1-induced cytopathic effects.  Our results reveal that in addn. to apoptosis, necroptosis also plays an important role in HIV-1-induced pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsm9SFldtsA7Vg90H21EOLACvtfcHk0lg0py_LrRlSPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ans7nL&md5=1abfb6f677d34c1a15df25f1bb21a395</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093944%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DG.%26aulast%3DRuiz%26aufirst%3DV.%2BC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DNecroptosis%2520takes%2520place%2520in%2520human%2520immunodeficiency%2520virus%2520type-1%2520%2528HIV-1%2529-infected%2520CD4%252B%2520T%2520lymphocytes%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93944%26doi%3D10.1371%2Fjournal.pone.0093944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span> <span> </span><span class="NLM_article-title">Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">15438</span>– <span class="NLM_lpage">15443</span>, <span class="refDoi"> DOI: 10.1073/pnas.1412767111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1412767111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25316792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKmtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15438-15443&author=X.+Wangauthor=Y.+Liauthor=S.+Liuauthor=X.+Yuauthor=L.+Liauthor=C.+Shiauthor=W.+Heauthor=J.+Liauthor=L.+Xuauthor=Z.+Huauthor=L.+Yuauthor=Z.+Yangauthor=Q.+Chenauthor=L.+Geauthor=Z.+Zhangauthor=B.+Zhouauthor=X.+Jiangauthor=S.+Chenauthor=S.+He&title=Direct+activation+of+RIP3%2FMLKL-dependent+necrosis+by+herpes+simplex+virus+1+%28HSV-1%29+protein+ICP6+triggers+host+antiviral+defense&doi=10.1073%2Fpnas.1412767111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense</span></div><div class="casAuthors">Wang, Xing; Li, Yun; Liu, Shan; Yu, Xiaoliang; Li, Lin; Shi, Cuilin; He, Wenhui; Li, Jun; Xu, Lei; Hu, Zhilin; Yu, Lu; Yang, Zhongxu; Chen, Qin; Ge, Lin; Zhang, Zili; Zhou, Biqi; Jiang, Xuejun; Chen, She; He, Sudan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15438-15443</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The receptor-interacting kinase-3 (RIP3) and its downstream substrate mixed lineage kinase domain-like protein (MLKL) have emerged as the key cellular components in programmed necrotic cell death.  Receptors for the cytokines of tumor necrosis factor (TNF) family and Toll-like receptors (TLR) 3 and 4 are able to activate RIP3 through receptor-interacting kinase-1 and Toll/IL-1 receptor domain-contg. adapter inducing IFN-β, resp.  This form of cell death has been implicated in the host-defense system.  However, the mol. mechanisms that drive the activation of RIP3 by a variety of pathogens, other than the above-mentioned receptors, are largely unknown.  Here, we report that human herpes simplex virus 1 (HSV-1) infection triggers RIP3-dependent necrosis.  This process requires MLKL but is independent of TNF receptor, TLR3, cylindromatosis, and host RIP homotypic interaction motif-contg. protein DNA-dependent activator of IFN regulatory factor.  After HSV-1 infection, the viral ribonucleotide reductase large subunit (ICP6) interacts with RIP3.  The formation of the ICP6-RIP3 complex requires the RHIM domains of both proteins.  An HSV-1 ICP6 deletion mutant failed to cause effective necrosis of HSV-1-infected cells.  Furthermore, ectopic expression of ICP6, but not RHIM mutant ICP6, directly activated RIP3/MLKL-mediated necrosis.  Mice lacking RIP3 exhibited severely impaired control of HSV-1 replication and pathogenesis.  Therefore, this study reveals a previously uncharacterized host antipathogen mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUpcOI635iSLVg90H21EOLACvtfcHk0lg0py_LrRlSPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKmtbzP&md5=e9afc1a54c5297b0069df7f9c5abf438</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1412767111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1412767111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DDirect%2520activation%2520of%2520RIP3%252FMLKL-dependent%2520necrosis%2520by%2520herpes%2520simplex%2520virus%25201%2520%2528HSV-1%2529%2520protein%2520ICP6%2520triggers%2520host%2520antiviral%2520defense%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D15438%26epage%3D15443%26doi%3D10.1073%2Fpnas.1412767111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmerkus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ki.2011.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fki.2011.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22237751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=751-761&author=A.+Linkermannauthor=J.+H.+Brasenauthor=N.+Himmerkusauthor=S.+Liuauthor=T.+B.+Huberauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Rip1+%28receptor-interacting+protein+kinase+1%29+mediates+necroptosis+and+contributes+to+renal+ischemia%2Freperfusion+injury&doi=10.1038%2Fki.2011.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; Himmerkus, Nina; Liu, Shuya; Huber, Tobias B.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-761</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of kidney function in renal ischemia/reperfusion injury is due to programmed cell death, but the contribution of necroptosis, a newly discovered form of programmed necrosis, has not been evaluated.  Here, we identified the presence of death receptor-mediated but caspase-independent cell death in murine tubular cells and characterized it as necroptosis by the addn. of necrostatin-1, a highly specific receptor-interacting protein kinase 1 inhibitor.  The detection of receptor-interacting protein kinase 1 and 3 in whole-kidney lysates and freshly isolated murine proximal tubules led us to investigate the contribution of necroptosis in a mouse model of renal ischemia/reperfusion injury.  Treatment with necrostatin-1 reduced organ damage and renal failure, even when administered after reperfusion, resulting in a significant survival benefit in a model of lethal renal ischemia/reperfusion injury.  Unexpectedly, specific blockade of apoptosis by zVAD, a pan-caspase inhibitor, did not prevent the organ damage or the increase in urea and creatinine in vivo in renal ischemia/reperfusion injury.  Thus, necroptosis is present and has functional relevance in the pathophysiol. course of ischemic kidney injury and shows the predominance of necroptosis over apoptosis in this setting.  Necrostatin-1 may have therapeutic potential to prevent and treat renal ischemia/reperfusion injury.  Kidney International (2012) 81, 751-761; doi:10.1038/ki.2011.450; published online 11 Jan. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdkP2OeYjeLVg90H21EOLACvtfcHk0ljeS6bd7kivJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D&md5=5eea0d0e70f6a604223d5a8eb848ae5e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fki.2011.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2011.450%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DHimmerkus%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DT.%2BB.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DRip1%2520%2528receptor-interacting%2520protein%2520kinase%25201%2529%2520mediates%2520necroptosis%2520and%2520contributes%2520to%2520renal%2520ischemia%252Freperfusion%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2012%26volume%3D81%26spage%3D751%26epage%3D761%26doi%3D10.1038%2Fki.2011.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonso, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borralho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez-Pinto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M.</span></span> <span> </span><span class="NLM_article-title">Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1042/CS20140732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1042%2FCS20140732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26201023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKqtLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2015&pages=721-739&author=M.+B.+Afonsoauthor=P.+M.+Rodriguesauthor=T.+Carvalhoauthor=M.+Caridadeauthor=P.+Borralhoauthor=H.+Cortez-Pintoauthor=R.+E.+Castroauthor=C.+M.+Rodrigues&title=Necroptosis+is+a+key+pathogenic+event+in+human+and+experimental+murine+models+of+non-alcoholic+steatohepatitis&doi=10.1042%2FCS20140732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis</span></div><div class="casAuthors">Afonso, Marta B.; Rodrigues, Pedro M.; Carvalho, Tania; Caridade, Marta; Borralho, Paula; Cortez-Pinto, Helena; Castro, Rui E.; Rodrigues, Cecilia M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">721-739</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Hepatocyte cell death, inflammation and oxidative stress constitute key pathogenic mechanisms underlying non-alc. fatty liver disease (NAFLD).  We aimed to investigate the role of necroptosis in human and exptl. NAFLD and its assocn. with tumor necrosis factor α (TNF-α) and oxidative stress.  Serum markers of necrosis, liver receptor-interacting protein 3 (RIP3) and phosphorylated mixed lineage kinase domain-like (MLKL) were evaluated in control individuals and patients with NAFLD.  C57BL/6 wild-type (WT) or RIP3-deficient (RIP3-/-) mice were fed a high-fat choline-deficient (HFCD) or methionine and choline-deficient (MCD) diet, with subsequent histol. and biochem. anal. of hepatic damage.  In primary murine hepatocytes, necroptosis and oxidative stress were also assessed after necrostatin-1 (Nec-1) treatment or RIP3 silencing.  We show that circulating markers of necrosis and TNF-α, as well as liver RIP3 and MLKL phosphorylation were increased in NAFLD.  Likewise, RIP3 and MLKL protein levels and TNF-α expression were increased in the liver of HFCD and MCD diet-fed mice.  Moreover, RIP3 and MLKL sequestration in the insol. protein fraction of NASH (non-alc. steatohepatitis) mice liver lysates represented an early event during stetatohepatitis progression.  Functional studies in primary murine hepatocytes established the assocn. between TNF-α-induced RIP3 expression, activation of necroptosis and oxidative stress.  Strikingly, RIP3 deficiency attenuated MCD diet-induced liver injury, steatosis, inflammation, fibrosis and oxidative stress.  In conclusion, necroptosis is increased in the liver of NAFLD patients and in exptl. models of NASH.  Further, TNF-α triggers RIP3-dependent oxidative stress during hepatocyte necroptosis.  As such, targeting necroptosis appears to arrest or at least impair NAFLD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzcqywp1nMLVg90H21EOLACvtfcHk0ljeS6bd7kivJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKqtLjJ&md5=186aa82572cc6ecf015743d96b2c2b9d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FCS20140732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20140732%26sid%3Dliteratum%253Aachs%26aulast%3DAfonso%26aufirst%3DM.%2BB.%26aulast%3DRodrigues%26aufirst%3DP.%2BM.%26aulast%3DCarvalho%26aufirst%3DT.%26aulast%3DCaridade%26aufirst%3DM.%26aulast%3DBorralho%26aufirst%3DP.%26aulast%3DCortez-Pinto%26aufirst%3DH.%26aulast%3DCastro%26aufirst%3DR.%2BE.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%26atitle%3DNecroptosis%2520is%2520a%2520key%2520pathogenic%2520event%2520in%2520human%2520and%2520experimental%2520murine%2520models%2520of%2520non-alcoholic%2520steatohepatitis%26jtitle%3DClin.%2520Sci.%26date%3D2015%26volume%3D129%26spage%3D721%26epage%3D739%26doi%3D10.1042%2FCS20140732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1038/s41422-018-0058-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41422-018-0058-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29941926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eku73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=868-870&author=D.+Jiaoauthor=Z.+Caiauthor=S.+Choksiauthor=D.+Maauthor=M.+Choeauthor=H.+J.+Kwonauthor=J.+Y.+Baikauthor=B.+G.+Rowanauthor=C.+Liuauthor=Z.+G.+Liu&title=Necroptosis+of+tumor+cells+leads+to+tumor+necrosis+and+promotes+tumor+metastasis&doi=10.1038%2Fs41422-018-0058-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis</span></div><div class="casAuthors">Jiao, Delong; Cai, Zhenyu; Choksi, Swati; Ma, Dan; Choe, Moran; Kwon, Hyung-Joon; Baik, Jin Young; Rowan, Brian G.; Liu, Chengyu; Liu, Zheng-gang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">868-870</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLjobNhhVTbVg90H21EOLACvtfcHk0ljeS6bd7kivJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eku73F&md5=d9f2c1f9d28386ccf909cf521c18675b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fs41422-018-0058-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-018-0058-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26aulast%3DBaik%26aufirst%3DJ.%2BY.%26aulast%3DRowan%26aufirst%3DB.%2BG.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DNecroptosis%2520of%2520tumor%2520cells%2520leads%2520to%2520tumor%2520necrosis%2520and%2520promotes%2520tumor%2520metastasis%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26spage%3D868%26epage%3D870%26doi%3D10.1038%2Fs41422-018-0058-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strilic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran-Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachsmuth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>536</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nature19076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature19076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27487218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1yqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=536&publication_year=2016&pages=215-218&author=B.+Strilicauthor=L.+Yangauthor=J.+Albarran-Juarezauthor=L.+Wachsmuthauthor=K.+Hanauthor=U.+C.+Mullerauthor=M.+Pasparakisauthor=S.+Offermanns&title=Tumour-cell-induced+endothelial+cell+necroptosis+via+death+receptor+6+promotes+metastasis&doi=10.1038%2Fnature19076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis</span></div><div class="casAuthors">Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Wachsmuth, Laurens; Han, Kang; Mueller, Ulrike C.; Pasparakis, Manolis; Offermanns, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">536</span>
        (<span class="NLM_cas:issue">7615</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is the leading cause of cancer-related death in humans.  It is a complex multistep process during which individual tumor cells spread primarily through the circulatory system to colonize distant organs.  Once in the circulation, tumor cells remain vulnerable, and their metastatic potential largely depends on a rapid and efficient way to escape from the blood stream by passing the endothelial barrier.  Evidence has been provided that tumor cell extravasation resembles leukocyte transendothelial migration.  However, it remains unclear how tumor cells interact with endothelial cells during extravasation and how these processes are regulated on a mol. level.  Here we show that human and murine tumor cells induce programmed necrosis (necroptosis) of endothelial cells, which promotes tumor cell extravasation and metastasis.  Treatment of mice with the receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-inhibitor necrostatin-1 or endothelial-cell-specific deletion of RIPK3 reduced tumor-cell-induced endothelial necroptosis, tumor cell extravasation and metastasis.  In contrast, pharmacol. caspase inhibition or endothelial-cell-specific loss of caspase-8 promoted these processes.  We furthermore show in vitro and in vivo that tumor-cell-induced endothelial necroptosis leading to extravasation and metastasis requires amyloid precursor protein expressed by tumor cells and its receptor, death receptor 6 (DR6), on endothelial cells as the primary mediators of these effects.  Our data identify a new mechanism underlying tumor cell extravasation and metastasis, and suggest endothelial DR6-mediated necroptotic signalling pathways as targets for anti-metastatic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2mtgcDEIwXrVg90H21EOLACvtfcHk0lh9tnlGYrjKNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1yqsbzF&md5=2c01e1fee7e4f9bab4c290a4b470c978</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnature19076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19076%26sid%3Dliteratum%253Aachs%26aulast%3DStrilic%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DAlbarran-Juarez%26aufirst%3DJ.%26aulast%3DWachsmuth%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DU.%2BC.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DTumour-cell-induced%2520endothelial%2520cell%2520necroptosis%2520via%2520death%2520receptor%25206%2520promotes%2520metastasis%26jtitle%3DNature%26date%3D2016%26volume%3D536%26spage%3D215%26epage%3D218%26doi%3D10.1038%2Fnature19076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span>; <span class="NLM_string-name">Webster, J. D.</span>; <span class="NLM_string-name">Varfolomeev, E.</span>; <span class="NLM_string-name">Kwon, Y. C.</span>; <span class="NLM_string-name">Cheng, J. H.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Dugger, D. L.</span>; <span class="NLM_string-name">Wickliffe, K. E.</span>; <span class="NLM_string-name">Maltzman, A.</span>; <span class="NLM_string-name">Sujatha-Bhaskar, S.</span>; <span class="NLM_string-name">Bir Kohli, P.</span>; <span class="NLM_string-name">Ramaswamy, S.</span>; <span class="NLM_string-name">Deshmukh, G.</span>; <span class="NLM_string-name">Liederer, B. M.</span>; <span class="NLM_string-name">Fong, R.</span>; <span class="NLM_string-name">Hamilton, G.</span>; <span class="NLM_string-name">Lupardus, P.</span>; <span class="NLM_string-name">Caplazi, P.</span>; <span class="NLM_string-name">Lee, W. P.</span>; <span class="NLM_string-name">van Lookeren Campagne, M.</span>; <span class="NLM_string-name">Johnson, A.</span>; <span class="NLM_string-name">McKenzie, B. S.</span>; <span class="NLM_string-name">Junttila, M. R.</span>; <span class="NLM_string-name">Newton, K.</span>; <span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases</span>.  <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1038/s41418-019-0347-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41418-019-0347-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31101885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=S.+Patel&author=J.+D.+Webster&author=E.+Varfolomeev&author=Y.+C.+Kwon&author=J.+H.+Cheng&author=J.+Zhang&author=D.+L.+Dugger&author=K.+E.+Wickliffe&author=A.+Maltzman&author=S.+Sujatha-Bhaskar&author=P.+Bir+Kohli&author=S.+Ramaswamy&author=G.+Deshmukh&author=B.+M.+Liederer&author=R.+Fong&author=G.+Hamilton&author=P.+Lupardus&author=P.+Caplazi&author=W.+P.+Lee&author=M.+van+Lookeren+Campagne&author=A.+Johnson&author=B.+S.+McKenzie&author=M.+R.+Junttila&author=K.+Newton&author=D.+Vucic&title=RIP1+inhibition+blocks+inflammatory+diseases+but+not+tumor+growth+or+metastases&doi=10.1038%2Fs41418-019-0347-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41418-019-0347-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-019-0347-0%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DRIP1%2520inhibition%2520blocks%2520inflammatory%2520diseases%2520but%2520not%2520tumor%2520growth%2520or%2520metastases%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26doi%3D10.1038%2Fs41418-019-0347-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaes, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Herde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leybaert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krysko, D. V.</span></span> <span> </span><span class="NLM_article-title">Necroptotic cell death in anti-cancer therapy</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1111/imr.12583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fimr.12583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29027225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Cit7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2017&pages=207-219&author=O.+Kryskoauthor=T.+L.+Aaesauthor=V.+E.+Kaganauthor=K.+D%E2%80%99Herdeauthor=C.+Bachertauthor=L.+Leybaertauthor=P.+Vandenabeeleauthor=D.+V.+Krysko&title=Necroptotic+cell+death+in+anti-cancer+therapy&doi=10.1111%2Fimr.12583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptotic cell death in anti-cancer therapy</span></div><div class="casAuthors">Krysko, Olga; Aaes, Tania Love; Kagan, Valerian E.; D'Herde, Katharina; Bachert, Claus; Leybaert, Luc; Vandenabeele, Peter; Krysko, Dmitri V.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-219</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Necroptosis is one the best-characterized forms of regulated necrosis.  Necroptosis is mediated by the kinase activities of receptor interacting protein kinase-1 and receptor interacting protein kinase-3, which eventually lead to the activation of mixed lineage kinase domain-like.  Necroptosis is characterized by rapid permeabilization of the plasma membrane, which is assocd. with the release of the cell content and subsequent exposure of damage-assocd. mol. patterns (DAMPs) and cytokines/chemokines.  This release underlies the immunogenic nature of necroptotic cancer cells and their ability to induce efficient anti-tumor immunity.  Triggering necroptosis has become esp. important in exptl. cancer treatments as an alternative to triggering apoptosis because one of the hallmarks of cancer is the blockade or evasion of apoptosis.  In this review, we discuss recent advances in necroptosis research and the functional consequences of necroptotic cancer cell death, with focus on its immunogenicity and its role in the activation of anti-tumor immunity.  Next, we discuss the mol. mechanisms of phosphatidylserine exposure during necroptosis and its role in the recognition of necroptotic cells.  We also highlight the complex role of the necroptotic pathway in tumor promotion and suppression and in metastasis.  Future studies will show whether necroptosis is truly a better strategy to overcome apoptosis resistance and provide the insights needed for development of novel treatment strategies for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2k39pvTdlULVg90H21EOLACvtfcHk0lh9tnlGYrjKNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Cit7zO&md5=12b615cea748b0dc3f1288d765df8990</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fimr.12583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12583%26sid%3Dliteratum%253Aachs%26aulast%3DKrysko%26aufirst%3DO.%26aulast%3DAaes%26aufirst%3DT.%2BL.%26aulast%3DKagan%26aufirst%3DV.%2BE.%26aulast%3DD%25E2%2580%2599Herde%26aufirst%3DK.%26aulast%3DBachert%26aufirst%3DC.%26aulast%3DLeybaert%26aufirst%3DL.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DKrysko%26aufirst%3DD.%2BV.%26atitle%3DNecroptotic%2520cell%2520death%2520in%2520anti-cancer%2520therapy%26jtitle%3DImmunol%2520Rev.%26date%3D2017%26volume%3D280%26spage%3D207%26epage%3D219%26doi%3D10.1111%2Fimr.12583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Methodology of drug screening and target identification for new necroptosis inhibitors</span>. <i>J. Pharm. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jpha.2018.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.jpha.2018.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31011462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FotVOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=71-76&author=P.+Panauthor=Z.+Caiauthor=C.+Zhuangauthor=X.+Chenauthor=Y.+Chai&title=Methodology+of+drug+screening+and+target+identification+for+new+necroptosis+inhibitors&doi=10.1016%2Fj.jpha.2018.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Methodology of drug screening and target identification for new necroptosis inhibitors</span></div><div class="casAuthors">Pan Pengchao; Chen Xiaofei; Chai Yifeng; Cai Zhenyu; Zhuang Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical analysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">71-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Apoptosis has been considered as the only form of regulated cell death for a long time.  However, a novel form of programmed cell death called necroptosis was recently reported.  The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases.  Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers.  Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years.  In addition, the identification of the critical drug targets of the necroptosis is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwHAkIZy4YwhpyrDyM_m9cfW6udTcc2eaAOD21AP31gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FotVOjtg%253D%253D&md5=21fd3cc590a27ed14021cccd1d4c988c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jpha.2018.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpha.2018.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DP.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DMethodology%2520of%2520drug%2520screening%2520and%2520target%2520identification%2520for%2520new%2520necroptosis%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Anal.%26date%3D2019%26volume%3D9%26spage%3D71%26epage%3D76%26doi%3D10.1016%2Fj.jpha.2018.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1767</span>, <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1767&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1767%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">15279</span>– <span class="NLM_lpage">15294</span>, <span class="refDoi"> DOI: 10.1021/ja074725f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.+Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+Smac+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP&doi=10.1021%2Fja074725f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Meagher, Jennifer L.; Yang, Chao-Yie; Qiu, Su; Tomita, York; Ueda, Yumi; Jiang, Sheng; Krajewski, Krzysztof; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15279-15294</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, resp.  Smac protein in its dimeric form effectively antagonizes XIAP by concurrently targeting both its BIR2 and BIR3 domains.  We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-mol. (SM-164) which mimics Smac protein for targeting XIAP.  Our study shows that SM-164 binds to XIAP contg. both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, resp.  SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays.  SM-164 targets cellular XIAP and effectively induces apoptosis at concns. as low as 1 nM in the HL-60 leukemia cell line.  The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGBGUOFcArLVg90H21EOLACvtfcHk0lgem6S54YFP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI&md5=11b7028aa71b875e07b80f7a3d952b46</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294%26doi%3D10.1021%2Fja074725f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callus, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koentgen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2007.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18022363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">682-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIABLO.  IAP antagonist compds. (IACs) have therefore been designed to inhibit XIAP to kill tumor cells.  Because XIAP inhibits postmitochondrial caspases, caspase 8 inhibitors should not block killing by IACs.  Instead, the authors show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-κB signaling via inhibition of cIAP1.  In sensitive tumor lines, IAP antagonist induced NF-κB-stimulated prodn. of TNFα that killed cells in an autocrine fashion.  Inhibition of NF-κB reduced TNFα prodn., and blocking NF-κB activation or TNFα allowed tumor cells to survive IAC-induced apoptosis.  Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNFα, suggesting novel uses of these compds. in treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNa8nssRGeLVg90H21EOLACvtfcHk0lgem6S54YFP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N&md5=9e973670c472d0612d947a2ffe688d20</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693%26doi%3D10.1016%2Fj.cell.2007.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fonc.2016.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27869161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1487-1502&author=C.+Safferthalauthor=K.+Rohdeauthor=S.+Fulda&title=Therapeutic+targeting+of+necroptosis+by+Smac+mimetic+bypasses+apoptosis+resistance+in+acute+myeloid+leukemia+cells&doi=10.1038%2Fonc.2016.310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span></div><div class="casAuthors">Safferthal, C.; Rohde, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1487-1502</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is assocd. with poor prognosis in acute myeloid leukemia (AML).  Here, we identify that Smac mimetics such as BV6, which antagonizes IAP proteins, elicit necroptosis in AML cells, in which apoptosis is inhibited pharmacol. by caspase inhibitors or genetically by caspase-8 knockdown.  Importantly, BV6 triggers necroptosis also in apoptosis-resistant patient-derived AML blasts, underlining the clin. relevance of our findings.  Mechanistically, we show that BV6-induced cell death depends on key components of necroptosis signaling such as RIP1, RIP3 and MLKL, since pharmacol. or genetic inhibition of these proteins significantly protects AML cells from BV6-mediated cell death, whereas PGAM5 is dispensable.  Interestingly, we identify constitutive tumor necrosis factor-alpha (TNFα) secretion and an autocrine/paracrine TNFα loop as crit. mediators of BV6-induced necroptosis in AML cell lines and patient-derived blasts, as the TNFα-blocking antibody Enbrel or tumor necrosis factor-alpha receptor 1 (TNFR1) knockdown significantly rescue cell death.  Notably, AML cells exhibit high basal levels of TNFα compared to non-malignant CD34+ cells, which is further increased by BV6.  In conclusion, this is the first report showing that Smac mimetics circumvent apoptosis resistance in AML cells by inducing necroptosis in a TNFα-dependent manner, which has important implications for the development of new strategies to overcome treatment resistance in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3FlE4mhKWHLVg90H21EOLACvtfcHk0lgem6S54YFP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE&md5=f5e560e534db4acf5c098c48d53a70bc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.310%26sid%3Dliteratum%253Aachs%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTherapeutic%2520targeting%2520of%2520necroptosis%2520by%2520Smac%2520mimetic%2520bypasses%2520apoptosis%2520resistance%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1487%26epage%3D1502%26doi%3D10.1038%2Fonc.2016.310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: current status and perspectives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5750</span>– <span class="NLM_lpage">5772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5750-5772&author=H.+Congauthor=L.+Xuauthor=Y.+Wuauthor=Z.+Quauthor=T.+Bianauthor=W.+Zhangauthor=C.+Xingauthor=C.+Zhuang&title=Inhibitor+of+apoptosis+protein+%28IAP%29+antagonists+in+anticancer+agent+discovery%3A+current+status+and+perspectives&doi=10.1021%2Facs.jmedchem.8b01668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: current status and perspectives</span></div><div class="casAuthors">Cong, Hui; Xu, Lijuan; Wu, Yougen; Qu, Zhuo; Bian, Tengfei; Zhang, Wannian; Xing, Chengguo; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5750-5772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells.  Resistance of apoptosis is a hallmark of cancer cells.  Inhibitor of apoptosis proteins (IAPs) is a class of key apoptosis regulators that promote cancer cell resistant to apoptosis, particularly in cancer treatment.  Disrupting the binding of IAPs with their functional partners therefore is a promising strategy to restore the apoptotic response to proapoptotic stimuli, particularly those introduced by std. cancer therapies.  The most successful example is the use of small mols. to mimic the IAP-binding motif of an endogenous IAP antagonist, second mitochondria-derived activator of caspase (SMAC).  Here we will review the functions of IAPs, the structural interactions of IAPs with SMAC, four generations of SMAC-mimetic IAP antagonists, and representative antagonists in clin. evaluations, focusing on research articles over the past 15 years.  Outlooks and perspectives on the assocd. challenges are provided as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxBHQlIfyQrVg90H21EOLACvtfcHk0lhxij73mfHemg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWksrY%253D&md5=e3a0daceb7979f37d994f55b2323995e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26aulast%3DCong%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DZ.%26aulast%3DBian%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DInhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520antagonists%2520in%2520anticancer%2520agent%2520discovery%253A%2520current%2520status%2520and%2520perspectives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5750%26epage%3D5772%26doi%3D10.1021%2Facs.jmedchem.8b01668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2108</span>, <span class="refDoi"> DOI: 10.1111/bph.14653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fbph.14653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30825190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosl2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=2095-2108&author=X.+Chenauthor=C.+Zhuangauthor=Y.+Renauthor=H.+Zhangauthor=X.+Qinauthor=L.+Huauthor=J.+Fuauthor=Z.+Miaoauthor=Y.+Chaiauthor=Z.+G.+Liuauthor=H.+Zhangauthor=Z.+Caiauthor=H.+Y.+Wang&title=Identification+of+the+Raf+kinase+inhibitor+TAK-632+and+its+analogues+as+potent+inhibitors+of+necroptosis+by+targeting+RIPK1+and+RIPK3&doi=10.1111%2Fbph.14653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span></div><div class="casAuthors">Chen, Xiaofei; Zhuang, Chunlin; Ren, Yibin; Zhang, Hao; Qin, Xia; Hu, Longmiao; Fu, Jing; Miao, Zhenyuan; Chai, Yifeng; Liu, Zheng-gang; Zhang, Haibing; Cai, Zhenyu; Wang, Hong-yang</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2095-2108</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Necroptosis is a form of programmed, caspase-independent, cell death, mediated by receptor-interacting protein kinases, RIPK1 and RIPK3, and the mixed lineage kinase domain-like (MLKL).  Necroptosis contributes to the pathophysiol. of various inflammatory, infectious, and degenerative diseases.  Thus, identification of low MW inhibitors for necroptosis has broad therapeutic relevance.  Here, we identified that the pan-Raf inhibitor TAK-632 was also an inhibitor of necroptosis.  We have further generated a more selective, highly potent analog of TAK-632 by targeting RIPK1 and RIPK3.  Exptl. Approach : Cell viability was measured by MTT, propidium staining, or CellTiter-Glo luminescent assays.  Effects of TAK-632 on necroptosis signalling pathways were investigated by western blotting, immunopptn., and in vitro kinase assays.  Downstream targets of TAK-632 were identified by a drug affinity responsive target stability assay and a pull-down assay with biotinylated TAK-632.  A mouse model of TNF-α-induced systemic inflammatory response syndrome (SIRS) was further used to explore the role of TAK-632 in protecting against necroptosis-assocd. inflammation in vivo.  Key Results : TAK-632 protected against necroptosis in human and mouse cells but did not protect cells from apoptosis.  TAK-632 directly bound with RIPK1 and RIPK3 to inhibit kinase activities of both enzymes.  In vivo, TAK-632 alleviated TNF-induced SIRS.  Furthermore, we performed a structure-activity relationship anal. of TAK-632 analogs and generated SZM594, a highly potent inhibitor of RIPK1/3.  Conclusions and Implications : TAK-632 is an inhibitor of necroptosis and represents a new lead compd. in the development of highly potent inhibitors of RIPK1 and RIPK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvb-w5Nn5QV7Vg90H21EOLACvtfcHk0lhxij73mfHemg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosl2lsLs%253D&md5=42bad0990a0998b25a2cce3d4117401f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fbph.14653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14653%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BY.%26atitle%3DIdentification%2520of%2520the%2520Raf%2520kinase%2520inhibitor%2520TAK-632%2520and%2520its%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520necroptosis%2520by%2520targeting%2520RIPK1%2520and%2520RIPK3%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D2095%26epage%3D2108%26doi%3D10.1111%2Fbph.14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of novel necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5044</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2005.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16153840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5039-5044&author=X.+Tengauthor=A.+Degterevauthor=P.+Jagtapauthor=X.+Xingauthor=S.+Choiauthor=R.+Denuauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+novel+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2005.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of novel necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Degterev, Alexei; Jagtap, Prakash; Xing, Xuechao; Choi, Sungwoon; Denu, Regine; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5039-5044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling necrosis.  It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-α.  5-(1H-Indol-3-ylmethyl)-2-thiohydantoin derivs. and 5-(1H-indol-3-ylmethyl)hydantoin derivs. were found to be potent necroptosis inhibitors (called necrostatins).  A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity.  The hydantoin ring was also quite sensitive to structural modifications.  A representative member of this compd. class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkqj1HWHSSLVg90H21EOLACvtfcHk0lhxij73mfHemg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O&md5=5a2b77e2d0461c24eaef8182ab7d4cdf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520novel%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5039%26epage%3D5044%26doi%3D10.1016%2Fj.bmcl.2005.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of RIP1 inhibition by necrostatins</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.str.2013.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23473668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVOqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=493-499&author=T.+Xieauthor=W.+Pengauthor=Y.+Liuauthor=C.+Yanauthor=J.+Makiauthor=A.+Degterevauthor=J.+Yuanauthor=Y.+Shi&title=Structural+basis+of+RIP1+inhibition+by+necrostatins&doi=10.1016%2Fj.str.2013.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of RIP1 Inhibition by Necrostatins</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Liu, Yexing; Yan, Chuangye; Maki, Jenny; Degterev, Alexei; Yuan, Junying; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">493-499</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism that mediates necrotic cell death.  The receptor-interacting serine/threonine protein kinase 1 (RIP1) is an essential upstream signaling mol. in tumor-necrosis-factor-α-induced necroptosis.  Necrostatins, a series of small-mol. inhibitors, suppress necroptosis by specifically inhibiting RIP1 kinase activity.  Both RIP1 structure and the mechanisms by which necrostatins inhibit RIP1 remain unknown.  Here, we report the crystal structures of the RIP1 kinase domain individually bound to necrostatin-1 analog, necrostatin-3 analog, and necrostatin-4.  Necrostatin, caged in a hydrophobic pocket between the N- and C-lobes of the kinase domain, stabilizes RIP1 in an inactive conformation through interactions with highly conserved amino acids in the activation loop and the surrounding structural elements.  Structural comparison of RIP1 with the inhibitor-bound oncogenic kinase B-RAF reveals partially overlapping binding sites for necrostatin and for the anticancer compd. PLX4032.  Our study provides a structural basis for RIP1 inhibition by necrostatins and offers insights into potential structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtw_1OVLFe4rVg90H21EOLACvtfcHk0lgmQpEh1-62rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVOqsLk%253D&md5=42a3f8951b390358b9068bb1b885445e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DMaki%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520RIP1%2520inhibition%2520by%2520necrostatins%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D493%26epage%3D499%26doi%3D10.1016%2Fj.str.2013.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knighton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Eyck, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuong, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowadski, J. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1126/science.1862342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1862342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1862342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADyaK3MXmsFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=407-414&author=D.+R.+Knightonauthor=J.+H.+Zhengauthor=L.+F.+Ten+Eyckauthor=V.+A.+Ashfordauthor=N.+H.+Xuongauthor=S.+S.+Taylorauthor=J.+M.+Sowadski&title=Crystal+structure+of+the+catalytic+subunit+of+cyclic+adenosine+monophosphate-dependent+protein+kinase&doi=10.1126%2Fscience.1862342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase</span></div><div class="casAuthors">Knighton, Daniel R.; Zheng, Jianhua; Ten Eyck, Lynn F.; Ashford, Victor A.; Nguyen Huu Xuong; Taylor, Susan S.; Sowadski, Janusz M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">5018</span>),
    <span class="NLM_cas:pages">407-14</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase complexed with a 20-amino acid substrate analog inhibitor has been solved and partially refined at 2.7 Å resoln. to an R factor of 0.212.  The magnesium ATP (MgATP) binding site was located by difference Fourier synthesis.  The enzyme structure is bilobal with a deep cleft between the lobes.  The cleft is filled by MgATP and a portion of the inhibitor peptide.  The smaller lobe, consisting mostly of amino-terminal sequence, is assocd. with nucleotide binding, and its largely antiparallel β sheet architecture constitutes an unusual nucleotide binding motif.  The large lobe is dominated by helical structure with a single β sheet at the domain interface.  This lobe is primarily involved in peptide binding and catalysis.  Residues 40 through 280 constitute a conserved catalytic core that is shared by more than 100 protein kinases.  Most of the invariant amino acids in this conserved catalytic core are clustered at the site of nucleotide binding and catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BPvdNuboTbVg90H21EOLACvtfcHk0lgmQpEh1-62rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsFSqsLw%253D&md5=1b1dc6aaa1a63fc665b81f8967e143b1</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1126%2Fscience.1862342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1862342%26sid%3Dliteratum%253Aachs%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DZheng%26aufirst%3DJ.%2BH.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26aulast%3DAshford%26aufirst%3DV.%2BA.%26aulast%3DXuong%26aufirst%3DN.%2BH.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DSowadski%26aufirst%3DJ.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520subunit%2520of%2520cyclic%2520adenosine%2520monophosphate-dependent%2520protein%2520kinase%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D407%26epage%3D414%26doi%3D10.1126%2Fscience.1862342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">366</span>, <span class="refDoi"> DOI: 10.1038/cdd.2012.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2012.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23197295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=366&author=A.+Degterevauthor=J.+L.+Makiauthor=J.+Yuan&title=Activity+and+specificity+of+necrostatin-1%2C+small-molecule+inhibitor+of+RIP1+kinase&doi=10.1038%2Fcdd.2012.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase</span></div><div class="casAuthors">Degterev, A.; Maki, J. L.; Yuan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This paper describes activity and specificity of necrostatin-1, small-mol. inhibitor of RIP1 kinase.  RIP3 and IDO-deficient animals and/or short hairpin RNA knockdowns, can help further distinguish between these two pathways.  Perfect correlation between inhibition of RIP1 kinase and cellular necroptosis by Nec-1 analogs was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpv-luvvc_57Vg90H21EOLACvtfcHk0liM1Ujzn0v6oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVygtw%253D%253D&md5=33f5ef417c17d93bb6214aa8aebd96a7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2012.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2012.133%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DActivity%2520and%2520specificity%2520of%2520necrostatin-1%252C%2520small-molecule%2520inhibitor%2520of%2520RIP1%2520kinase%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D366%26doi%3D10.1038%2Fcdd.2012.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e437</span>, <span class="refDoi"> DOI: 10.1038/cddis.2012.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2012.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=23190609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e437&author=N.+Takahashiauthor=L.+Duprezauthor=S.+Grootjansauthor=A.+Cauwelsauthor=W.+Nerinckxauthor=J.+B.+DuHadawayauthor=V.+Goossensauthor=R.+Roelandtauthor=F.+Van+Hauwermeirenauthor=C.+Libertauthor=W.+Declercqauthor=N.+Callewaertauthor=G.+C.+Prendergastauthor=A.+Degterevauthor=J.+Yuanauthor=P.+Vandenabeele&title=Necrostatin-1+analogues%3A+critical+issues+on+the+specificity%2C+activity+and+in+vivo+use+in+experimental+disease+models&doi=10.1038%2Fcddis.2012.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span></div><div class="casAuthors">Takahashi, N.; Duprez, L.; Grootjans, S.; Cauwels, A.; Nerinckx, W.; DuHadaway, J. B.; Goossens, V.; Roelandt, R.; Van Hauwermeiren, F.; Libert, C.; Declercq, W.; Callewaert, N.; Prendergast, G. C.; Degterev, A.; Yuan, J.; Vandenabeele, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e437, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation.  We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Nec-1s), its more stable variant.  We report that Nec-1 is identical to methyl-thiohydantoin-tryptophan, an inhibitor of the potent immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO).  Both Nec-1 and Nec-1i inhibited human IDO, but Nec-1s did not, as predicted by mol. modeling.  Therefore, Nec-1s is a more specific RIPK1 inhibitor lacking the IDO-targeting effect.  Next, although Nec-1i was ∼100 × less effective than Nec-1 in inhibiting human RIPK1 kinase activity in vitro, it was only 10 times less potent than Nec-1 and Nec-1s in a mouse necroptosis assay and became even equipotent at high concns.  Along the same line, in vivo, high doses of Nec-1, Nec-1i and Nec-1s prevented tumor necrosis factor (TNF)-induced mortality equally well, excluding the use of Nec-1i as an inactive control.  Paradoxically, low doses of Nec-1 or Nec-1i, but not Nec-1s, even sensitized mice to TNF-induced mortality.  Importantly, Nec-1s did not exhibit this low dose toxicity, stressing again the preferred use of Nec-1s in vivo.  Our findings have important implications for the interpretation of Nec-1-based data in exptl. disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2yIQ4UD-yb7Vg90H21EOLACvtfcHk0liM1Ujzn0v6oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D&md5=2d4f57016d88e474cbfe00dee540b8fa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.176%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecrostatin-1%2520analogues%253A%2520critical%2520issues%2520on%2520the%2520specificity%252C%2520activity%2520and%2520in%2520vivo%2520use%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De437%26doi%3D10.1038%2Fcddis.2012.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofferson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upperman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">A novel role for RIP1 kinase in mediating TNFalpha production</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e320</span>, <span class="refDoi"> DOI: 10.1038/cddis.2012.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2012.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22695613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGgur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e320&author=D.+E.+Christoffersonauthor=Y.+Liauthor=J.+Hitomiauthor=W.+Zhouauthor=C.+Uppermanauthor=H.+Zhuauthor=S.+A.+Gerberauthor=S.+Gygiauthor=J.+Yuan&title=A+novel+role+for+RIP1+kinase+in+mediating+TNFalpha+production&doi=10.1038%2Fcddis.2012.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A novel role for RIP1 kinase in mediating TNFα production</span></div><div class="casAuthors">Christofferson, D. E.; Li, Y.; Hitomi, J.; Zhou, W.; Upperman, C.; Zhu, H.; Gerber, S. A.; Gygi, S.; Yuan, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">E320/1-E320/10</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein 1 (RIP1) is a Ser/Thr kinase with both kinase-dependent and kinase-independent roles in death receptor signaling.  The kinase activity of RIP1 is required for necroptosis, a caspase-independent pathway of programmed cell death.  In some cell types, the inhibition of caspases leads to autocrine prodn. of TNFα, which then activates necroptosis.  Here, we describe a novel role for RIP1 kinase in regulating TNFα prodn. after caspase inhibition.  Caspase inhibitors activate RIP1 kinase and another protein, EDD, to mediate JNK signaling, which stimulates Sp1-dependent transcription of TNFα.  This pathway is independent of nuclear factor κB and also occurs after Smac mimetic/IAP antagonist treatment or the loss of TNF receptor-assocd. factor 2 (Traf2).  These findings implicate cIAP1/2 and Traf2 as neg. regulators of this RIP1 kinasedependent TNFα prodn. pathway and suggest a novel role for RIP1 kinase in mediating TNFα prodn. under certain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooeT4tCLMEOrVg90H21EOLACvtfcHk0liaa1hyvNtPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGgur3L&md5=7164220279f3d57ec7a3ecdeb4f82a17</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.64%26sid%3Dliteratum%253Aachs%26aulast%3DChristofferson%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DUpperman%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DGygi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DA%2520novel%2520role%2520for%2520RIP1%2520kinase%2520in%2520mediating%2520TNFalpha%2520production%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De320%26doi%3D10.1038%2Fcddis.2012.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0liaa1hyvNtPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzen, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gefter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavarana, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliff, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and selection of DNA-encoded small-molecule libraries</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1038/nchembio.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=19648931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Ogtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=647-654&author=M.+A.+Clarkauthor=R.+A.+Acharyaauthor=C.+C.+Arico-Muendelauthor=S.+L.+Belyanskayaauthor=D.+R.+Benjaminauthor=N.+R.+Carlsonauthor=P.+A.+Centrellaauthor=C.+H.+Chiuauthor=S.+P.+Creaserauthor=J.+W.+Cuozzoauthor=C.+P.+Davieauthor=Y.+Dingauthor=G.+J.+Franklinauthor=K.+D.+Franzenauthor=M.+L.+Gefterauthor=S.+P.+Haleauthor=N.+J.+Hansenauthor=D.+I.+Israelauthor=J.+Jiangauthor=M.+J.+Kavaranaauthor=M.+S.+Kelleyauthor=C.+S.+Kollmannauthor=F.+Liauthor=K.+Lindauthor=S.+Mataruseauthor=P.+F.+Medeirosauthor=J.+A.+Messerauthor=P.+Myersauthor=H.+O%E2%80%99Keefeauthor=M.+C.+Oliffauthor=C.+E.+Riseauthor=A.+L.+Satzauthor=S.+R.+Skinnerauthor=J.+L.+Svendsenauthor=L.+Tangauthor=K.+van+Vlotenauthor=R.+W.+Wagnerauthor=G.+Yaoauthor=B.+Zhaoauthor=B.+A.+Morgan&title=Design%2C+synthesis+and+selection+of+DNA-encoded+small-molecule+libraries&doi=10.1038%2Fnchembio.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and selection of DNA-encoded small-molecule libraries</span></div><div class="casAuthors">Clark, Matthew A.; Acharya, Raksha A.; Arico-Muendel, Christopher C.; Belyanskaya, Svetlana L.; Benjamin, Dennis R.; Carlson, Neil R.; Centrella, Paolo A.; Chiu, Cynthia H.; Creaser, Steffen P.; Cuozzo, John W.; Davie, Christopher P.; Ding, Yun; Franklin, G. Joseph; Franzen, Kurt D.; Gefter, Malcolm L.; Hale, Steven P.; Hansen, Nils J. V.; Israel, David I.; Jiang, Jinwei; Kavarana, Malcolm J.; Kelley, Michael S.; Kollmann, Christopher S.; Li, Fan; Lind, Kenneth; Mataruse, Sibongile; Medeiros, Patricia F.; Messer, Jeffrey A.; Myers, Paul; O'Keefe, Heather; Oliff, Matthew C.; Rise, Cecil E.; Satz, Alexander L.; Skinner, Steven R.; Svendsen, Jennifer L.; Tang, Lujia; van Vloten, Kurt; Wagner, Richard W.; Yao, Gang; Zhao, Baoguang; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">647-654</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Biochem. combinatorial techniques such as phage display, RNA display and oligonucleotide aptamers have proven to be reliable methods for generation of ligands to protein targets.  Adapting these techniques to small synthetic mols. has been a long-sought goal.  We report the synthesis and interrogation of an 800-million-member DNA-encoded library in which small mols. are covalently attached to an encoding oligonucleotide.  The library was assembled by a combination of chem. and enzymic synthesis, and interrogated by affinity selection.  We describe methods for the selection and deconvolution of the chem. display library, and the discovery of inhibitors for two enzymes: Aurora A kinase and p38 MAP kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp32j3MHOgNurVg90H21EOLACvtfcHk0liaa1hyvNtPvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Ogtbo%253D&md5=8a40148f5fca24ecf912ed360802e19d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.211%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBenjamin%26aufirst%3DD.%2BR.%26aulast%3DCarlson%26aufirst%3DN.%2BR.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DChiu%26aufirst%3DC.%2BH.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DFranzen%26aufirst%3DK.%2BD.%26aulast%3DGefter%26aufirst%3DM.%2BL.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DHansen%26aufirst%3DN.%2BJ.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKavarana%26aufirst%3DM.%2BJ.%26aulast%3DKelley%26aufirst%3DM.%2BS.%26aulast%3DKollmann%26aufirst%3DC.%2BS.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DLind%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DMedeiros%26aufirst%3DP.%2BF.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DOliff%26aufirst%3DM.%2BC.%26aulast%3DRise%26aufirst%3DC.%2BE.%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DSvendsen%26aufirst%3DJ.%2BL.%26aulast%3DTang%26aufirst%3DL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DR.%2BW.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520selection%2520of%2520DNA-encoded%2520small-molecule%2520libraries%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D647%26epage%3D654%26doi%3D10.1038%2Fnchembio.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lhDIgY769Grhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lgjxJ4hZw7k8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolstenholme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards-Peterson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verticelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. L.</span></span> <span> </span><span class="NLM_article-title">Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00365</span>, <span class="refDoi"> DOI: 10.1002/prp2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1002%2Fprp2.365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=e00365&author=K.+Weiselauthor=N.+E.+Scottauthor=D.+J.+Tompsonauthor=B.+J.+Vottaauthor=S.+Madhavanauthor=K.+Poveyauthor=A.+Wolstenholmeauthor=M.+Simeoniauthor=T.+Rudoauthor=L.+Richards-Petersonauthor=T.+Sahotaauthor=J.+G.+Wangauthor=J.+Lichauthor=J.+Fingerauthor=A.+Verticelliauthor=M.+Reillyauthor=P.+J.+Goughauthor=P.+A.+Harrisauthor=J.+Bertinauthor=M.+L.+Wang&title=Randomized+clinical+study+of+safety%2C+pharmacokinetics%2C+and+pharmacodynamics+of+RIPK1+inhibitor+GSK2982772+in+healthy+volunteers&doi=10.1002%2Fprp2.365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fprp2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.365%26sid%3Dliteratum%253Aachs%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DTompson%26aufirst%3DD.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DMadhavan%26aufirst%3DS.%26aulast%3DPovey%26aufirst%3DK.%26aulast%3DWolstenholme%26aufirst%3DA.%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DRudo%26aufirst%3DT.%26aulast%3DRichards-Peterson%26aufirst%3DL.%26aulast%3DSahota%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%2BG.%26aulast%3DLich%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DVerticelli%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%2BL.%26atitle%3DRandomized%2520clinical%2520study%2520of%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520RIPK1%2520inhibitor%2520GSK2982772%2520in%2520healthy%2520volunteers%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26spage%3De00365%26doi%3D10.1002%2Fprp2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a RIP1 kinase inhibitor clinical candidate (gsk3145095) for the treatment of pancreatic cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFymu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=857-862&author=P.+A.+Harrisauthor=J.+M.+Marinisauthor=J.+D.+Lichauthor=S.+B.+Bergerauthor=A.+Chiralaauthor=J.+A.+Coxauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=P.+J.+Goughauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=L.+K.+Leisterauthor=M.+K.+Mahajanauthor=G.+Millerauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=H.+H.+Sunauthor=J.+H.+Thorpeauthor=R.+D.+Totoritisauthor=W.+Wangauthor=D.+Wuauthor=D.+Zhangauthor=J.+Bertinauthor=R.+W.+Marquis&title=Identification+of+a+RIP1+kinase+inhibitor+clinical+candidate+%28gsk3145095%29+for+the+treatment+of+pancreatic+cancer&doi=10.1021%2Facsmedchemlett.9b00108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer</span></div><div class="casAuthors">Harris, Philip A.; Marinis, Jill M.; Lich, John D.; Berger, Scott B.; Chirala, Anirudh; Cox, Julie A.; Eidam, Patrick M.; Finger, Joshua N.; Gough, Peter J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Leister, Lara K.; Mahajan, Mukesh K.; Miller, George; Nagilla, Rakesh; Ouellette, Michael T.; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Sun, Helen H.; Thorpe, James H.; Totoritis, Rachel D.; Wang, Wei; Wu, Dongling; Zhang, Daohua; Bertin, John; Marquis, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">857-862</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates cell death and inflammation and is believed to play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases and cancer.  While small-mol. inhibitors of RIP1 kinase have been advanced to the clinic for inflammatory diseases and CNS indications, RIP1 inhibitors for oncol. indications have yet to be described.  Herein we report on the discovery and profile of GSK3145095 (compd. 6).  Compd. 6 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinase-dependent cellular responses.  Highlighting its potential as a novel cancer therapy, the inhibitor was also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures.  Compd. 6 is currently in phase 1 clin. studies for pancreatic adenocarcinoma and other selected solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24k3UrtmbXbVg90H21EOLACvtfcHk0ljMbjytAKUm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFymu7g%253D&md5=3e4783b47ed7240e15ae537749f20f2f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00108%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DChirala%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DMiller%26aufirst%3DG.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DIdentification%2520of%2520a%2520RIP1%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528gsk3145095%2529%2520for%2520the%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D857%26epage%3D862%26doi%3D10.1021%2Facsmedchemlett.9b00108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakariya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogo, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-oxo-2,4,5,7-tetrahydro-6 h-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2384-2409&author=M.+Yoshikawaauthor=M.+Saitohauthor=T.+Katohauthor=T.+Sekiauthor=S.+V.+Bigiauthor=Y.+Shimizuauthor=T.+Ishiiauthor=T.+Okaiauthor=M.+Kunoauthor=H.+Hattoriauthor=E.+Watanabeauthor=K.+S.+Saikatenduauthor=H.+Zouauthor=M.+Nakakariyaauthor=T.+Tatamiyaauthor=Y.+Nakadaauthor=T.+Yogo&title=Discovery+of+7-oxo-2%2C4%2C5%2C7-tetrahydro-6+h-pyrazolo%5B3%2C4-+c%5Dpyridine+derivatives+as+potent%2C+orally+available%2C+and+brain-penetrating+receptor+interacting+protein+1+%28RIP1%29+kinase+inhibitors%3A+analysis+of+structure-kinetic+relationships&doi=10.1021%2Facs.jmedchem.7b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships</span></div><div class="casAuthors">Yoshikawa, Masato; Saitoh, Morihisa; Katoh, Taisuke; Seki, Tomohiro; Bigi, Simone V.; Shimizu, Yuji; Ishii, Tsuyoshi; Okai, Takuro; Kuno, Masako; Hattori, Harumi; Watanabe, Etsuro; Saikatendu, Kumar S.; Zou, Hua; Nakakariya, Masanori; Tatamiya, Takayuki; Nakada, Yoshihisa; Yogo, Takatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2384-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery of 7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine derivs. as a novel class of receptor interacting protein 1 (RIP1) kinase inhibitors.  On the basis of the overlay study between HTS hit 10 and GSK2982772 in RIP1 kinase, the authors designed and synthesized a novel class of RIP1 kinase inhibitor (11, (3S)-3-(2-Benzyl-4-oxo-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one trifluoroacetic acid) possessing moderate RIP1 kinase inhibitory activity and P-gp mediated efflux.  The optimization of the core structure and the exploration of appropriate substituents utilizing SBDD approach led to the discovery of (22, (3S)-3-(2-Benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile), a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with excellent PK profiles.  Compd. 22 significantly suppressed necroptotic cell death both in mouse and human cells.  Oral administration of 22 (10 mg/kg, bid) attenuated disease progression in the mouse exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS).  Moreover, anal. of structure-kinetic relationship (SKR) for the authors' novel chem. series was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8rRmbdh7w7Vg90H21EOLACvtfcHk0ljMbjytAKUm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D&md5=a76ab7f12af03e277ba37d7ea08274c9</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01647%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DNakakariya%26aufirst%3DM.%26aulast%3DTatamiya%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DY.%26aulast%3DYogo%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25207-oxo-2%252C4%252C5%252C7-tetrahydro-6%2520h-pyrazolo%255B3%252C4-%2520c%255Dpyridine%2520derivatives%2520as%2520potent%252C%2520orally%2520available%252C%2520and%2520brain-penetrating%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520inhibitors%253A%2520analysis%2520of%2520structure-kinetic%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2384%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.7b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1497</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2019.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31000154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVSqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1497-1501&author=G.+L.+Hamiltonauthor=H.+Chenauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=R.+Fongauthor=A.+Johnsonauthor=P.+B.+Kohliauthor=P.+J.+Lupardusauthor=B.+M.+Liedererauthor=S.+Ramaswamyauthor=H.+Wangauthor=J.+Wangauthor=Z.+Xuauthor=Y.+Zhuauthor=D.+Vucicauthor=S.+Patel&title=Potent+and+selective+inhibitors+of+receptor-interacting+protein+kinase+1+that+lack+an+aromatic+back+pocket+group&doi=10.1016%2Fj.bmcl.2019.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group</span></div><div class="casAuthors">Hamilton, Gregory L.; Chen, Huifen; Deshmukh, Gauri; Eigenbrot, Charles; Fong, Rina; Johnson, Adam; Kohli, Pawan Bir; Lupardus, Patrick J.; Liederer, Bianca M.; Ramaswamy, Sreemathy; Wang, Haowei; Wang, Jian; Xu, Zhaowu; Zhu, Yunliang; Vucic, Domagoj; Patel, Snahel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1497-1501</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1), a key component of the cellular necroptosis pathway, has gained recognition as an important therapeutic target.  Pharmacol. inhibition or genetic inactivation of RIPK1 has shown promise in animal models of disease ranging from acute ischemic conditions, chronic inflammation, and neurodegeneration.  We present here a class of RIPK1 inhibitors that is distinguished by a lack of a lipophilic arom. group present in most literature inhibitors that typically occupies a hydrophobic back pocket of the protein active site.  Despite not having this ubiquitous feature of many known RIPK1 inhibitors, we were able to obtain compds. with good potency, kinase selectivity, and pharmacokinetic properties in rats (e.g., I).  The use of the lipophilic yet metabolically stable pentafluoroethyl group was crit. to balancing the potency and properties of optimized analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8Y4EUFlsAbVg90H21EOLACvtfcHk0ljMbjytAKUm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVSqsLo%253D&md5=c6e65988cf17060faaf7615ede8b6304</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%2BL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520receptor-interacting%2520protein%2520kinase%25201%2520that%2520lack%2520an%2520aromatic%2520back%2520pocket%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1497%26epage%3D1501%26doi%3D10.1016%2Fj.bmcl.2019.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigorel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meslamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasikanti, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolven, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and lead-optimization of 4,5-dihydropyrazoles as mono-kinase selective, orally bioavailable and efficacious inhibitors of receptor interacting protein 1 (RIP1) kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5096</span>– <span class="NLM_lpage">5110</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00318</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00318" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1Sgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5096-5110&author=P.+A.+Harrisauthor=N.+Faucherauthor=N.+Georgeauthor=P.+M.+Eidamauthor=B.+W.+Kingauthor=G.+V.+Whiteauthor=N.+A.+Andersonauthor=D.+Bandyopadhyayauthor=A.+M.+Bealauthor=V.+Benetonauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=S.+Camposauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=A.+Dauganauthor=F.+Doncheauthor=M.+H.+Fouchetauthor=J.+N.+Fingerauthor=B.+Geddesauthor=P.+J.+Goughauthor=P.+Grondinauthor=B.+L.+Hoffmanauthor=S.+J.+Hoffmanauthor=S.+E.+Hutchinsonauthor=J.+U.+Jeongauthor=E.+Jigorelauthor=P.+Lamoureuxauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=M.+K.+Mahajanauthor=J.+Meslamaniauthor=J.+E.+Mosleyauthor=R.+Nagillaauthor=P.+M.+Nassauauthor=S.+L.+Ngauthor=M.+T.+Ouelletteauthor=K.+K.+Pasikantiauthor=F.+Potvainauthor=M.+A.+Reillyauthor=E.+J.+Riveraauthor=S.+Sautetauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=H.+Sunauthor=J.+H.+Thorpeauthor=R.+D.+Totoritisauthor=P.+Wardauthor=N.+Wellawayauthor=D.+D.+Wisnoskiauthor=J.+M.+Woolvenauthor=J.+Bertinauthor=R.+W.+Marquis&title=Discovery+and+lead-optimization+of+4%2C5-dihydropyrazoles+as+mono-kinase+selective%2C+orally+bioavailable+and+efficacious+inhibitors+of+receptor+interacting+protein+1+%28RIP1%29+kinase&doi=10.1021%2Facs.jmedchem.9b00318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase</span></div><div class="casAuthors">Harris, Philip A.; Faucher, Nicolas; George, Nicolas; Eidam, Patrick M.; King, Bryan W.; White, Gemma V.; Anderson, Niall A.; Bandyopadhyay, Deepak; Beal, Allison M.; Beneton, Veronique; Berger, Scott B.; Campobasso, Nino; Campos, Sebastien; Capriotti, Carol A.; Cox, Julie A.; Daugan, Alain; Donche, Frederic; Fouchet, Marie-Helene; Finger, Joshua N.; Geddes, Brad; Gough, Peter J.; Grondin, Pascal; Hoffman, Bonnie L.; Hoffman, Sandra J.; Hutchinson, Susan E.; Jeong, Jae U.; Jigorel, Emilie; Lamoureux, Pauline; Leister, Lara K.; Lich, John D.; Mahajan, Mukesh K.; Meslamani, Jamel; Mosley, Julie E.; Nagilla, Rakesh; Nassau, Pamela M.; Ng, Sze-Ling; Ouellette, Michael T.; Pasikanti, Kishore K.; Potvain, Florent; Reilly, Michael A.; Rivera, Elizabeth J.; Sautet, Stephane; Schaeffer, Michelle C.; Sehon, Clark A.; Sun, Helen; Thorpe, James H.; Totoritis, Rachel D.; Ward, Paris; Wellaway, Natalie; Wisnoski, David D.; Woolven, James M.; Bertin, John; Marquis, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5096-5110</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 kinase regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including inflammatory and neurol. diseases.  Currently, RIP1 kinase inhibitors have advanced into early clin. trials for evaluation in inflammatory diseases such as psoriasis, rheumatoid arthritis, and ulcerative colitis and neurol. diseases such as amyotrophic lateral sclerosis and Alzheimer's disease.  In this paper, we report on the design of potent and highly selective dihydropyrazole (DHP) RIP1 kinase inhibitors starting from a high-throughput screen and the lead-optimization of this series from a lead with minimal rat oral exposure to the identification of dihydropyrazole 77 with good pharmacokinetic profiles in multiple species.  Addnl., we identified a potent murine RIP1 kinase inhibitor 76 as a valuable in vivo tool mol. suitable for evaluating the role of RIP1 kinase in chronic models of disease.  DHP 76 showed efficacy in mouse models of both multiple sclerosis and human retinitis pigmentosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3idrD-dQkF7Vg90H21EOLACvtfcHk0lgjlIF1aNb3kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1Sgsb8%253D&md5=eb3cdf239442f7364f51a79a56d43cbd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00318%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DFaucher%26aufirst%3DN.%26aulast%3DGeorge%26aufirst%3DN.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWhite%26aufirst%3DG.%2BV.%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGeddes%26aufirst%3DB.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHoffman%26aufirst%3DB.%2BL.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DHutchinson%26aufirst%3DS.%2BE.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DJigorel%26aufirst%3DE.%26aulast%3DLamoureux%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNassau%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPasikanti%26aufirst%3DK.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSautet%26aufirst%3DS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWellaway%26aufirst%3DN.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DDiscovery%2520and%2520lead-optimization%2520of%25204%252C5-dihydropyrazoles%2520as%2520mono-kinase%2520selective%252C%2520orally%2520bioavailable%2520and%2520efficacious%2520inhibitors%2520of%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5096%26epage%3D5110%26doi%3D10.1021%2Facs.jmedchem.9b00318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of GSK’963: a structurally distinct, potent and selective inhibitor of RIP1 kinase</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15009</span>, <span class="refDoi"> DOI: 10.1038/cddiscovery.2015.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddiscovery.2015.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27551444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ais7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15009&author=S.+B.+Bergerauthor=P.+Harrisauthor=R.+Nagillaauthor=V.+Kasparcovaauthor=S.+Hoffmanauthor=B.+Swiftauthor=L.+Dareauthor=M.+Schaefferauthor=C.+Capriottiauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=J.+Coxauthor=M.+Reillyauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Characterization+of+GSK%E2%80%99963%3A+a+structurally+distinct%2C+potent+and+selective+inhibitor+of+RIP1+kinase&doi=10.1038%2Fcddiscovery.2015.9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase</span></div><div class="casAuthors">Berger, S. B.; Harris, P.; Nagilla, R.; Kasparcova, V.; Hoffman, S.; Swift, B.; Dare, L.; Schaeffer, M.; Capriotti, C.; Ouellette, M.; King, B. W.; Wisnoski, D.; Cox, J.; Reilly, M.; Marquis, R. W.; Bertin, J.; Gough, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15009</span>CODEN:
                <span class="NLM_cas:coden">CDDEB5</span>;
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis and signaling regulated by RIP1 kinase activity is emerging as a key driver of inflammation in a variety of disease settings.  A significant amt. has been learned about how RIP1 regulates necrotic cell death through the use of the RIP1 kinase inhibitor Necrostatin-1 (Nec-1).  Nec-1 has been a transformational tool for exploring the function of RIP1 kinase activity; however, its utility is somewhat limited by moderate potency, off-target activity against indoleamine-2,3-dioxygenase (IDO), and poor pharmacokinetic properties.  These limitations of Nec-1 have driven an effort to identify next-generation tools to study RIP1 function, and have led to the identification of 7-Cl-O-Nec-1 (Nec-1s), which has improved pharmacokinetic properties and lacks IDO inhibitory activity.  Here we describe the characterization of GSK'963, a chiral small-mol. inhibitor of RIP1 kinase that is chem. distinct from both Nec-1 and Nec-1s.  GSK'963 is significantly more potent than Nec-1 in both biochem. and cellular assays, inhibiting RIP1-dependent cell death with an IC50 of between 1 and 4 nM in human and murine cells.  GSK'963 is >10 000-fold selective for RIP1 over 339 other kinases, lacks measurable activity against IDO and has an inactive enantiomer, GSK'962, which can be used to confirm on-target effects.  The increased in vitro potency of GSK'963 also translates in vivo, where GSK'963 provides much greater protection from hypothermia at matched doses to Nec-1, in a model of TNF-induced sterile shock.  Together, we believe GSK'963 represents a next-generation tool for examg. the function of RIP1 in vitro and in vivo, and should help to clarify our current understanding of the role of RIP1 in contributing to disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtMEuOlAairrVg90H21EOLACvtfcHk0lgZatr2QOc0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ais7%252FJ&md5=c1424386e8dcb6d4e3c2df92f142220f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fcddiscovery.2015.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddiscovery.2015.9%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DHarris%26aufirst%3DP.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DHoffman%26aufirst%3DS.%26aulast%3DSwift%26aufirst%3DB.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DSchaeffer%26aufirst%3DM.%26aulast%3DCapriotti%26aufirst%3DC.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520GSK%25E2%2580%2599963%253A%2520a%2520structurally%2520distinct%252C%2520potent%2520and%2520selective%2520inhibitor%2520of%2520RIP1%2520kinase%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2015%26volume%3D1%26spage%3D15009%26doi%3D10.1038%2Fcddiscovery.2015.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savadkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaboh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinwand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochen Rossi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aykut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glacken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevaraja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeegbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdatlioglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.ccell.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30423296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=757-774&author=W.+Wangauthor=J.+M.+Marinisauthor=A.+M.+Bealauthor=S.+Savadkarauthor=Y.+Wuauthor=M.+Khanauthor=P.+S.+Taunkauthor=N.+Wuauthor=W.+Suauthor=J.+Wuauthor=A.+Ahsanauthor=E.+Kurzauthor=T.+Chenauthor=I.+Yabohauthor=F.+Liauthor=J.+Gutierrezauthor=B.+Diskinauthor=M.+Hundeyinauthor=M.+Reillyauthor=J.+D.+Lichauthor=P.+A.+Harrisauthor=M.+K.+Mahajanauthor=J.+H.+Thorpeauthor=P.+Nassauauthor=J.+E.+Mosleyauthor=J.+Leinwandauthor=J.+A.+Kochen+Rossiauthor=A.+Mishraauthor=B.+Aykutauthor=M.+Glackenauthor=A.+Ochiauthor=N.+Vermaauthor=J.+I.+Kimauthor=V.+Vasudevarajaauthor=D.+Adeegbeauthor=C.+Almonteauthor=E.+Bagdatliogluauthor=D.+J.+Cohenauthor=K.+K.+Wongauthor=J.+Bertinauthor=G.+Miller&title=RIP1+kinase+drives+macrophage-mediated+adaptive+immune+tolerance+in+pancreatic+cancer&doi=10.1016%2Fj.ccell.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer</span></div><div class="casAuthors">Wang, Wei; Marinis, Jill M.; Beal, Allison M.; Savadkar, Shivraj; Wu, Yue; Khan, Mohammed; Taunk, Pardeep S.; Wu, Nan; Su, Wenyu; Wu, Jingjing; Ahsan, Aarif; Kurz, Emma; Chen, Ting; Yaboh, Inedouye; Li, Fei; Gutierrez, Johana; Diskin, Brian; Hundeyin, Mautin; Reilly, Michael; Lich, John D.; Harris, Philip A.; Mahajan, Mukesh K.; Thorpe, James H.; Nassau, Pamela; Mosley, Julie E.; Leinwand, Joshua; Kochen Rossi, Juan A.; Mishra, Ankita; Aykut, Berk; Glacken, Michael; Ochi, Atsuo; Verma, Narendra; Kim, Jacqueline I.; Vasudevaraja, Varshini; Adeegbe, Dennis; Almonte, Christina; Bagdatlioglu, Ece; Cohen, Deirdre J.; Wong, Kwok-Kin; Bertin, John; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-774.e7</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and immunotherapeutic resistance.  We discovered upregulation of receptor-interacting serine/threonine protein kinase 1 (RIP1) in tumor-assocd. macrophages (TAMs) in PDA.  To study its role in oncogenic progression, we developed a selective small-mol. RIP1 inhibitor with high in vivo exposure.  Targeting RIP1 reprogrammed TAMs toward an MHCIIhiTNFα+IFNγ+ immunogenic phenotype in a STAT1-dependent manner.  RIP1 inhibition in TAMs resulted in cytotoxic T cell activation and T helper cell differentiation toward a mixed Th1/Th17 phenotype, leading to tumor immunity in mice and in organotypic models of human PDA.  Targeting RIP1 synergized with PD1-and inducible co-stimulator-based immunotherapies.  Tumor-promoting effects of RIP1 were independent of its co-assocn. with RIP3.  Collectively, our work describes RIP1 as a checkpoint kinase governing tumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOuua4gAvrLVg90H21EOLACvtfcHk0lgZatr2QOc0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO&md5=9210358fa2dbb4da0d0981e84ac696f9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DSavadkar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DTaunk%26aufirst%3DP.%2BS.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAhsan%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYaboh%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DDiskin%26aufirst%3DB.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DNassau%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DLeinwand%26aufirst%3DJ.%26aulast%3DKochen%2BRossi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DAykut%26aufirst%3DB.%26aulast%3DGlacken%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DVasudevaraja%26aufirst%3DV.%26aulast%3DAdeegbe%26aufirst%3DD.%26aulast%3DAlmonte%26aufirst%3DC.%26aulast%3DBagdatlioglu%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DRIP1%2520kinase%2520drives%2520macrophage-mediated%2520adaptive%2520immune%2520tolerance%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D757%26epage%3D774%26doi%3D10.1016%2Fj.ccell.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) for the treatment of systemic inflammatory response syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFaitbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=972-986&author=Y.+Renauthor=Y.+Suauthor=L.+Sunauthor=S.+Heauthor=L.+Mengauthor=D.+Liaoauthor=X.+Liuauthor=Y.+Maauthor=C.+Liuauthor=S.+Liauthor=H.+Ruanauthor=X.+Leiauthor=X.+Wangauthor=Z.+Zhang&title=Discovery+of+a+highly+potent%2C+selective%2C+and+metabolically+stable+inhibitor+of+receptor-interacting+protein+1+%28RIP1%29+for+the+treatment+of+systemic+inflammatory+response+syndrome&doi=10.1021%2Facs.jmedchem.6b01196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Ren, Yan; Su, Yaning; Sun, Liming; He, Sudan; Meng, Lingjun; Liao, Daohong; Liu, Xiao; Ma, Yongfen; Liu, Chunyan; Li, Sisi; Ruan, Hanying; Lei, Xiaoguang; Wang, Xiaodong; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">972-986</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on its essential role in driving inflammation and disease pathol., cell necrosis has gradually been verified as a promising therapeutic target for treating atherosclerosis, systemic inflammatory response syndrome (SIRS), and ischemia injury, among other diseases.  Most necrosis inhibitors targeting receptor-interacting protein 1 (RIP1) still require further optimization because of weak potency or poor metabolic stability.  The authors conducted a phenotypic screen and identified a micromolar hit with novel amide structure.  Medicinal chem. efforts yielded a highly-potent, selective, and metabolically stable drug candidate - compd. 56 (RIPA-56, N-benzyl-N-hydroxy-2,2-dimethylbutanamide).  Biochem. studies and mol. docking revealed that RIP1 is the direct target of this new series of type III kinase inhibitors.  In the SIRS mice disease model, 56 efficiently reduced tumor necrosis factor alpha (TNFα)-induced mortality and multi-organ damage.  Compared to known RIP1 inhibitors, 56 is potent in both human and murine cells, is much more stable in vivo, and is efficacious in animal model studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqos-N-fJJ4vbVg90H21EOLACvtfcHk0lh7QBeyHX0GDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFaitbfO&md5=6e7045a9646be5f9dc9559d90efe8aed</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01196%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRuan%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520metabolically%2520stable%2520inhibitor%2520of%2520receptor-interacting%2520protein%25201%2520%2528RIP1%2529%2520for%2520the%2520treatment%2520of%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D972%26epage%3D986%26doi%3D10.1021%2Facs.jmedchem.6b01196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e27692</span>, <span class="refDoi"> DOI: 10.7554/eLife.27692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.7554%2FeLife.27692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28807105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGrtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=e27692&author=D.+Liauthor=L.+Mengauthor=T.+Xuauthor=Y.+Suauthor=X.+Liuauthor=Z.+Zhangauthor=X.+Wang&title=RIPK1-RIPK3-MLKL-dependent+necrosis+promotes+the+aging+of+mouse+male+reproductive+system&doi=10.7554%2FeLife.27692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system</span></div><div class="casAuthors">Li, Dianrong; Meng, Lingjun; Xu, Tao; Su, Yaning; Liu, Xiao; Zhang, Zhiyuan; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e27692/1-e27692/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">A pair of kinases, RIPK1 and RIPK3, as well as the RIPK3 substrate MLKL cause a form of programmed necrotic cell death in mammals termed necroptosis.  We report here that male reproductive organs of both Ripk3- and Mlkl-knockout mice retain 'youthful' morphol. and function into advanced age, while those of age-matched wild-type mice deteriorate.  The RIPK3 phosphorylation of MLKL, the activation marker of necroptosis, is detected in spermatogonial stem cells in the testes of old but not in young wild-type mice.  When the testes of young wild-type mice are given a local necroptotic stimulus, their reproductive organs showed accelerated aging.  Feeding of wild-type mice with an RIPK1 inhibitor prior to the normal onset of age-related changes in their reproductive organs blocked the appearance of signs of aging.  Thus, necroptosis in testes promotes the aging-assocd. deterioration of the male reproductive system in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbVNZyGgYXLVg90H21EOLACvtfcHk0lh7QBeyHX0GDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGrtrvI&md5=31babcdb3fee62f7ab2c327f3d4fa0b5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.7554%2FeLife.27692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.27692%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DRIPK1-RIPK3-MLKL-dependent%2520necrosis%2520promotes%2520the%2520aging%2520of%2520mouse%2520male%2520reproductive%2520system%26jtitle%3DeLife%26date%3D2017%26volume%3D6%26spage%3De27692%26doi%3D10.7554%2FeLife.27692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koytiger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeskind, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laifenfeld, D.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing from the perspective of pharmaceutical companies</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1111/bph.13798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fbph.13798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28369768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvF2rt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=168-180&author=Y.+Chaauthor=T.+Erezauthor=I.+J.+Reynoldsauthor=D.+Kumarauthor=J.+Rossauthor=G.+Koytigerauthor=R.+Kuskoauthor=B.+Zeskindauthor=S.+Rissoauthor=E.+Kaganauthor=S.+Papapetropoulosauthor=I.+Grossmanauthor=D.+Laifenfeld&title=Drug+repurposing+from+the+perspective+of+pharmaceutical+companies&doi=10.1111%2Fbph.13798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Drug repurposing from the perspective of pharmaceutical companies</span></div><div class="casAuthors">Cha, Y.; Erez, T.; Reynolds, I. J.; Kumar, D.; Ross, J.; Koytiger, G.; Kusko, R.; Zeskind, B.; Risso, S.; Kagan, E.; Papapetropoulos, S.; Grossman, I.; Laifenfeld, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-180</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Drug repurposing holds the potential to bring medications with known safety profiles to new patient populations.  Numerous examples exist for the identification of new indications for existing mols., most stemming from serendipitous findings or focused recent efforts specifically limited to the mode of action of a specific drug.  In recent years, the need for new approaches to drug research and development, combined with the advent of big data repositories and assocd. anal. methods, has generated interest in developing systematic approaches to drug repurposing.  A variety of innovative computational methods to enable systematic repurposing screens, exptl. as well as through in silico approaches, have emerged.  An efficient drug repurposing pipeline requires the combination of access to mol. data, appropriate anal. expertise to enable robust insights, expertise and exptl. set-up for validation and clin. development know-how.  In this review, we describe some of the main approaches to systematic repurposing and discuss the various players in this field and the need for strategic collaborations to increase the likelihood of success in bringing existing mols. to new indications, as well as the current advantages, considerations and challenges in repurposing as a drug development strategy pursued by pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8pikAVXcZSbVg90H21EOLACvtfcHk0lh7QBeyHX0GDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvF2rt7g%253D&md5=1aec5588b3eeac7724d3fcaf6371961f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fbph.13798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13798%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DY.%26aulast%3DErez%26aufirst%3DT.%26aulast%3DReynolds%26aufirst%3DI.%2BJ.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DJ.%26aulast%3DKoytiger%26aufirst%3DG.%26aulast%3DKusko%26aufirst%3DR.%26aulast%3DZeskind%26aufirst%3DB.%26aulast%3DRisso%26aufirst%3DS.%26aulast%3DKagan%26aufirst%3DE.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DGrossman%26aufirst%3DI.%26aulast%3DLaifenfeld%26aufirst%3DD.%26atitle%3DDrug%2520repurposing%2520from%2520the%2520perspective%2520of%2520pharmaceutical%2520companies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D168%26epage%3D180%26doi%3D10.1111%2Fbph.13798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.1021/ml400382p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1238-1243&author=P.+A.+Harrisauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=K.+M.+Kahlerauthor=R.+Lehrauthor=J.+D.+Lichauthor=R.+Nagillaauthor=R.+T.+Nolteauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=M.+C.+Schaefferauthor=A.+Smallwoodauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Discovery+of+small+molecule+RIP1+kinase+inhibitors+for+the+treatment+of+pathologies+associated+with+necroptosis&doi=10.1021%2Fml400382p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis</span></div><div class="casAuthors">Harris, Philip A.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Finger, Joshua N.; Hoffman, Sandra J.; Kahler, Kirsten M.; Lehr, Ruth; Lich, John D.; Nagilla, Rakesh; Nolte, Robert T.; Ouellette, Michael T.; Pao, Christina S.; Schaeffer, Michelle C.; Smallwood, Angela; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1238-1243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent inhibitors of RIP1 kinase from three distinct series, 1-aminoisoquinolines, pyrrolo-[2,3-b]-pyridines, and furo-[2,3-d]-pyrimidines, all of the type II class recognizing a DLG-out inactive conformation, were identified from screening of our inhouse kinase focused sets.  An exemplar from the furo-[2,3-d]-pyrimidine series showed a dose proportional response in protection from hypothermia in a mouse model of TNFα induced lethal shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN6cNcMjIyjrVg90H21EOLACvtfcHk0limS5gP81JoTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrnF&md5=818a831f7083f7f17767daf02992ba55</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fml400382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400382p%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520RIP1%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pathologies%2520associated%2520with%2520necroptosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1238%26epage%3D1243%26doi%3D10.1021%2Fml400382p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1038/nchembio799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations&doi=10.1038%2Fnchembio799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0limS5gP81JoTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span> <span> </span><span class="NLM_article-title">Identification of 5-(2,3-dihydro-1 h-indol-5-yl)-7 h-pyrrolo[2,3- d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11398</span>– <span class="NLM_lpage">11414</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01652</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01652" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlalsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11398-11414&author=Y.+Liauthor=Y.+Xiongauthor=G.+Zhangauthor=L.+Zhangauthor=W.+Yangauthor=J.+Yangauthor=L.+Huangauthor=Z.+Qiaoauthor=Z.+Miaoauthor=G.+Linauthor=Q.+Sunauthor=T.+Niuauthor=L.+Chenauthor=D.+Niuauthor=L.+Liauthor=S.+Yang&title=Identification+of+5-%282%2C3-dihydro-1+h-indol-5-yl%29-7+h-pyrrolo%5B2%2C3-+d%5Dpyrimidin-4-amine+derivatives+as+a+new+class+of+receptor-interacting+protein+kinase+1+%28RIPK1%29+inhibitors%2C+which+showed+potent+activity+in+a+tumor+metastasis+model&doi=10.1021%2Facs.jmedchem.8b01652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 5-(2,3-Dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors, which showed potent activity in a tumor metastasis model</span></div><div class="casAuthors">Li, Yueshan; Xiong, Yu; Zhang, Guo; Zhang, Liting; Yang, Wei; Yang, Jiao; Huang, Luyi; Qiao, Zeen; Miao, Zhuang; Lin, Guifeng; Sun, Qiu; Niu, Ting; Chen, Lijuan; Niu, Dawen; Li, Linli; Yang, Shengyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11398-11414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We herein report the structural optimization and structure-activity relationship studies of 5-(2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivs. as a new class of receptor-interacting protein kinase 1 (RIPK1) inhibitors.  Among all obtained RIPK1 inhibitors, I is the most active one.  This compd. potently inhibited RIPK1 with a binding affinity (KD) of 0.004 μM and an enzymic IC50 value of 0.011 μM and also showed good kinase selectivity.  It could efficiently protect cells from necroptosis and attenuate the necrotic cell death of vascular endothelial cells induced by tumor cells both in vitro and in vivo.  Importantly, I exhibited excellent antimetastasis activity in the exptl. B16 melanoma lung metastasis model.  It also displayed favorable pharmacokinetic properties.  Collectively, I could be a promising agent for preventing tumor metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-ByDgYrec7Vg90H21EOLACvtfcHk0lgh9ZgB-JxitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlalsLrM&md5=fcaa76f5196c502cca35c6733c6b2371</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01652%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DNiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DIdentification%2520of%25205-%25282%252C3-dihydro-1%2520h-indol-5-yl%2529-7%2520h-pyrrolo%255B2%252C3-%2520d%255Dpyrimidin-4-amine%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520receptor-interacting%2520protein%2520kinase%25201%2520%2528RIPK1%2529%2520inhibitors%252C%2520which%2520showed%2520potent%2520activity%2520in%2520a%2520tumor%2520metastasis%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11398%26epage%3D11414%26doi%3D10.1021%2Facs.jmedchem.8b01652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">493</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-1735-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41419-019-1735-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31235688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3MzgtlyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=493&author=J.+Houauthor=J.+Juauthor=Z.+Zhangauthor=C.+Zhaoauthor=Z.+Liauthor=J.+Zhengauthor=T.+Shengauthor=H.+Zhangauthor=L.+Huauthor=X.+Yuauthor=W.+Zhangauthor=Y.+Liauthor=M.+Wuauthor=H.+Maauthor=X.+Zhangauthor=S.+He&title=Discovery+of+potent+necroptosis+inhibitors+targeting+RIPK1+kinase+activity+for+the+treatment+of+inflammatory+disorder+and+cancer+metastasis&doi=10.1038%2Fs41419-019-1735-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis</span></div><div class="casAuthors">Hou Jue; Ju Jie; Zhang Zili; Zhao Cong; Yu Xiaoliang; Zhang Wei; Wu Meng; Ma Haikuo; He Sudan; Hou Jue; Ju Jie; Zhang Zili; Zhao Cong; Yu Xiaoliang; Zhang Wei; Wu Meng; He Sudan; Li Zhanhui; Zheng Jiyue; Sheng Tian; Zhang Hongjian; Ma Haikuo; Zhang Xiaohu; Hu Linkun; Yu Xiaoliang; Zhang Wei; He Sudan; Yu Xiaoliang; Zhang Wei; He Sudan; Li Yangxin</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a form of regulated necrosis controlled by receptor-interacting kinase 1 (RIPK1 or RIP1), RIPK3 (RIP3), and pseudokinase mixed lineage kinase domain-like protein (MLKL).  Increasing evidence suggests that necroptosis is closely associated with pathologies including inflammatory diseases, neurodegenerative diseases, and cancer metastasis.  Herein, we discovered the small-molecule PK6 and its derivatives as a novel class of necroptosis inhibitors that directly block the kinase activity of RIPK1.  Optimization of PK6 led to PK68, which has improved efficacy for the inhibition of RIPK1-dependent necroptosis, with an EC50 of around 14-22 nM in human and mouse cells.  PK68 efficiently blocks cellular activation of RIPK1, RIPK3, and MLKL upon necroptosis stimuli.  PK68 displays reasonable selectivity for inhibition of RIPK1 kinase activity and favorable pharmacokinetic properties.  Importantly, PK68 provides strong protection against TNF-α-induced systemic inflammatory response syndrome in vivo.  Moreover, pre-treatment of PK68 significantly represses metastasis of both melanoma cells and lung carcinoma cells in mice.  Together, our study demonstrates that PK68 is a potent and selective inhibitor of RIPK1 and also highlights its great potential for use in the treatment of inflammatory disorders and cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnOsV83il4N8vLc4ARHEmzfW6udTcc2ea9fOOTF23e_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzgtlyrtA%253D%253D&md5=a5b78fdb3739cd1785335fa6e94c59e8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1735-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1735-6%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520necroptosis%2520inhibitors%2520targeting%2520RIPK1%2520kinase%2520activity%2520for%2520the%2520treatment%2520of%2520inflammatory%2520disorder%2520and%2520cancer%2520metastasis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26spage%3D493%26doi%3D10.1038%2Fs41419-019-1735-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suebsuwong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1860</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2015.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25801024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1850-1860&author=M.+Najjarauthor=C.+Suebsuwongauthor=S.+S.+Rayauthor=R.+J.+Thapaauthor=J.+L.+Makiauthor=S.+Nogusaauthor=S.+Shahauthor=D.+Salehauthor=P.+J.+Goughauthor=J.+Bertinauthor=J.+Yuanauthor=S.+Balachandranauthor=G.+D.+Cunyauthor=A.+Degterev&title=Structure+guided+design+of+potent+and+selective+ponatinib-based+hybrid+inhibitors+for+RIPK1&doi=10.1016%2Fj.celrep.2015.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1</span></div><div class="casAuthors">Najjar, Malek; Suebsuwong, Chalada; Ray, Soumya S.; Thapa, Roshan J.; Maki, Jenny L.; Nogusa, Shoko; Shah, Saumil; Saleh, Danish; Gough, Peter J.; Bertin, John; Yuan, Junying; Balachandran, Siddharth; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1860</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIPK1 and RIPK3, two closely related RIPK family members, have emerged as important regulators of pathol. cell death and inflammation.  In the current work, we report that the Bcr-Abl inhibitor and anti-leukemia agent ponatinib is also a first-in-class dual inhibitor of RIPK1 and RIPK3.  Ponatinib potently inhibited multiple paradigms of RIPK1- and RIPK3-dependent cell death and inflammatory tumor necrosis factor alpha (TNF-α) gene transcription.  We further describe design strategies that utilize the ponatinib scaffold to develop two classes of inhibitors (CS and PN series), each with greatly improved selectivity for RIPK1.  In particular, we detail the development of PN10, a highly potent and selective "hybrid" RIPK1 inhibitor, capturing the best properties of two different allosteric RIPK1 inhibitors, ponatinib and necrostatin-1.  Finally, we show that RIPK1 inhibitors from both classes are powerful blockers of TNF-induced injury in vivo.  Altogether, these findings outline promising candidate mols. and design approaches for targeting RIPK1- and RIPK3-driven inflammatory pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQJThkEIWBbVg90H21EOLACvtfcHk0lgh9ZgB-JxitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D&md5=c13215958ddcca5a685a4d1e82a96560</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DNajjar%26aufirst%3DM.%26aulast%3DSuebsuwong%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBalachandran%26aufirst%3DS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DStructure%2520guided%2520design%2520of%2520potent%2520and%2520selective%2520ponatinib-based%2520hybrid%2520inhibitors%2520for%2520RIPK1%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D10%26spage%3D1850%26epage%3D1860%26doi%3D10.1016%2Fj.celrep.2015.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Rivera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvaeye, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span> <span> </span><span class="NLM_article-title">When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1110</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2017.58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28452996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1100-1110&author=D.+Rojas-Riveraauthor=T.+Delvaeyeauthor=R.+Roelandtauthor=W.+Nerinckxauthor=K.+Augustynsauthor=P.+Vandenabeeleauthor=M.+J.+M.+Bertrand&title=When+PERK+inhibitors+turn+out+to+be+new+potent+RIPK1+inhibitors%3A+critical+issues+on+the+specificity+and+use+of+GSK2606414+and+GSK2656157&doi=10.1038%2Fcdd.2017.58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157</span></div><div class="casAuthors">Rojas-Rivera, Diego; Delvaeye, Tinneke; Roelandt, Ria; Nerinckx, Wim; Augustyns, Koen; Vandenabeele, Peter; Bertrand, Mathieu J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1110</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes a state of cellular stress known as ER stress.  The cells respond to ER stress by activating the unfolded protein response (UPR), a signaling network emerging from the ER-anchored receptors IRE1α, PERK and ATF6.  The UPR aims at restoring ER protein-folding homeostasis, but turns into a toxic signal when the stress is too severe or prolonged.  Recent studies have demonstrated links between the UPR and inflammation.  Consequently, small mol. inhibitors of IRE1α and PERK have become attractive tools for the potential therapeutic manipulation of the UPR in inflammatory conditions.  TNF is a master pro-inflammatory cytokine that drives inflammation either directly by promoting gene activation, or indirectly by inducing RIPK1 kinase-dependent cell death, in the form of apoptosis or necroptosis.  To evaluate the potential contribution of the UPR to TNF-induced cell death, we tested the effects of two commonly used PERK inhibitors, GSK2606414 and GSK2656157.  Surprisingly, we obsd. that both compds. completely repressed TNF-mediated RIPK1 kinase-dependent death, but found that this effect was independent of PERK inactivation.  Indeed, these two compds. turned out to be direct RIPK1 inhibitors, with comparable potency to the recently developed RIPK1 inhibitor GSK'963 (about 100 times more potent than NEC-1s).  Importantly, these compds. completely inhibited TNF-mediated RIPK1-dependent cell death at a concn. that did not affect PERK activity in cells.  In vivo, GSK2656157 administration protected mice from LDs of TNF independently of PERK inhibition and as efficiently as GSK'963.  Together, our results not only report on new and very potent RIPK1 inhibitors but also highlight the risk of misinterpretation when using these two PERK inhibitors in the context of ER stress, cell death and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1y3OTFwAv3LVg90H21EOLACvtfcHk0lg_f0UhiZa9BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOks7s%253D&md5=174d131f4a17be95a3c9459d35d18f98</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.58%26sid%3Dliteratum%253Aachs%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DDelvaeye%26aufirst%3DT.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26atitle%3DWhen%2520PERK%2520inhibitors%2520turn%2520out%2520to%2520be%2520new%2520potent%2520RIPK1%2520inhibitors%253A%2520critical%2520issues%2520on%2520the%2520specificity%2520and%2520use%2520of%2520GSK2606414%2520and%2520GSK2656157%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1100%26epage%3D1110%26doi%3D10.1038%2Fcdd.2017.58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rompaey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span> <span> </span><span class="NLM_article-title">Tozasertib analogues as inhibitors of necroptotic cell death</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1895</span>– <span class="NLM_lpage">1920</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01449</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01449" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1895-1920&author=S.+Hofmansauthor=L.+Devisscherauthor=S.+Martensauthor=D.+Van+Rompaeyauthor=K.+Goossensauthor=T.+Divertauthor=W.+Nerinckxauthor=N.+Takahashiauthor=H.+De+Winterauthor=P.+Van+Der+Vekenauthor=V.+Goossensauthor=P.+Vandenabeeleauthor=K.+Augustyns&title=Tozasertib+analogues+as+inhibitors+of+necroptotic+cell+death&doi=10.1021%2Facs.jmedchem.7b01449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Tozasertib Analogues as Inhibitors of Necroptotic Cell Death</span></div><div class="casAuthors">Hofmans, Sam; Devisscher, Lars; Martens, Sofie; Van Rompaey, Dries; Goossens, Kenneth; Divert, Tatyana; Nerinckx, Wim; Takahashi, Nozomi; De Winter, Hans; Van Der Veken, Pieter; Goossens, Vera; Vandenabeele, Peter; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1895-1920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Receptor interacting protein kinase 1 (RIPK1) plays a crucial role in tumor necrosis factor (TNF)-induced necroptosis, suggesting that this pathway might be druggable.  Most inhibitors of RIPK1 are classified as either type II or type III kinase inhibitors.  This opened up some interesting perspectives for the discovery of novel inhibitors that target the active site of RIPK1.  Tozasertib, a type I pan-aurora kinase (AurK) inhibitor, was found to show a very high affinity for RIPK1.  Because tozasertib presents the typical structural elements of a type I kinase inhibitor, the development of structural analogs of tozasertib is a good starting point for identifying novel type I RIPK1 inhibitors.  In this paper, we identified interesting inhibitors of mTNF-induced necroptosis with no significant effect on AurK A and B, resulting in no nuclear abnormalities as is the case for tozasertib.  Compds. 71 and 72 outperformed tozasertib in an in vivo TNF-induced systemic inflammatory response syndrome (SIRS) mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS01GQAzqRfLVg90H21EOLACvtfcHk0lg_f0UhiZa9BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gurY%253D&md5=46878ea604761962a7663c2db7bc9cfa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01449%26sid%3Dliteratum%253Aachs%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DVan%2BRompaey%26aufirst%3DD.%26aulast%3DGoossens%26aufirst%3DK.%26aulast%3DDivert%26aufirst%3DT.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDe%2BWinter%26aufirst%3DH.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DTozasertib%2520analogues%2520as%2520inhibitors%2520of%2520necroptotic%2520cell%2520death%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1895%26epage%3D1920%26doi%3D10.1021%2Facs.jmedchem.7b01449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuylsteke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">211</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0245-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41419-017-0245-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29434255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=211&author=S.+Martensauthor=V.+Goossensauthor=L.+Devisscherauthor=S.+Hofmansauthor=P.+Claeysauthor=M.+Vuylstekeauthor=N.+Takahashiauthor=K.+Augustynsauthor=P.+Vandenabeele&title=RIPK1-dependent+cell+death%3A+a+novel+target+of+the+Aurora+kinase+inhibitor+Tozasertib+%28VX-680%29&doi=10.1038%2Fs41419-017-0245-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)</span></div><div class="casAuthors">Martens Sofie; Goossens Vera; Claeys Polien; Vuylsteke Marnik; Takahashi Nozomi; Vandenabeele Peter; Martens Sofie; Goossens Vera; Claeys Polien; Vuylsteke Marnik; Takahashi Nozomi; Vandenabeele Peter; Devisscher Lars; Hofmans Sam; Augustyns Koen; Vuylsteke Marnik</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Aurora kinase family (Aurora A, B and C) are crucial regulators of several mitotic events, including cytokinesis.  Increased expression of these kinases is associated with tumorigenesis and several compounds targeting Aurora kinase are under evaluation in clinical trials (a.o.  AT9283, AZD1152, Danusertib, MLN8054).  Here, we demonstrate that the pan-Aurora kinase inhibitor Tozasertib (VX-680 and MK-0457) not only causes cytokinesis defects through Aurora kinase inhibition, but is also a potent inhibitor of necroptosis, a cell death process regulated and executed by the RIPK1, RIPK3 and MLKL signalling axis.  Tozasertib's potency to inhibit RIPK1-dependent necroptosis and to block cytokinesis in cells is in the same concentration range, with an IC50 of 1.06 μM and 0.554 μM, respectively.  A structure activity relationship (SAR) analysis of 67 Tozasertib analogues, modified at 4 different positions, allowed the identification of analogues that showed increased specificity for either cytokinesis inhibition or for necroptosis inhibition, reflecting more specific inhibition of Aurora kinase or RIPK1, respectively.  These results also suggested that RIPK1 and Aurora kinases are functionally non-interacting targets of Tozasertib and its analogues.  Indeed, more specific Aurora kinase inhibitors did not show any effect in necroptosis and Necrostatin-1s treatment did not result in cytokinesis defects, demonstrating that both cellular processes are not interrelated.  Finally, Tozasertib inhibited recombinant human RIPK1, human Aurora A and human Aurora B kinase activity, but not RIPK3.  The potency ranking of the newly derived Tozasertib analogues and their specificity profile, as observed in cellular assays, coincide with ADP-Glo recombinant kinase activity assays.  Overall, we show that Tozasertib not only targets Aurora kinases but also RIPK1 independently, and that we could generate analogues with increased selectivity to RIPK1 or Aurora kinases, respectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CXO4gDb7JggCfW6udTcc2eZaMgULDA8tXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSltQ%253D%253D&md5=13f5c240129319d6d469eedb005d3cdc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0245-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0245-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DDevisscher%26aufirst%3DL.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DClaeys%26aufirst%3DP.%26aulast%3DVuylsteke%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIPK1-dependent%2520cell%2520death%253A%2520a%2520novel%2520target%2520of%2520the%2520Aurora%2520kinase%2520inhibitor%2520Tozasertib%2520%2528VX-680%2529%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D211%26doi%3D10.1038%2Fs41419-017-0245-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. M.</span></span> <span> </span><span class="NLM_article-title">RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1609</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1042/CS20190599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1042%2FCS20190599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31315969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWgsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=1609-1627&author=J.+N.+Wangauthor=M.+M.+Liuauthor=F.+Wangauthor=B.+Weiauthor=Q.+Yangauthor=Y.+T.+Caiauthor=X.+Chenauthor=X.+Q.+Liuauthor=L.+Jiangauthor=C.+Liauthor=X.+W.+Huauthor=J.+T.+Yuauthor=T.+T.+Maauthor=J.+Jinauthor=Y.+G.+Wuauthor=J.+Liauthor=X.+M.+Meng&title=RIPK1+inhibitor+Cpd-71+attenuates+renal+dysfunction+in+cisplatin-treated+mice+via+attenuating+necroptosis%2C+inflammation+and+oxidative+stress&doi=10.1042%2FCS20190599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress</span></div><div class="casAuthors">Wang, Jia-nan; Liu, Ming-ming; Wang, Fang; Wei, Biao; Yang, Qin; Cai, Yu-ting; Chen, Xin; Liu, Xue-qi; Jiang, Ling; Li, Chao; Hu, Xiao-wei; Yu, Ju-tao; Ma, Tao-tao; Jin, Juan; Wu, Yong-gui; Li, Jun; Meng, Xiao-ming</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1609-1627</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Acute kidney injury (AKI) is a destructive clin. condition induced by multiple insults including ischemic reperfusion, nephrotoxic drugs and sepsis.  It is characterized by a sudden decline in renal function, in addn. to excessive inflammation, oxidative stress and programmed cell death of renal tubular epithelial cells.  RIPK1-mediated necroptosis plays an important role in AKI.  In the present study, we evaluated the treatment effects of Compd.-71 (Cpd-71), a novel RIPK1 inhibitor, by comparing with Necrostatin-1 (Nec-1), a classic RIPK1 inhibitor, which has several drawbacks like the narrow structure-activity relationship (SAR) profile, moderate potency and non-ideal pharmacokinetic properties, in vivo and in vitro.  Our results showed that pretreatment of Cpd-71 attenuated cisplatin-induced renal injury, restored renal function and suppressed renal inflammation, oxidative stress and cell necroptosis.  In addn., Cpd-71 inhibited renal damage while reducing the up-regulated serum creatinine (Cr) and blood urea nitrogen (BUN) levels in established AKI mice model.  Consistently, we confirmed that Cpd-71 exhibited more effectively suppressive effect on cisplatin-induced renal tubular cell necroptosis than Nec-1, by phys. binding to the allosteric type III ligand binding site of RIPK1, thereby reduced RIPK1 kinase activity, RIPK1/RIPK3 complex formation and phosphor-MLKL membrane translocation by mol. docking, Western blot, co-immunopptn. and cellular thermal shift assay (CETSA).  Taken together, we currently showed that targeting RIPK1 with Cpd-71 may serve as a promising clin. candidate for AKI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAFqnJD8kOrVg90H21EOLACvtfcHk0lj8JOuTzv722Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWgsrvE&md5=1ac5b5e21e5d8663a107ba99e7c55ad2</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1042%2FCS20190599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20190599%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DY.%2BT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%2BQ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DX.%2BW.%26aulast%3DYu%26aufirst%3DJ.%2BT.%26aulast%3DMa%26aufirst%3DT.%2BT.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%2BG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DX.%2BM.%26atitle%3DRIPK1%2520inhibitor%2520Cpd-71%2520attenuates%2520renal%2520dysfunction%2520in%2520cisplatin-treated%2520mice%2520via%2520attenuating%2520necroptosis%252C%2520inflammation%2520and%2520oxidative%2520stress%26jtitle%3DClin.%2520Sci.%26date%3D2019%26volume%3D133%26spage%3D1609%26epage%3D1627%26doi%3D10.1042%2FCS20190599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotze, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeh, H. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Aurora kinase A induces necroptosis in pancreatic carcinoma</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2017.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1053%2Fj.gastro.2017.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28764929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2017&pages=1429-1443&author=Y.+Xieauthor=S.+Zhuauthor=M.+Zhongauthor=M.+Yangauthor=X.+Sunauthor=J.+Liuauthor=G.+Kroemerauthor=M.+Lotzeauthor=H.+J.+Zehauthor=R.+Kangauthor=D.+Tang&title=Inhibition+of+Aurora+kinase+A+induces+necroptosis+in+pancreatic+carcinoma&doi=10.1053%2Fj.gastro.2017.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma</span></div><div class="casAuthors">Xie, Yangchun; Zhu, Shan; Zhong, Meizuo; Yang, Manhua; Sun, Xiaofan; Liu, Jinbao; Kroemer, Guido; Lotze, Michael; Zeh, Herbert J., III; Kang, Rui; Tang, Daolin</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1429-1443.e5</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Induction of nonapoptotic cell death could be an approach to eliminate apoptosis-resistant tumors.  We investigated necroptosis-based therapies in mouse models of pancreatic ductal adenocarcinoma cancer (PDAC).  We screened 273 com. available kinase inhibitors for cytotoxicity against a human PDAC cell line (PANC1).  We evaluated the ability of the aurora kinase inhibitor CCT137690 to stimulate necroptosis in PDAC cell lines (PANC1, PANC2.03, CFPAC1, MiaPaCa2, BxPc3, and PANC02) and the HEK293 cell line, measuring loss of plasma membrane integrity, gain in cell vol., swollen organelles, and cytoplasmic vacuoles.  We tested the effects of CCT137690 in colon formation assays, and the effects of the necroptosis (necrostatin-1 and necrosulfonamide), apoptosis, autophagy, and ferroptosis inhibitors.  We derived cells from tumors that developed in Pdx1-Cre;K-RasG12D/+;p53R172H/+ (KPC) mice.  Genes encoding proteins in cell death pathways were knocked out, knocked down, or expressed from transgenes in PDAC cell lines.  Athymic nude or B6 mice were given s.c. injections of PDAC cells or tail-vein injections of KPC tumor cells.  Mice were given CCT137690 (80 mg/kg) or vehicle and tumor growth was monitored; tumor tissues were collected and analyzed by immunohistochem.  We compared gene expression levels between human pancreatic cancer tissues (n = 130) with patient survival times using the online R2 genomics anal. and visualization platform.  CCT137690 induced necrosis-like death in PDAC cell lines and reduced colony formation; these effects required RIPK1, RIPK3, and MLKL, as well as inhibition of aurora kinase A (AURKA).  AURKA interacted directly with RIPK1 and RIPK3 to reduce necrosome activation.  AURKA-mediated phosphorylation of glycogen synthase kinase 3 beta (GSK3β) at serine 9 inhibited activation of the RIPK3 and MLKL necrosome.  Mutations in AURKA (D274A) or GSK3β (S9A), or pharmacol. inhibitors of RIPK1 signaling via RIPK3 and MLKL, reduced the cytotoxic activity of CCT137690 in PDAC cells.  Oral administration of CCT137690 induced necroptosis and immunogenic cell death in s.c. and orthotopic tumors in mice, and reduced tumor growth and tumor cell phosphorylation of AURKA and GSK3β.  CCT137690 increased survival times of mice with orthotopic KPC PDACs and reduced tumor growth, stroma, and metastasis.  Increased expression of AURKA and GSK3β mRNAs assocd. with shorter survival times of patients with pancreatic cancer.  We identified the aurora kinase inhibitor CCT137690 as an agent that induces necrosis-like death in PDAC cells, via RIPK1, RIPK3, and MLKL.  CCT137690 slowed growth of orthotopic tumors from PDAC cells in mice, and expression of AURKA and GSK3β assoc. with patient survival times.  AURKA might be targeted for treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYB2PQImwQrVg90H21EOLACvtfcHk0lj8JOuTzv722Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChtr%252FK&md5=80b9c6315e08861e348a2ab49abf7238</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DLotze%26aufirst%3DM.%26aulast%3DZeh%26aufirst%3DH.%2BJ.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520Aurora%2520kinase%2520A%2520induces%2520necroptosis%2520in%2520pancreatic%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2017%26volume%3D153%26spage%3D1429%26epage%3D1443%26doi%3D10.1053%2Fj.gastro.2017.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staples, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2012.06.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22832318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5685-5688&author=S.+Choiauthor=H.+Keysauthor=R.+J.+Staplesauthor=J.+Yuanauthor=A.+Degterevauthor=G.+D.+Cuny&title=Optimization+of+tricyclic+Nec-3+necroptosis+inhibitors+for+in+vitro+liver+microsomal+stability&doi=10.1016%2Fj.bmcl.2012.06.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability</span></div><div class="casAuthors">Choi, Sungwoon; Keys, Heather; Staples, Richard J.; Yuan, Junying; Degterev, Alexei; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5685-5688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death pathway with morphol. features resembling passive non-regulated necrosis.  Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of 3,3a,4,5-tetrahydro-2H-benz[g]indazoles (referred to as the Nec-3 series) displaying potent activity in cellular assays.  However, evaluation of the tricyclic necroptosis inhibitor's stability in mouse liver microsomes indicated that they were rapidly degraded.  A structure-activity relation (SAR) study of this compd. series revealed that increased liver microsomal stability could be accomplished by modification of the pendent Ph ring and by introduction of a hydrophilic substituent (i.e., α-hydroxyl) to the acetamide at the 2-position of the tricyclic ring without significantly compromising necroptosis inhibitory activity.  Further increases in microsomal stability could be achieved by utilizing the 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro-[1]benzothiopyrano[4,3-c]pyrazoles.  However, in this case necroptosis inhibitory activity was not maintained.  Overall, these results provide a strategy for generating potent and metabolically stable tricyclic necrostatin analogs (e.g., 33, LDN-193191) potentially suitable for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2xFVUiAnFqbVg90H21EOLACvtfcHk0lg0oRsBIBAMHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqtb3K&md5=dc04b5305081d8f75c8c22488cb3ef63</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.098%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DStaples%26aufirst%3DR.%2BJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DOptimization%2520of%2520tricyclic%2520Nec-3%2520necroptosis%2520inhibitors%2520for%2520in%2520vitro%2520liver%2520microsomal%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5685%26epage%3D5688%26doi%3D10.1016%2Fj.bmcl.2012.06.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of tricyclic necroptosis inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1895</span>, <span class="refDoi"> DOI: 10.1021/jm061016o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061016o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVKhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1886-1895&author=P.+G.+Jagtapauthor=A.+Degterevauthor=S.+Choiauthor=H.+Keysauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+tricyclic+necroptosis+inhibitors&doi=10.1021%2Fjm061016o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Study of Tricyclic Necroptosis Inhibitors</span></div><div class="casAuthors">Jagtap, Prakash G.; Degterev, Alexei; Choi, Sungwoon; Keys, Heather; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1886-1895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that can be induced in multiple cell types and is characterized by morphol. features resembling necrosis.  Here we describe a series of tricyclic heterocycles (i.e., 3-phenyl-3,3a,4,5-tetrahydro-2H-benz[g]indazoles, 3-phenyl-2,3,3a,4-tetrahydro[1]benzopyrano[4,3-c]pyrazoles, 3-phenyl-2,3,3a,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazoles, and 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro[1]benzothiopyrano[4,3-c]pyrazoles), collectively termed Nec-3, that can potently inhibit necroptosis.  For example, compds. 8, 22, 41, 53, and 55 inhibit necroptosis in an FADD-deficient variant of human Jurkat T cells treated for 24 h with TNF-α with EC50 values in the range 0.15-0.29 μM.  Distinct from the previously described series of hydantoin-contg. indole derivs. (Nec-1), the Nec-3 series exhibits specificity in inhibiting TNF-α-induced necroptosis.  A structure-activity relationship (SAR) study revealed that the (3R,3aR)-rel-diastereomers were more active than the (3R,3aS)-rel-diastereomers for all four ring systems.  Introduction of fluorine or methoxy to the 8-position of the tricyclic ring and a methoxy to the 4-position of the pendent Ph ring increased activity.  Amides at the 2-position of the tricyclic ring were best.  The Nec-3 series provides new tools for elucidating caspase-independent cell death pathways and potentially lead compds. for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLywsvKF2dbVg90H21EOLACvtfcHk0lg0oRsBIBAMHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVKhsLo%253D&md5=94689677b48230d8cc775673a1eb76a6</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm061016o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061016o%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%2BG.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520tricyclic%2520necroptosis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1886%26epage%3D1895%26doi%3D10.1021%2Fjm061016o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeevanandam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6836</span>– <span class="NLM_lpage">6840</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2007.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17964153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6836-6840&author=X.+Tengauthor=H.+Keysauthor=A.+Jeevanandamauthor=J.+A.+Porcoauthor=A.+Degterevauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+%5B1%2C2%2C3%5Dthiadiazole+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2007.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Keys, Heather; Jeevanandam, Arumugasamy; Porco, John A., Jr.; Degterev, Alexei; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6836-6840</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling non-regulated necrosis.  This form of cell death can be induced in an array of cell types in apoptotic deficient conditions with death receptor family ligands.  A series of [1,2,3]thiadiazole benzylamides was found to be potent necroptosis inhibitors (called necrostatins).  A structure-activity relationship study revealed that small cyclic alkyl groups (i.e. cyclopropyl) and 2,6-dihalobenzylamides at the 4- and 5-positions of the [1,2,3]thiadiazole, resp., were optimal.  In addn., when a small alkyl group (i.e. methyl) was present on the benzylic position all the necroptosis inhibitory activity resided with the (S)-enantiomer.  Finally, replacement of the [1,2,3]thiadiazole with a variety of thiophene derivs. was tolerated, although some erosion of potency was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2f7iOQs6QnLVg90H21EOLACvtfcHk0ljH0mjHF1nc2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWjtL7E&md5=3e0da099adbfbe07217adef2771b5c25</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DJeevanandam%26aufirst%3DA.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520%255B1%252C2%252C3%255Dthiadiazole%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6836%26epage%3D6840%26doi%3D10.1016%2Fj.bmcl.2007.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3219</span>– <span class="NLM_lpage">3223</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2008.04.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=18467094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1yiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3219-3223&author=X.+Tengauthor=H.+Keysauthor=J.+Yuanauthor=A.+Degterevauthor=G.+D.+Cuny&title=Structure-activity+relationship+and+liver+microsome+stability+studies+of+pyrrole+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Keys, Heather; Yuan, Junying; Degterev, Alexei; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3219-3223</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death pathway resulting in morphol. reminiscent of passive nonregulated necrosis.  Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of [1,2,3]thiadiazole benzylamide derivs.  However, initial evaluation of mouse liver microsome stability indicated that this series of compds. was rapidly degraded.  A structure-activity relationship (SAR) study of the [1,2,3]thiadiazole benzylamide series revealed that increased mouse liver microsome stability and increased necroptosis inhibitory activity could be accomplished by replacement of the 4-cyclopropyl-[1,2,3]thiadiazole with a 5-cyano-1-methylpyrrole.  In addn., the SAR and the cellular activity profiles, utilizing different cell types and necroptosis-inducing stimuli, of representative [1,2,3]thiadiazole and pyrrole derivs. were very similar suggesting that the two compd. series inhibit necroptosis in the same manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3pYcZsdMo4bVg90H21EOLACvtfcHk0ljH0mjHF1nc2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1yiu7o%253D&md5=ef94e23fda4b78eab1b53c3ed22565bb</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.048%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520and%2520liver%2520microsome%2520stability%2520studies%2520of%2520pyrrole%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3219%26epage%3D3223%26doi%3D10.1016%2Fj.bmcl.2008.04.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1465</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.bmcl.2006.11.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=17270434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1455-1465&author=K.+Wangauthor=J.+Liauthor=A.+Degterevauthor=E.+Hsuauthor=J.+Yuanauthor=C.+Yuan&title=Structure-activity+relationship+analysis+of+a+novel+necroptosis+inhibitor%2C+necrostatin-5&doi=10.1016%2Fj.bmcl.2006.11.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5</span></div><div class="casAuthors">Wang, Ke; Li, Jinfeng; Degterev, Alexei; Hsu, Emily; Yuan, Junying; Yuan, Chengye</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1455-1465</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Necrostatin-5 (Nec-5) is a novel potent small-mol. inhibitor of necroptosis structurally distinct from previously described Necrostatin-1 (Nec-1), and therefore, represents a new direction for the inhibition of this cellular caspase-independent necrotic cell death mechanism.  Here, the authors describe a series of structural modifications of Nec-5 and the structure-activity relationship (SAR) of Nec-5 series in inhibiting necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbt5G1OwRibVg90H21EOLACvtfcHk0ljH0mjHF1nc2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtLY%253D&md5=fd40143368ccf1df86cebfe52fcc074a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520a%2520novel%2520necroptosis%2520inhibitor%252C%2520necrostatin-5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1455%26epage%3D1465%26doi%3D10.1016%2Fj.bmcl.2006.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Do, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.yexcr.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28803066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCltrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&pages=30-38&author=Y.+J.+Doauthor=J.+W.+Sulauthor=K.+H.+Jangauthor=N.+S.+Kangauthor=Y.+H.+Kimauthor=Y.+G.+Kimauthor=E.+Kim&title=A+novel+RIPK1+inhibitor+that+prevents+retinal+degeneration+in+a+rat+glaucoma+model&doi=10.1016%2Fj.yexcr.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model</span></div><div class="casAuthors">Do, Yun-Ju; Sul, Jee-Won; Jang, Ki-Hong; Kang, Nam Sook; Kim, Young-Hoon; Kim, Young-Gwan; Kim, Eunhee</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-38</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In glaucoma, retinal ganglion cells (RGCs) are exposed to ischemic stress with elevation of the intraocular pressure and are subsequently lost.  Necroptosis, a type of regulated necrosis, is known to play a pivotal role in this loss.  We obsd. that receptor-interacting protein kinase 1 (RIPK1), the key player of necroptosis, was activated by diverse ischemic stresses, including TCZ, chem. hypoxia (CH), and oxygen glucose deprivation (OGD).  In this study, we introduce a RIPK1-inhibitory compd. (RIC) with a novel scaffold.  RIC inhibited downstream events following RIPK1 activation, including necrosome formation and mitochondrial dysfunction in RGC5 cells.  Moreover, RIC protected RGCs against ischemic injury in the rat glaucoma model, which was induced by acute high intraocular pressure.  However, RIC displayed biochem. characteristics that are distinct from those of previous RIPK1 inhibitors (necrostatin-1; Nec-1 and Compd. 27; Cpd27).  RIC protected RGCs against OGD insult, while Nec-1 and Cpd27 did not.  Conversely, Nec-1 and Cpd27 protected RGCs from TNF-stimulated death, while RIC failed to inhibit the death of RGCs.  This implies that RIPK1 activates alternative pathways depending on the context of the ischemic insults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrQPQIQ65XpLVg90H21EOLACvtfcHk0lh9q_UNgnb8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCltrfM&md5=7edf4033beccc888c20d93fb47681bf5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DY.%2BJ.%26aulast%3DSul%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DK.%2BH.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DA%2520novel%2520RIPK1%2520inhibitor%2520that%2520prevents%2520retinal%2520degeneration%2520in%2520a%2520rat%2520glaucoma%2520model%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D359%26spage%3D30%26epage%3D38%26doi%3D10.1016%2Fj.yexcr.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Cann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delehouze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier-Penna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filliol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalande, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piquet-Pellorce, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faurez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettey, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goekjian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimanche-Boitrel, M. T.</span></span> <span> </span><span class="NLM_article-title">Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3050</span>– <span class="NLM_lpage">3068</span>, <span class="refDoi"> DOI: 10.1111/febs.14176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Ffebs.14176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28715128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSgsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=3050-3068&author=F.+Le%0ACannauthor=C.+Delehouzeauthor=S.+Leverrier-Pennaauthor=A.+Filliolauthor=A.+Comteauthor=O.+Delalandeauthor=N.+Desbanauthor=B.+Baratteauthor=I.+Gallaisauthor=C.+Piquet-Pellorceauthor=F.+Faurezauthor=M.+Bonnetauthor=Y.+Metteyauthor=P.+Goekjianauthor=M.+Samsonauthor=P.+Vandenabeeleauthor=S.+Bachauthor=M.+T.+Dimanche-Boitrel&title=Sibiriline%2C+a+new+small+chemical+inhibitor+of+receptor-interacting+protein+kinase+1%2C+prevents+immune-dependent+hepatitis&doi=10.1111%2Ffebs.14176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis</span></div><div class="casAuthors">Le Cann, Fabienne; Delehouze, Claire; Leverrier-Penna, Sabrina; Filliol, Aveline; Comte, Arnaud; Delalande, Olivier; Desban, Nathalie; Baratte, Blandine; Gallais, Isabelle; Piquet-Pellorce, Claire; Faurez, Florence; Bonnet, Marion; Mettey, Yvette; Goekjian, Peter; Samson, Michel; Vandenabeele, Peter; Bach, Stephane; Dimanche-Boitrel, Marie-Therese</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3050-3068</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Necroptosis is a regulated form of cell death involved in several disease models including in particular liver diseases.  Receptor-interacting protein kinases, RIPK1 and RIPK3, are the main serine/threonine kinases driving this cell death pathway.  We screened a noncommercial, kinase-focused chem. library which allowed us to identify Sibiriline as a new inhibitor of necroptosis induced by tumor necrosis factor (TNF) in Fas-assocd. protein with death domain (FADD)-deficient Jurkat cells.  Moreover, Sib inhibits necroptotic cell death induced by various death ligands in human or mouse cells while not protecting from caspase-dependent apoptosis.  By using competition binding assay and recombinant kinase assays, we demonstrated that Sib is a rather specific competitive RIPK1 inhibitor.  Mol. docking anal. shows that Sib is trapped closed to human RIPK1 ATP-binding site in a relatively hydrophobic pocket locking RIPK1 in an inactive conformation.  In agreement with its RIPK1 inhibitory property, Sib inhibits both TNF-induced RIPK1-dependent necroptosis and RIPK1-dependent apoptosis.  Finally, Sib protects mice from Con A-induced hepatitis.  These results reveal the small-mol. Sib as a new RIPK1 inhibitor potentially of interest for the treatment of immune-dependent hepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOShDtyIUxXrVg90H21EOLACvtfcHk0lh9q_UNgnb8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSgsbnO&md5=08b7e21652891c30728f969681c162ae</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14176%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BCann%26aufirst%3DF.%26aulast%3DDelehouze%26aufirst%3DC.%26aulast%3DLeverrier-Penna%26aufirst%3DS.%26aulast%3DFilliol%26aufirst%3DA.%26aulast%3DComte%26aufirst%3DA.%26aulast%3DDelalande%26aufirst%3DO.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGallais%26aufirst%3DI.%26aulast%3DPiquet-Pellorce%26aufirst%3DC.%26aulast%3DFaurez%26aufirst%3DF.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DMettey%26aufirst%3DY.%26aulast%3DGoekjian%26aufirst%3DP.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DDimanche-Boitrel%26aufirst%3DM.%2BT.%26atitle%3DSibiriline%252C%2520a%2520new%2520small%2520chemical%2520inhibitor%2520of%2520receptor-interacting%2520protein%2520kinase%25201%252C%2520prevents%2520immune-dependent%2520hepatitis%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D3050%26epage%3D3068%26doi%3D10.1111%2Ffebs.14176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2012.05.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.ab.2012.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=22658960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVekur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=164-174&author=J.+L.+Makiauthor=E.+E.+Smithauthor=X.+Tengauthor=S.+S.+Rayauthor=G.+D.+Cunyauthor=A.+Degterev&title=Fluorescence+polarization+assay+for+inhibitors+of+the+kinase+domain+of+receptor+interacting+protein+1&doi=10.1016%2Fj.ab.2012.05.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1</span></div><div class="casAuthors">Maki, Jenny L.; Smith, Elizabeth E.; Teng, Xin; Ray, Soumya S.; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necrotic cell death is prevalent in many different pathol. disease states and in traumatic injury.  Necroptosis is a form of necrosis that stems from specific signaling pathways, with the key regulator being receptor interacting protein 1 (RIP1), a serine/threonine kinase.  Specific inhibitors of RIP1, termed necrostatins, are potent inhibitors of necroptosis.  Necrostatins are structurally distinct from one another yet still possess the ability to inhibit RIP1 kinase activity.  To further understand the differences in the binding of the various necrostatins to RIP1 and to develop a robust high-throughput screening (HTS) assay, which can be used to identify new classes of RIP1 inhibitors, we synthesized fluorescein derivs. of Necrostatin-1 (Nec-1) and Nec-3.  These compds. were used to establish a fluorescence polarization (FP) assay to directly measure the binding of necrostatins to RIP1 kinase.  The fluorescein-labeled compds. are well suited for HTS because the assays have a DMSO (DMSO) tolerance up to 5% and Z' scores of 0.62 (fluorescein-Nec-1) and 0.57 (fluorescein-Nec-3).  In addn., results obtained from the FP assays and ligand docking studies provide insights into the putative binding sites of Nec-1, Nec-3, and Nec-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRs-1l1HAXBLVg90H21EOLACvtfcHk0lh9q_UNgnb8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVekur%252FP&md5=459d3cad4920efb0000a06c6b452b028</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2012.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2012.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DE.%2BE.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DFluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520the%2520kinase%2520domain%2520of%2520receptor%2520interacting%2520protein%25201%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D427%26spage%3D164%26epage%3D174%26doi%3D10.1016%2Fj.ab.2012.05.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Execution of RIPK3-regulated necrosis</span>. <i>Mol. Cell Oncol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e960759</span>, <span class="refDoi"> DOI: 10.4161/23723548.2014.960759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.4161%2F23723548.2014.960759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27308332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=e960759&author=Z.+Caiauthor=Z.+G.+Liu&title=Execution+of+RIPK3-regulated+necrosis&doi=10.4161%2F23723548.2014.960759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Execution of RIPK3-regulated necrosis</span></div><div class="casAuthors">Cai, Zhenyu; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e960759/1-e960759/7</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated necrotic cell death that is mediated by receptor-interacting protein 1 (RIP1) and RIP3 kinases.  Diverse receptors, including death receptors, Toll-like receptors, interferon receptors, and DAI DNA receptors are able to trigger necroptosis.  The newly identified MLKL protein functions downstream of RIP1/RIP3 and is essential for the execution of necroptosis.  Studies also indicate involvement of reactive oxygen species and calcium and sodium ions.  Identification of the key mediators of necroptosis is crit. for understanding the mol. mechanisms of the necroptotic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt35ztg1n-rrVg90H21EOLACvtfcHk0liJ6hQ0eq4W3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN&md5=65d7f10e73fc3e518584c01f9ded2975</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.960759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.960759%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DExecution%2520of%2520RIPK3-regulated%2520necrosis%26jtitle%3DMol.%2520Cell%2520Oncol%26date%3D2014%26volume%3D1%26spage%3De960759%26doi%3D10.4161%2F23723548.2014.960759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">31268</span>– <span class="NLM_lpage">31279</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.462341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1074%2Fjbc.M113.462341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24019532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yhsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=31268-31279&author=W.+J.+Kaiserauthor=H.+Sridharanauthor=C.+Huangauthor=P.+Mandalauthor=J.+W.+Uptonauthor=P.+J.+Goughauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=E.+S.+Mocarski&title=Toll-like+receptor+3-mediated+necrosis+via+TRIF%2C+RIP3%2C+and+MLKL&doi=10.1074%2Fjbc.M113.462341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL</span></div><div class="casAuthors">Kaiser, William J.; Sridharan, Haripriya; Huang, Chunzi; Mandal, Pratyusha; Upton, Jason W.; Gough, Peter J.; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Mocarski, Edward S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">31268-31279</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR) signaling is triggered by pathogen-assocd. mol. patterns that mediate well established cytokine-driven pathways, activating NF-κB together with IRF3/IRF7.  In addn., TLR3 drives caspase 8-regulated programmed cell death pathways reminiscent of TNF family death receptor signaling.  We find that inhibition or elimination of caspase 8 during stimulation of TLR2, TLR3, TLR4, TLR5, or TLR9 results in receptor interacting protein (RIP) 3 kinase-dependent programmed necrosis that occurs through either TIR domain-contg. adapter-inducing interferon-β (TRIF) or MyD88 signal transduction.  TLR3 or TLR4 directly activates programmed necrosis through a RIP homotypic interaction motif-dependent assocn. of TRIF with RIP3 kinase (also called RIPK3).  In fibroblasts, this pathway proceeds independent of RIP1 or its kinase activity, but it remains dependent on mixed lineage kinase domain-like protein (MLKL) downstream of RIP3 kinase.  Here, we describe two small mol. RIP3 kinase inhibitors and employ them to demonstrate the common requirement for RIP3 kinase in programmed necrosis induced by RIP1-RIP3, DAI-RIP3, and TRIF-RIP3 complexes.  Cell fate decisions following TLR signaling parallel death receptor signaling and rely on caspase 8 to suppress RIP3-dependent programmed necrosis whether initiated directly by a TRIF-RIP3-MLKL pathway or indirectly via TNF activation and the RIP1-RIP3-MLKL necroptosis pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNB5p5-dbMrVg90H21EOLACvtfcHk0liJ6hQ0eq4W3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yhsL%252FL&md5=b31c4a29d6e0fd1b5e72fdafe208a9cb</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.462341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.462341%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DSridharan%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DUpton%26aufirst%3DJ.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26atitle%3DToll-like%2520receptor%25203-mediated%2520necrosis%2520via%2520TRIF%252C%2520RIP3%252C%2520and%2520MLKL%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D31268%26epage%3D31279%26doi%3D10.1074%2Fjbc.M113.462341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley-Bauer, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roback, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span> <span> </span><span class="NLM_article-title">RIP3 induces apoptosis independent of pronecrotic kinase activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.molcel.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25459880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=481-495&author=P.+Mandalauthor=S.+B.+Bergerauthor=S.+Pillayauthor=K.+Moriwakiauthor=C.+Huangauthor=H.+Guoauthor=J.+D.+Lichauthor=J.+Fingerauthor=V.+Kasparcovaauthor=B.+Vottaauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=A.+S.+Lakdawalaauthor=M.+P.+DeMartinoauthor=L.+N.+Casillasauthor=P.+A.+Haileauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Uptonauthor=L.+P.+Daley-Bauerauthor=L.+Robackauthor=N.+Ramiaauthor=C.+M.+Doveyauthor=J.+E.+Caretteauthor=F.+K.+Chanauthor=J.+Bertinauthor=P.+J.+Goughauthor=E.+S.+Mocarskiauthor=W.+J.+Kaiser&title=RIP3+induces+apoptosis+independent+of+pronecrotic+kinase+activity&doi=10.1016%2Fj.molcel.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity</span></div><div class="casAuthors">Mandal, Pratyusha; Berger, Scott B.; Pillay, Sirika; Moriwaki, Kenta; Huang, Chunzi; Guo, Hongyan; Lich, John D.; Finger, Joshua; Kasparcova, Viera; Votta, Bart; Ouellette, Michael; King, Bryan W.; Wisnoski, David; Lakdawala, Ami S.; DeMartino, Michael P.; Casillas, Linda N.; Haile, Pamela A.; Sehon, Clark A.; Marquis, Robert W.; Upton, Jason; Daley-Bauer, Lisa P.; Roback, Linda; Ramia, Nancy; Dovey, Cole M.; Carette, Jan E.; Chan, Francis Ka-Ming; Bertin, John; Gough, Peter J.; Mocarski, Edward S.; Kaiser, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-495</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease.  Here, three selective small-mol. compds. are shown to inhibit RIP3 kinase-dependent necroptosis, although their therapeutic value is undermined by a surprising, concn.-dependent induction of apoptosis.  These compds. interact with RIP3 to activate caspase 8 (Casp8) via RHIM-driven recruitment of RIP1 (RIPK1) to assemble a Casp8-FADD-cFLIP complex completely independent of pronecrotic kinase activities and MLKL.  RIP3 kinase-dead D161N mutant induces spontaneous apoptosis independent of compd., whereas D161G, D143N, and K51A mutants, like wild-type, only trigger apoptosis when compd. is present.  Accordingly, RIP3-K51A mutant mice (Rip3K51A/K51A) are viable and fertile, in stark contrast to the perinatal lethality of Rip3D161N/D161N mice.  RIP3 therefore holds both necroptosis and apoptosis in balance through a Ripoptosome-like platform.  This work highlights a common mechanism unveiling RHIM-driven apoptosis by therapeutic or genetic perturbation of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaOmUttaymrVg90H21EOLACvtfcHk0liJ6hQ0eq4W3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK&md5=43567ddc4cb1b78b17294118acb8a951</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DPillay%26aufirst%3DS.%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DDeMartino%26aufirst%3DM.%2BP.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DUpton%26aufirst%3DJ.%26aulast%3DDaley-Bauer%26aufirst%3DL.%2BP.%26aulast%3DRoback%26aufirst%3DL.%26aulast%3DRamia%26aufirst%3DN.%26aulast%3DDovey%26aufirst%3DC.%2BM.%26aulast%3DCarette%26aufirst%3DJ.%2BE.%26aulast%3DChan%26aufirst%3DF.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26atitle%3DRIP3%2520induces%2520apoptosis%2520independent%2520of%2520pronecrotic%2520kinase%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D481%26epage%3D495%26doi%3D10.1016%2Fj.molcel.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cripps, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2015.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=26024392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSiurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=76-88&author=D.+A.+Rodriguezauthor=R.+Weinlichauthor=S.+Brownauthor=C.+Guyauthor=P.+Fitzgeraldauthor=C.+P.+Dillonauthor=A.+Oberstauthor=G.+Quaratoauthor=J.+Lowauthor=J.+G.+Crippsauthor=T.+Chenauthor=D.+R.+Green&title=Characterization+of+RIPK3-mediated+phosphorylation+of+the+activation+loop+of+MLKL+during+necroptosis&doi=10.1038%2Fcdd.2015.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis</span></div><div class="casAuthors">Rodriguez, D. A.; Weinlich, R.; Brown, S.; Guy, C.; Fitzgerald, P.; Dillon, C. P.; Oberst, A.; Quarato, G.; Low, J.; Cripps, J. G.; Chen, T.; Green, D. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-88</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like pseudokinase (MLKL) mediates necroptosis by translocating to the plasma membrane and inducing its rupture.  The activation of MLKL occurs in a multimol. complex (the 'necrosome'), which is comprised of MLKL, receptor-interacting serine/threonine kinase (RIPK)-3 (RIPK3) and, in some cases, RIPK1.  Within this complex, RIPK3 phosphorylates the activation loop of MLKL, promoting conformational changes and allowing the formation of MLKL oligomers, which migrate to the plasma membrane.  Previous studies suggested that RIPK3 could phosphorylate the murine MLKL activation loop at Ser345, Ser347 and Thr349.  Moreover, substitution of the Ser345 for an aspartic acid creates a constitutively active MLKL, independent of RIPK3 function.  Here we examine the role of each of these residues and found that the phosphorylation of Ser345 is crit. for RIPK3-mediated necroptosis, Ser347 has a minor accessory role and Thr349 seems to be irrelevant.  We generated a specific monoclonal antibody to detect phospho-Ser345 in murine cells.  Using this antibody, a series of MLKL mutants and a novel RIPK3 inhibitor, we demonstrate that the phosphorylation of Ser345 is not required for the interaction between RIPK3 and MLKL in the necrosome, but is essential for MLKL translocation, accumulation in the plasma membrane, and consequent necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjrS_O0spUN7Vg90H21EOLACvtfcHk0lj6-OUHLIFuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSiurjF&md5=85f1eb0ff4ddaf746855d456f6ee6f6e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.70%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DGuy%26aufirst%3DC.%26aulast%3DFitzgerald%26aufirst%3DP.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DQuarato%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DJ.%26aulast%3DCripps%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520RIPK3-mediated%2520phosphorylation%2520of%2520the%2520activation%2520loop%2520of%2520MLKL%2520during%2520necroptosis%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D76%26epage%3D88%26doi%3D10.1038%2Fcdd.2015.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">125</span>, <span class="refDoi"> DOI: 10.1038/s12276-018-0152-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs12276-018-0152-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=30237400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BB3czhtVWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=125&author=H.+H.+Parkauthor=S.+Y.+Parkauthor=S.+Mahauthor=J.+H.+Parkauthor=S.+S.+Hongauthor=S.+Hongauthor=Y.+S.+Kim&title=HS-1371%2C+a+novel+kinase+inhibitor+of+RIP3-mediated+necroptosis&doi=10.1038%2Fs12276-018-0152-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis</span></div><div class="casAuthors">Park Han-Hee; Park Se-Yeon; Kim You-Sun; Park Han-Hee; Park Se-Yeon; Kim You-Sun; Mah Shinmee; Hong Sungwoo; Mah Shinmee; Hong Sungwoo; Park Jung-Hee; Hong Soon-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & molecular medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">125</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a type of programmed cell death that usually occurs under apoptosis-deficient conditions.  Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is a central player in necroptosis, and its kinase activity is essential for downstream necroptotic signaling events.  Since RIP3 kinase activity has been associated with various diseases, the development of specific RIP3 inhibitors is an attractive strategy for therapeutic application.  In this study, we identified a potent RIP3 inhibitor, HS-1371, by the extensive screening of chemical libraries focused on kinases.  HS-1371 directly binds to RIP3 in an ATP-competitive and time-independent manner, providing a mechanism of action.  Moreover, the compound inhibited TNF-induced necroptosis but did not inhibit TNF-induced apoptosis, indicating that this novel inhibitor has a specific inhibitory effect on RIP3-mediated necroptosis via the suppression of RIP3 kinase activity.  Our results suggest that HS-1371 could serve as a potential preventive or therapeutic agent for diseases involving RIP3 hyperactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPh9ctMIKK5Oqrn-c4Of3KfW6udTcc2ea9sOESFC0m2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czhtVWmtA%253D%253D&md5=9b064775dbc9415b930d2654e06f5971</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fs12276-018-0152-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-018-0152-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DMah%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DHS-1371%252C%2520a%2520novel%2520kinase%2520inhibitor%2520of%2520RIP3-mediated%2520necroptosis%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2018%26volume%3D50%26spage%3D125%26doi%3D10.1038%2Fs12276-018-0152-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span> <span> </span><span class="NLM_article-title">The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1278</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2014.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24901049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1278&author=J.+X.+Liauthor=J.+M.+Fengauthor=Y.+Wangauthor=X.+H.+Liauthor=X.+X.+Chenauthor=Y.+Suauthor=Y.+Y.+Shenauthor=Y.+Chenauthor=B.+Xiongauthor=C.+H.+Yangauthor=J.+Dingauthor=Z.+H.+Miao&title=The+B-Raf%28V600E%29+inhibitor+dabrafenib+selectively+inhibits+RIP3+and+alleviates+acetaminophen-induced+liver+injury&doi=10.1038%2Fcddis.2014.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span></div><div class="casAuthors">Li, J.-X.; Feng, J-.M.; Wang, Y.; Li, X.-H.; Chen, X.-X.; Su, Y.; Shen, Y.-Y.; Chen, Y.; Xiong, B.; Yang, C.-H.; Ding, J.; Miao, Z.-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1278</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein (RIP)3 is a crit. regulator of necroptosis and has been demonstrated to be assocd. with various diseases, suggesting that its inhibitors are promising in the clinic.  However, there have been few RIP3 inhibitors reported as yet.  B-RafV600E inhibitors are an important anticancer drug class for metastatic melanoma therapy.  In this study, we found that 6 B-Raf inhibitors could inhibit RIP3 enzymic activity in vitro.  Among them, dabrafenib showed the most potent inhibition on RIP3, which was achieved by its ATP-competitive binding to the enzyme.  Dabrafenib displayed highly selective inhibition on RIP3 over RIP1, RIP2 and RIP5.  Moreover, only dabrafenib rescued cells from RIP3-mediated necroptosis induced by the necroptosis-induced combinations, i.e., tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand or Fas ligand plus Smac mimetic and the caspase inhibitor z-VAD.  Dabrafenib decreased the RIP3-mediated Ser358 phosphorylation of mixed lineage kinase domain-like protein (MLKL) and disrupted the interaction between RIP3 and MLKL.  Notably, RIP3 inhibition of dabrafenib appeared to be independent of its B-Raf inhibition.  Dabrafenib was further revealed to prevent acetaminophen-induced necrosis in normal human hepatocytes, which is considered to be mediated by RIP3.  In acetaminophen-overdosed mouse models, dabrafenib was found to apparently ease the acetaminophen-caused liver damage.  The results indicate that the anticancer B-RafV600E inhibitor dabrafenib is a RIP3 inhibitor, which could serve as a sharp tool for probing the RIP3 biol. and as a potential preventive or therapeutic agent for RIP3-involved necroptosis-related diseases such as acetaminophen-induced liver damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40b524L_pOLVg90H21EOLACvtfcHk0lidLdPfG46lWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D&md5=a425dc91c461e5725d553428187db972</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DX.%2BX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26atitle%3DThe%2520B-Raf%2528V600E%2529%2520inhibitor%2520dabrafenib%2520selectively%2520inhibits%2520RIP3%2520and%2520alleviates%2520acetaminophen-induced%2520liver%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1278%26doi%3D10.1038%2Fcddis.2014.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2904</span>, <span class="refDoi"> DOI: 10.1038/cddis.2017.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcddis.2017.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28661484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e2904&author=S.+Martensauthor=M.+Jeongauthor=W.+Tonnusauthor=F.+Feldmannauthor=S.+Hofmansauthor=V.+Goossensauthor=N.+Takahashiauthor=J.+H.+Brasenauthor=E.+W.+Leeauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Fuldaauthor=A.+Linkermannauthor=J.+Songauthor=P.+Vandenabeele&title=Sorafenib+tosylate+inhibits+directly+necrosome+complex+formation+and+protects+in+mouse+models+of+inflammation+and+tissue+injury&doi=10.1038%2Fcddis.2017.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span></div><div class="casAuthors">Martens, Sofie; Jeong, Manhyung; Tonnus, Wulf; Feldmann, Friederike; Hofmans, Sam; Goossens, Vera; Takahashi, Nozomi; Brasen, Jan Hinrich; Lee, Eun-Woo; Van der Veken, Pieter; Joossens, Jurgen; Augustyns, Koen; Fulda, Simone; Linkermann, Andreas; Song, Jaewhan; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2904</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis contributes to the pathophysiol. of several inflammatory, infectious and degenerative disorders.  TNF-induced necroptosis involves activation of the receptor-interacting protein kinases 1 and 3 (RIPK1/3) in a necrosome complex, eventually leading to the phosphorylation and relocation of mixed lineage kinase domain like protein (MLKL).  Using a high-content screening of small compds. and FDA-approved drug libraries, we identified the anti-cancer drug Sorafenib tosylate as a potent inhibitor of TNF-dependent necroptosis.  Interestingly, Sorafenib has a dual activity spectrum depending on its concn.  In murine and human cell lines it induces cell death, while at lower concns. it inhibits necroptosis, without affecting NF-κB activation.  Pull down expts. with biotinylated Sorafenib show that it binds independently RIPK1, RIPK3 and MLKL.  Moreover, it inhibits RIPK1 and RIPK3 kinase activity.  In vivo Sorafenib protects against TNF-induced systemic inflammatory response syndrome (SIRS) and renal ischemia-reperfusion injury (IRI).  Altogether, we show that Sorafenib can, next to the reported Braf/Mek/Erk and VEGFR pathways, also target the necroptotic pathway and that it can protect in an acute inflammatory RIPK1/3-mediated pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfswPD82jd67Vg90H21EOLACvtfcHk0lht88pz2GGfGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO&md5=bb4e411a5d4a9a76e2a52d84075ddb3c</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.298%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DM.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DSorafenib%2520tosylate%2520inhibits%2520directly%2520necrosome%2520complex%2520formation%2520and%2520protects%2520in%2520mouse%2520models%2520of%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26spage%3De2904%26doi%3D10.1038%2Fcddis.2017.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span> <span> </span><span class="NLM_article-title">N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d] thiazol-2-yl)cyclopropanecarboxamide (TAK-632) analogues as novel necroptosis inhibitors by targeting receptor-interacting protein kinase 3 (RIPK3): synthesis, structure-activity relationships, and in vivo efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6665</span>– <span class="NLM_lpage">6681</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVOkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6665-6681&author=H.+Zhangauthor=L.+Xuauthor=X.+Qinauthor=X.+Chenauthor=H.+Congauthor=L.+Huauthor=L.+Chenauthor=Z.+Miaoauthor=W.+Zhangauthor=Z.+Caiauthor=C.+Zhuang&title=N-%287-cyano-6-%284-fluoro-3-%282-%283-%28trifluoromethyl%29phenyl%29acetamido%29phenoxy%29benzo%5Bd%5D+thiazol-2-yl%29cyclopropanecarboxamide+%28TAK-632%29+analogues+as+novel+necroptosis+inhibitors+by+targeting+receptor-interacting+protein+kinase+3+%28RIPK3%29%3A+synthesis%2C+structure-activity+relationships%2C+and+in+vivo+efficacy&doi=10.1021%2Facs.jmedchem.9b00611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure-Activity Relationships, and in Vivo Efficacy</span></div><div class="casAuthors">Zhang, Hao; Xu, Lijuan; Qin, Xia; Chen, Xiaofei; Cong, Hui; Hu, Longmiao; Chen, Long; Miao, Zhenyuan; Zhang, Wannian; Cai, Zhenyu; Zhuang, Chunlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6665-6681</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Necroptosis, a form of programmed cell death, plays a crit. role in various diseases, including inflammatory, infectious, and degenerative diseases.  We previously identified N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (6) as a potent inhibitor of necroptosis by targeting both receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) kinases.  Herein, we performed three rounds of structural optimizations of TAK-632 and elucidated structure-activity relationships to generate more potent inhibitors by targeting RIPK3.  The analogs with carbamide groups exhibited great antinecroptotic activities, and compd. 42 showed >60-fold selectivity for RIPK3 than RIPK1.  It blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells.  In a tumor necrosis factor-induced systemic inflammatory response syndrome model, it significantly protected mice from hypothermia and death at a dose of 5 mg/kg, which was much more effective than TAK-632.  Moreover, it showed favorable and druglike pharmacokinetic properties in rats with an oral bioavailability of 25.2%.  Thus, these RIPK3-targeting small mols. represent promising lead structures for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1wo_oM-kczbVg90H21EOLACvtfcHk0lht88pz2GGfGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVOkurs%253D&md5=a854b3004c4055a47a3935756f49cc55</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00611%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCong%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DZhuang%26aufirst%3DC.%26atitle%3DN-%25287-cyano-6-%25284-fluoro-3-%25282-%25283-%2528trifluoromethyl%2529phenyl%2529acetamido%2529phenoxy%2529benzo%255Bd%255D%2520thiazol-2-yl%2529cyclopropanecarboxamide%2520%2528TAK-632%2529%2520analogues%2520as%2520novel%2520necroptosis%2520inhibitors%2520by%2520targeting%2520receptor-interacting%2520protein%2520kinase%25203%2520%2528RIPK3%2529%253A%2520synthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6665%26epage%3D6681%26doi%3D10.1021%2Facs.jmedchem.9b00611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural insights into RIP3-mediated necroptotic signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.celrep.2013.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24095729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=70-78&author=T.+Xieauthor=W.+Pengauthor=C.+Yanauthor=J.+Wuauthor=X.+Gongauthor=Y.+Shi&title=Structural+insights+into+RIP3-mediated+necroptotic+signaling&doi=10.1016%2Fj.celrep.2013.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into RIP3-Mediated Necroptotic Signaling</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Yan, Chuangye; Wu, Jianping; Gong, Xinqi; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3 is an essential upstream kinase in necroptosis.  The pseudokinase MLKL functions as a substrate of RIP3 to mediate downstream signaling.  The mol. mechanism by which RIP3 recognizes and phosphorylates MLKL remains unknown.  Here, we report the crystal structures of the mouse RIP3 kinase domain, the MLKL kinase-like domain, and a binary complex between the two.  Both RIP3 and MLKL adopt the canonical kinase fold.  Free RIP3 exists in an active conformation, whereas MLKL-bound RIP3 is stabilized by AMP-PNP to adopt an inactive conformation.  The formation of the RIP3-MLKL complex, involving their resp. N- and C-lobes, is accompanied by pronounced conformational changes of the αC helix and activation loop in RIP3 and the corresponding structural elements in MLKL.  RIP3-mediated MLKL phosphorylation, though important for downstream signaling, is dispensable for stable complex formation between RIP3 and MLKL.  Our study serves as a framework for mechanistic understanding of RIP3-mediated necroptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7R60YS-0cP7Vg90H21EOLACvtfcHk0lhkqxV-FU7_AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL&md5=53fa2aefe1223dfca855a95d28e5d478</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520insights%2520into%2520RIP3-mediated%2520necroptotic%2520signaling%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D5%26spage%3D70%26epage%3D78%26doi%3D10.1016%2Fj.celrep.2013.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A. C.</span>; <span class="NLM_string-name">Abell, L.</span>; <span class="NLM_string-name">Guo, J.</span>; <span class="NLM_string-name">Mertzman, M. E.</span>; <span class="NLM_string-name">Padmanabha, R.</span>; <span class="NLM_string-name">Macor, J. E.</span>; <span class="NLM_string-name">Chaudhry, C.</span>; <span class="NLM_string-name">Lu, H.</span>; <span class="NLM_string-name">O’Malley, K.</span>; <span class="NLM_string-name">Shaw, P. J.</span>; <span class="NLM_string-name">Weigelt, C.</span>; <span class="NLM_string-name">Pokross, M.</span>; <span class="NLM_string-name">Kish, K.</span>; <span class="NLM_string-name">Kim, K. S.</span>; <span class="NLM_string-name">Cornelius, L.</span>; <span class="NLM_string-name">Douglas, A. E.</span>; <span class="NLM_string-name">Calambur, D.</span>; <span class="NLM_string-name">Zhang, P.</span>; <span class="NLM_string-name">Carpenter, B.</span>; <span class="NLM_string-name">Pitts, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIPK3 type II inhibitors using high-throughput mechanistic studies in hit triage</span>.  <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00065</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=A.+C.+Hart&author=L.+Abell&author=J.+Guo&author=M.+E.+Mertzman&author=R.+Padmanabha&author=J.+E.+Macor&author=C.+Chaudhry&author=H.+Lu&author=K.+O%E2%80%99Malley&author=P.+J.+Shaw&author=C.+Weigelt&author=M.+Pokross&author=K.+Kish&author=K.+S.+Kim&author=L.+Cornelius&author=A.+E.+Douglas&author=D.+Calambur&author=P.+Zhang&author=B.+Carpenter&author=W.+J.+Pitts&title=Identification+of+RIPK3+type+II+inhibitors+using+high-throughput+mechanistic+studies+in+hit+triage&doi=10.1021%2Facsmedchemlett.9b00065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00065%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520of%2520RIPK3%2520type%2520II%2520inhibitors%2520using%2520high-throughput%2520mechanistic%2520studies%2520in%2520hit%2520triage%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26doi%3D10.1021%2Facsmedchemlett.9b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span> <span> </span><span class="NLM_article-title">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1039/c3md00278k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1039%2Fc3md00278k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1yls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=333-337&author=D.+Liaoauthor=L.+Sunauthor=W.+Liuauthor=S.+Heauthor=X.+Wangauthor=X.+Lei&title=Necrosulfonamide+inhibits+necroptosis+by+selectively+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2Fc3md00278k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span></div><div class="casAuthors">Liao, Daohong; Sun, Liming; Liu, Weilong; He, Sudan; Wang, Xiaodong; Lei, Xiaoguang</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-337</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Through high-throughput screening of 200 000 compds. and subsequent structure-activity relationship (SAR) studies we identified necrosulfonamide (NSA) as a potent small mol. inhibitor for necroptosis, induced by a combination of TNF-a, Smac mimetic, and z-VAD-fmk (T/S/Z).  Applying a forward chem. genetic approach, we utilized an NSA based chem. probe to further reveal that NSA selectively targeted the Mixed Lineage Kinase Domain-like Protein (MLKL) to block the necrosome formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Hlqz0b1OmbVg90H21EOLACvtfcHk0lhkqxV-FU7_AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1yls78%253D&md5=a1a32fada660dc22dd208e64e2ecda87</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2Fc3md00278k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00278k%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26atitle%3DNecrosulfonamide%2520inhibits%2520necroptosis%2520by%2520selectively%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D333%26epage%3D337%26doi%3D10.1039%2Fc3md00278k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3637</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1039/C7CC00667E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1039%2FC7CC00667E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=28267172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=3637-3640&author=B.+Yanauthor=L.+Liuauthor=S.+Huangauthor=Y.+Renauthor=H.+Wangauthor=Z.+Yaoauthor=L.+Liauthor=S.+Chenauthor=X.+Wangauthor=Z.+Zhang&title=Discovery+of+a+new+class+of+highly+potent+necroptosis+inhibitors+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2FC7CC00667E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein</span></div><div class="casAuthors">Yan, Bo; Liu, Lei; Huang, Shaoqiang; Ren, Yan; Wang, Huayi; Yao, Zhenglin; Li, Lin; Chen, She; Wang, Xiaodong; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3637-3640</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report the development of novel Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitors with single nanomolar potency (compd. 15 is also named as TC13172).  Using the converting biochem. to chem. activity-based protein profiling (BTC-ABPP) method, the authors were able to det. that the inhibitors covalently bind to Cysteine 86 (Cys 86) of MLKL.  This is the first example of the use of LC-MS/MS to identify the binding site of an MLKL inhibitor.  The novel MLKL inhibitors provide powerful tools to study the biol. function of MLKL and demonstrate that MLKL should be viewed as a druggable target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9iUTEGlqF7Vg90H21EOLACvtfcHk0ljLJ-oL0hdApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVSgsrk%253D&md5=e3b110a609ce907845d00ca6d7a29cae</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2FC7CC00667E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC00667E%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520highly%2520potent%2520necroptosis%2520inhibitors%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2017%26volume%3D53%26spage%3D3637%26epage%3D3640%26doi%3D10.1039%2FC7CC00667E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucet, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spall, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripaydonis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babon, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcair, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">15072</span>– <span class="NLM_lpage">15077</span>, <span class="refDoi"> DOI: 10.1073/pnas.1408987111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1408987111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25288762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15072-15077&author=J.+M.+Hildebrandauthor=M.+C.+Tanzerauthor=I.+S.+Lucetauthor=S.+N.+Youngauthor=S.+K.+Spallauthor=P.+Sharmaauthor=C.+Pierottiauthor=J.+M.+Garnierauthor=R.+C.+Dobsonauthor=A.+I.+Webbauthor=A.+Tripaydonisauthor=J.+J.+Babonauthor=M.+D.+Mulcairauthor=M.+J.+Scanlonauthor=W.+S.+Alexanderauthor=A.+F.+Wilksauthor=P.+E.+Czabotarauthor=G.+Lesseneauthor=J.+M.+Murphyauthor=J.+Silke&title=Activation+of+the+pseudokinase+MLKL+unleashes+the+four-helix+bundle+domain+to+induce+membrane+localization+and+necroptotic+cell+death&doi=10.1073%2Fpnas.1408987111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death</span></div><div class="casAuthors">Hildebrand, Joanne M.; Tanzer, Maria C.; Lucet, Isabelle S.; Young, Samuel N.; Spall, Sukhdeep K.; Sharma, Pooja; Pierotti, Catia; Garnier, Jean-Marc; Dobson, Renwick C. J.; Webb, Andrew I.; Tripaydonis, Anne; Babon, Jeffrey J.; Mulcair, Mark D.; Scanlon, Martin J.; Alexander, Warren S.; Wilks, Andrew F.; Czabotar, Peter E.; Lessene, Guillaume; Murphy, James M.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15072-15077</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Necroptosis is considered to be complementary to the classical caspase-dependent programmed cell death pathway, apoptosis.  The pseudokinase Mixed Lineage Kinase Domain-Like (MLKL) is an essential effector protein in the necroptotic cell death pathway downstream of the protein kinase Receptor Interacting Protein Kinase-3 (RIPK3).  How MLKL causes cell death is unclear, however RIPK3-mediated phosphorylation of the activation loop in MLKL trips a mol. switch to induce necroptotic cell death.  Here, we show that the MLKL pseudokinase domain acts as a latch to restrain the N-terminal four-helix bundle (4HB) domain and that unleashing this domain results in formation of a high-mol.-wt., membrane-localized complex and cell death.  Using alanine-scanning mutagenesis, we identified two clusters of residues on opposing faces of the 4HB domain that were required for the 4HB domain to kill cells.  The integrity of one cluster was essential for membrane localization, whereas MLKL mutations in the other cluster did not prevent membrane translocation but prevented killing; this demonstrates that membrane localization is necessary, but insufficient, to induce cell death.  Finally, we identified a small mol. that binds the nucleotide binding site within the MLKL pseudokinase domain and retards MLKL translocation to membranes, thereby preventing necroptosis.  This inhibitor provides a novel tool to investigate necroptosis and demonstrates the feasibility of using small mols. to target the nucleotide binding site of pseudokinases to modulate signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBj_zEe5HYP7Vg90H21EOLACvtfcHk0ljLJ-oL0hdApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtLnJ&md5=4acef514a3c5a8c3b7fb7dd7b61dc2cd</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1408987111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1408987111%26sid%3Dliteratum%253Aachs%26aulast%3DHildebrand%26aufirst%3DJ.%2BM.%26aulast%3DTanzer%26aufirst%3DM.%2BC.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BN.%26aulast%3DSpall%26aufirst%3DS.%2BK.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DPierotti%26aufirst%3DC.%26aulast%3DGarnier%26aufirst%3DJ.%2BM.%26aulast%3DDobson%26aufirst%3DR.%2BC.%26aulast%3DWebb%26aufirst%3DA.%2BI.%26aulast%3DTripaydonis%26aufirst%3DA.%26aulast%3DBabon%26aufirst%3DJ.%2BJ.%26aulast%3DMulcair%26aufirst%3DM.%2BD.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DW.%2BS.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520pseudokinase%2520MLKL%2520unleashes%2520the%2520four-helix%2520bundle%2520domain%2520to%2520induce%2520membrane%2520localization%2520and%2520necroptotic%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D15072%26epage%3D15077%26doi%3D10.1073%2Fpnas.1408987111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramasivam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolotti-Ciarlet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moree, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L. F.</span></span> <span> </span><span class="NLM_article-title">ATP-competitive MLKL binders have no functional impact on necroptosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0165983</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0165983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1371%2Fjournal.pone.0165983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27832137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlWnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0165983&author=B.+Maauthor=D.+Marcotteauthor=M.+Paramasivamauthor=K.+Michelsenauthor=T.+Wangauthor=A.+Bertolotti-Ciarletauthor=J.+H.+Jonesauthor=B.+Moreeauthor=M.+Butkoauthor=J.+Salafskyauthor=X.+Sunauthor=T.+McKeeauthor=L.+F.+Silvian&title=ATP-competitive+MLKL+binders+have+no+functional+impact+on+necroptosis&doi=10.1371%2Fjournal.pone.0165983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-competitive MLKL binders have no functional impact on necroptosis</span></div><div class="casAuthors">Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Howard, Jones John; Moree, Ben; Butko, Margaret; Salafsky, Joshua; Sun, Xin; McKee, Timothy; Silvian, Laura F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e0165983/1-e0165983/19</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">MLKL is a pore forming pseudokinase involved in the final stage of necroptosis, a form of programmed cell death.  Its phosphorylation by RIPK3 is necessary for triggering necroptosis but not for triggering apoptosis, which makes it a unique target for pharmacol. inhibition to block necroptotic cell death.  This mechanism has been described as playing a role in disease progression in neurodegenerative and inflammatory diseases.  A type II kinase inhibitor (cpd 1) has been described that reportedly binds to the MLKL pseudokinase domain and prevents necroptosis.  Here we describe five compds. that bind to the MLKL ATP-binding site, however the four MLKL-selective compds. have no activity in rescuing cells from necroptosis.  We use kinase selectivity panels, crystallog. and a new conformationally sensitive method of measuring protein conformational changes (SHG) to confirm that the one previously reported compd. that can rescue cells (cpd 1) is a non-selective type II inhibitor that also inhibits the upstream kinase RIPK1.  Although this compd. can shift the GFE motif of the activation loop to an "out" position, the accessibility of the key residue Ser358 in the MLKL activation loop is not affected by compd. binding to the MLKL active site.  Our studies indicate that an ATP-pocket inhibitor of the MLKL pseudokinase domain does not have any impact on the necroptosis pathway, which is contrary to a previously reported study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg4NB28MjYebVg90H21EOLACvtfcHk0ljLJ-oL0hdApA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlWnur4%253D&md5=2e8429a8d5a591faa411e1515362bf8b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0165983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0165983%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DParamasivam%26aufirst%3DM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBertolotti-Ciarlet%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DMoree%26aufirst%3DB.%26aulast%3DButko%26aufirst%3DM.%26aulast%3DSalafsky%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DMcKee%26aufirst%3DT.%26aulast%3DSilvian%26aufirst%3DL.%2BF.%26atitle%3DATP-competitive%2520MLKL%2520binders%2520have%2520no%2520functional%2520impact%2520on%2520necroptosis%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0165983%26doi%3D10.1371%2Fjournal.pone.0165983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span>Denali
Therapeutics. <a href="https://denalitherapeutics.com/pipeline" class="extLink">https://denalitherapeutics.com/pipeline</a> (accessed June 12, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Denali%0ATherapeutics.+https%3A%2F%2Fdenalitherapeutics.com%2Fpipeline+%28accessed+June+12%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moynagh, P. N.</span></span> <span> </span><span class="NLM_article-title">RIP kinases: key decision makers in cell death and innate immunity</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/cdd.2014.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcdd.2014.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=25146926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCrsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=225-236&author=F.+Humphriesauthor=S.+Yangauthor=B.+Wangauthor=P.+N.+Moynagh&title=RIP+kinases%3A+key+decision+makers+in+cell+death+and+innate+immunity&doi=10.1038%2Fcdd.2014.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">RIP kinases: key decision makers in cell death and innate immunity</span></div><div class="casAuthors">Humphries, F.; Yang, S.; Wang, B.; Moynagh, P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-236</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Innate immunity represents the first line of defense against invading pathogens.  It consists of an initial inflammatory response that recruits white blood cells to the site of infection in an effort to destroy and eliminate the pathogen.  Some pathogens replicate within host cells, and cell death by apoptosis is an important effector mechanism to remove the replication niche for such microbes.  However, some microbes have evolved evasive strategies to block apoptosis, and in these cases host cells may employ further countermeasures, including an inflammatory form of cell death know as necroptosis.  This review aims to highlight the importance of the RIP kinase family in controlling these various defense strategies.  RIP1 is initially discussed as a key component of death receptor signalling and in the context of dictating whether a cell triggers a pathway of pro-inflammatory gene expression or cell death by apoptosis.  The mol. and functional interplay of RIP1 and RIP3 is described, esp. with respect to mediating necroptosis and as key mediators of inflammation.  The function of RIP2, with particular emphasis on its role in NOD signalling, is also explored.  Special attention is given to emphasizing the physiol. and pathophysiol. contexts for these various functions of RIP kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPApofbdnkLLVg90H21EOLACvtfcHk0liRS-rbxSeKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCrsLnP&md5=f25195c56cf9a7553367a4eed0f1b34a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.126%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMoynagh%26aufirst%3DP.%2BN.%26atitle%3DRIP%2520kinases%253A%2520key%2520decision%2520makers%2520in%2520cell%2520death%2520and%2520innate%2520immunity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26spage%3D225%26epage%3D236%26doi%3D10.1038%2Fcdd.2014.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Receptor-interacting protein (RIP) kinase family</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/cmi.2010.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fcmi.2010.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=20383176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=243-249&author=D.+Zhangauthor=J.+Linauthor=J.+Han&title=Receptor-interacting+protein+%28RIP%29+kinase+family&doi=10.1038%2Fcmi.2010.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-interacting protein (RIP) kinase family</span></div><div class="casAuthors">Zhang, Duanwu; Lin, Juan; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Receptor-interacting protein (RIP) kinases are a group of threonine/serine protein kinases with a relatively conserved kinase domain but distinct non-kinase regions.  A no. of different domain structures, such as death and caspase activation and recruitment domain (CARD) domains, were found in different RIP family members, and these domains should be keys in detg. the specific function of each RIP kinase.  It is known that RIP kinases participate in different biol. processes, including those in innate immunity, but their downstream substrates are largely unknown.  This review will give an overview of the structures and functions of RIP family members, and an update of recent progress in RIP kinase research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICS9EnND6QLVg90H21EOLACvtfcHk0liRS-rbxSeKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSms7w%253D&md5=e110b4cbd223b7ddef4855830c7d4156</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2010.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2010.10%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DReceptor-interacting%2520protein%2520%2528RIP%2529%2520kinase%2520family%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2010%26volume%3D7%26spage%3D243%26epage%3D249%26doi%3D10.1038%2Fcmi.2010.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chirieleison, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kertesy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D. W.</span></span> <span> </span><span class="NLM_article-title">Synthetic biology reveals the uniqueness of the RIP kinase domain</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">4291</span>– <span class="NLM_lpage">4297</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1502631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.4049%2Fjimmunol.1502631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27045108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=4291-4297&author=S.+M.+Chirieleisonauthor=S.+B.+Kertesyauthor=D.+W.+Abbott&title=Synthetic+biology+reveals+the+uniqueness+of+the+RIP+kinase+domain&doi=10.4049%2Fjimmunol.1502631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain</span></div><div class="casAuthors">Chirieleison, Steven M.; Kertesy, Sylvia B.; Abbott, Derek W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4291-4297</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The RIP kinases (RIPKs) play an essential role in inflammatory signaling and inflammatory cell death.  However, the function of their kinase activity has been enigmatic, and only recently has kinase domain activity been shown to be crucial for their signal transduction capacity.  Despite this uncertainty, the RIPKs have been the subject of intense pharmaceutical development with a no. of compds. currently in preclin. testing.  In this work, we seek to det. the functional redundancy between the kinase domains of the four major RIPK family members.  We find that although RIPK1, RIPK2, and RIPK4 are similar in that they can all activate NF-κB and induce NF-κB essential modulator ubiquitination, only RIPK2 is a dual-specificity kinase.  Domain swapping expts. showed that the RIPK4 kinase domain could be converted to a dual-specificity kinase and is essentially indistinct from RIPK2 in biochem. and mol. activity.  Surprisingly, however, replacement of RIPK2's kinase domain with RIPK4's did not complement a nucleotide-binding oligomerization domain 2 signaling or gene expression induction defect in RIPK2-/- macrophages.  These findings suggest that RIPK2's kinase domain is functionally unique compared with other RIPK family members and that pharmacol. targeting of RIPK2 can be sepd. from the other RIPKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BtYagqNBrVg90H21EOLACvtfcHk0liRS-rbxSeKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCntLg%253D&md5=b5482ea6e9e0c17c8d097686d208430f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1502631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1502631%26sid%3Dliteratum%253Aachs%26aulast%3DChirieleison%26aufirst%3DS.%2BM.%26aulast%3DKertesy%26aufirst%3DS.%2BB.%26aulast%3DAbbott%26aufirst%3DD.%2BW.%26atitle%3DSynthetic%2520biology%2520reveals%2520the%2520uniqueness%2520of%2520the%2520RIP%2520kinase%2520domain%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26spage%3D4291%26epage%3D4297%26doi%3D10.4049%2Fjimmunol.1502631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-independent signaling by the RIP kinases in inflammation</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2203-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1007%2Fs00018-016-2203-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27048814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2325-2334&author=K.+Moriwakiauthor=F.+K.+Chan&title=Necroptosis-independent+signaling+by+the+RIP+kinases+in+inflammation&doi=10.1007%2Fs00018-016-2203-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-independent signaling by the RIP kinases in inflammation</span></div><div class="casAuthors">Moriwaki, Kenta; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Recent advances have identified a signaling cascade involving receptor interacting protein kinase 1 (RIPK1), RIPK3 and the pseudokinase mixed lineage kinase domain-like (MLKL) that is crucial for induction of necroptosis, a non-apoptotic form of cell death.  RIPK1-RIPK3-MLKL-mediated necroptosis has been attributed to cause many inflammatory diseases through the release of cellular damage-assocd. mol. patterns (DAMPs).  In addn. to necroptosis, emerging evidence suggests that these necroptosis signal adaptors can also facilitate inflammation independent of cell death.  In particular, the RIP kinases can drive NF-κB and inflammasome activation independent of cell death.  In this review, we will discuss recent discoveries that led to this realization and present arguments why cell death-independent signaling by the RIP kinases may have a more important role in inflammation than necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wW0-uJ6xhbVg90H21EOLACvtfcHk0lgyETuA7rEVbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D&md5=8ba1cc7565ca54604626eb5d030dce48</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2203-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2203-4%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DNecroptosis-independent%2520signaling%2520by%2520the%2520RIP%2520kinases%2520in%2520inflammation%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2325%26epage%3D2334%26doi%3D10.1007%2Fs00018-016-2203-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Targeting RIPK1 for the treatment of human diseases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9714</span>– <span class="NLM_lpage">9722</span>, <span class="refDoi"> DOI: 10.1073/pnas.1901179116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1073%2Fpnas.1901179116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=31048504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Clu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=9714-9722&author=A.+Degterevauthor=D.+Ofengeimauthor=J.+Yuan&title=Targeting+RIPK1+for+the+treatment+of+human+diseases&doi=10.1073%2Fpnas.1901179116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RIPK1 for the treatment of human diseases</span></div><div class="casAuthors">Degterev, Alexei; Ofengeim, Dimitry; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9714-9722</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  RIPK1 kinase has emerged as a promising therapeutic target for the treatment of a wide range of human neurodegenerative, autoimmune, and inflammatory diseases.  This was supported by extensive studies which demonstrated that RIPK1 is a key mediator of apoptotic and necrotic cell death as well as inflammatory pathways.  Furthermore, human genetic evidence has linked the dysregulation of RIPK1 to the pathogenesis of ALS as well as other inflammatory and neurodegenerative diseases.  Importantly, unique allosteric small-mol. inhibitors of RIPK1 that offer high selectivity have been developed.  These mols. can penetrate the blood-brain barrier, thus offering the possibility to target neuroinflammation and cell death which drive various neurol. conditions including Alzheimer's disease, ALS, and multiple sclerosis as well as acute neurol. diseases such as stroke and traumatic brain injuries.  We discuss the current understanding of RIPK1 regulatory mechanisms and emerging evidence for the pathol. roles of RIPK1 in human diseases, esp. in the context of the central nervous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCMIOEQUbM87Vg90H21EOLACvtfcHk0lgyETuA7rEVbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Clu7s%253D&md5=c3c83482fe0621d4775dcd2dd6e36af5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1901179116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1901179116%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DOfengeim%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DTargeting%2520RIPK1%2520for%2520the%2520treatment%2520of%2520human%2520diseases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D9714%26epage%3D9722%26doi%3D10.1073%2Fpnas.1901179116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cripps, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quarato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llambi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janke, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelliher, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanneganti, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.cell.2014.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24813850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=1189-1202&author=C.+P.+Dillonauthor=R.+Weinlichauthor=D.+A.+Rodriguezauthor=J.+G.+Crippsauthor=G.+Quaratoauthor=P.+Gurungauthor=K.+C.+Verbistauthor=T.+L.+Brewerauthor=F.+Llambiauthor=Y.+N.+Gongauthor=L.+J.+Jankeauthor=M.+A.+Kelliherauthor=T.+D.+Kannegantiauthor=D.+R.+Green&title=RIPK1+blocks+early+postnatal+lethality+mediated+by+caspase-8+and+RIPK3&doi=10.1016%2Fj.cell.2014.04.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3</span></div><div class="casAuthors">Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Janke, Laura J.; Kelliher, Michelle A.; Kanneganti, Thirumala-Devi; Green, Douglas R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1202</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase (RIPK)-1 is involved in RIPK3-dependent and -independent signaling pathways leading to cell death and/or inflammation.  Genetic ablation of ripk1 causes postnatal lethality, which was not prevented by deletion of ripk3, caspase-8, or fadd.  However, animals that lack RIPK1, RIPK3, and either caspase-8 or FADD survived weaning and matured normally.  RIPK1 functions in vitro to limit caspase-8-dependent, TNFR-induced apoptosis, and animals lacking RIPK1, RIPK3, and TNFR1 survive to adulthood.  The role of RIPK3 in promoting lethality in ripk1-/- mice suggests that RIPK3 activation is inhibited by RIPK1 postbirth.  Whereas TNFR-induced RIPK3-dependent necroptosis requires RIPK1, cells lacking RIPK1 were sensitized to necroptosis triggered by poly I:C or interferons.  Disruption of TLR (TRIF) or type I interferon (IFNAR) signaling delayed lethality in ripk1-/-tnfr1-/- mice.  These results clarify the complex roles for RIPK1 in postnatal life and provide insights into the regulation of FADD-caspase-8 and RIPK3-MLKL signaling by RIPK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7TSpMVJ47sLVg90H21EOLACvtfcHk0lgyETuA7rEVbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGru74%253D&md5=e1b4cca701a96c7860515fa61ff03552</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DCripps%26aufirst%3DJ.%2BG.%26aulast%3DQuarato%26aufirst%3DG.%26aulast%3DGurung%26aufirst%3DP.%26aulast%3DVerbist%26aufirst%3DK.%2BC.%26aulast%3DBrewer%26aufirst%3DT.%2BL.%26aulast%3DLlambi%26aufirst%3DF.%26aulast%3DGong%26aufirst%3DY.%2BN.%26aulast%3DJanke%26aufirst%3DL.%2BJ.%26aulast%3DKelliher%26aufirst%3DM.%2BA.%26aulast%3DKanneganti%26aufirst%3DT.%2BD.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DRIPK1%2520blocks%2520early%2520postnatal%2520lethality%2520mediated%2520by%2520caspase-8%2520and%2520RIPK3%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D1189%26epage%3D1202%26doi%3D10.1016%2Fj.cell.2014.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickliffe, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almagro, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komuves, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1126/science.1249361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1126%2Fscience.1249361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=24557836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=1357-1360&author=K.+Newtonauthor=D.+L.+Duggerauthor=K.+E.+Wickliffeauthor=N.+Kapoorauthor=M.+C.+de+Almagroauthor=D.+Vucicauthor=L.+Komuvesauthor=R.+E.+Ferrandoauthor=D.+M.+Frenchauthor=J.+Websterauthor=M.+Roose-Girmaauthor=S.+Warmingauthor=V.+M.+Dixit&title=Activity+of+protein+kinase+RIPK3+determines+whether+cells+die+by+necroptosis+or+apoptosis&doi=10.1126%2Fscience.1249361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis</span></div><div class="casAuthors">Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; de Almagro, M. Cristina; Vucic, Domagoj; Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua; Roose-Girma, Merone; Warming, Soren; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6177</span>),
    <span class="NLM_cas:pages">1357-1360</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 trigger pro-inflammatory cell death termed "necroptosis.".  Studies with RIPK3-deficient mice or the RIPK1 inhibitor necrostatin-1 suggest that necroptosis exacerbates pathol. in many disease models.  We engineered mice expressing catalytically inactive RIPK3 D161N or RIPK1 D138N to det. the need for the active kinase in the whole animal.  Unexpectedly, RIPK3 D161N promoted lethal RIPK1- and caspase-8-dependent apoptosis.  In contrast, mice expressing RIPK1 D138N were viable and, like RIPK3-deficient mice, resistant to tumor necrosis factor (TNF)-induced hypothermia.  Cells expressing RIPK1 D138N were resistant to TNF-induced necroptosis, whereas TNF-induced signaling pathways promoting gene transcription were unperturbed.  Our data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_ux2V9rge7Vg90H21EOLACvtfcHk0lilsqHd8RuvQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D&md5=a07b82bee66bdc1fe471b15e3294792b</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249361%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDugger%26aufirst%3DD.%2BL.%26aulast%3DWickliffe%26aufirst%3DK.%2BE.%26aulast%3DKapoor%26aufirst%3DN.%26aulast%3Dde%2BAlmagro%26aufirst%3DM.%2BC.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DKomuves%26aufirst%3DL.%26aulast%3DFerrando%26aufirst%3DR.%2BE.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DWebster%26aufirst%3DJ.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DActivity%2520of%2520protein%2520kinase%2520RIPK3%2520determines%2520whether%2520cells%2520die%2520by%2520necroptosis%2520or%2520apoptosis%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D1357%26epage%3D1360%26doi%3D10.1126%2Fscience.1249361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werba, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giao Ly, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alothman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alqunaibit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Hernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergamo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambirinis, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pansari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>532</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/nature17403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fnature17403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27049944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=245-249&author=L.+Seifertauthor=G.+Werbaauthor=S.+Tiwariauthor=N.+N.+Giao+Lyauthor=S.+Alothmanauthor=D.+Alqunaibitauthor=A.+Avanziauthor=R.+Barillaauthor=D.+Daleyauthor=S.+H.+Grecoauthor=A.+Torres-Hernandezauthor=M.+Pergamoauthor=A.+Ochiauthor=C.+P.+Zambirinisauthor=M.+Pansariauthor=M.+Rendonauthor=D.+Tippensauthor=M.+Hundeyinauthor=V.+R.+Maniauthor=C.+Hajduauthor=D.+Engleauthor=G.+Miller&title=The+necrosome+promotes+pancreatic+oncogenesis+via+CXCL1+and+Mincle-induced+immune+suppression&doi=10.1038%2Fnature17403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression</span></div><div class="casAuthors">Seifert, Lena; Werba, Gregor; Tiwari, Shaun; Ly, Nancy Ngoc Giao; Alothman, Sara; Alqunaibit, Dalia; Avanzi, Antonina; Barilla, Rocky; Daley, Donnele; Greco, Stephanie H.; Torres-Hernandez, Alejandro; Pergamo, Matthew; Ochi, Atsuo; Zambirinis, Constantinos P.; Pansari, Mridul; Rendon, Mauricio; Tippens, Daniel; Hundeyin, Mautin; Mani, Vishnu R.; Hajdu, Cristina; Engle, Dannielle; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7598</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neoplastic pancreatic epithelial cells are believed to die through caspase 8-dependent apoptotic cell death, and chemotherapy is thought to promote tumor apoptosis.  Conversely, cancer cells often disrupt apoptosis to survive.  Another type of programmed cell death is necroptosis (programmed necrosis), but its role in pancreatic ductal adenocarcinoma (PDA) is unclear.  There are many potential inducers of necroptosis in PDA, including ligation of tumor necrosis factor receptor 1 (TNFR1), CD95, TNF-related apoptosis-inducing ligand (TRAIL) receptors, Toll-like receptors, reactive oxygen species, and chemotherapeutic drugs.  Here we report that the principal components of the necrosome, receptor-interacting protein (RIP)1 and RIP3, are highly expressed in PDA and are further upregulated by the chemotherapy drug gemcitabine.  Blockade of the necrosome in vitro promoted cancer cell proliferation and induced an aggressive oncogenic phenotype.  By contrast, in vivo deletion of RIP3 or inhibition of RIP1 protected against oncogenic progression in mice and was assocd. with the development of a highly immunogenic myeloid and T cell infiltrate.  The immune-suppressive tumor microenvironment assocd. with intact RIP1/RIP3 signalling depended in part on necroptosis-induced expression of the chemokine attractant CXCL1, and CXCL1 blockade protected against PDA.  Moreover, cytoplasmic SAP130 (a subunit of the histone deacetylase complex) was expressed in PDA in a RIP1/RIP3-dependent manner, and Mincle-its cognate receptor-was upregulated in tumor-infiltrating myeloid cells.  Ligation of Mincle by SAP130 promoted oncogenesis, whereas deletion of Mincle protected against oncogenesis and phenocopied the immunogenic reprogramming of the tumor microenvironment that was induced by RIP3 deletion.  Cellular depletion suggested that whereas inhibitory macrophages promote tumorigenesis in PDA, they lose their immune-suppressive effects when RIP3 or Mincle is deleted.  Accordingly, T cells, which are not protective against PDA progression in mice with intact RIP3 or Mincle signalling, are reprogrammed into indispensable mediators of anti-tumor immunity in the absence of RIP3 or Mincle.  Our work describes parallel networks of necroptosis-induced CXCL1 and Mincle signalling that promote macrophage-induced adaptive immune suppression and thereby enable PDA progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpme8FBoik-1LVg90H21EOLACvtfcHk0lilsqHd8RuvQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gs7s%253D&md5=7c9b5b47993341fdadb9c0983e1eea7b</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnature17403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17403%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DL.%26aulast%3DWerba%26aufirst%3DG.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DGiao%2BLy%26aufirst%3DN.%2BN.%26aulast%3DAlothman%26aufirst%3DS.%26aulast%3DAlqunaibit%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DA.%26aulast%3DBarilla%26aufirst%3DR.%26aulast%3DDaley%26aufirst%3DD.%26aulast%3DGreco%26aufirst%3DS.%2BH.%26aulast%3DTorres-Hernandez%26aufirst%3DA.%26aulast%3DPergamo%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DZambirinis%26aufirst%3DC.%2BP.%26aulast%3DPansari%26aufirst%3DM.%26aulast%3DRendon%26aufirst%3DM.%26aulast%3DTippens%26aufirst%3DD.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DMani%26aufirst%3DV.%2BR.%26aulast%3DHajdu%26aufirst%3DC.%26aulast%3DEngle%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DThe%2520necrosome%2520promotes%2520pancreatic%2520oncogenesis%2520via%2520CXCL1%2520and%2520Mincle-induced%2520immune%2520suppression%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D245%26epage%3D249%26doi%3D10.1038%2Fnature17403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">Assessing lysine and cysteine reactivities for designing targeted covalent kinase inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">6553</span>– <span class="NLM_lpage">6560</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=6553-6560&author=R.+Liuauthor=Z.+Yueauthor=C.+C.+Tsaiauthor=J.+Shen&title=Assessing+lysine+and+cysteine+reactivities+for+designing+targeted+covalent+kinase+inhibitors&doi=10.1021%2Fjacs.8b13248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors</span></div><div class="casAuthors">Liu, Ruibin; Yue, Zhi; Tsai, Cheng-Chieh; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6553-6560</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted covalent inhibitor design is gaining increasing interest and acceptance.  A typical covalent kinase inhibitor design targets a reactive cysteine; however, this strategy is limited by the low abundance of cysteine and acquired drug resistance from point mutations.  Inspired by the recent development of lysine-targeted chem. probes, we asked if nucleophilic (reactive) catalytic lysines are common on the basis of the published crystal structures of the human kinome.  Using a newly developed pKa prediction tool based on continuous const. pH mol. dynamics, the catalytic lysines of eight unique kinases from various human kinase groups were retrospectively and prospectively predicted to be nucleophilic, when kinase is in the rare DFG-out/αC-out type of conformation.  Importantly, other reactive lysines as well as cysteines at various locations were also identified.  On the basis of the findings, we proposed a new strategy in which selective type II reversible kinase inhibitors are modified to design highly selective, lysine-targeted covalent inhibitors.  Traditional covalent drugs were discovered serendipitously; the presented tool, which can assess the reactivities of any potentially targetable residues, may accelerate the rational discovery of new covalent inhibitors.  Another significant finding of the work is that lysines and cysteines in kinases may adopt neutral and charged states at physiol. pH, resp.  This finding may shift the current paradigm of computational studies of kinases, which assume fixed soln. protonation states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXUZJq48FZTLVg90H21EOLACvtfcHk0lgxBqL0bVbXwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgur8%253D&md5=aab2762e5cbcedae163c38445f48bdd7</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13248%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DTsai%26aufirst%3DC.%2BC.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DAssessing%2520lysine%2520and%2520cysteine%2520reactivities%2520for%2520designing%2520targeted%2520covalent%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D6553%26epage%3D6560%26doi%3D10.1021%2Fjacs.8b13248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0lgxBqL0bVbXwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07526.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1111%2Fj.1471-4159.2011.07526.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=21985437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=70-77&author=W.+W.+Chenauthor=H.+Yuauthor=H.+B.+Fanauthor=C.+C.+Zhangauthor=M.+Zhangauthor=C.+Zhangauthor=Y.+Chengauthor=J.+Kongauthor=C.+F.+Liuauthor=D.+Gengauthor=X.+Xu&title=RIP1+mediates+the+protection+of+geldanamycin+on+neuronal+injury+induced+by+oxygen-glucose+deprivation+combined+with+zVAD+in+primary+cortical+neurons&doi=10.1111%2Fj.1471-4159.2011.07526.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons</span></div><div class="casAuthors">Chen, Wei-Wei; Yu, Hailong; Fan, Hong-Bin; Zhang, Cui-Cui; Zhang, Min; Zhang, Caiyi; Cheng, Yanbo; Kong, Jiming; Liu, Chun-Feng; Geng, Deqin; Xu, Xingshun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Caspase-dependent apoptosis is considered one of the most important cell death pathways.  When the apoptotic process is blocked, a form of programmed necrosis called necroptosis occurs.  Apoptosis and necroptosis may share some regulatory mechanisms.  Recent studies indicated that receptor interacting protein 1 (RIP1), an Hsp90-assocd. kinase, is an important regulatory switch between apoptosis and necroptosis.  In this study, we showed that oxygen-glucose deprivation (OGD) combined with a caspase inhibitor zVAD (OGD/zVAD)-induced RIP1 protein expression in a time-dependent manner.  We found that geldanamycin (GA), a benzoquinone ansamycin, protected against neuronal injury induced by OGD/zVAD treatment in cultured primary neurons.  More importantly, GA decreased RIP1 protein level in a time- and concn.-dependent manner.  In this study, we found that GA also decreased the Hsp90 protein level, which caused instability of RIP1 protein, resulting in decreased RIP1 protein level but not RIP1 mRNA level after GA treatment.  We concluded that the GA-mediated protection against OGD/zVAD-induced neuronal injury was assocd. with enhanced RIP1 protein instability by decreasing Hsp90 protein level.  GA and its derivs. may be promising for the prevention of neuronal injury during ischemic injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrackQ7AKU6MLVg90H21EOLACvtfcHk0lgxBqL0bVbXwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygtbs%253D&md5=1afb3022b78177cf4c93269a162a943d</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07526.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07526.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BW.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%2BF.%26aulast%3DGeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DRIP1%2520mediates%2520the%2520protection%2520of%2520geldanamycin%2520on%2520neuronal%2520injury%2520induced%2520by%2520oxygen-glucose%2520deprivation%2520combined%2520with%2520zVAD%2520in%2520primary%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26spage%3D70%26epage%3D77%26doi%3D10.1111%2Fj.1471-4159.2011.07526.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span> <span> </span><span class="NLM_article-title">Natural product Kongensin A is a non-canonical HSP90 inhibitor that blocks RIP3-dependent necroptosis</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1016%2Fj.chembiol.2015.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=27028885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=257-266&author=D.+Liauthor=C.+Liauthor=L.+Liauthor=S.+Chenauthor=L.+Wangauthor=Q.+Liauthor=X.+Wangauthor=X.+Leiauthor=Z.+Shen&title=Natural+product+Kongensin+A+is+a+non-canonical+HSP90+inhibitor+that+blocks+RIP3-dependent+necroptosis&doi=10.1016%2Fj.chembiol.2015.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis</span></div><div class="casAuthors">Li, Dianrong; Li, Chao; Li, Lin; Chen, She; Wang, Lei; Li, Qiang; Wang, Xiaodong; Lei, Xiaoguang; Shen, Zhirong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3-dependent necroptosis has recently garnered significant interest because of the unique signaling mechanisms and pathol. functions involved in this process.  Accordingly, a no. of chem. screens have identified several effective small-mol. inhibitors that specifically block necroptosis.  Here, we report the discovery that kongensin A (KA), a natural product isolated from Croton kongensis, is a potent inhibitor of necroptosis and an inducer of apoptosis.  Using a new bioorthogonal ligation method (TQ ligation), we reveal that the direct cellular target of KA is heat shock protein 90 (HSP90).  Further studies demonstrate that KA covalently binds to a previously uncharacterized cysteine 420 in the middle domain of HSP90 and dissocs. HSP90 from its cochaperone CDC37, which leads to inhibition of RIP3-dependent necroptosis and promotion of apoptosis in multiple cancer cell lines.  Collectively, our findings demonstrate that KA is an effective HSP90 inhibitor that has potential anti-necroptosis and anti-inflammation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCEeQjx4di8rVg90H21EOLACvtfcHk0lgCbO7GvcqH5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D&md5=0750612b811f8bd7379feca734ab6014</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DZ.%26atitle%3DNatural%2520product%2520Kongensin%2520A%2520is%2520a%2520non-canonical%2520HSP90%2520inhibitor%2520that%2520blocks%2520RIP3-dependent%2520necroptosis%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D257%26epage%3D266%26doi%3D10.1016%2Fj.chembiol.2015.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delehouze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier-Penna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Cann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquard-Fevai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalande, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faurez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauteville, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goekjian, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuillier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimanche-Boitrel, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span> <span> </span><span class="NLM_article-title">6E11, a highly selective inhibitor of receptor-interacting protein kinase 1, protects cells against cold hypoxia-reoxygenation injury</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12931</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-12788-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.1038%2Fs41598-017-12788-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=29018243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252Fptlahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=12931&author=C.+Delehouzeauthor=S.+Leverrier-Pennaauthor=F.+Le+Cannauthor=A.+Comteauthor=M.+Jacquard-Fevaiauthor=O.+Delalandeauthor=N.+Desbanauthor=B.+Baratteauthor=I.+Gallaisauthor=F.+Faurezauthor=M.+C.+Bonnetauthor=M.+Hautevilleauthor=P.+G.+Goekjianauthor=R.+Thuillierauthor=F.+Favreauauthor=P.+Vandenabeeleauthor=T.+Hauetauthor=M.+T.+Dimanche-Boitrelauthor=S.+Bach&title=6E11%2C+a+highly+selective+inhibitor+of+receptor-interacting+protein+kinase+1%2C+protects+cells+against+cold+hypoxia-reoxygenation+injury&doi=10.1038%2Fs41598-017-12788-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury</span></div><div class="casAuthors">Delehouze C; Desban N; Baratte B; Bach S; Leverrier-Penna S; Le Cann F; Gallais I; Faurez F; Bonnet M C; Dimanche-Boitrel M T; Leverrier-Penna S; Le Cann F; Gallais I; Faurez F; Bonnet M C; Dimanche-Boitrel M T; Le Cann F; Vandenabeele P; Le Cann F; Vandenabeele P; Comte A; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Jacquard-Fevai M; Thuillier R; Favreau F; Hauet T; Delalande O; Bonnet M C; Hauteville M; Goekjian P G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12931</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Necroptosis is a programmed cell death pathway that has been shown to be of central pathophysiological relevance in multiple disorders (hepatitis, brain and cardiac ischemia, pancreatitis, viral infection and inflammatory diseases).  Necroptosis is driven by two serine threonine kinases, RIPK1 (Receptor Interacting Protein Kinase 1) and RIPK3, and a pseudo-kinase MLKL (Mixed Lineage Kinase domain-Like) associated in a multi-protein complex called necrosome.  In order to find new inhibitors for use in human therapy, a chemical library containing highly diverse chemical structures was screened using a cell-based assay.  The compound 6E11, a natural product derivative, was characterized as a positive hit.  Interestingly, this flavanone compound: inhibits necroptosis induced by death receptors ligands TNF-α (Tumor Necrosis Factor) or TRAIL (TNF-Related Apoptosis-Inducing Ligand); is an extremely selective inhibitor, among kinases, of human RIPK1 enzymatic activity with a nM Kd; has a non-ATP competitive mode of action and a novel putative binding site; is weakly cytotoxic towards human primary blood leukocytes or retinal pigment epithelial cells at effective concentrations; protects human aortic endothelial cells (HAEC) from cold hypoxia/reoxygenation injury more effectively than necrostatin-1 (Nec-1) and Nec-1s.  Altogether, these data demonstrate that 6E11 is a novel potent small molecular inhibitor of RIPK1-driven necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVJKELZUTFBlHFYivNCdPRfW6udTcc2ebzUVFoEcSEArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252Fptlahug%253D%253D&md5=ca9cc681c13af6a490fef52eacecef6a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-12788-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-12788-4%26sid%3Dliteratum%253Aachs%26aulast%3DDelehouze%26aufirst%3DC.%26aulast%3DLeverrier-Penna%26aufirst%3DS.%26aulast%3DLe%2BCann%26aufirst%3DF.%26aulast%3DComte%26aufirst%3DA.%26aulast%3DJacquard-Fevai%26aufirst%3DM.%26aulast%3DDelalande%26aufirst%3DO.%26aulast%3DDesban%26aufirst%3DN.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGallais%26aufirst%3DI.%26aulast%3DFaurez%26aufirst%3DF.%26aulast%3DBonnet%26aufirst%3DM.%2BC.%26aulast%3DHauteville%26aufirst%3DM.%26aulast%3DGoekjian%26aufirst%3DP.%2BG.%26aulast%3DThuillier%26aufirst%3DR.%26aulast%3DFavreau%26aufirst%3DF.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DHauet%26aufirst%3DT.%26aulast%3DDimanche-Boitrel%26aufirst%3DM.%2BT.%26aulast%3DBach%26aufirst%3DS.%26atitle%3D6E11%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520receptor-interacting%2520protein%2520kinase%25201%252C%2520protects%2520cells%2520against%2520cold%2520hypoxia-reoxygenation%2520injury%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D12931%26doi%3D10.1038%2Fs41598-017-12788-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, E. A.</span></span> <span> </span><span class="NLM_article-title">Regulated cell death signaling pathways and marine natural products that target them</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">76</span>, <span class="refDoi"> DOI: 10.3390/md17020076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=10.3390%2Fmd17020076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlakurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=76&author=E.+A.+Guzman&title=Regulated+cell+death+signaling+pathways+and+marine+natural+products+that+target+them&doi=10.3390%2Fmd17020076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Regulated cell death signaling pathways and marine natural products that target them</span></div><div class="casAuthors">Guzman, Esther A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">76</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Our understanding of cell death used to consist in necrosis, an unregulated form, and apoptosis, regulated cell death.  That understanding expanded to acknowledge that apoptosis happens through the intrinsic or extrinsic pathways.  Actually, many other regulated cell death processes exist, including necroptosis, a regulated form of necrosis, and autophagy-dependent cell death.  We also understand that apoptosis occurs beyond the intrinsic and extrinsic pathways with caspase independent forms of apoptosis existing.  Our knowledge of the signaling continues to grow, and with that, so does our ability to target different parts of the pathways with small mols.  Marine natural products co-evolve with their targets, and these unique mols. have complex structures with exquisite biol. activities and specificities.  This article offers a review of our current understanding of the signaling pathways regulating cell death, and highlights marine natural products that can affect these signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo74olq98TXU7Vg90H21EOLACvtfcHk0lisy79_j5-Clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlakurnM&md5=fe75028159be55334da7275852bbdfa4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3390%2Fmd17020076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17020076%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DE.%2BA.%26atitle%3DRegulated%2520cell%2520death%2520signaling%2520pathways%2520and%2520marine%2520natural%2520products%2520that%2520target%2520them%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D17%26spage%3D76%26doi%3D10.3390%2Fmd17020076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajapaksa, N. S.</span></span> <span> </span><span class="NLM_article-title">Kinase inhibitors for the treatment of immunological disorders: Recent advances</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9030</span>– <span class="NLM_lpage">9058</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9030-9058&author=M.+C.+Bryanauthor=N.+S.+Rajapaksa&title=Kinase+inhibitors+for+the+treatment+of+immunological+disorders%3A+Recent+advances&doi=10.1021%2Facs.jmedchem.8b00667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances</span></div><div class="casAuthors">Bryan, Marian C.; Rajapaksa, Naomi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9030-9058</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mol. inhibitors targeting autoimmune and inflammatory processes have been an area of intense focus within academia and industry.  Much of this work has been aimed at key kinases operating as central nodes in inflammatory signaling pathways.  While this focus has led to over 30 FDA-approved small mol. kinase inhibitors, only one is currently approved for autoimmune and inflammatory diseases.  Despite this lack of success, there remains tremendous reason for excitement.  Our growing understanding of the biol. involved in the inflammatory response, the factors that lead to safer small mol. kinase inhibitors, and the availability of selective tool mols. for interrogating specific nodes and pathways are all pushing the field forward.  This article focuses on recent developments requiring novel approaches to create safe and effective small mol. kinase inhibitors and where further work is needed to realize the promise of small mol. kinase inhibitors for patient benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVucOE4LCJALVg90H21EOLACvtfcHk0lisy79_j5-Clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmsLzI&md5=aff62adff54c9152d2b2156b05d67400</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DRajapaksa%26aufirst%3DN.%2BS.%26atitle%3DKinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520immunological%2520disorders%253A%2520Recent%2520advances%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9030%26epage%3D9058%26doi%3D10.1021%2Facs.jmedchem.8b00667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CPK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CPK','PDB','2CPK'); return false;">PDB: 2CPK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITH','PDB','4ITH'); return false;">PDB: 4ITH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HX6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HX6','PDB','5HX6'); return false;">PDB: 5HX6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TX5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TX5','PDB','5TX5'); return false;">PDB: 5TX5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RLN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RLN','PDB','6RLN'); return false;">PDB: 6RLN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C3E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C3E','PDB','6C3E'); return false;">PDB: 6C3E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C4D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6C4D','PDB','6C4D'); return false;">PDB: 6C4D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NW2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NW2','PDB','6NW2'); return false;">PDB: 6NW2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NYH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NYH','PDB','6NYH'); return false;">PDB: 6NYH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OCQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OCQ','PDB','6OCQ'); return false;">PDB: 6OCQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6R5F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6R5F','PDB','6R5F'); return false;">PDB: 6R5F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NEU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NEU','PDB','4NEU'); return false;">PDB: 4NEU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITI','PDB','4ITI'); return false;">PDB: 4ITI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ITJ','PDB','4ITJ'); return false;">PDB: 4ITJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OKO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OKO','PDB','6OKO'); return false;">PDB: 6OKO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KNJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KNJ','PDB','5KNJ'); return false;">PDB: 5KNJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KO1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KO1','PDB','5KO1'); return false;">PDB: 5KO1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e2266-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i15"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01317">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86686"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01317">10.1021/acs.jmedchem.9b01317</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01317/suppl_file/jm9b01317_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01317/suppl_file/jm9b01317_si_001.csv">jm9b01317_si_001.csv (5.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01317&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01317" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01317" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a9476db342308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
